<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:106.8pt;left:359.4pt;line-height:8.0pt"><span style="font-family:AdvP465FCF,serif;font-size:8.0pt">Open camera or QR reader and</span></p>
<p style="top:116.8pt;left:360.3pt;line-height:8.0pt"><span style="font-family:AdvP465FCF,serif;font-size:8.0pt">scan code to access this article</span></p>
<p style="top:126.7pt;left:375.6pt;line-height:8.0pt"><span style="font-family:AdvP465FCF,serif;font-size:8.0pt">and other resources online.</span></p>
<img style="position:absolute;transform:matrix(.6395556,0,-0,.6384889,610.4213,85.4413)" src="data:image/jpeg;base64,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">
<p style="top:178.4pt;left:59.8pt;line-height:12.5pt"><span style="font-family:AdvP7CD3,serif;font-size:12.5pt;color:#ffffff">REVIEW</span></p>
<p style="top:206.4pt;left:59.8pt;line-height:18.9pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:18.9pt">Photobiomodulation in Acute Traumatic Brain Injury:</span></p>
<p style="top:228.2pt;left:59.8pt;line-height:18.9pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:18.9pt">A Systematic Review and Meta-Analysis</span></p>
<p style="top:257.9pt;left:59.8pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">Andrew Robert Stevens,</span><sup><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">1&#x2013;3,</span></sup><sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">* </span></sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">Mohammed Hadis,</span><sup><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">3</span></sup><sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">Michael Milward,</span><sup><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">3</span></sup><sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">Zubair Ahmed,</span><sup><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">1,2,4</span></sup></p>
<p style="top:269.8pt;left:59.8pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">Antonio Belli,</span><sup><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">1,2,4</span></sup><sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">William Palin,</span><sup><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">3</span></sup><sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">and David James Davies</span><sup><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">1&#x2013;4</span></sup></p>
<p style="top:300.6pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">Abstract</span></p>
<p style="top:313.5pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">Photobiomodulation (PBM) is a therapeutic modality that has gained increasing interest in neuroscience</span></p>
<p style="top:326.5pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">applications, including acute traumatic brain injury (TBI). Its proposed mechanisms for therapeutic effect</span></p>
<p style="top:339.4pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">when delivered to the injured brain include antiapoptotic and anti-in&#xfb02;ammatory effects. This systematic</span></p>
<p style="top:352.4pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">review summarizes the available evidence for the value of PBM in improving outcomes in acute TBI and</span></p>
<p style="top:365.3pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">presents a meta-analysis of the pre-clinical evidence for neurological severity score (NSS) and lesion size</span></p>
<p style="top:378.3pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">in animal models of TBI. A systematic review of the literature was performed, with searches and data extrac-</span></p>
<p style="top:391.2pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">tion performed independently in duplicate by two authors. Eighteen published articles were identi&#xfb01;ed for</span></p>
<p style="top:404.2pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">inclusion: seventeen pre-clinical studies of</span><span style="font-family:AdvOT65f8a23b.I,serif;font-size:10.0pt"> in vivo</span><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt"> animal models and one clinical study in human patients.</span></p>
<p style="top:417.1pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">The available human study supports safety and feasibility of PBM in acute moderate TBI. For pre-clinical</span></p>
<p style="top:430.0pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">studies, meta-analysis for NSS and lesion size were found to favor intervention versus control. Subgroup</span></p>
<p style="top:443.0pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">analysis based on PBM parameter variables for these outcomes was performed. Favorable parameters</span></p>
<p style="top:455.9pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">were identi&#xfb01;ed as: wavelengths in the region of 665 nm and 810 nm; time to &#xfb01;rst administration of PBM</span></p>
<p style="top:468.9pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvPSSym,serif;font-size:10.0pt">&#xa3;</span><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">4 h; total number of daily treatments</span><span style="font-family:AdvPSSym,serif;font-size:10.0pt"> &#xa3;</span><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">3. No differences were identi&#xfb01;ed between pulsed and continuous</span></p>
<p style="top:481.9pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">wave modes or energy delivery. Mechanistic substudies within included</span><span style="font-family:AdvOT65f8a23b.I,serif;font-size:10.0pt"> in vivo</span><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt"> studies are presented and</span></p>
<p style="top:494.8pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">were found to support hypotheses of antiapoptotic, anti-in&#xfb02;ammatory, and pro-proliferative effects, and a</span></p>
<p style="top:507.8pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">modulation of cellular metabolism. This systematic review provides substantial meta-analysis evidence of</span></p>
<p style="top:520.7pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">the bene&#xfb01;ts of PBM on functional and histological outcomes of TBI in</span><span style="font-family:AdvOT65f8a23b.I,serif;font-size:10.0pt"> in vivo</span><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt"> mammalian models. Study</span></p>
<p style="top:533.7pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">design and PBM parameters should be closely considered for future human clinical studies.</span></p>
<p style="top:552.6pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">Keywords:</span><span style="font-family:AdvOT07517017,serif;font-size:10.0pt"> low-level light therapy; meta-analysis; systematic review; photobiomodulation; therapeutics;</span></p>
<p style="top:565.5pt;left:83.7pt;line-height:10.0pt"><span style="font-family:AdvOT07517017,serif;font-size:10.0pt">traumatic brain injury</span></p>
<p style="top:602.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.5pt">Introduction</span></p>
<p style="top:614.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Traumatic brain injury (TBI) is a global health problem</span></p>
<p style="top:627.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and a signi&#xfb01;cant cause of death and life-long disabil-</span></p>
<p style="top:639.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ity. Worldwide, annual incidence of TBI is estimated at</span></p>
<p style="top:651.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">more than 50 million,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">1,2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with annual costs to the global</span></p>
<p style="top:664.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">economy approximately US$400 billion.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">1</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">No effective</span></p>
<p style="top:601.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">disease-modifying therapy has been identi&#xfb01;ed to control</span></p>
<p style="top:614.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the variety of post-injury responses and prevent second-</span></p>
<p style="top:626.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ary injury to brain tissue and cell damage/loss.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">3</span></sup></p>
<p style="top:639.0pt;left:321.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">These pathophysiological mechanisms include the</span></p>
<p style="top:651.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">well-established factors such as raised intracranial pres-</span></p>
<p style="top:663.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sure (ICP) and cerebral hypoxia, and current therapeutic</span></p>
<p style="top:686.9pt;left:59.8pt;line-height:4.9pt"><span style="font-family:AdvOT46dcae81,serif;font-size:4.9pt">1</span><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">Department of Neuroscience and Ophthalmology, Institute of In&#xfb02;ammation and Ageing, and</span><span style="font-family:AdvOT46dcae81,serif;font-size:4.9pt"> 4</span><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">Centre for Trauma Sciences Research, University of Birmingham, Edgbaston,</span></p>
<p style="top:696.7pt;left:59.8pt;line-height:7.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">Birmingham, United Kingdom.</span></p>
<p style="top:703.6pt;left:59.8pt;line-height:4.9pt"><span style="font-family:AdvOT46dcae81,serif;font-size:4.9pt">2</span><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">NIHR Surgical Reconstruction and Microbiology Research Centre, University Hospitals Birmingham, Birmingham, United Kingdom.</span></p>
<p style="top:712.0pt;left:59.8pt;line-height:4.9pt"><span style="font-family:AdvOT46dcae81,serif;font-size:4.9pt">3</span><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">Phototherapy Research Group, School of Dentistry, University of Birmingham, Birmingham, United Kingdom.</span></p>
<p style="top:730.2pt;left:59.8pt;line-height:7.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">*Address correspondence to:</span><span style="font-family:AdvOT65f8a23b.I,serif;font-size:7.0pt"> Mr. Andrew R. Stevens</span><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">,</span><span style="font-family:AdvOT65f8a23b.I,serif;font-size:4.9pt"> </span><sup><span style="font-family:AdvOT65f8a23b.I,serif;font-size:4.9pt">1</span></sup><span style="font-family:AdvOT65f8a23b.I,serif;font-size:7.0pt">Department of Neuroscience and Ophthalmology</span><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">,</span><span style="font-family:AdvOT65f8a23b.I,serif;font-size:7.0pt"> Institute of In&#xfb02;ammation and Ageing</span><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">,</span><span style="font-family:AdvOT65f8a23b.I,serif;font-size:7.0pt"> University of Birmingham</span><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">,</span></p>
<p style="top:738.6pt;left:59.8pt;line-height:7.0pt"><span style="font-family:AdvOT65f8a23b.I,serif;font-size:7.0pt">Edgbaston, Birmingham, B15 2TT</span><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">,</span><span style="font-family:AdvOT65f8a23b.I,serif;font-size:7.0pt"> United Kingdom</span><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">,</span><span style="font-family:AdvOT65f8a23b.I,serif;font-size:7.0pt"> E-mail:</span><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt"> a.stevens@bham.ac.uk</span></p>
<p style="top:30.4pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:8.0pt">Journal of Neurotrauma</span></p>
<p style="top:39.8pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:8.0pt">39:1&#x2013;18 (XXXX 00, 2022)</span></p>
<p style="top:49.3pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&#xaa;</span><span style="font-family:AdvOT46dcae81,serif;font-size:8.0pt"> Mary Ann Liebert, Inc.</span></p>
<p style="top:58.8pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:8.0pt">DOI: 10.1089/neu.2022.0140</span></p>
<p style="top:758.6pt;left:302.4pt;line-height:9.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:9.0pt">1</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:61.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">paradigms are centered on monitoring and maintaining</span></p>
<p style="top:73.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">intracranial homeostasis, principally with respect to pres-</span></p>
<p style="top:86.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sure and oxygenation.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">4</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Other pathways of injury are</span></p>
<p style="top:98.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">gaining increasing recognition, however: mitochondrial</span></p>
<p style="top:111.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">dysfunction,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">5</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">neuroin&#xfb02;ammation,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">6</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">excitotoxicity,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">7</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and</span></p>
<p style="top:123.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">oxidative stress.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">8</span></sup></p>
<p style="top:136.3pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Pharmacological therapeutics typically target discrete</span></p>
<p style="top:148.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">pathways or mechanisms, but have thus far failed to dem-</span></p>
<p style="top:161.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">onstrate clear bene&#xfb01;t in the context of this multi-faceted</span></p>
<p style="top:173.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">pathology.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">9</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Trialing of multiple novel therapies in a clin-</span></p>
<p style="top:186.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ical setting is challenging without stepwise integration of</span></p>
<p style="top:198.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">single novel therapies into standard of care, which indi-</span></p>
<p style="top:210.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">vidually may not surpass the threshold for detectable</span></p>
<p style="top:223.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">therapeutic bene&#xfb01;t. Single therapies that are able to target</span></p>
<p style="top:235.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">multiple mechanisms within the pathophysiological path-</span></p>
<p style="top:248.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">way therefore hold considerable therapeutic potential.</span></p>
<p style="top:260.8pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Photobiomodulation (PBM) is the application of red/</span></p>
<p style="top:273.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">near-infrared (R/NIR) light (600&#x2013;1100 nm) to biologi-</span></p>
<p style="top:285.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cal tissue for the purpose of therapeutic advantage, resto-</span></p>
<p style="top:298.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ration of function, or enhancement of physiology.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">10</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The</span></p>
<p style="top:310.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">concept of the biological effect of photons from across</span></p>
<p style="top:323.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the electromagnetic (EM) spectrum is well established.</span></p>
<p style="top:335.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Photons with low wavelength and high energy (gamma</span></p>
<p style="top:347.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">rays) are administered as radiotherapy, and photons in</span></p>
<p style="top:360.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the ultraviolet part (UVB) of the EM spectrum are inte-</span></p>
<p style="top:372.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">gral in the biological synthesis of cholecalciferol. The</span></p>
<p style="top:385.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">use of 5-aminolavulanic acid, preferentially taken up by</span></p>
<p style="top:397.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">high-grade glioma tissue and converted to protoporphy-</span></p>
<p style="top:410.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">rin IX that &#xfb02;uoresces under violet-blue (405 nm) light,</span></p>
<p style="top:422.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">has become central in oncological neurosurgery to max-</span></p>
<p style="top:435.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">imize resection margins.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">11</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">PBM is similarly based on</span></p>
<p style="top:447.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">a photobiological interaction of longer, lower energy</span></p>
<p style="top:460.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">photons.</span></p>
<p style="top:472.4pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Although the mechanism of PBM is not fully es-</span></p>
<p style="top:484.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tablished,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">12,13</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cytochrome c oxidase (CCO), the terminal</span></p>
<p style="top:497.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">component of the electron transport chain, is thought to</span></p>
<p style="top:509.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">be the principle chromophore of absorption of R/NIR</span></p>
<p style="top:522.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">light.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">14</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Absorption of R/NIR photons by CCO is thought</span></p>
<p style="top:534.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to lead to downstream modulation of reactive oxygen</span></p>
<p style="top:547.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">species production via effects on mitochondrial membrane</span></p>
<p style="top:559.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">potential (MMP), an increase in nitric oxide dissociation,</span></p>
<p style="top:572.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and raised adenosine triphosphate (ATP) production.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">15</span></sup></p>
<p style="top:584.5pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">PBM is additionally proposed to potentiate light-</span></p>
<p style="top:597.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sensitive ion channels,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">16</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">resulting in increased intracel-</span></p>
<p style="top:609.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">lular calcium concentrations, in turn affecting levels of</span></p>
<p style="top:621.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cyclic adenosine monophosphate and modulation of</span></p>
<p style="top:634.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">downstream transcription factors. Together, these mo-</span></p>
<p style="top:646.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">lecular interactions are proposed to lead to the various</span></p>
<p style="top:659.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">reported effects (antiapoptotic, anti-in&#xfb02;ammatory, pro-</span></p>
<p style="top:671.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">proliferative</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">12&#x2013;15</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">).</span></p>
<p style="top:684.2pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The application of R/NIR light, because of its high</span></p>
<p style="top:696.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">scatter and absorbance in biological tissue resulting in at-</span></p>
<p style="top:709.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tenuated tissue irradiance at depth, lends itself more read-</span></p>
<p style="top:721.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ily to topical application for externally accessible tissues.</span></p>
<p style="top:734.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The scienti&#xfb01;c and clinical interest in such contexts has a</span></p>
<p style="top:61.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">broad evidence base, particularly in: dermatological</span></p>
<p style="top:73.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">pathology,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">17</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">burns,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">18</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">wound healing,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">15</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cancer-related lym-</span></p>
<p style="top:86.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">phedema,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">19</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and oral in&#xfb02;ammatory conditions.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">20</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">After</span></p>
<p style="top:98.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">these successes, attention to the targeting of R/NIR light</span></p>
<p style="top:111.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">at deeper biological tissues has since increased in recent</span></p>
<p style="top:123.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">years,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">21&#x2013;24</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">including the central nervous system.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">25&#x2013;29</span></sup></p>
<p style="top:136.3pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The application of PBM in the &#xfb01;eld of TBI has gath-</span></p>
<p style="top:148.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ered interest and scienti&#xfb01;c evidence in the last decade.</span></p>
<p style="top:161.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The application of PBM as a therapeutic intervention</span></p>
<p style="top:173.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">for the injured brain has taken two principle forms: (1)</span></p>
<p style="top:186.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in the acute setting post-injury, intended as a neuropro-</span></p>
<p style="top:198.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tective/neurorestorative therapy; and (2) in the rehabili-</span></p>
<p style="top:210.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tative setting in the chronic phase post-injury, for the</span></p>
<p style="top:223.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">purpose of improving symptomatology or neurocognitive/</span></p>
<p style="top:235.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">neuropsychological function.</span></p>
<p style="top:248.3pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Pre-clinical studies on the ef&#xfb01;cacy of PBM in acute</span></p>
<p style="top:260.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">TBI have generated positive results, utilizing moderate</span></p>
<p style="top:273.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">or severe models of TBI in rodent species,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">30</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with prom-</span></p>
<p style="top:285.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ising results in an early clinical study.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">31</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The methodol-</span></p>
<p style="top:298.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ogy, outcome measures, and hypothesized mechanisms</span></p>
<p style="top:310.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in chronic contexts differ greatly from acute applications,</span></p>
<p style="top:323.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and as such, the chronic/rehabilitative phase of TBI re-</span></p>
<p style="top:335.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">covery is beyond the scope of this review.</span></p>
<p style="top:347.9pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The ef&#xfb01;cacy of PBM in ischemic stroke had also</span></p>
<p style="top:360.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">been considered promising.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">32</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Such promise culminated</span></p>
<p style="top:372.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in a phase III randomized controlled trial&#x2014;the NEST-3</span></p>
<p style="top:385.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">study,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">33</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">which did not demonstrate ef&#xfb01;cacy and was ter-</span></p>
<p style="top:397.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">minated early. The study design, however, has stimulated</span></p>
<p style="top:410.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">criticism,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">34</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the themes of which represent ongoing scien-</span></p>
<p style="top:422.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ti&#xfb01;c &#x2018;&#x2018;unknowns&#x2019;&#x2019; in PBM research. The optimal vari-</span></p>
<p style="top:435.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ables of dosing are yet to be established, including</span></p>
<p style="top:447.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">irradiance (both surface and after tissue penetration),</span></p>
<p style="top:460.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">time of initiation post-injury, optimal duration of thera-</span></p>
<p style="top:472.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">peutic course, and optimal brain regions for irradiance.</span></p>
<p style="top:484.9pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Formally establishing the evidence base in TBI is</span></p>
<p style="top:497.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">essential for informing future directions in both pre-</span></p>
<p style="top:509.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">clinical, translational, and clinical research, to minimize</span></p>
<p style="top:522.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the risk of future clinical PBM studies in TBI using sub-</span></p>
<p style="top:534.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">optimal parameters.</span></p>
<p style="top:565.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.5pt">Aims</span></p>
<p style="top:578.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">This systematic review and meta-analysis seeks to com-</span></p>
<p style="top:590.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">prehensively identify and summarize the scienti&#xfb01;c litera-</span></p>
<p style="top:603.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ture on the use of PBM in acute TBI. The variables of</span></p>
<p style="top:615.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">PBM implemented in identi&#xfb01;ed studies will be analyzed</span></p>
<p style="top:628.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with respect to the observed outcomes.</span></p>
<p style="top:659.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.5pt">Methods</span></p>
<p style="top:671.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">A systematic review of the literature was performed</span></p>
<p style="top:684.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">on October 4, 2021 following the methodology of the</span></p>
<p style="top:696.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">Cochrane Handbook for Systematic Reviews</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> and pre-</span></p>
<p style="top:709.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sented in accordance with the Preferred Reporting</span></p>
<p style="top:721.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Items for Systematic Reviews and Meta-analyses</span></p>
<p style="top:734.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(PRISMA).</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">35</span></sup></p>
<p style="top:29.7pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">2</span></p>
<p style="top:29.7pt;left:481.6pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">STEVENS ET AL.</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:61.5pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Systematic searches were performed independently in</span></p>
<p style="top:73.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">duplicate. The following databases were searched, from</span></p>
<p style="top:86.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">their respective inception to October 4</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">,</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">2021: Medline,</span></p>
<p style="top:98.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Embase, Cochrane Central, Scopus, Google Scholar,</span></p>
<p style="top:111.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and Web of Science. Reference lists of pertinent articles</span></p>
<p style="top:123.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">on the topic were hand-searched for suitable articles.</span></p>
<p style="top:136.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Reference lists of identi&#xfb01;ed articles for inclusion were</span></p>
<p style="top:148.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">also hand-searched for suitable articles. An example</span></p>
<p style="top:161.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">search strategy for Medline is given below:</span></p>
<p style="top:173.6pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Search:</span></p>
<p style="top:192.5pt;left:70.2pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">1. Exp Low-Level Light Therapy (LLLT)</span></p>
<p style="top:205.0pt;left:70.2pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">2. Photobiomodulation.mp</span></p>
<p style="top:217.4pt;left:70.2pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">3. Exp Phototherapy/</span></p>
<p style="top:229.9pt;left:70.2pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">4. Phototherapy.mp</span></p>
<p style="top:242.3pt;left:70.2pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">5. Low level laser therapy.mp</span></p>
<p style="top:254.8pt;left:70.2pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">6. 1 or 2 or 3 or 4 or 5</span></p>
<p style="top:267.2pt;left:70.2pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">7. Exp Brain Injuries, Traumatic/</span></p>
<p style="top:279.7pt;left:70.2pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">8. Exp Craniocerebral Trauma/</span></p>
<p style="top:292.2pt;left:70.2pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">9. Head injury.mp</span></p>
<p style="top:304.6pt;left:65.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">10. 7 or 8 or 9</span></p>
<p style="top:317.0pt;left:65.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">11. 6 and 10</span></p>
<p style="top:354.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Study selection</span></p>
<p style="top:366.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Studies were independently screened for inclusion by two</span></p>
<p style="top:379.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">reviewers (A.R.S., and Z.A.). Initial screening based on</span></p>
<p style="top:391.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">title and abstract were performed, followed by full text</span></p>
<p style="top:404.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">screening. Eligibility for study inclusion was de&#xfb01;ned</span></p>
<p style="top:416.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">as: use of PBM therapy (R/NIR) in acute TBI. Any meth-</span></p>
<p style="top:429.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">odology was accepted, and studies involving</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> in vitro/</span></p>
<p style="top:441.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">in vivo</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> animal or human subjects were included. Studies</span></p>
<p style="top:454.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">that only reported computational modeling methods were</span></p>
<p style="top:466.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">excluded. Articles were excluded where blue or white</span></p>
<p style="top:479.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">light therapy was used, and where PBM was used in</span></p>
<p style="top:491.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the chronic or rehabilitative phase of injury.</span></p>
<p style="top:503.9pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Conference abstracts were excluded to avoid duplicate</span></p>
<p style="top:516.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">reporting where insuf&#xfb01;cient detail was available in ab-</span></p>
<p style="top:528.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">stracts to identify such cases; where full manuscripts</span></p>
<p style="top:541.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">were available for conference proceedings, these were</span></p>
<p style="top:553.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">screened against included manuscripts to exclude dupli-</span></p>
<p style="top:566.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cate reporting.</span></p>
<p style="top:596.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Data extraction</span></p>
<p style="top:609.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Data were extracted from included reports using a piloted</span></p>
<p style="top:621.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">form. Data extracted from pre-clinical studies included:</span></p>
<p style="top:634.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">species and injury model used, number of replicates,</span></p>
<p style="top:646.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">PBM therapy variables (wavelength, irradiance, timing,</span></p>
<p style="top:659.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">doses, light source, delivery site), outcomes, and &#xfb01;ndings</span></p>
<p style="top:671.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of any mechanistic substudies. Data were extracted for</span></p>
<p style="top:684.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">meta-analysis for neurological severity score and lesion</span></p>
<p style="top:696.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">size indices, and other functional and histological out-</span></p>
<p style="top:709.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">comes were extracted for narrative presentation. Where</span></p>
<p style="top:721.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">data were not directly reported as values, values were ex-</span></p>
<p style="top:734.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">trapolated from published &#xfb01;gures. From clinical studies,</span></p>
<p style="top:61.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">patient characteristics, PBM therapy variables, any com-</span></p>
<p style="top:73.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">parator used, outcome measures, and outcomes were</span></p>
<p style="top:86.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">recorded.</span></p>
<p style="top:113.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Synthesis of results</span></p>
<p style="top:126.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">This systematic review presents a combination of meta-</span></p>
<p style="top:138.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">analysis and narrative presentation of available data.</span></p>
<p style="top:151.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Speci&#xfb01;c outcome measures were deemed suitable for</span></p>
<p style="top:163.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">meta-analysis where</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &#x2021;</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 3 studies had presented data</span></p>
<p style="top:176.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(either directly or suitable for accurate extrapolation) in</span></p>
<p style="top:188.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">this regard. Remaining outcomes reported in included</span></p>
<p style="top:201.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">articles will be presented in tabular and narrative form</span></p>
<p style="top:213.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">without statistical analysis.</span></p>
<p style="top:240.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Risk of bias</span></p>
<p style="top:253.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Risk of bias in individual studies was assessed using the</span></p>
<p style="top:265.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">SYRCLE tool for assessing risk of bias,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">36</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and overall risk</span></p>
<p style="top:278.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of bias was determined as low, moderate, or high for each</span></p>
<p style="top:290.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">included article. For clinical trials, Cochrane Risk of Bias</span></p>
<p style="top:303.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tool</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">37</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with overall risk of bias determined via design</span></p>
<p style="top:315.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">quality assessment as good, fair, or poor for each in-</span></p>
<p style="top:328.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cluded article.</span></p>
<p style="top:355.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Statistical analysis</span></p>
<p style="top:367.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Data for meta-analysis were extracted as mean, standard</span></p>
<p style="top:380.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">deviation (SD), and</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> n</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> number. Where standard error of</span></p>
<p style="top:392.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the mean (SEM) was presented, SD was calculated using</span></p>
<p style="top:405.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">SEM and</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> n</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> number. Review Manager 5.4.1 (Cochrane</span></p>
<p style="top:417.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Collaboration, 2022) was used for meta-analysis. Effect</span></p>
<p style="top:430.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">size was calculated with a 95% con&#xfb01;dence interval,</span></p>
<p style="top:442.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">using a standardized mean difference model because of</span></p>
<p style="top:455.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">heterogenous data reporting. A &#xfb01;xed effects model was</span></p>
<p style="top:467.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">used, and where heterogeneity was calculated by chi-</span></p>
<p style="top:480.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">square test as</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &#x2021;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">50%, a random effects model was used.</span></p>
<p style="top:507.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.5pt">Results</span></p>
<p style="top:519.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The search strategy identi&#xfb01;ed 1784 records, with 1459</span></p>
<p style="top:532.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">remaining after removal of duplicates, leaving 93 full-</span></p>
<p style="top:544.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">text articles that were assessed for eligibility against</span></p>
<p style="top:557.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the inclusion/exclusion criteria after abstract screening.</span></p>
<p style="top:569.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Eighteen studies met the criteria for inclusion, with 17</span></p>
<p style="top:582.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">pre-clinical studies being conducted in animal mod-</span></p>
<p style="top:594.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">els</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38&#x2013;54</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and one clinical study using human partici-</span></p>
<p style="top:607.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">pants.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">31</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The full &#xfb02;owchart for search results is shown</span></p>
<p style="top:619.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in the PRISMA diagram in Figure 1.</span></p>
<p style="top:646.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Human studies</span></p>
<p style="top:659.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">We identi&#xfb01;ed a single study of PBM in acute TBI in</span></p>
<p style="top:671.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">human participants. Figuero Longo and associates (2020)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">31</span></sup></p>
<p style="top:684.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">randomized 68 patients with moderate TBI to receive ei-</span></p>
<p style="top:696.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ther sham therapy or transcranial PBM within 72 h of in-</span></p>
<p style="top:709.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">jury. The PBM therapy application used an 810 nm light-</span></p>
<p style="top:721.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">emitting diode (LED) array within a custom helmet, with</span></p>
<p style="top:734.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">reported average irradiance to the scalp of 36 mW/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">for</span></p>
<p style="top:30.2pt;left:59.8pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">PHOTOBIOMODULATION IN ACUTE TBI</span></p>
<p style="top:30.2pt;left:544.4pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">3</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:484.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">20 min applications. The authors calculated that their sys-</span></p>
<p style="top:497.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tem provides a surface energy of 1.3 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">per session</span></p>
<p style="top:509.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">based</span></p>
<p style="top:509.8pt;left:96.6pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">on</span></p>
<p style="top:509.8pt;left:117.9pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cadaveric</span></p>
<p style="top:509.8pt;left:168.9pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">modeling.</span></p>
<p style="top:509.8pt;left:221.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Patients</span></p>
<p style="top:509.8pt;left:265.7pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">received</span></p>
<p style="top:522.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">3</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &#xb7;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 20 min sessions, at least 12 h apart. Twenty-eight pa-</span></p>
<p style="top:534.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tients received at least one PBM session and were evalu-</span></p>
<p style="top:547.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ated for diffusion magnetic resonance imaging outcomes</span></p>
<p style="top:559.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and Rivermead post-concussion questionnaire (RPQ) in</span></p>
<p style="top:572.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">comparison with the control group.</span></p>
<p style="top:584.5pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">There were signi&#xfb01;cant changes in radial diffusivity,</span></p>
<p style="top:597.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">mean diffusivity, and fractional anisotropy at the late sub-</span></p>
<p style="top:609.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">acute stage between PBM and sham groups, although not</span></p>
<p style="top:621.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">for axial diffusivity or other time points. The RPQ scores</span></p>
<p style="top:634.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">were somewhat improved in the PBM group versus sham,</span></p>
<p style="top:646.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">although not of statistical signi&#xfb01;cance; it is noteworthy</span></p>
<p style="top:659.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">that the study is not appropriately powered to identify sig-</span></p>
<p style="top:671.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ni&#xfb01;cance for functional outcomes.</span></p>
<p style="top:696.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Animal studies</span></p>
<p style="top:709.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">We identi&#xfb01;ed 17 studies of PBM in animal models of</span></p>
<p style="top:721.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">TBI</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38&#x2013;54</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(Table 1). All studies used an</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> in vivo</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> model of</span></p>
<p style="top:734.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">TBI, with one study using neuronal cell cultures as an</span></p>
<p style="top:484.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">additional model.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">39</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Four studies used rats,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">45,47,48,52</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">one</span></p>
<p style="top:497.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">study used a transgenic (X-1 knock-out) mouse,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">46</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and</span></p>
<p style="top:509.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">13 used wild-type (WT) mice.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38&#x2013;44,49&#x2013;51,53</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">. Seven studies</span></p>
<p style="top:522.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">used controlled cortical impact (CCI) models,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38,41&#x2013;44,49,52</span></sup></p>
<p style="top:534.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">six used weight drop (WD)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">40,50,51,53,54</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(one in a repeated</span></p>
<p style="top:547.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">TBI model</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">45</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">), two used controlled scalp impact,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">39,46</span></sup></p>
<p style="top:559.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">one open lateral &#xfb02;uid percussion (LFP),</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">48</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and one</span></p>
<p style="top:572.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">blast-induced neurotrauma (BINT).</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">47</span></sup></p>
<p style="top:584.5pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The available reported PBM variables for therapeutic</span></p>
<p style="top:597.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">regimens are given in Table 1, with all used permutations</span></p>
<p style="top:609.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of a variable given (where a study has used multiple ther-</span></p>
<p style="top:621.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">apeutic regimens). Notably, 15 studies used a wavelength</span></p>
<p style="top:634.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in the 800&#x2013;810 nm region, either alone or in comparison</span></p>
<p style="top:646.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with another wavelength, with two studies not using</span></p>
<p style="top:659.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">a wavelength in this region</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">48,52</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(using 670 or 830 nm).</span></p>
<p style="top:671.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Full width half of maximum values were not reported.</span></p>
<p style="top:684.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Two studies used a LED,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">48,52</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">15 employing a laser</span></p>
<p style="top:696.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">source.</span></p>
<p style="top:709.1pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Two studies delivered PBM directly to the cortical sur-</span></p>
<p style="top:721.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">face of the lesion site</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">49,53</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with 15 studies applying the</span></p>
<p style="top:734.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">source to skull or scalp. Four studies used a pulsed</span></p>
<img style="position:absolute;transform:matrix(.63993898,0,-0,.6398387,71.752689,-31.99533)" src="data:image/jpeg;base64,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">
<p style="top:427.8pt;left:79.0pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">FIG. 1.</span></p>
<p style="top:427.8pt;left:117.5pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">Preferred Reporting Items for Systematic Reviews and Meta-analyses &#xfb02;ow chart of systematic</span></p>
<p style="top:440.7pt;left:79.0pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">review process.</span></p>
<p style="top:29.7pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">4</span></p>
<p style="top:29.7pt;left:481.6pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">STEVENS ET AL.</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:735.2pt;left:95.4pt;line-height:9.0pt"><span style="font-family:AdvTimBolLiebert,serif;font-size:9.0pt">Table 1. Summary Table of Included Studies</span></p>
<p style="top:669.5pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Species</span></p>
<p style="top:625.6pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">TBI Model</span></p>
<p style="top:574.3pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Severity</span></p>
<p style="top:531.0pt;left:140.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Wavelength</span></p>
<p style="top:518.9pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">(nm)</span></p>
<p style="top:466.4pt;left:140.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Site of</span></p>
<p style="top:480.2pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">administration</span></p>
<p style="top:409.5pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Mode</span></p>
<p style="top:369.0pt;left:140.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Laser/</span></p>
<p style="top:365.4pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">LED</span></p>
<p style="top:336.9pt;left:131.2pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Average</span></p>
<p style="top:340.0pt;left:140.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">irradiance</span></p>
<p style="top:340.4pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">(mW/cm2)</span></p>
<p style="top:290.8pt;left:131.2pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Cortical</span></p>
<p style="top:294.8pt;left:140.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">irradiance</span></p>
<p style="top:295.2pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">(mW/cm2)</span></p>
<p style="top:249.9pt;left:131.2pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Exposure</span></p>
<p style="top:242.2pt;left:140.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">time</span></p>
<p style="top:243.5pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">(min)</span></p>
<p style="top:203.0pt;left:131.2pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Energy</span></p>
<p style="top:204.2pt;left:140.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">(J/cm2)</span></p>
<p style="top:206.1pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">per dose</span></p>
<p style="top:152.4pt;left:113.3pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Cortical</span></p>
<p style="top:151.6pt;left:122.2pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">surface</span></p>
<p style="top:150.9pt;left:131.2pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">energy</span></p>
<p style="top:152.2pt;left:140.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">(J/cm2)</span></p>
<p style="top:154.1pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">per dose</span></p>
<p style="top:106.8pt;left:131.2pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">First dose</span></p>
<p style="top:99.0pt;left:140.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">post-</span></p>
<p style="top:105.9pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">injury (h)</span></p>
<p style="top:52.5pt;left:131.2pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Total</span></p>
<p style="top:53.3pt;left:140.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">doses</span></p>
<p style="top:57.7pt;left:149.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">(regime)</span></p>
<p style="top:736.0pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Ando et al.,</span></p>
<p style="top:728.1pt;left:174.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2011</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">38</span></p>
<p style="top:677.3pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:629.0pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CCI</span></p>
<p style="top:580.1pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Severe</span></p>
<p style="top:517.2pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:480.2pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp (over</span></p>
<p style="top:472.2pt;left:176.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">craniotomy)</span></p>
<p style="top:422.7pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW, 10 Hz,</span></p>
<p style="top:414.7pt;left:176.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">100 Hz</span></p>
<p style="top:367.9pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:325.3pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">50</span></p>
<p style="top:286.3pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">3-7.5</span></p>
<p style="top:238.8pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:200.6pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">36</span></p>
<p style="top:141.6pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:97.5pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:45.9pt;left:167.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:736.0pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Dong et al.,</span></p>
<p style="top:728.1pt;left:192.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2015</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">39</span></p>
<p style="top:677.3pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:629.0pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:621.0pt;left:194.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">impact</span></p>
<p style="top:580.1pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Moderate</span></p>
<p style="top:517.2pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:480.2pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:422.7pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">10 Hz</span></p>
<p style="top:367.9pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:329.2pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">150</span></p>
<p style="top:283.0pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">8.9</span></p>
<p style="top:234.8pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:200.6pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">36</span></p>
<p style="top:155.3pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1.8 to 2.5</span></p>
<p style="top:97.5pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:45.9pt;left:185.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:736.0pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Esenaliev</span></p>
<p style="top:728.1pt;left:210.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">et al., 2018</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">47</span></p>
<p style="top:677.3pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Rat</span></p>
<p style="top:629.0pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Closed</span></p>
<p style="top:621.0pt;left:212.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">BINT</span></p>
<p style="top:580.1pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mild to</span></p>
<p style="top:572.1pt;left:212.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">moderate</span></p>
<p style="top:517.2pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">808</span></p>
<p style="top:480.2pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:422.7pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">NPLT (20Hz)</span></p>
<p style="top:367.9pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:325.3pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:280.0pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:234.9pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">5</span></p>
<p style="top:193.6pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:145.6pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">300</span></p>
<p style="top:97.5pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:45.9pt;left:203.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:736.0pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Giacci et al.,</span></p>
<p style="top:728.1pt;left:228.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2014</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">48</span></p>
<p style="top:677.3pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Rat</span></p>
<p style="top:629.0pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Open LFP</span></p>
<p style="top:580.1pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mild</span></p>
<p style="top:525.5pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">670, 830</span></p>
<p style="top:480.2pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp (over</span></p>
<p style="top:472.2pt;left:230.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">craniotomy)</span></p>
<p style="top:422.7pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:367.9pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">LED</span></p>
<p style="top:325.3pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:280.0pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:238.8pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">30</span></p>
<p style="top:209.3pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">28.4 / 22.5</span></p>
<p style="top:141.6pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:97.5pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0</span></p>
<p style="top:55.6pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">7 (OD)</span></p>
<p style="top:736.0pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Khuman et al.,</span></p>
<p style="top:728.1pt;left:246.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2012</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">49</span></p>
<p style="top:677.3pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:629.0pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CCI</span></p>
<p style="top:580.1pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Not stated</span></p>
<p style="top:517.2pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">800</span></p>
<p style="top:480.2pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Cortex or</span></p>
<p style="top:472.2pt;left:247.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">scalp over</span></p>
<p style="top:472.2pt;left:256.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">craniotomy</span></p>
<p style="top:422.7pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:367.9pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:338.5pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">250, 500,</span></p>
<p style="top:331.2pt;left:247.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1000</span></p>
<p style="top:297.6pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*, 250, 500,</span></p>
<p style="top:286.0pt;left:247.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1000</span></p>
<p style="top:241.1pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2, 7</span></p>
<p style="top:211.2pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">30, 60, 105,</span></p>
<p style="top:205.9pt;left:247.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">120, 210</span></p>
<p style="top:163.5pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*, 30, 60, 105,</span></p>
<p style="top:153.9pt;left:247.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">120, 210</span></p>
<p style="top:100.5pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1 or 4</span></p>
<p style="top:45.9pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:736.0pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Oron et al.,</span></p>
<p style="top:728.1pt;left:273.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2007</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">50</span></p>
<p style="top:677.3pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:629.0pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull WD</span></p>
<p style="top:580.1pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mild</span></p>
<p style="top:517.2pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">808</span></p>
<p style="top:480.2pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull</span></p>
<p style="top:422.7pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:367.9pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:325.3pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:291.9pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">10 or 20</span></p>
<p style="top:234.8pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:193.6pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:161.1pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1.2-2.4 J/cm2</span></p>
<p style="top:97.5pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:45.9pt;left:265.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:736.0pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Oron et al.,</span></p>
<p style="top:728.1pt;left:291.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2012</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">51</span></p>
<p style="top:677.3pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:629.0pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull WD</span></p>
<p style="top:580.1pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mild to</span></p>
<p style="top:572.1pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">moderate</span></p>
<p style="top:517.2pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">808</span></p>
<p style="top:480.2pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull</span></p>
<p style="top:422.7pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW, 100 Hz,</span></p>
<p style="top:414.7pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">600 Hz</span></p>
<p style="top:367.9pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:325.3pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">21</span></p>
<p style="top:282.0pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">10</span></p>
<p style="top:234.9pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:196.6pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2.52</span></p>
<p style="top:144.6pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1.2</span></p>
<p style="top:104.9pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4, 6 or 8</span></p>
<p style="top:45.9pt;left:283.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:736.0pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Quirk et al.,</span></p>
<p style="top:728.1pt;left:309.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2012</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">52</span></p>
<p style="top:677.3pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Rat</span></p>
<p style="top:629.0pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CCI</span></p>
<p style="top:580.1pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Moderate</span></p>
<p style="top:517.2pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">670</span></p>
<p style="top:480.2pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp (over</span></p>
<p style="top:472.2pt;left:310.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">craniotomy)</span></p>
<p style="top:422.7pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:367.9pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">LED</span></p>
<p style="top:325.3pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">50</span></p>
<p style="top:280.0pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:234.8pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">5</span></p>
<p style="top:200.6pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">15</span></p>
<p style="top:141.6pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:107.2pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Not stated</span></p>
<p style="top:65.4pt;left:301.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">6 or 20 (BD)</span></p>
<p style="top:736.0pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Shemesh</span></p>
<p style="top:728.1pt;left:327.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">et al., 2022</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">53</span></p>
<p style="top:677.3pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:629.0pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp WD</span></p>
<p style="top:580.1pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Severe</span></p>
<p style="top:517.2pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:480.2pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Cortex</span></p>
<p style="top:422.7pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:367.9pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:325.3pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">50</span></p>
<p style="top:282.0pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">50</span></p>
<p style="top:238.8pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">15</span></p>
<p style="top:200.6pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">45</span></p>
<p style="top:143.6pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">45</span></p>
<p style="top:97.5pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0.16</span></p>
<p style="top:45.9pt;left:319.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:736.0pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Wu et al.,</span></p>
<p style="top:728.1pt;left:345.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2010</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">54</span></p>
<p style="top:677.3pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:629.0pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull WD</span></p>
<p style="top:580.1pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Moderate</span></p>
<p style="top:572.1pt;left:346.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">to severe</span></p>
<p style="top:533.8pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">660, 810, 980</span></p>
<p style="top:480.2pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:422.7pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:367.9pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:329.2pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">150</span></p>
<p style="top:280.0pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:234.8pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:200.6pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">36</span></p>
<p style="top:141.6pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:97.5pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:45.9pt;left:337.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:736.0pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Wu et al.,</span></p>
<p style="top:728.1pt;left:362.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2012</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">40</span></p>
<p style="top:677.3pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:629.0pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull WD</span></p>
<p style="top:580.1pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Moderate</span></p>
<p style="top:572.1pt;left:364.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">to severe</span></p>
<p style="top:533.8pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">665, 730,</span></p>
<p style="top:525.8pt;left:364.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810, 980</span></p>
<p style="top:480.2pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:422.7pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:367.9pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:329.2pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">150</span></p>
<p style="top:280.0pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:234.8pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:200.5pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">36</span></p>
<p style="top:141.6pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:97.5pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:45.9pt;left:355.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:736.0pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Xuan et al.,</span></p>
<p style="top:728.1pt;left:380.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2013</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">41</span></p>
<p style="top:677.3pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:629.0pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CCI</span></p>
<p style="top:580.1pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Severe</span></p>
<p style="top:517.2pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:480.2pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp (over</span></p>
<p style="top:472.2pt;left:382.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">craniotomy)</span></p>
<p style="top:422.7pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:367.9pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:325.3pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">25</span></p>
<p style="top:280.0pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:238.8pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:200.6pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">18</span></p>
<p style="top:141.6pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:97.5pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:63.9pt;left:373.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1/3/14 (OD)</span></p>
<p style="top:736.0pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Xuan et al.,</span></p>
<p style="top:728.1pt;left:398.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2014</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">43</span></p>
<p style="top:677.3pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:629.0pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CCI</span></p>
<p style="top:580.1pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Moderate</span></p>
<p style="top:572.1pt;left:400.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">to severe</span></p>
<p style="top:517.2pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:480.2pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp (over</span></p>
<p style="top:472.2pt;left:400.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">craniotomy)</span></p>
<p style="top:422.7pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:367.9pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:325.3pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">25</span></p>
<p style="top:280.0pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:238.8pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:200.6pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">18</span></p>
<p style="top:141.6pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:97.5pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:58.8pt;left:391.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1/3 (OD)</span></p>
<p style="top:736.0pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Xuan et al.,</span></p>
<p style="top:728.1pt;left:416.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2015</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">42</span></p>
<p style="top:677.3pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:629.0pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CCI</span></p>
<p style="top:580.1pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Severe</span></p>
<p style="top:517.2pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:480.2pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp (over</span></p>
<p style="top:472.2pt;left:418.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">craniotomy)</span></p>
<p style="top:422.7pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:367.9pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:325.3pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">50</span></p>
<p style="top:280.0pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:238.8pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:200.6pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">36</span></p>
<p style="top:141.6pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:97.5pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:58.8pt;left:409.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1/3 (OD)</span></p>
<p style="top:736.0pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Xuan et al.,</span></p>
<p style="top:728.1pt;left:434.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2016</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">44</span></p>
<p style="top:677.3pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:629.0pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CCI</span></p>
<p style="top:580.1pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Severe</span></p>
<p style="top:517.2pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:480.2pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp (over</span></p>
<p style="top:472.2pt;left:436.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">craniotomy)</span></p>
<p style="top:422.7pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:367.9pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:325.3pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">25</span></p>
<p style="top:280.0pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:238.8pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:200.6pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">18</span></p>
<p style="top:141.6pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:97.5pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:60.7pt;left:427.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">3/14 (OD)</span></p>
<p style="top:736.0pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Yang et al.,</span></p>
<p style="top:728.1pt;left:452.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2020</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">45</span></p>
<p style="top:677.3pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Rat</span></p>
<p style="top:629.0pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull WD</span></p>
<p style="top:621.0pt;left:454.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(repeated)</span></p>
<p style="top:580.1pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mild</span></p>
<p style="top:517.2pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">808</span></p>
<p style="top:480.2pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:422.7pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:367.9pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:329.2pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">350</span></p>
<p style="top:282.0pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">25</span></p>
<p style="top:234.9pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:193.6pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:141.6pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:97.5pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:57.6pt;left:445.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">15 (OD)</span></p>
<p style="top:736.0pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Zhang et al.,</span></p>
<p style="top:728.1pt;left:470.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2014</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">46</span></p>
<p style="top:677.3pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mouse</span></p>
<p style="top:669.3pt;left:472.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(X-1 KO)</span></p>
<p style="top:629.0pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:621.0pt;left:472.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">impact</span></p>
<p style="top:580.1pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mild</span></p>
<p style="top:517.2pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:480.2pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:422.7pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">10 Hz</span></p>
<p style="top:367.9pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Laser</span></p>
<p style="top:329.2pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">150</span></p>
<p style="top:294.7pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Not stated</span></p>
<p style="top:234.9pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:200.6pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">36</span></p>
<p style="top:150.9pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1.8-2.5</span></p>
<p style="top:97.5pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:45.9pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:727.1pt;left:490.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">TBI, traumatic brain injury; LED, light-emitting diode; CCI, controlled cortical impact; CW, continuous wave; BINT, blast-induced neurotrauma; NPLT, nano-pulsed laser therapy; LFP, lateral &#xfb02;uid percussion; WD, weight</span></p>
<p style="top:736.0pt;left:498.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">drop; BD, twice a day; OD, once a day.</span></p>
<p style="top:727.1pt;left:507.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*denotes where a protocol has been used but irradiance parameters have not been presented.</span></p>
<p style="top:758.6pt;left:302.4pt;line-height:9.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:9.0pt">5</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:61.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">wave (PW) source,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38,39,46,51</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">alone or on combination</span></p>
<p style="top:73.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with continuous wave (CW), one used nano-pulsed</span></p>
<p style="top:86.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">laser therapy (NPLT)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">47</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">, and 12 used CW alone. One</span></p>
<p style="top:98.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">study used PBM in combination with metabolic sub-</span></p>
<p style="top:111.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">strates,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">39</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">16 using PBM alone. All studies commenced</span></p>
<p style="top:123.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">PBM within 8 h of injury. Ten studies used PBM proto-</span></p>
<p style="top:136.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cols with a single dose of PBM,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38&#x2013;40,46&#x2013;48,50,51,53,54</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with</span></p>
<p style="top:148.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">seven using alternative and additional course durations</span></p>
<p style="top:161.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">up to 15 days.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">45</span></sup></p>
<p style="top:190.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Meta-analysis</span></p>
<p style="top:203.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Two outcomes were suf&#xfb01;ciently reported in the included</span></p>
<p style="top:215.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">studies to permit robust meta-analysis: neurological</span></p>
<p style="top:228.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">severity score (NSS) and lesion size. The NSS was pre-</span></p>
<p style="top:240.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">dominantly reported as baseline NSS (</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt">&#x2013;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> SD/SEM) and</span></p>
<p style="top:253.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">end-point NSS (</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt">&#x2013;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> SD/SEM). Insuf&#xfb01;cient detail was avail-</span></p>
<p style="top:265.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">able in any included study, or in the wider literature, to</span></p>
<p style="top:277.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">calculate or infer the</span><span style="font-family:AdvPi1,serif;font-size:10.5pt"> D</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">SD, and so the end-point NSS</span></p>
<p style="top:290.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">was used in a standardized mean difference model.</span></p>
<p style="top:317.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.5pt">NSS.</span></p>
<p style="top:317.8pt;left:91.6pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Meta-analysis was performed for the nine studies</span></p>
<p style="top:330.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">reporting NSS values in PBM and control groups. Given</span></p>
<p style="top:342.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the frequent use of substudy groups based on varying</span></p>
<p style="top:355.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">therapeutic protocols, a total of 28 therapeutic protocols</span></p>
<p style="top:367.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">from across nine studies are included in the analysis</span></p>
<p style="top:380.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(Fig. 2). Overall, effect size is -1.55 (-2.10, -1.01) in</span></p>
<p style="top:392.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">favor of PBM versus control (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.00001, I</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">82%).</span></p>
<p style="top:405.0pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Given the heterogeneity of therapeutic regimens</span></p>
<p style="top:417.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">employed, both inter- and intra- article, subgroup analy-</span></p>
<p style="top:429.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sis was performed based on distinct variables: CW versus</span></p>
<p style="top:442.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">PW, wavelength of PBM, timing of &#xfb01;rst dose post-injury,</span></p>
<p style="top:61.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">total number of doses, and incident energy per dose (cal-</span></p>
<p style="top:73.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">culated for cortical surface energy). Both continuous and</span></p>
<p style="top:86.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">pulsed wave PBM have statistically signi&#xfb01;cant effects on</span></p>
<p style="top:98.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">NSS.</span></p>
<p style="top:111.3pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Ando and colleagues (2011)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">reported statistically</span></p>
<p style="top:123.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">signi&#xfb01;cant advantage of PW at 10 Hz over CW, but not</span></p>
<p style="top:136.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of PW at 100 Hz. Wavelengths in the region of 665/</span></p>
<p style="top:148.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">810 nm are associated with positive effects, but not</span></p>
<p style="top:161.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">730/980 nm. A &#xfb01;rst dose after 4 h post-injury or a course</span></p>
<p style="top:173.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of treatment with more than three doses were not effec-</span></p>
<p style="top:186.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tive, and all energy values were associated with reduced</span></p>
<p style="top:198.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">NSS. Dosing regimens for substudies and therapeutic</span></p>
<p style="top:210.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">protocols included in the meta-analysis are described in</span></p>
<p style="top:223.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Table 2 and subgroup analysis in Table 3.</span></p>
<p style="top:250.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.5pt">Lesion size.</span></p>
<p style="top:250.8pt;left:374.6pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Ten studies reported outcomes of lesion</span></p>
<p style="top:263.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">size at study endpoint, encompassing 21 therapeutic pro-</span></p>
<p style="top:275.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tocols. Overall effect size was -1.55 in favor of PBM,</span></p>
<p style="top:288.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(-2.19, -0.95) (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.00001, I</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvPSSym,serif;font-size:10.5pt">=</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 75%). Standardized mean</span></p>
<p style="top:300.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">difference was used because of heterogeneity in reported</span></p>
<p style="top:313.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">effect and measurement techniques. Forest plot for lesion</span></p>
<p style="top:325.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">size across included studies is illustrated in Figure 3. Dos-</span></p>
<p style="top:338.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ing regimens for substudies and therapeutic protocols in-</span></p>
<p style="top:350.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cluded in the meta-analysis are described in Table 2.</span></p>
<p style="top:379.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Alternative functional outcomes</span></p>
<p style="top:392.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Morris Water Maze (MWM) was an outcome measure</span></p>
<p style="top:405.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">used in</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 5 studies.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">39,43,44,47,49</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">There was signi&#xfb01;cant</span></p>
<p style="top:417.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">heterogeneity, however, between training schedules, tim-</span></p>
<p style="top:429.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ing of testing post-injury (varying from seven to 55 days</span></p>
<p style="top:442.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">post-injury), the use of hidden platform, visible platform,</span></p>
<img style="position:absolute;transform:matrix(.64022329,0,-0,.6393852,72.43536,573.82809)" src="data:image/jpeg;base64,
/9j/7gAOQWRvYmUAZIAAAAAA/9sAQwAGBAQEBQQGBQUGCQYFBgkLCAYGCAsMCgoL
CgoMEAwMDAwMDBAMDg8QDw4MExMUFBMTHBsbGxwfHx8fHx8fHx8f/8AACwgBggKj
AQERAP/EANIAAAAHAQEBAQEAAAAAAAAAAAQFAwIGAQAHCAkKCxAAAgEDAwIEAgYH
AwQCBgJzAQIDEQQABSESMUFRBhNhInGBFDKRoQcVsUIjwVLR4TMWYvAkcoLxJUM0
U5KismNzwjVEJ5OjszYXVGR0w9LiCCaDCQoYGYSURUaktFbTVSga8uPzxNTk9GV1
hZWltcXV5fVmdoaWprbG1ub2N0dXZ3eHl6e3x9fn9zhIWGh4iJiouMjY6PgpOUlZ
aXmJmam5ydnp+So6SlpqeoqaqrrK2ur6/9oACAEBAAA/APVObNmzZs2bNmzZs2bI
r+aU91B5A1iW0kliuFiT05ICyyAmVB8JT4unhnK9c86/mDc6VrtuNTuIoza6pNby
W9ssctuNP1GOBOEgWrcoHbkTvtUYPufzK88JceYFtbyJxp1jey21u0avJ6UECvaX
qKkdW9ZjVuTcDX4RthjceZ/zO0/WINKimbVjLpv6cjuHtYk5xw27rJZERKoDPctE
Vp8XHbCm0/MTz/e6XaPb6rGy3NzMpvYbeOaRfS02S6eB19JIl4TooFKmnwtvgeDz
n5zbWReNczXd7ejRru20V4ysVJtOllk9EAKyq1woQ1J3674LtfzC8+3drbxW+pF4
7ie1SXVBZIGinltLia7shGy8P9HkiQVIqK0Yk51fyTqt9q3lDRtTvwBe3lnBNc0U
oPUeMFvhP2d+2HWbNmxK8NyLSc2oBuRG3oBunPieNfpzjmleZUsfKD3um3l7P51h
tol8xpP9ZnFq7zot1PLbtWIPBVmRQB8I6FcBah+ZP5gRxma0vvVs7SC4uLW7+poR
qMMWoQW8UrAKOAkilf7FK05DBejeYPO3+Im0aDWbmWSTWtaN1HLBE8ghtI0ltIFZ
0pGkoOx8OmB9M86+cNYvtDS7upZoW1DTJb9ooWtvql5M063OmPxC80iVVJ51P8xN
Rncs2bNmzZs2Enncyjyhq/pXz6ZKbWUJqEcbytAxWgk4RguePfiK5xXS/NfmmCw0
S8tJZ4DBLrETQQzS3mn6hcw2gkt3gkuA0vpyNXjGW2IIXJl+VXmz19T1WLUdXm1O
TU7q3Gm3MkUiJI62Mcs6RqqiONUavSgJ985x5p1Tzr+kfNem217qC2Wo6jc38N1H
JMDbw6VIEkgiI3RZjImy9d8lsf5med45Nda6dYUsIbgS2SRq9xaMkyR20wUx/YeN
ubmVj/MooKYWf8rP/MR9GeeLUkeawi1KVp4rRZEuvqlzCkFSY46B0lbdFWvUZJvz
N1Syi80Wcep309nDNoN5JZLDNcQ1v/Uj9H0xERyl68Qa5DLvVPPl3NaJe6le2N5b
fpV7mK2Tivr22kxTAvVTyIldl8K9N8OPKvnHzpZXOjaKLv8Adx2FrKYb0cprmGaz
M81zUxvK0iSnj9oJtRt8V/x7+YltYeWGk1FHudYso74S3UEcEc1zJIqtZcUiduKo
a0X4961pj2/MT8w4Z9UKSm6X6vqUlvD9UH+j/U9QS3WRSgDS8YGZqN9qlcU178xf
NVqumxaJrUWpWk6zNb63PbCCK6uUlRVtWCxuH+BjvAqk9uhzs0LO0KNIoWRlBdRu
ASNxj82bNmzZs2bNmzZwjzHq+vQ+c/NlrYX1xeTS2N/LY3FpJcx3GnPDbKRBPaSD
0Hjdl/czItak0OO0/wA7atJ5j8v/AF3Wp5bGwkieS3SJqTWX6KaZ7yV4lq/KWo4n
ao2HLDP84fMur2ep+VPMGgS3M1tZW93qklpB6qpdQqsICSIKV+GQkBhkV0Dzb+YX
l/TU02S/YXUuoXpa+1AtIk12HhK2dZElYR0kaixAN/Kdjhrq35redo9e122s7nhH
b2eoNFZS2ytLbXFm8QjaipukgdivNyXXei4eat5g8xXH5Veb5L+8le80y8ltIb6K
M20rQJJEQ1IeNPhcjkvbIx5h1/VYE1r/AAzqF03l6RL19IvUM05WSLTBJMttLJyP
D1hSu9GJ44jZ615v8uTajPFq13NAr6VYS315xKWkEmnfWfUHqI8QLzkIzMp/4LJD
c+d/zIFrql+s6tLpek6ZctYW9sDA8t6zLcz+pKglpEi+oF7ftAjAl3+Yf5gLpltc
walE6R295dJcQWyzrdRwXkEUPqN6cahjHK4b0hQ0quGl3+YPmuL/ABJIt5/ua083
a23lj6ny9K2hkRYrz1wOW8R9T4iVboBtkw/LLXdX1rQJbrUbmK9VbmSOzvoafvYR
ShfgkUfIEkExjjkuzZs2bNmzZs2Q+5/NHy/b6lrVrJDdG28vq51XUUjV4IXjiExj
YKxlBKMOJKcWOwOGGmefvKOow20lvqcIN16YjikbhIGlgNyqMrfZb0QX+WAdM/NX
yRqN7fW0GoIsdlQ/W5CFhlHoG5cxMT8QjiUs2w9qjDjUPNvlnTreyub7UoLeDUeJ
spJHAEoYBgy/5NCKt0HfHaf5o8v6jql3pdjfRXOoWBpe28ZLGI7bOQKA7jauE2g/
mb5d1iF7tVmtNONwtraajchFguZXlaFUiZHch/UWnBwrdNt8yfmn5LbX4dFN8qy3
MMc9pdmn1eX1JngEaSV+36kZFCBgp/zG8ix/Xuet2ijTafXiZB+6rL6I5fOX4Pnt
in+PvJokeI6vbrJHbG9kRm4lbcJ6hdgaUonxU603pjbz8w/JFnGZLrWrWJFcRkl/
22iE4Wg7+kwf5b4fQTw3EEc8EiywyqHikQhlZWFQwI6gjH5HPNnnzRfK97olpqaz
ctevBYWkkShkSVhsZSSOK70qK4A0n82vJmoQX9xJdNYW9hfPpplvAI1lljFS8VC1
Y6GvI098Np/O/lG3v57CfVbeO7toXuZ4mcDjFGgkdq9PhQhjvsN8F6J5g0LXLd7n
R72G9gif0pHhYNxYANxPh8LA/LDHI5q/nfTdM8y2XlwWtzealeRC5aO2VG9KBpPS
9VwzozKH+1wDEDcimA9B/MvR9X1W3sBZXdn9dkuodNurhIxFcvYuUnVDHJIyleJI
5hajpkk1W+lsLCW7hs5b54hy+q25jEjb78fVaNNuu7ZHNI/M3y7eaPZ6tf8APRLT
UmC6b+kGhRp1IrzURSS8VHctSnfHp+aXkcjUWm1JLaPS7xrC6knVkX1kQO3Go+JQ
OrdMNdC8z6drV1qlvZh66Tci0ndgODuYkmDRkE8lKyjfAOv+fdE0LzJo2gX6zLc6
3631WdVBhT0F5H1WLArXtscA+XPzb8l65pNvqaXZsILu6ls7VL0LE8jwuELAAt8B
LCjHxw0l8+eTobi+t5dXto5tNRpL5WcD00VgjMSdqKzBWp0PXDHR9a0nWbMX2lXU
d5aszR+tEajnGeLKfAqRQg4NpkZvPPul2/mxvLUdrc3V7FClxeywKjR28cof02lB
dZOLemRyVSBtUiuB/KP5kaT5lntoYrK7sGv7U3+nG7WMLcW6sEZ4zFJLQqWFVah3
w78y65+g9HuNUNlPfRWqmSeK19P1FiRSzvSV41IUDpWuFmnfmDoFxaabNfudHm1g
BtOs754hNLG1Cj0ieVQrchSp67dcRsvzU8iXVqtyNVjgie5ls0NwGiJlgk9J9mAo
vIgBjthzoHmGy1yC7mtEkRbO7nsZRKAp9W2fg5FC3w16HCPzd+aHl/yodT/SsNyP
0XbW943pIr+slzK0KrCOQLMrqeQNMUh/M7yk0l2Li6+p29qbZfrU/FYpGu4BcIsZ
BYnjGwL1Api11+Y3lCx+tNqWowWMVrObcyyyIVZhGspYcCxC8HB+KmBP+VseSln1
q3nvDBcaGskl1C61eSKKNZWlhC8vUXi46b+2SXSNVstW0u11OxcyWl5Es0DkFSUc
VFQdxgugpSmwyLS/mJokPm4eV5IbhLwyrb/WSi/VxLJbm5jTny5VeNWp8PUYN0fz
dp+q+WZPMUEM6WCLcOokVRI6WzMpdFDEEPwJXfcYT6P+a3l29jeS+guNGX6pBqET
XwipLbXLFYnQwSTbltuJ+L2w1Tz95KaaxgTWbUy6mqPYIJB+9WRjGhX/AFnUqPfb
Aafmd5Mk1e/05b5Cul231u9viR9WjHrGDhzru/MUoB+OCLj8xvItuIDPrlpGLmJZ
4eUgHKNmKBvYcxx377YbaPrWkazZLf6XdR3lozMgmiNRyQ8WU+BBG4ORFvzi8rrp
97fywXUVvax+vamRY1+twmf6r6kBMgFPWPH94VPfpgmH80tEOoW2nXFrc297dWwu
ooj6MoPJ+CRq8MkiM7D4hxJFO+HHmLzPaaKbKA2s99qGoOyWOn2qoZZDGvORqyNH
Gqou5LMMrRfNtjq2qXOmR21zbXlpb291PFcxiMqt1z4KRUnkPTPIYI8y+YLby/o8
2rXUM01rbFDcegoZkjZgrSkEr8CA8m9sJ9O/M/yheq0huxa2zXcljZXM5VY7p4iF
eSAgtWIOePM0FcHS+e/J0NxfW8ur20c2mRvPfKzgelHGQHdidqISA1OnfDPStV0/
VbCK/wBPmFxZzisUyggMAaVFQDgrNmzZs2bNhL5q81WPluzgu7q3nuTdTraQQ2yq
8jSurMq0ZkG/Ajr1wLovnvRdYv8ATbPT0mlOp6d+lo5QqiOOAuEUSnlVXZmIAp2O
A9f/ADN0nRNYutPubC8lisBaNqF/EsRhhF85jhJDSLK3xDfghphhJ5+8lxvfJLrF
sjaaV+uhnp6fKT0gTXr+8PHbvtgTWPzQ8laZpUGpHUEuors0tIrYh5JeMqwPxUkf
Yd6NWn34Pn88+T7eS/in1e1jfTADqCtIB6QJC/F8mYA+B65tI87+UNXvVsNM1W3u
rtkd1t42+PjGeL7eKnqOuBfM/n/RfLuoQ2N7FPKzwi6upIUVktrYyrAJpuTKeJkc
L8AY96Uwrufzf0CD9NyCzuprXQZja3c8Zt25zrIIyiR+t6v2m2ZlUGhockumeZdJ
1DSZtWgcppsAZmuJF4qUjXkzjvxA74RR/mbp31K31CfSdRtrG9mtYbC5lijCTrey
enDItJCVXcMQ9GANaZMgANhmzZs2bNmzZsic35p+R4ZpIZL2YSRMyOBZXpoymh3E
JB3HbOZa3L5K1Xzdf63Prb24urS6shJaaNqMVzJFdQGER3Ugj9OdIa8kPANXvTAK
Q+VJbyOS98yStaukX12KHRdTV3lj059NJjdkbgpjYPQgmvthdqsOiy6TJZfpiW9u
b660xJLqHS7+0W3s7CE2s3IPFI0hmtyyEL3Phkw876t5F1yeCax1qex5adcaNdo2
lX86mwuuBk9ICJfTmX0xxJqPEYbeTPN/kTy/HqyLq1zMmoXr3cQbTb9GjUxRxKh5
QnmQIvtd8hEdt5RS51O+XXvQv725s7uNbXQ9ThtXnsrgzie4gCkGWQHgzRlRTfE4
7HyqqxW7eZpWspra3tNUX9CakssiW9+9/WB+FIyzOF3Bp164C0qaxumvbTVr59Ps
IEgtdKkj0++uHeG31Q6gpfjCpJZfhq3Hft4yDW38i6tfaismv3cej39xcagtuuka
h9YS9ubQ2jH1vSo0IQ8gnGtdq0wmM1raXtjcWeurPdG6klurt9H1JYoY/wBFjT0C
wFC8hPCuzCnyzqXlnz9+Xmh+XtO0e31G6kg0+3jt0kksb4OwjULUgwbVwz/5Wx5E
/wCW6f8A6Qb7/qjkI/MnWvIfnAWEZ1m5tBYrdlWXS9QlPqXEBiikUrEtDE9H+jIp
Jo/kdYojb+YJmljDRFZ9I1b0ngmtIra4EiwrE7M7Q8x8XHejA4tqdn5QvdUnuB5j
lW0NvdW1mj6LqbzQx3Vl9U9IPw4CKKnJVVR7k9cmXkjzV5H8vTatK2rz3H6Slt5Q
Dpl/Fw9C1itqbwnlX0uX05KH/NvyGtK3twa7fDYX7fqgyC+fNZ8l+Ztd0m+Orm3i
0yWKeKZdH1Fr6F4pRI31a6jjXiJVHB0dWFPfA/ljU/KtjrFhPqGvPcWGj3N/eaXB
FpGpQP6moM5YzyPG6t6ayELxAzoFx+avkSSCRPr045qy1FjfGlRTp6OcyuR5MbRN
K0+38w3Ec9npVxoV9PJo2oOstndlTK0SekPTlHAcSSR4jAutQeVr22v7G18zTJpt
7cTTC2uNG1SUcbi0S2b1OKIJHiMYaMnbrUHJh5D81eSPLi6msmrz3J1CaKcH9F6h
CE9K2it+PxRNWvo8vpwp/M288i+crmGUa9c2LQWk1vEyaXqErLLLLFIsoZYlpxER
WnvhF+ivIMMgFtrUhtZJbhLi1n0jVjEbKeZJliVYhFV09OlXqp/l2xt5Y+VbzU9S
u5/M80i3kF3bQSPouptcCO6uI51EshTiwh9LgoVVFPfOg+T/ADv5G0O21GJtVnuD
fahc3/I6bfxcRcsG4UaE14+OH/8AytjyJ/y3T/8ASDff9UcgHmnVvJet+ddO19tX
MCaaVaKWLRtRF8AFZXgFykYV4JC1WV0PtjPIereVdEutKk1XXWvRoVjJp+krBpGp
W4CTOrSSTNJHJychFA40HXJl5g/MnyLqOhahpy6jPG17bTWwlGn38nEzRlOXEQ70
5VyC6nceSrxLKGPXrmO3OmWekauraRqLPLBZSCVHt29Iei7MCDXkKe4wn1yy8u6n
aSaf/iiQae0108UM2iao/AXN0LsSABVUzK1U5EU49gc6H5O87eR9Csb2B9VnuGvL
65vi36Nv4uP1l+fDi0J+z44T+b9W/LnzB5x0LXZ9Vukg0lJku7FdM1B1ulcViVmE
NKRvVuhyJ2ui+RrPQ7Syh8xXNxfW1zeSSXF1pOrelLb3qCL0nSFYnPpxIir8fE03
FMC+a/0TG1wfLN61wdSjuLKcTaffQx21rcWkNuOKPCeZBt61B2G3E4dyp5HmmmeX
zBdKk7XjsiaRqJK/XNOjsKBjFvw9Pn03zoPl38y/KFjoNhY3mpST3NrBHBLNHp2o
RIxjULyCPEzLUDucMf8AlbHkT/lun/6Qb7/qjnOPNl15J1uTzFND5hu7K91eaxuL
G6TSdQZrSSxjMXIfuhz5ozDt1w5sfPXlq1sbzQodSki8vrpkVhpSjS9Q9WOURtHJ
JJSH4gfhNNsiUFl5J02ya00PX5bK3mhsPr1q2i6kYbi5sfhd2CIjrFOn241b7Qr4
5tJsPJVhaWVu3mKdxaRWsLBNF1FFYW2otfmg9M8eXLgPDrl21v5UgYkeZZiLKGCH
Rf8AcJqNYza3rXsRuax/vvibgwXj4ihx7W3kpjqEreYrj19Uhpdn9DajwFxJfrfS
vGvp7J8PFF7dSTkm8s+d/L+h6vdlNXkn0e/ub3ULqM6VqCSie5kUxKp9FqhEUhvE
4Q2kvkq1udQv4tVjN/KOGnI+g6k9nHH9Z+s/vbZ1Ycy21YigH2gK4+WH8uH8u/o9
tUY3jJdH67+hr7mktzIZRHGoiDJbxs7Uj5fThpP5i8q2+m+W/wBGa/cLrXl2JooL
u60rUp4Zo5oxHMksaxI4rxBWj1FB1ww8uecvKVj5h1DW77XJ7y61C0tLab/cVf24
5WvqEuB6RFG9XYdsPtU/M/yFdabdWrXsxW5ieEg6ffSCkild1EG43zmtzD5EfTtA
sotZkaPS9PGk30c2kat6M9uHVyyxwiGjcl6OWX2wHfaf5UvdR1O5m8zTOt7aX1lb
yvoupvcLHeujL6shTiwhCcVCqu3vnXLb81PIsVvFEb+dvTRV5fUb4VoKVp6OKf8A
K2PIn/LdP/0g33/VHN/ytjyJ/wAt0/8A0g33/VHN/wArY8if8t0//SDe/wDVHN/y
tjyJ/wAt0/8A0hXv/VHN/wArY8if8t0//SFe/wDVHN/ytjyJ/wAt0/8A0hXv/VHN
/wArY8if8t0//SDff9Uc3/K2PIn/AC3T/wDSDff9UcIPN3nfyLrQ0gDVLiEaZqVv
qTU02/l9QW/L93tCOPLl1yK+X9W8t+Vn1O40PXJprrUL6FoBc6TqAS20xJS7Wifu
eo9RyG8e2P8AM1z+X2seZrrzGmrTQasH0+TSrhtH1CQ27WLs0it+6AkSdXIK9uvX
CeSz8qzaje3lx5mlla5ARZm0XUzOyLfpfL6rspDMAnpjiAoFNsVuIPKZEgtfMksZ
upLg3pk0TUXrFLqP6RjWP92OLK3wMTWvXbK1ODyJcQzWsnmaaGzD3Q0dX0i/Eivq
N0lzOkzmMeseUfGMKB71Iwwu9Y8v2t5Nq+j67L+lY7rUr6xSbSNQ4CXUIkjRXJi6
R+nue+DvPWr+RvNc2nm61R4Y0hEOoNHpOpG4ZPUSWkMyRoFBePdZFZe9K4iL/wAi
XetXd5f6hFJamK6isbSPQb2FG+tuslb2sRWdo3jBU0Xffrinly7/AC80u78xetrd
5c6frdslo9qdO1BCqiNkkYsYSGJ5njxUUGI/p7SrrR9P0a/80PJY6VcWMlj6eiaj
G7RWEoceuxRqyOqBSVovemdE/wCVseRP+W6f/pBvv+qOb/lbHkT/AJbp/wDpBvv+
qOb/AJWx5E/5bp/+kG+/6o5v+VseRP8Alun/AOkG+/6o5v8AlbHkT/lun/6Qb3/q
jm/5Wx5E/wCW6f8A6Qb3/qjm/wCVseRP+W6f/pCvf+qOb/lbHkT/AJbp/wDpCvf+
qOb/AJWx5E/5bp/+kG+/6o4r/wArO8l+j631yb0/T9Wv1O8+x6no1p6Nft7U69+m
SnOfxeeterb67KlsfLl7fTaXBYqri7R4JZYRO0xb02DPAf3YTYEfETtiVh+cUdyu
nzTaHc21rdx2M91I8sLNbxatIYrBiik8zK4+IKfgG5w38n/mHD5jneJtNn0/laLf
2hmaNzLbtI0RekZbj8cZoDuRQ+2RiH86p9WfTBommqyXWq2NpM8kquv1K99Wj1Wg
ScejvEalfpw582fmlBoetzaH9VH1preU2c5miflcJbyXCBrdG9UR8YjVzTft3yX6
Hey32iaffTBVmuraGeQLUKGkjDGla7VOQPzJ55836FqOq2r/AFG84RWz23pRyqLN
r2+Szt1nZn/fl1dpKKEpwp0YHC24/M/zbFBcKEsjPoX119Vf05ON2tjerZlYV9T/
AEcvXlVi9Mleh6v5qufPWr6XPc2lxo2mxo0hS2khmSW5POCJZDNKknCJT6h4ruRQ
ZMM2bNkV1DWvMdn530zTudrNpmp+qFskjk+sxwwRc3unmLcKCUpH6fD9qvLrgbVP
MHmqz87WujxmzktdThuDYwvFOnpmGEuskl0T6cjNIvEwonIL8XQHF/IPmPWNWGrW
2qmGW40q7+rC5hhktTJWNXPK1mZ5Y+JbipY/GtGGxxD8w/NOu6KbaHR/q6Sta3+o
TSXKPKDHp0aSNCqo8dDL6lOdTxp0NcE635p1i1i8s3Fnaw/VdYurWG+klZi0SXK1
CxqoHJq/tHYAYTaL+YGt3v5i3GgzR2408TXduiKrK6C0VWWUXJYxTtJy+OFF5Rft
Z0PNkC1/z9rejf4ymuLKD0PL9hb3unRhnZ5RMZ1LSkDuYQQiitO9Tsb+QfMGo6xp
l0NTdG1KwumtbpVge1ZTwSVRJC7zcWKSK20jbEdDVRJsQvvr31Ob6h6X13gfq5n5
ekHp8Jfj8VPlkV8qeZ/MOp+W9UuHigvNU066mtIDwkskmMaoQ8kEpllgoXPwtUkD
kNmGHXlDVrnWPKukardKi3N/ZwXE6xghA8sYZgoYk0qdq4b5B/LfnDXr/wAzra3g
tv0bfnVBZRRI6zQHSbtLVvUkLssvrc+Wyrx6b47yp+YX+IfPfmDRLf0DpmkwwG0m
Rg0s0vqyxXLEAmiJJFwXb375Ns2EPnnXL3RPLN1qNkFNyjRRxs6NKF9aVYi4hQq8
rIH5CNTVjsOuV5G1y91ry9Fe3vA3AlmgaREaESejIYxIYHLPCzcamJzyU7HD/If+
aHno+UPLrXdt9Xk1WduNjb3MgjRglGmkapUlY46nbvQd8U/MLX9d0by/+mNIktvR
tlM0/qwy3HqgCqRr6TKsSP8AtTOeKDcimRPWvzW8zaT5lis7yyhttKvZo44Lpo5Z
CkaxpM7Reny+uNMhfiIgOHH4s6pbXNvdW0VzbSLNbzoskMqGqsjiqspHUEHFMp3V
EZ2NFUEsT2AyEeZfOV+dKstd8rX1jeaY86wegY5JZL24eURJbwurIsW9auwancUr
grznqvmqz1bRLXQ7mzU6nOLdrS6t5JSQgaWaUypNHwVYkIHwH4qeOA/J/nHX9U81
X1hrELabE0c02k6bPaNDNJbwziEz/WPWkVx0PExoaMDvleXvOep655XuFgv7FPNU
SyTTwrDLKsEAndEb6ujmSRvTTYBhybwxNvO2vyfl7bazEIIr6a5FpNfPDI0MEYna
JruW25CRPhXk0TOCpPEnbCWz/NHzNefoO5e3Nhos3ppqesPYySQSSy3bWscaVnik
t2cx/EGR+Bda9M6XqOuaTps9nb311Hbz6hJ6FjG5oZZaV4L74U+UvMWr6nDrh1O2
ihudL1Ca0jt7Zmf92kMcsYLNTk5Eu9ABXIZB5/8AzBfS7tTpsp8wzTW31XShp5El
na3BkYTzKbvjMvGFk+3GQ/UZI/y+83ajr13ex3FzBe2sdpYXdpdQW72pP1oSrKjx
vJKQVkgPf2364bedb7WtP0Ke+0y6tLL6orT3VzexyTKIo1LcUjjaMszkBftfQTtk
Km/MzzVb6gs93ZwW9nC1rZXulMGMq3V1p5vjJ9ZDcQsZX0yvp+9cZF5/85v5d1O6
luLGO9sbfT9RieO1klWWLU42aO1EProRIjgL6nPcb8RnTNJ/Sf6Mtf0qYTqfpJ9c
NuGEPq0+P0wxLca9KnBWbNmzZs2bNmzGoBoKnsMiU3mPz8EPDyjuOhN/A34AVwbp
Wtebbm9ih1Dy39Qtmr6l19dhm4UFR8CAManbE/PIH1XRz3GsafT/AKSFGSTNmzZs
2bNmzZs2bNmzZF4/KvkqXVW1WNkklvIpJ0hW4Y23xjhLdQwBvSV2V6NKi13675UP
5feS5jpN5b2/qQ6fb28Nl6cztBLBbAG09VQxSf0ftRM9aHcYO07yv5a0H07m2iW2
W3tF09ZJJGKi3EhkVCXYj7ch3O+AYPy08qwQxwpHcmOC7gvrRWurhhBJaktDHByc
+nEnIgRr8NDSma88heSdc1E63JALmWYljJDPIIWlET2rS8I3EbSek5jL0rQU7YtY
6bpVjr9va2OsNG1pbyGXQWuPUrG6wxxymN2LokQgotBSrN3OFdp5O/L65t9X1CG+
a9sNalP1+RtRkntvrBlUq8dZGSOVJFQIUoVoAMdJ5C/Lxrmx0d2Bv7VXnNqbt/rN
1HJIJJWu15+pco8q8m9SoLZJtOsNI0+7vYrPjHdX0pv7yLnydndVi9TiSSAREBtt
tgyG4gm5+jIknpuY5ODBuLr1VqdCO4x+bNkUuPLHlObzjcXx1CePzDdWvCazj1CZ
Cbbg0QYWyyABV5kqwXZt+uJL5e/L+XzLKHvEutY9FoZNNlvmlK8ofTkl+rNIeMrw
7PIF5Ffng/yZp/lOzs7keXbtL9ZJa3t59aN7M8iqFVZZ2eRyUQKqhjstBi/mXyfo
fmSOBNTjkP1ct6bwyyQOUkAEsTNGVLRSgAOh2bvireV9IdIo5EkeOC7S/t0aWQrF
NEoVBGK/CigbIPh9sCWXlHyrbeZ7jV7eMfpZg0zw+qzJE1x8Mk6QE8I3m4UdwoLU
3yQZsKr/AMt6BdNqc99bpKup2yWuo+qx4PBD6hUEE8V4+qxqMR8oaX5dsNIB0GcX
lpcyNNJf+ubt7iT7BeS4ZnaRgEC1LbAU7Yd4hf2Ntf2U9ldJzt7hDHKgJUlWFDRl
IIPuMJ9L8p6DoFtzhlnSKETyXVxc3UrmUzBfUluXkY+oyrEoDv8AZUUGD/L0WjQ6
HYwaJLHNpMEKQ2UkMgmjMUY4LxkBblTjStcMMjkf5f8AluLULy/hSeG4vORJjuJl
WEySLNN9XUNSH1pEDS8Kcz1wVp3lvyvZ6/f6vp1pbw6vcRx2+oSwBVcqrNKokVej
MZORJFTt7Yc5sLfMdho9/ot1b6w4j07iJJpzKYPS9Mh1lEwKmNo2UMGBFCMry3p+
jWOjwRaO4msHBmS5EpnMzSHk0zTEsZGkY8i5JrhnhT5m0Hy3rWkzWnmC1t7nTyp9
T6yF4oDsWDt9j5g4V+avLnkp7NH1+6+pWXqni0l69rEVkQI9t9tFMMiR/FD9k+GV
rfljyFrMrC+aE3NjDBBG8Vx6UtpG7cofSKMrQ+qaCopzG24yTWlpbWdrDaWsaw21
uixQQoKKiIOKqB4ADFc2R/zH5T0HWNS0y/1C4ube8sZGGnm3vJrUF3FWHCN0WQlU
PUH4a9q4ITQNDttUsr6RmbUYVuYbKSed3fjdOJpkUOx5D90KD9kDbbAmg6D5QtNe
1G70uVZtVUmO6i+stcG1Ep9Ro0iZ3+rrIw5lVABOAdK0HQLbyE2l32speaTbvMz6
tHMLQx/6Q0gPrwuODwuePIMNxviknlnyXD5aY/XpLbRWhRvr6ahLEg/eGUXQuRIP
3rvIS0vKrV3JwJL5e/LCO60eGW8t0khSN7Cza+IS6BkMsMkkJk43J9Ul0dgx5b5K
tE0+407S4LK5vZdQmhBD3k9PUkqxYFqeFaYA07TvLFzLffou5WST9IG71IWtyWP1
sIsbJMEY0+BADG23thFH5X/LdNH1Jo9T42iTKt3qY1OUy2jwk+nCt0ZecCxmQhY+
QA5HbfDDyh5c0XStV1WbS76GeCSKyto7CDhS0ht43aNWKszM0hmaTk3Wv04v550P
yvq2lQp5jvHsbG3uI5op1vHsQJ12jrIjx1IY1UE9ffAp8p+RW8xwmeVZ9X+rqf0f
PdtJ6yxx+gLmS2dyJJBH8Hqla074jb+Ufy50XSzM8sUVjb3kFwb26vGYRz2T0t4j
NI+ywN8KRlqDpTJkrKyhlIZWFVYbgg5ebNmzZs2bNmzZsxIAqdhkb88kC10cE0rr
GnAf9JCnJJmzZs2bNmzZs2bNmzZiAQQeh65wy5/LbzTHpl5c21u66jpEjaNoaRsV
J0uYSxlowCNkF4Dyb4qRnuBU/wDLOl+cNP8AOlhpr2l5Fomn3mqyvOrgWH1W4jT6
jDGobcR8TReNEO2RrzL5T89apc+b4tQi1G7s3aWRLOH1RHcRLeRS2SwyfWAheKBG
+GKNN9nJNMl35gWnm+bzJoUuhWt56Fv9Wf145ZPTVfrKC6WSMSxRqwtz1lWTnuFA
KkkX5B1EeWfLGiaFrNnc2V7c3UtrApiqhkuJrmdByUkD93FUntUeOFPnXSJtb81X
unWPl+6tpYrG9a31lIFihutQubJoI/UulYERxxsU+L7TkfyVwqm8m6hqvl7UruHQ
ri0ZtU0e40zT5UFvIptDbRXUxgVuG3puyk/6ww/m0PVG/MgONKl31ePVRq/BfQFk
ul/VGi9evIP6+/pU6fFhT5pstZn1PzLZ21pcz6zc6hayerbyTRt+jDblLOggktne
NLkSK4WReBPJ+QFMP/yvXUW1PUZrlHWb9H6VFrTPT49Zjtz9bNRVWZYzEjlduQp1
GdDzZs5fdaTqcH5gSXQ0a4l9HVG1n9JRRqyPZLpP1T0ElqGMpuOkP+ywbqflm417
X9f1CTTprIR6SLTR7iMRRXLz3sLm4mikNOEyqUh+PpTrQnBX5U6fqFhp1/A9rc2m
kCdBo8eoRQw3vprCiy+usIVf74NwP8tO2TnNkQ0Py42n/mR5i1OK2dLTU7GwZ7pi
WElxHLc+ooLEn4EZNugHTJfmwi896bd6n5M1rT7OD61dXVpLHDblzFzZlIC8xSmE
n5TaXqNjo2oy31tLbtfXz3ETTxJazSJ6UcfOS0jJjtzyjI4J1A5dWOTjNhb5jkgj
0K9kn059XijiLnTIkWV5yu4jVHIUkkd9sI/yvtJIPLBlns57C7vbq4uru0nh+ren
JK9eEcVWAjRaKCPtU5UFcl2bIp5R0BtJ8x+a3jtWt7O+u7ee3lY8vWY2qCV+RLM3
xgjf9WSvNkY/MrT72/8AJ13BZQPcXCyW8wjiVZZOMNwkjMkTkJKyqpIjbZ/snrjf
y00+9sfKscd5bvbTSz3E4SVRFIUmmZ1d4V+CFmDVMS7L0GSnIB+dWgeatd8ovYaF
bQXsZJlvLKSV4ZJTFR4FjZUcECUBmU0rQb9cBfmZpuqatb2VzBZam2o2Anhs4bNI
JbQ38sSGGW4S4VuduGqvqBdhyrSuRzzp5C8yweY7PX9LtJrm4hZb7UHjjjmEU0qq
hW3gJT6yySxiRRIxEa149RTs2lvqEmm2kmoxJDqDwxteQxHkiTFQZFVu4DVpgnKf
nwbgQHoeJIqK9qjbIRrXl3XLq/8AKWoahHDf6vp2qFri7tEeGGK1e3nVmEUsktKl
kVjUn6MV1nTX1TzR5U1yDTZ1lsL26iuZZhxaG3+q3EfLiWICyS8KEbkUyN/lp5Y1
3TvOt9cXunSW1vBFeRCWQBUU3N4J41hlB5Xaug5GST4oz8I65vKFxdQfls92mnQe
YNGi9b6jodpbc7prpLyTl6heT0mAfc/ACtO5wbYyNpf5crA3ly+1i9RPrn1GSyRA
13cXDk8bd3KxrFJV+H7KUpjdB8n/AFlvKNtcac/6O0+3nv76W8to43e89QGKJo2L
PCElleaNQxUAAeGTG11S91yz0zVNBuIY9Nmdmu1u4JDLJEpKFY6PH6bclO7K3yzn
35eaPrWlylZ9Hu7UppsOi3LGJUEt6s0ztcVRjzhCOo9bCKz8pa4ujQXTaNeQSaLb
6Vby27WcUxub2yW5juJjaiSP6zFS5Uhw1WIB3ockn5Kabc6Zfarp13x/SFnp2kw3
6rx5LN/pT8JOOwcRulV7Cg6ZJfzQlePy9SDQpdcvZWMNqIrZbr6qZUKtctGxFQik
7DdjttWuQuz8oajF5lsLO10u8FoLnTbuDUZ14enp9vpv1SaGS4Deokxk6xfTi8fl
W60by9piLotxcaXpPmPULuXS4oluJnspjdJCyws37wFpkbc1p8WdA8h6Zf6X5M0b
TtQHG9tbSKK4Xlyo6rQivemHubNmzZs2bNmzZsi+pflv5c1C7nup5L/1rhzI6i/u
/SDN14wNI0IHtwoO2R/zD+X/AJf0ibQdQs2vTcW+r2IjFxfXlxHR5QhHpTSvH0bb
4du2dIzZs2bNmzZs2bNmzZsxrQ03PYZzBfzoMcdrJdaSywiyll1SeJ+aW1/GszCz
NQOTH6q496rSoyR6B+YWn6lNp+n3EMkGrXct3ZyxIOcKXWnorXKrIeJZKt8Dcfi8
BhN5i/OrQ9O/Sttp1ncajqemsUS2X01E5huI7e5EZL8h6LSivNVr+zXJHr/nnStC
1DT7PUILhP0iyItwET0omlcRorszqWJdgKRhiOpoN8W8l+YZPMflq01ia3W2kuGm
BhVuYUwzPDsxA6hK4T+Z/PGs+XdWYXelxT6Q1vdTQNBOWuyLK3NxJM8ZQIkNaRV5
EhmXxwqm/NHXbLS7mS90aOW/tL6wtbk2s5NqkOo+iySs8ipJVVnC8Qm7e2+HEvnj
UU84DSvqMX6JF8uktcGRvrP1t7P68HEfHh6Pp/D9vly7UwLrP5ltp/mBrODSZb+z
juf0c81t8dw90tpJdyRxRbCkaqgZmYL8XXbDjyr5ug1u8vLdIRGiRW1/YTKTxuLG
+QvDNQgFW5I6Mp7r4ZI82bAuragmm6Ve6i6GRLKCW4aNaAsIkLkCvc0yL+TfO2r6
5b6pFc6fCmqafFb3EcNvMTDKl7B9YgT1JFUqwHwv8NK9K4L8i+a77zBBqK3kECT6
bdG1e4spGmtZWChmETusb1jJ4PVftA02xLz55w1Ly+LaPTrOG7nkt7y+mNxI0SC3
sEWSZVKK5MjhxwqOPicZ5t82a/p2j6XqWiWdrdNqTwxR2l3LJFI8tzx9GOMxpInc
8ixAAHfA2ifmFc6p55vNBNvDaWNtJNbwvcC4S4uJrZV9b0OUQt5ERmP2ZS3Hegyc
ZsLvMmrvo2gahqsds129jBJOtshAZyi141PTCr8v/Ns/mfR5ryaOANBcNbi5s5Gl
tLgKqt6tu7qjlfj4Hko+JT2yTZsDalJfxWMz6fAlxehf9Hhkf00Z+g5PRqL47HCr
yX5gvNc0mW5vIIobm3up7OR7Z2kt5Wt3KNJA7BWZOQK7jqDh9kO8v+eNR1LzIdPu
LGKHT7o3406ZJGaeul3K2s/roVCrzd+ScGO3XA/k/wDMeXXvM9zo8tvBCvo3Fzar
FMXuI47W6+qsLuMqojeRvjQKT8PXJzmwl85+YX8veXLvVkiSRoPTA9VikSepIsfq
SsoZhHHy5PRSaDbK8meYZfMGgQanLEkbu0kZaFi8EvpOU9WBmCsYpOPJOQBph3kc
8/ecB5U8vS6mlqb+75KltZK3EuSauxahosaVdjToPHN538wa1oWkNqenWdtcwWqN
Pem5naH92gFI4QqPyllJ4pWgr1yKap+ck2m+Y30q70xbW2aWOIXlzL6S24CJLK91
yUKOSSEwqhYtxPTOmo6SIrowZGAZWU1BB3BBGXmZgoLMaAbknoBka1TzklvqOgw6
fAmoadrF2bSTU4pkMMTCKRwF4li7loqU6Dx7YWeefzFm8taxb2i29u9t6cM1y9xM
YpZRc3H1ZIrRQrCSUN8TAkClMNdF84DVfNus6JFalLXSYoGS/LVWeSVpFlVFp9mJ
o+JNdzXwwv0bznfal5Rm1C0h0+PWk9aR9Oa5KxwxLO6CWdlQyAcE5tRN+gyx58v2
/LmbzXBpgvLmGGaUW0MoEMggLAzJK4U+i4Tmp48uJ6Vwv8x/mo+ka1YWf1WA2sy6
e1wZZjHPK2pzGCJbSPjSQxFeUtSKLk7uL6xtXhinnigkuG4W0buqNI/XigJHI+wy
HeS/zDvNdkm+u2UdukliurWHoSNIxtXkkiCTc1SkwaI141X3wj0/847690Jb6O2s
EnvZ7dLBpJ547eKG6jklWW6eSFCEUQsvOMMjP8IOxw//AC68+v5ta7l+pxWsP1ay
vbd43Ls6XYlU86qoqr27cSOqkdMO/N2qa1pekSXul29rM0CvNdSXszQQxQxIXdiV
SRiaLQbU7k5FrX80dQn1e1jbSfR06Z7S0mheQ/Xku76z+uxr6fERcFUcDV68vbHQ
fmPrl7odhNbaTDaa1qerXWkW9neTN6UT2pmJM0kSOalLY7KpHI9ab5LvLOuR695e
07WY4jCl/Ak4iYgleYrSo60wzzZs2bNmzZs2bCzXtbl0mCKWPS73VDK/Ax2CRyOm
1eTiSSLbtthCv5hah6pU+UNc4dqQwFx/rAzBRXtRj70xmu6tJqmkaTcyafd6aRrd
ggt75USU0uF+Kkbyih7b5NM2bNmzZs2bNmzZs2bNkTn/ACz8qz6dqNg0biHVL0ah
MysoZJFIPCM8fhjI5AjwdvHHWP5caHZ+aF8wwT3QljluZ4LH1B9VjlvVC3DqnGtZ
OIO7bdqDbAVz+Uvl6aXW3W6uoF1vm0iRNEvoyyyieSWNvTLszSqG/eMwHRQBg7zD
+XWi69qtnqV9NcevZrCKRuoWQ20y3ELNVSVKyA14ceQNGrQU2neTrzRoNMs9C1WW
HTbS59S7trgJKJIG9d5I0YKpVnlnUk16KBjL38v7O+8yXur3mq3s0d/aPY3Gks0P
1b6tJGY2jSkfrICW5njJu1K9Bidt+WujDRLrTbm+u743tzbXV1fzSR+u7WLxtbpW
NEQKggVdlqR133wW/kbS281DXTdXHL1ReHTea/VjeLD9WF0V4+pzEHwU58e9K74X
al+W0d9rV5djUriyt55hqFqLRhHPBftbtaTShmDq6SQlaowpUe+GXlTyjFol3d3K
yiSN4raw0+Fa8YLCyQpDFyJq7cnd2Y9zToMkmbNiN7Z297Zz2dynO2uY3hmSpHJJ
FKsKih3ByNaF+Xen6PBPHDqN9LJdAJd3DyIsskMcJggiLxonEQIfgKUaoqScH+Vv
K1poUd26XdxqN7fyiW91G7ZGmlaNBFHy9NY0+CNAuy9t6nEvN3kuw8zJb/WLq4sp
YFlhM1qyqz29yoW4gbmrrwlVRUgchTYjHnylp/1zTbia6nkGlXElxp9u7p6aB7c2
4i4hRySNWJSvxBt64yLydYL5pXXpr26uZ4fVaxsp5Q8Fs86hZnhFOfxqKcWYqP2Q
MkObAWtaPY6zpN3pV+hezvYmhnVSVJVxQ0I6HAflby1aaDZzpDczX1zezG6vtQuW
RpZ5iqx829NUjFEjVfhUDbxw5zYD1jT21HS7qwW7nsTcxtF9ctWCTx8hTlGzBgrD
saYE8qeX4/L+h2+lRXs19Bb1EM9x6XPgTsv7lIloPGlfHDfIna/l7p9rqt1f2upX
sUjmU2kKvEUs/rcy3F16AaMn/SJEBb1C1P2aYK0XyVp2meYb7W1u7i6u7kOiRzsj
LAkzLJIqcVV25tGu8jMQAACBkizYW+YtDtdb0mXT7mWSBXKSR3MJCyxSwuJY5ELB
lqjoG3BHiMry7oVrommLZ28slxyd557qYhpJppmMksr8Qq1dmJ+FQPAYZ4QecvIv
ljzjpv1DXrNbmNQ4hl6SxeoKMY3/AGagb4D8yeQotZt7W3/TeoafBZ3C3FtFbNBw
BRFSKMrLFIHWMryUNX4jXwo7zP8Al9o3mK5gu766uY76xjVbG5ikVWt3qeUqKVZO
ci/AxZT8Owpkh07T7XTtPttPtE9O0tIkgt46k8Y41CqKmpNAMEZmUMCrCoOxB6EY
UXPlXRZRpiRQC0h0q7+vWsFqFhj9b05I/iVRQgiZiffC3VvIlprEtnNe6rezRWru
zxc4eEyNL6qo9I6qEYAAxlWKijE4tonkPyjomv3mv6TZx2l7qUQhuDEaRt+9eYsF
6BneSrU64B0DyG1j5YOl3F0trrDmQHWtNUQXJT12li+Jw/LiGAZWqvtTBlp5H0+H
RL3Q/r11NZX1rNbXiM8fJpLppGnuaqg4yymU1p8PgoxPWPIGjate6bPdXNx6GlrE
v1IOnpSegyyRF+Sl0KuisfTZeVPiqMM9M0iRtOsRrrQarqdoS63xhQUcsSHjFDwP
GgquE+hflzpekSO1rqN5KBwt40keJhHZRlmFkKRg+lykJqfj/wArA0H5XaTDpd1Z
pq1/ykWGCG8Z4We3trQsYLZVaIxNHHzbaVGJruagUGeTfJY8uanqTwyxnT5YLO0s
IF5GVI7VZGZpmY0Z5JJ2PwgCmDPOnlSPzNpcdhNqd3pkKTJM72bRL6hQ1VJRLHKr
JyoeJFDTfAY/L3Sj5gg1ae+uriWJoLiS0keMRS3ltEII7xwqK/qCPaisE/ycu+8g
aZLpot4b+7sbiLUJ9Ut9RheP14bi6aQy8fUR4+JWZ0oynY+O+H+kaVZaRpdrplih
jtLOJYYEJLEKgoKk9cF5s2bNmzZs2bNmzZG/PJ/0XSP+2xp3/UQuSTNmzZs2bNmz
Zs2bNmzEAgg9DtnBZfLvnO00u5vrRbuO48vF/LunW6M5ElrOJYxPwIPqlWuICXG3
wVP2ckflO/8AM9l5v03yyyXkWnafdaok0ZhY2qWCxJ+jY/rBXiRxB4fFX+bfI15q
uvPmpy+cLK9ur6Gxtmkka2tUmMiQQ3kTWbwcbfgvKAMzBJJGfuFpkx/MDWvNNp5l
0KPRPr7wn6s7CNSbeWOS5SK4MipDIXaOFuTB5IwoIK8jWgz8tNasdK8paPpOqySW
eoz3E0EMFzHKrPJNcXMsaAstCTHEzdenzGEHnRNPvPO99aaFBd2vmSDTb2SS/iiu
Ve7uZLNkt7SO4K+l6SA+ow5ACThT4uWEw0b635T1ObQ7a9t9Jj1fRpdOsoI5rdJJ
Ea1S8ZrdlWQqsodmqOJYcjXJHcWjn81lYWs/6X/Skc6XfpyU/Qo0wxuonp6Yi+uf
7q5V5b074D17UNVi8z6vK11e2twNTgtruXT4vXuItNFo0mnelHxlHCe+LLJt8XRu
I3yXfl6WS+8y21qeWiW+oUsG2oJpIlkvY1odglyz/CNgagZMs2bNgXVDaDTLs3nP
6oIZDcenz5+nxPPj6f7yvHpx38MhX5PHS5tL1W80uGWwsbm9ZrfSHhmt0tI1jVUU
RzKlHkUepLxqObHeuGX5h6bNdRaHcQ/WHktNY0+T0YS/AqbqMO8qp9oIlftfCOuF
n5gaZpHmu40fR3083ZfUntby8kgcfVoYYvrFwFlZQU9ZUVFddiTQGuFPl/Tp7X83
bqVUbUbi4ku21C5ubD0HsbURqLNYLvpKj8eFAx8aA51bNhD5+gvJ/JWtw2Uc8t3J
ZzLDHatwmZihoEbxyP8A5NwSxeX78+l6VnLfSPYenFLa2rQ+lGOVpaz/AL6CLmGq
r9X5N0IyfZsK/NMulxeXdQl1aKWfTUhZrqCBZJJJIwKlFSL42LdOI65H/wAo1tv8
HrNbKYYbm6uJo7H05YY7RXkPG2jjmWNgsa0rQceXLjtk0zkfleSLTfO1zeT21zBd
251UeYrkwTkyC5v4/wBF83CkT/uCfT4cuC9aY78t7C+t/wAxdVAjZoYLe7j1K8MN
xDJPcy3iywNctKFjkYQllj9MuAg+18QUdazZFPzShnm8j36QxtL8UDSoqPMvpLOj
SmWGP95LEEBMkabstQMb+VsM0Xk+BXjaKMzXDWy8Hhj9BpmMRghk/eQwlCPTjf4l
XY5Lc57+eEXmi48mS2mh2E97FITJf/U5kiuAkNHjRA1CwkkAD8TXjUUNcJPzfe8v
30iWG2kkjs0vI5LWS1luozqhihezgpHQKztyQTg0WpowOEvnbQ/MmmeZrfW7dJ50
maG+1aL0p5LeEcUWCO7ELGS7EM8f7pEHwqSW9+3aXc3V1plpc3dsbO6nhjkntGIY
xOygtGSOvE7YJzZG/wAyINSuPIeuQ6YsjXz2kghWKvMmm4AG5+Guw65AAVb8v/NF
joVvcQWF9cvc6BapbTxr+johai5CRFAyKX9X93QM29Acjuqacz2ExttOu20i5GqL
5JSKCdVhu5XtjY+jHxDWzfBMyO4UAV3GdG1T9IL+ZmmvYQW9zqiaI4ZLuZouMLXc
QmdCiSkv9G/jhD5TI07zvc3U1vcQ3MM2qjzDcG3nrItzex/or1HCkTUiLcCnLgvW
mRe+0nVxceZIrK3lmjhjddXuI7e6SWeRtSimD3yuq/WUW25j04CxMQIDfEBnSfyo
vIIdAj0iRjFes11e2toyvGDZNcssUtvDIA8Nuaj043+JRscjH5WiSxuJFkiubOSa
whsdXk+rzoX1xppi7vyUepJ6fHlL9np8WRWPTL5dGvfTs/8AcNb3Omx6gxs71reS
aAXC3U+o2jrHPcu5aJpPSFAxT4m4E5Pfyct3ttQ1KGaOWG7/AEZpD3kU7B5hMRci
shFPiMapSorx4g9MOPzeutBt/K1dVsH1J5JPSsIBDcTxLcOpCzTpAr/u4vtEkbU+
H4qZC7TSrqPznp8EJvLvU/V002urvFKs7aOum+lcubh0CKpuDyaNjy578cUfR4dP
8p6dbavb3V35ds/M2otqqXMU900loz3QheWMK8kgaZoyG4kVoemdK8hQ6nB5L0SH
VBINRjs4luRMayBwoqGrXfD7NmzZs2bNmzZs2bOa+b/JU9uunSnzFq1z6+p2kIWe
eM+j60vESQcYlCyJy+EsDk30HRJNJt5IX1O91QyPzE1/IkjrsBxUokQ47V6YZ5s2
bNmzZs2bNmzZs2Q9vzR8uQX+twagJrG00Qx+rfyoxhlDyCBjFwDFuEzBGoMZrP5s
eUtO0X9JpK9yzLKyWixyJKGhYRukwdR6BEjBP3vH4iB1w407zn5c1HWp9GtLrnf2
5kBUo6o5hIWYRSsojlMTELIEY8T1wm1z82vKmlwXTo097NaTRQNDBBMTJzuUtpHh
bhxlWGR6SFK8T8PUjDfV/Mflm11ex07Ud7x3R7V2t5JI4pZKxxFpuBjheQkonJgT
0GL+VPMMXmLy7Ya3DC1vFfxCVYZCCygkihI27YSa9+Yv6A1OeDVNIuYdOWC4mtL9
HjkMxtIvWl/cqSyJx2V26tttUYHf80VtbeNdR0e5t9S/SlvpNzaRMk8cL3PolJXu
FpHw4XKHxJ+EDDqz1+wufOd9pCWEkd7aWcUr6jIioJY3kdfTjJ+NlRhWv2anbvgF
vPHlvSJdQtRayQadp0wtzNaW7yo9y6tPcLHFbo7UhBDSuRQMd98NPL/miz1q41C3
hQxy2EiDchllgnQSW9zEw+1HKh2PiCO2HObGTzJDDJM4YpGpdgil2ooqaKoJJ9hh
H5Z82p5g8tvrltYXEXGS6iWwkCC4LWszw8SCwVWcx9C23fK8n+bD5gjvlmsmsbzT
p/q91CJUuIuRQOPTni+B6BqOB9lqqemI+dPOn+G1txHp8mozzRXF1JGkiRBLWyRX
uJOT7FlVxxQfawL5s/Me00C30+dLJ7tL6B7w1kjg428QQvw9T+9mPqjhCvxNvTph
jo3nC11XzJquhw2lxC+lRW8z3E6emsv1gyL+6VviKqYSOVKHth/myJ6h+Yum2DeZ
Dc2dykPlq3iuZ5WUD1xMZFHoqTyIDQkcjQHttvhh5U8zNrsF6txZtp+oabcmz1Cz
Z1lCSiNJRwlT4XBjlU18du2HmIX1xLbWc08Nu91LGhaO2jKh5GA2VS5VRX3ORiL8
w7aPyprGu6pZtp8mhySW9/aGRJV9eMKVRJl+BgxlVeX7LVB6HDXyj5hfzBocWqNB
Hb+qzARRXEd0tFNP7yP4a+I7YV+c/wAw7fyxeRwPYS3kaW7X+oSxuiehaJKkLSBW
3kbnIPgGV5t/MS18uaxZ6bJYy3X1hElnlRkUrHJKIF9GNvinfmasibqu+O8p/mBa
+Zdb1Sws4Ixa6a7xi6FzG8kjRyGJj9XH7xF5K27eGSzNkMf8zbP6lr1ymnXIfRb2
DTo4Z6QNcTXXpCFhz/u42edRyftvTD3yzr665phuzbtaXEM01pd2rMH9O4t5DFKg
ddnAdTRh1w2wj86ebrHypoE2sXkUlwqMkcVtCAZJHkagVa+AqzeCgnAPnbz/AGnl
aXToJLcXE+oGRkDzxWyCOEoJD6kxCl6yrxTv4imFd3+b2lW3mV9Bexm9czCCCYvG
I6pwNw85J/cJEsqkM32/2cn2bNhLrXmiDStX0fTXtZ5m1e4NutwigQxERvIDI5pu
3p0Cip+jA3mrzdPoF1ZBtNe5sbiRI57xZokKNI4RFihY+pM/cqo2G+A/K35i2vmD
XrvSY7GW3EIme3nZlfkttN6EgmjX4rd+Zqivuy74pp2uHV9Ai812nl/19XpNb2Ns
XhE/p+uYyDcNtGjenzYdvAnFoPONxd+UjrllpjzXKM8Uli08UarJDIYpSblyI/SQ
ox9QdRuBhEPzisGudMiXTJ+N4kLXLF4w0ZuJ2tk9BPtXSiVCXaLZUo52OT429v6/
1n0l+sBPT9biOfCvLjy60rvTIv5P/MCLzJPLF9Qks+Vsl/YFpEk9ezkdo0kIX+7f
nGQUPTC5/wA0riMz2kuhyJrIuYbW0sBcwOsjTrK6iWdCY4XVLd2dGqV28cGeQfN2
jeZLvUrnTtMFi8sVneS3X7svcpcI6IzlN+UZgZPiJ2oRscOvM2tahpGn/WrHTH1S
RSWkjWWOBY40Us7vJIaCgGwANTkdtfzWsLnU7WKLT7gaZc/V4zfMQJEubu1+uQwm
2FZDWHqw/a2x6/mjZHyfL5m/RV6IoryWyNmUUTKYrgwNJLvxjXbkeRqOnXbJtmzZ
s2bNmzZs2bNkSu/zP8u2zujW2ps8bMjU068VaqaHi8kaI3TbiST2rhbr3m/TNai0
qOyhu0KazpgkN3aXNoPjmLDj9Yjj5n4N+PTJ/mzZs2bNmzZs2bNmzZiCQQDQ9jnO
JvyT0VrWzEF49tqKMW1TUUjQyXpa5S8f1FPwpyuIlf4OnTpimpflBHdNfmDWp7T9
Jy3xvSkUbFob6ZbgxLy+zwkjHxdStRt1Bpof5dwaV5kbVxfyT20L3sum2JRV9B9T
lWa7LSg1lDOg4AgcRtvhN/ypeyik1iW01BbebUJfXtJxaRNNC7XiXz+pITymUzRi
g+EBdt+uG/mX8uYte8x6frM+oyxiwe2mS14K6iW1nEymNm/uxJTjIAPi+Hccd1dB
8s+YPLlnoWkabfRXWkWREV99Yj4TegsMm8ZQkF2nZDv0WuBdW/LzUNX13Vb3UNbM
umanYy6atgtsiyQW8qiqxXHMneQc2qnxUA6AY6P8uZZdLlg1LVnu9RutUtNXvL5I
EhV5LFoTHGsILBFKWyqdz3OSBdCjHmeTXvWb1JLJLH6vQcQqSvLz5dannSmRDWfy
vutWl1Wwkv8A6vot7eHUYlVRKxe5jMd1FLG/wHiwEkL78Sehphz5J8pXehz3893K
sjSx2ljZhO1np8RihaTYD1JGd3amwqF7VyVZs2R/SvK1xpemvp9nqTxRTXV9dTSr
GnqVvpZZgIyeSr6Ty1BKmtNxleTvKT+Xor5p7369e6jP9ZupUhS2h5hQg9O3jJRC
QtXI+01W74j528lSeZFt2g1FtOnhjuLWWQRLMr2t6ipcR8WK8XZUHF6/D4HCzzJ+
WMmuQ2sEmrGOK0EltCrW0cvCylWNSkfNvguF9KqXI+JanbJDY+WobTzNf66tw7yX
1pa2bQMBRVtGlYPy6kt6+/yw5zZGtb8i2Osvr31u4kEWvWMFhMiAKY1t2mYOrdyT
P38MEeU/LMmh2961zenUNS1O5N5qF36awo8pjSIcIlLBFEcSinI71PfD3A+pQXlx
p9xBZXP1K7ljZILvgJfSdhRX9NqK3E70ORfQ/JGtaX5eXRjrqyUFwzXS2USu88zr
Ik7q7SqziQOz1+2W7Uw28p+XJNC0+eKe7N/fXlzLe3136YhWSeanIpEpYItFAAqc
K/On5eReZ7yKdr+Szje3aw1KFI1f17N5UmaNGJHpPzjHxiu3bA/mT8tD5g1Wz1G8
1V1eD93MqQrUwpcG4iFu/KtvKuyPKm7qKHDHSPKFzZ+ZZ9au9SN6FhlttNthBHAL
eC4lWaVWaP8AvTzjWjUFB1qTXJLmyK6t5Di1CLXR9deKbWLq0vYpPTRlgmsViEPw
HaRedurMG69MNPK+gfoPTDavcm7uZp5ru8uiojElxcyGWVljBIRSzGi1NMNsjPnz
yDpPnLS/qV9NcW0sayLbXVrNJE8ZlXi+yMquCu1GrgLzV+XUnmBYQ+qtAYI7izRj
Csx+oXsSRXENXavqsI9puoqdjiHmv8qNN19rWQXZtn0+KJLJTDHNF6kYMfq3EbUE
59E8FDfZ6jJjpenxadptpp8LvJFZwxwRvK3ORljUKC7d2IG5wTlOiujI4qrAhge4
OxyPv5I0eODR7bTkGn2ej336QhtoR8Dv6csZU16A+uW2wLr3kzVdbexW71r/AEW2
n9a4hW1i5Pwl9SEwyk84JEX4C6k8h2GJeVfy5t/L/mC81dL6S4E4mS3hKKjKtxN6
8n1iUEtcuH2jd91X4cAaD+XupWvlK5tkmh0PzTeLLb3GtWqi5Yw/WHeMgSemKmNq
f5Jwzg8n65b+WI9Dt9Zht1htktoGisIhCCjNy5QM7q0bxkIyV7VrvhOPycsxdaVM
uqS8LFIVuFMSF3NvO1yn1WStbRTI5V1j2aOidslNpob6hZ6ZceZ7a2uNa092mjlh
DenHLUgPFy3HwUwl8sfl3c6BcCaHWGm9KOOytQ1uilNOid5BASG+KQvISZaf7HA0
35XXVxZaot3rCXN/qMkL/WJLC3MJW3LFPXthRJZD6hDygqxovQCmCvIHki58sahq
UYCfowWtjZac4flJItqJmkkkQKqx1e4IVRXYYZ+efLOqeY9G/Rljqv6KjkcG8Jt1
uVnhHWB1Zk+B/wBuh3G3Q4WD8uGfzFBq0+pl7dJba+uLJIEj9S+tLf6tHKsgJKR+
n/uqh374Lm8iQzeV9V0Br2QJqt1cXclyqKGQ3Nybgqq9KCvHJTmzZs2bNmzZs2bN
myM+e41a20Vj1TWdPZfn64X9RyTZs2bNmzZs2bNmzZs2YkAEnYDcnOE3HnnztYy6
jrkMk0Nn5mdB5ckuuFxbL6d7FCnpQoRIBLZu0vx8Onc47zT5982/oa+02fVVtJbM
6larfJAUlv5bO5jhVE9Mj05PScyfu+lKn4a5K/KfnXzHqHny40u6mSW3MmopdaYs
IV9PSzmSOzkdx8Z+uRsXHPY0+HbIdrXnzzvqC+YIJdTTSbWwvIjLJH6Pr2iQ6rFB
GCgrIsc8BMjmehI+z8BOTHzt541rSPO+jaZZXBNtPJZpc2hhj4yx3dx6DSiRm9V/
TBr+6WiGnM/EMM/ys1+2m8j6BFf6gsuqzwKrJcS1uHkYPIAQ55MxRC3yGRHzprFv
H5s1yHy1rk41+y0u9n1C1FyZWaUwf6Pa29qTxUxf3xeNKjYE/Fsgbyf9DNN5e1q6
k8vWvmfTIdPeKd7hLi3nazEyfWpDJK8SzPLyAaldjsKZPbE6hF+aGoQy3s09rNpM
E8Vq5pDCfrMiURAAKkDdjUn5AZA/NHmjWrXzDc3x1p9IeLUr6yKyK0sEEFrY87as
JIQG4Z+YeTb4tv2cmX5darqd3qWswXbOUMdhftA5Zvqt1f25lubReXxKqMFcI268
/CmTjNhd5jkvYvL2qS2PP66lpO1r6Y5P6oiYpxWhqeVKDOYeQdcuBonmSLT9WZ42
tIDo1zcyS3ajUTYNLehGb1ZZDHMOUka149ABh9+TdwG0vUrZLgalDa3KKmtxT3Nx
BeFoEZ2jN1JOy+mxMbhXpyB2HTA35zX31ZLAT301jZm11KSB4ppLcPqMUUZsU5xl
Czly3CMmj+BphJ+Z/mK7aw0b0tRZLiK0uBOouJLUrqcaQMip6P8AfXi8z6dq9Fep
r0yXeWJNVX8yfMdvd39xd250/Tbi3hmASOD1XuQUjjWijZByPUnr2ycZs5f5ruvM
tjL+YRsL+7uLqPSrO509E3+rl2ulZYEUUBCICTux6nDn8q7lJrLW0srqS90GDUnj
0K5eV7hWtfq8LN6c8hdpVE7SCpY0NR2yb4A1+Wxi0S+l1C7awsY4Ha6vEcxNFEqk
u4cbqQO43zmeg63bz/lpq36I8wQ2630l3Loz3FzLePaWCNGj85FZ5+So/qtvyjL0
qOOSn8qLmObysyxMJ4Le7nhhv0mnuIrtEYUuIpLiSeTg1af3jCoNDkX/ADl1LULX
V4FgvLi2nTTZZtCihkkjE2qi6hVEVEIE8npM1Im5ClTTA/5oa9dHzZpX6Ov5hGsc
Ytfq8zoTcrfejOLWJD6d5OEBWSGTZE+Lrhn+Xt3cf4+1m3udQj1e7mS5mupreW74
2RS6CRWssE0jRIzRkFeMafYb7QNc6fmzkWrz6zY6d55iuNXubqKLV9NE107tEILK
4W1N0itHx9GJInepSlBVq13yZflncvP5bdlne5sY728j0q4kdpS9ilw62zLK5ZpF
9IDi5JqO+SvOe/nfrWv6b5NlGjw3wMpLXV/p6B5IIoaSU+0rD1SOHIdBX2xD82NZ
0xvLQmj1GS11OHmLK2W6mtSLsRq4SkO0t1GGBit5Go5298iPnPUPNeg+Z7W/fUZ5
rC9MN1fW7Sy28SwKqfVxevxdLRROjJSIVl5b9DnbtLvvr+mWl96Mlt9ahjm+rzDj
JH6ihuDjsy1ocE5TlgjFV5MASF6VPhvnLvP+uW8kOhpqdxJ5b81Xtx6WlWUmoLHH
CBKoku5BC/ozcU+yj15E8aVOK/mXrOkNPpNzYaqx1ZZ1Szgt7uZGZUuBHOba2j/d
Xc6sODRudlqfmd+SV1KHzT5xtrzUZ9QWO8tngMx+GJZbRH9KNQAqqteg+Z3yPeXt
Qr+XU8WuG5tdIAlkbXpr90E8j3b/ALt5Y2e4gjrRWfYBem2J2/mjWIPymnXSnmv9
e9OVYFgY3M0FrLcSRR3UTOwlnhijUmKU7uACe+ROTXvMDWvki6jvLp9Qu7HRvqdv
LcyRXIJnC6hM9qai7M8JFftcFBY8dq9wuNWuX+oSaVafpOzu5Ck95BNCEgjG3q/E
37wV7JU5HfJN/JanzBa6nqkk8g12W0s7m8YcmeS3hkWKIUVaBmbiiimR19U0vT/J
HmJ/Nmr3slnZ65dQLM1y9tNcNyHpW4ki9NkRnagCFQAPAHDL8q2vl1HUIrrU21Qy
aZpNy1z6xnhaWVbhWeJqslCsaKWWgbjy6nB/5t6l5f0/yuZtZvpbQNJ6dhDFdPZe
vdMpEKPKhQhFb42JPEAVNemQq21DVl85WFsdblvdb9fTbeGWOVis+my6byubtbUH
0XiNz8Xq8eu1cHStrsP5UazJ+m72W803Vr1frwf9/OkOoMqoXAqqEbUSm2w2zrub
NmzZs2bNmzZsIte0fzPe3SS6V5hbSYAnF7cWkFxyepPPlLuNtqYVr5V8/qpVfOsg
rWldPtXp71b9WCfO0TfUtCEjmSSLWNOJegXk3rBSSBtvWuSjNmzZs2bNmzZs2bNm
zZGo/wAwPKDahq+ny3iWzaCYlv5bgelCnqkIpEjUWnM8PnjdV/MLyTp2jQ6xLqEE
1rcLJJZeiyO83AfvPSUkVYdD92Gdl5h8u3msXul2d7bzatZhTe20bKZUB6cgPD8M
KNa/MbyHpMWoSXeowO1jNb22oxRUeRJLiRYow6jrQtv4Yb3nmLy7aataaZdX1vFq
l4pNnau6iV16/COu9NvHA2jzeXvNOm6R5ihteca1u9MkmTjJEzI8JagJoeDsvyOF
+p+fvLmkavcW+p2dzZCKOaSPU5bfjBObeL1po4XB9RmWME148TTYnEk/M3yzBaW4
urW6066l1CLSxpc0AE8dxOYyhdY2eNU4zo5flQA+O2Hdp5n0m78x3mgwF3v7GBJ7
luBEQWRioQSHZmHH4gOmFs3mXyRY67qZupIbS7D2ljf3s1EilnkDPBByJo8iI1Tt
8IIqfAf5UutEu7S7udLtjaPJeTjUYZF4zC7Rykvq7tU/CKGtONKbUw6zYyeeKCGS
eZxHDEpeR22CqoqSfkMJfL/mjRNZ8vHXtNilNgjXHFfQZZmNvI8chWEDnVmQ8RSp
8Md5X8zafrcV1Hb2k+n3VhKIrzT7uNYpomkQSoWVGdPjRwwo3fffEfN/m/SPLsdv
9etZ715hLOsNtGsrJDagNPcNzZAEiDAmh5b7A4h5j88eX9FitJZrea9S4hfUa2sS
v6VrCEMt5JzKUSP1VrSrb7DBuk+btD1bXdS0awd5bvSkhe8k4FY/35cKquacyvpn
lTp064d5sjdz5/8ALVtJr3qySKnl2KObU5vSbhSTmAsZp+8IMTA02B2wX5X8x2Gt
2c7WttNYy2UxtbywuUWOWCUKsnBwhdN0kVhxYihw5wPqFzHa2M9zJFJOkSF2hhQy
yPQfZRBuxPYYQWfnTy+3l3UdamtpdOi0lpItRs7mOOOeKVVVzGQrMhaRXTjR6Gow
z8s61BrOjw39vZzWMElRFBOIg3FTSo9F5Uoe1Gwt81+etB8u3dvb6jDNMxjN3NLD
GJFtbdHWJrmUkqQgeQL8AZvbK8yeefL+galb2V9DNI5RbieeGIPHaxTS+gk0xJBA
eU8fgDHxFMV8u+cNK1zWNTstOtZuNg7R3GokQ+hJJG3plVKSNISCGHxIOhyRZsin
/Kx/LEtjrV1CJrmLSLqOwuESLee4nCCOOAOVD82lVAxote9N8OfLut2Ws6Yt3aRy
QKjvBNazKEkhmhYxyROqllDIy0PEkeGGWFPmrzPpHlnRJ9Y1Z2SyhKIwRebs0rhE
VVHUlmwH5p836P5flsoLu1mu7m+cvDb20aO4WIqHlPNkHwGRRRSWJICg4BuPzN8r
Jrx0GSO4e/mmW1tYxDUXMoK+ssdT/wAe/qAy8+IHauTDNmwm1nzDodhq2laXeq0l
7qspis1WIuqlUaQs704oP3ZAqdz0xHzD5o0/Q7q1S70+6lt3YGTUIYVa3tvUcRq0
rllI5O1KIGPcimI+X/P2ha5rE2m2cc8cgWWW1uJYwsV1HbS+hPJAwJJWOX4DzCnw
qMDeXdW8v2vkgX+haNdjSjLOLfS4ouc8jNcOr8I2cqFeTk3xMAB1pg6HzZYy+XRr
Vlp13dEMbY6bBCpu1ljkMTwsvIIpjdSGJfiKdcKP+Vq+U2uLFRDcsJBF9Yn9EcbF
rmZrWJLg8qq0k8bR/AG3G+2+S7TtOsNMsY7KwgW2s4ARFCgoqgksaD5nCPyz550X
zHNNFawXELRxrd25uIwouLZ2ZEuYeLPVGZCByo3tgCb8y9FEU0VzpOoR34lhjttI
mt0Fzc/WPU9J4kL8KMIZPtspHE1A2xbyPrflHV9S1a70KzkguriOzuLy5kTgJ43j
dICnxNQR+m6FaChB+eG3mfW7fSLFZ5dOutU5MR9WtIRMwUAsztzKIqqo7t7Cpwmt
/wAzPKc+p2sMCStbTxxCPVxEq2qtcQfWooGYkSKzw/H9jj71x6/md5TbysfMimf9
GG6ezjX0H9V5UmMJIj6heQ5cmp8O5yXZs2bNmzZs2bNmzZFJvzU/LyKWSJtdtmli
LLLHGxdk4Gj8goJAWm+Fmu+dPK+vQ6XHoupQai0es6Z63oNy4B56qW8K+mcn2bNm
zZs2bNmzZs2bNmNaGnXtXOV3n5LXU1lb+nqtdQnYtrrz+tNbzh7yO+cQQPIVh/fR
AD/J2x2q/lDrFy2p/VdStYxq0uoC59a3aThBeXKXUfpjkB6ivEFLHsajcYceXfy7
vdL81fpOa8il06zk1GbTYkjZZy+rzLPcCdiSpEbIBHxHTrhF/wAqb1OKXV5re+tz
NNKZtJln+syFPV1CPUZUkjMvpRqXiCfuUFRud8PvNnkDV9d8zafqaamsFhaSWk8l
oRIKyWdwJiKI6JIJBtWUMUIHHqcEeWNH80+WNL8v6BFHbahp9uRb314paJ4olilc
yBWJ5cpuCgDsTgHX/I3mjXtf1WS/vLIaJeafPptgESb61bJOg5uKt6TO8gHI0+yA
o71cPIGuXmlXA1O9tl1W+1ix1e7NtHJ9WVbFoAIow7F/jjtRux+0fDJKuhSr5vl1
71V9KTT47EQcTy5JO8pflWlKPSlMh9x5C8wtr11JZyW8UEeoTahaXNzGJ45ItTh9
K8ieEMp9SErWOvwsCK98kfkzR7+1k1rVdQi+rXet3zXRs+Sv6UUUSW0ILKSOTRQK
7UJoTTJLmzZGtD8t6xo2kyafaXcCme81C6e4MbMYxeTSzxcELAMY2kXly6gHGeQ/
KuoaBb6i1/NbtcaldNdvbWSOlrExUKxiEheSshHN6n7RNNsR8/8AlDVtfFtJpd3B
bTxwXljOLlHdDbahGsczpwKn1UCDhX4fHCfzf+Wuta/bafbG6s/S04SWtt60crGO
B0iVLtOLL/pkRjPGv7v4txko07y3PaebtS11rgSRX1lZ2aw8aOrWjzMzlq0PL1/D
th9myI+YvIba2/mVZLsQw6/p1tYIUSrxNbtO3M1NGBM429sGeTPL2o6RDqVzqk8M
2qaxeG+vRaqy26P6UcASIOS/HhCpPI9SckWBtTXUW0+5XTXij1AxsLSS4VmiWUj4
C6qVYqD1AOQzSPJfmeDypLomotpN1LdNcz3szwzTRz3UkiSpJLHK+4Z+fNew4haU
w78j+XLvQdImgvHga6u7qW8mitEMdrE0xH7qBG3CLx7964T+fvy9v/Mt+s9peRW0
N3ZNpWpiVGZxavMk5eAqQPVDR0HP4aHA/m78uta8xa7puqPfW8DWh9Oqo5e3SO4M
yTWhrQTOgWOTnVfDDDy15IvNL813esSmwhtfSmt7ODT7c27SrcTrO0l3uVaRGWil
etWPfJjmyF615DvL+LzGYrqFJtWvbHULIOjFEk09YCiTUYMyu9t8XGhocOfKGhXW
jaVJDeTRzX13c3F9eNCpWITXcrTSLEGJbgrNReW+HeRL8x/IbecdHFnHqdxplzCJ
DbywFDGXkThWWN1flRSeJFCK7HCzz1+XWq+Z1tK3Noz2kd1ZRNdRPIRbXsUcclwO
JUC6jMdUNOO/TAvnD8oTrNxBdWNzBBNbRRB1ljb/AE2ZV9JmvJI2SRl9ICiqftbm
tBnQdLs5bLTLSzluHu5baGOJ7qX+8lZFCmR/8pqVOCcp1DoyGoDAgkEg7+BGRu58
mRiLQrezuphBo+ojUHN3LLdSyD0poynqysz/AGpqip2ApgLzP5V8z69JpiTXOnx2
9rdC4lcQymeIxSlopLZufHmY/gcOCO48MDeS/wAur7y/5o1LV5r2OaK69YL6aMs1
wbib1vVuySVMkX92npgAr13wN5a8p+abLybcfUHOk+arhZbcC+mkurOJfrLssscE
UnpqWjbkCoBr9rwwxtPLPmm08nLoNsdLjMdosAidLmWCRi7CZZSz+qUkjI+KvLlU
74QD8ntSW+0K4GpwkabFDHJIY39W2EFw1xwsTy4hJQ/ov6oY8FBG+Ta10+81ez0y
91yKXT9UtHaZrW1upFiD1IAk9NlWZSoB4vUZHfJ/kLzB5fukmN5Zyi2gi0u14Ryq
TYRSyTepJVj/AKQWl7fBgK4/LPzDc2+rXFxcaadUvbiG4iWKK5ht2eAOpuHZJRPF
PKkvFjE9ABShqcG/ln5MvvLF/qNpJCVsILPTrKzuiUpObcTvKyIrMyIrXAReW+2H
Xn7R/M+saE2m6BdWto9y3C+a7WUh7YgiSJGhZWQv9ksNwK033wjT8utVPmW2v3ur
WHTRPZalcQQRyCUXdla/VFiiLMUFuU33HLB8/kS7l8nazoAu40m1W8urtJxGeEa3
N0bgKVrUkKadeuTHNmzZs2bNmzZs2bE5La3lAEkSOAQwDKDuOh375HfPMUf1bRjx
FV1nTmU+B9cD9RyTZs2bNmzZs2bNmzZs2bOVweaNXjuIdafVnk1O41K60+78tMU9
CG1t3mCuIQBMjrHEkrSFtw38pGBdP/NjzYw0me9h04Jc2+k3d3aw+r6kqa5MYo1t
mZutsBzkJVuVafD1yQeQfPmu65c+nqsFoi3OmpqtoLQyVWNppICkhcnkWMfKoApW
m/XIja/mh501saJKvoaXb3Ws6YGb06F7W89bnaMpmkZiPTX97ReVaBRTDfzv+aWq
aV5oudCtWgMDxzWquiOJoLn6jJeLK0rsEJURj92sbChrzr8OdB8s3/1zQNMmlnWa
6ltIHnao5GRokZiQO/xV+nOZ+Z/MOtaffeYf0R5hmu7WEWsGozSNAy2tzd38UJjt
Aij0jBau3qFqgFkJ3BwZofmDzIz6DGdXa40+PzHf6OzOqPNd28Edz6DSzdGoIQSU
UcjvXDvRru+b8x7+0tdck1Gxhgd9WtpmiaKG4d1+rQWqRhWRooqmata8kJ3yI65+
a2t6FpUmu+vFObq6v7h9MmR2Mdnp1x9TEMTBokj5leTSsWPJtkIyfeRdUvrh9b0u
8le6bRr9raG9koXlimijuowxAALRLP6ZPfjXJTmyD6jf3MX5kWNtaa3JJWOSbV9M
eSEWttZLCfTrHQSetLN8SsW+yrdsj1v5t1ZvP+pxXeqS2mnG4u7C1dZoGgiSCxW6
WdrZ4yVVPiPqtJu1Bx45IPyv1PULka7ZXV9NfRaderFaPcyR3E4ieFJQz3MIEUok
581C7oDxO4wN+bGs6lYmzhtdTl0tPqWp3/qQsiNJcWMUb28bM4YFGZzyQbt9Gbzh
d6hqWm+WoNP1i60/W9Wmjth9SkRApaET3MkkTq/L0YkZglR13r0wXpFvqc35k6oY
dXvpdK0yGMXVpLJG9u13dLzEKp6atGIYgkmzGvqddqZN82R/8wdVv9I8j65qentx
vbOzmmt2oGIdVJFA2337YXflhql5d6Tf2l5cTXVxpd69q080yXXIGKOYcLhEh9UA
S0JK7NUbgA5Mc54mtXdt+aUVomtPc6bexXRuoJJIZII5LalIIo4gHt3irV3lPx1p
1yOxefPMulecdVa4e51KBYdWmeyjMc9ufqU8aWMdqkAeWNvTl/flh9qu1VyY/k95
gv8AX/INlqGo3ZvtQM95FdXRjMIZ4rqVBxRlSihQANvxwh/NvzLrml6n/oGpSWIs
NLl1O2gjKhbm6S5ihWKUMCZE4SN+7Wnjki8zanrMHnHyilpqCJo97d3FreWaKpea
RbOeQcpCT8KNEPhUDfqe2AfLeqXv/Kxr/Tl1eXUtOns5LoCSSCWP1o50jKwLCAYB
DzKMsm7ncdDk+zYS+dLm2tfKupXdzeTWEFtC0z3Vs4ilX0/iAV2WQDkRx+yeuV5K
stYs/LFhFrF3Neak8fq3MlxxMiPL8ZhJUAH0uXAHvTDvIZ+al7c2fl157TVJtPvI
Vknggt5YIJJ2iXlu04PJIx8bRp8TDbIt+YnnDXoND8vTWGptHNPp89/dyWvC3LTQ
W8UqyuJwaxKZCXth+8cEAdDhb5o84+d9E802Rm1BpNM1d4pktYTErSW8caOnperw
ForvzSVpW+IlQvt2XTNQt9S0211G25fV7yFJ4eYKtwkUMvJT0ND0wTlO3FGahbiC
eK7k07DOeecNdvbuz0i70+9v9D1i5uPR03Rbj0LcyyeoA811GxdngijBZgrdP8oj
H/mVrE1i+n6hYa1JBJbyx+pZwTQCL03mEck88BDTXCj+74R9Dvhn5NvNek8y+bbL
Vr5b1bO7t/qSIgjSGGa1SQRqoLNsTUliST7YR+Xddvr/AMkTW2oX+o2t1+9dtfcw
QJKXunVILe4k/dq1AIxVPh+eA7nzPrTflfayrqEp1OS+WykKSxR3fpfW2g9P60w9
AS8U4m4+wxBI6jAMvmnWho/lnUl1+Y3puIbe6tucBjWKS9NuXuYAvrXLOo9IPF8I
Yep9nOq6hq31SaziS0ubsXkhi9a2QSRw0H25m5DinuK5z38rvMmq318ItQ1SS8XU
tMg1GcTPG3oXk88sTQw8QvprwjBWM1Iwt+t+YE0C71K11/UbnRrzVlsrdzPbG7Nn
beokklpLIsS+pNOtOJ6Ip+eHH5OeYvMGsteS6vdSzvLYabdCKQqVikl+sRycOIAo
wgUnqCakdckP5k3cdp5ce4k1i40ko1IFtGijnubggiC3jaUNu8lNh9JArkKi8x+b
YvNNol5q3PUEu9O0qWyiKGykW6076xPP6CjmaXHRw1OO2DoNV1A/l7f3HmHzFcx3
dlql/btd2DQW0900FzJHBawF1ZU5sFVQN+xPU50Dy22ptoGnNqsiTak1vGbuWKnB
pCoLEU26+GGObNmzZs2bNmzZFrm2/NAzzfVtQ0Vbcu3oCSzumcJX4Q5W5UFqdaDE
YrT82VBDanoj7/t2dyT96zxj5bff1zeYk1dNF0NdXlgm1AaxYevJao8UJ/0oU4o7
SMPhp1bJfmzZs2bNmzZs2bNmzZsi8OueRJfNlxbxxwfpySM2s+oG2IWUR/E1r9bK
cJHQCrRcyR4bYPWHydLe6aypp73tsskWkECEyxqigSJbU+JQq05BOgwXp6aH6jDT
ltfUt0WFvq4j5Rxn94iHh9lTy5AfThJdSfltpvFJItMj/SGqxwlY44W56qxLR8+A
P78Fa8m3GD9VXyhFeTXmpRWTahBatNK8qRvci0iDcmoQZCi8m6eJy7HQ/Lk93Y6/
Y26JJ6EhtpYR6StHdrFyZkAUElIIwCwqAKZHU1r8qbO81xxZWtrcLE41SY2JiN3G
8ojkVHMY+tAzOEYJyq5A6nDLSvM3kF7XQ7Sya3gW5me30bT/AEPSkint439SMQFQ
0DRKrq1QtOnfGaHd/l63my+h0qyt7bzDSX17pbT0HuArj6x6dwUT1+EhHqcWNDSu
BYX/ACzk8xXulSfV59QmunuXt7tOcC3fGOCb0GlUxCRvWVXVDUknatcOvJqaAuiU
0Nne0NxcGZpefrG59ZvrHq+pR+fq8q1w8zZErmT8vJfORs7nTrd/MNwjRG+ksqhy
0J5W/wBbaPg0hgrWPnXh2pilpqnkIecJNOtreBNf9H6m10trxDLEgkNoLngEZkjo
xiDVC70ww8qz+VpNNlj8spbx6da3M9s6WkYihW4ikKzgBQqkh61I74E87at5NsLa
0XzPBHdRNL61tC9sbso0G7XHBUkKLCGq0lKLXrjtX1jyjoZs7ue3Dz30zzWZsrR7
qZ5XjpJMot0kfeOgaTwoCcUsvNXliXzHc6Nbv6equS0pMLxrPJEoDqkzKqTSRJTk
FYlRh9mwPqNzb21hcXFyjS28UbNNHHG0zMgHxARoGZ6j9kDfCnyXqnle+0lo/LcH
1TT7GZ7VrQWr2QilWjunoyJFT7dTQdcPsi0GoeQr3zRf6YLWA61cp6V5LLalRdLB
QtEJ3QLP6NRyUMeOP0bXfJE/mnUrXTUhj116re3K25iNybY8JFW4KqJzAzBXCseB
NDhn5b1XQdW0eHUNBkjl0qdpTBLCvCNmWVlkZRResgY179cLPNuu+SNOv9MTzCkL
3SSfWLGSSAz/AFbiQhuWcK/oIGYL6jECp64Mu9Q8p6dq+l6TObaHVL6WeXS7UIvq
GTg8k8qBR8FV5cn2rWld8CeX9X8l3HmHVLbSLeODV3Pq38wtWtzdek3ptIsrIguB
G54syk0J98kubAGu3WnWuk3E2o273VkABPbxwPdM4YgU9GNZGfc/y43y/r+l6/pk
epaXI0lnIzorPG8LconKOCkiowoykdMMcJvN03lS20WS+80JbNpVm8crNdxrKiS8
wsTKpVvj5sAtBWuA/Nlz5N0yCB9Z05bs3F0s9tbw2TXszXUa1EyxRRyPyRV/vKbe
OBtS82fl3c6hc6PqRt57yVoLSS1nty5uHZwUhQMh9Yxu4LKteBO9MlwAAoNgOgzZ
sJvMuneUmtjq3mGytJ4tMUzLdXUKStCFIaqFlZgagfZ74WWt/wCQb7SF8wrYQ+jp
Essi+rZFLq1nY8pKQNH60crlw1AvJqg98y+fvJ8NrFqUCTtNqUxieC3sbh7wywqF
YXEMcZlQxrQEyAUFPbFNP0/yjpqReRBG11HcW9xeCwu0e5jNu01ZA7yKycfUloqs
fl0xaxi8i6q+o6LaWtjdrp0cWn6laLAjRpHQyRW7DjwKrWvAbL88LH8z/lsty8s0
EUVx5cQpZyy2ToyJyEBWwLRgyDmVjpDX4iB3GHPkuTy8fLdqmgM36Mh5xxpJzEkb
q59SOVZaSK6OSGVtxhf5a1H8vdUmvf0Pa2ySRTi/uHNr9X9WTdVvUZ0T1VJDBZlr
33wHP51/K658s3/1426eX7Xj9Ytry1aOGRJ3JikigkjHqpK9SjIpDGpGGnl6Hy1F
5l19dNMo1RRZpqMMgkWOOJYm+qrArAII+PP+72rXvjvO8/k6LTYj5osY9QtTJ+4t
5LQ3zc+J5MsSpK3wpUs1NhgG18w/lwPMVlHapbfpL6qkVlqUdt+6SB4/Vit1uwnp
ryi+NY+f2d6Ynfa9+Wmo+V/r0lrBrGhy3ksccMNi14JLpXdZWjgSNyx5ByXC+Jrk
p0iXTJdLtJNKMZ01okNn6AAi9KnwcAKACnQYLzZs2bNmzZs2bNjJ7iC3hee4kWGG
McpJZGCqoHUljQAZCfO/mzyu0GkIurWbN+l7BjS4iIAWcMSTy22XJnZ3tlewiezu
I7mAkgSwusiVHUclJG2LZs2bNmzZs2bNmzZs2c7/AMEeZeEeg/6N+g7G8n1S01Hm
31iWWaSaZbd4OPFOEk5rIGNVH2QcIrP8n9ZsjoNtbQ2McMFpo8V3dxkrJZz6VKZ7
hrdeFX+us3BzyQ925dMkPkD8vL7y3cwyOttCjaSlnefVqj1LwXMkrSt8K8vhkHxH
ft0yL6J+UXmSxjsWnhtp7jTtU02XnJOrCe3sWl5zqqW8Qjkb1+QD83NKM/TDPzl+
WvmzWfOb6nZyWcennk3PaKVlexltfSl4xPK5Ejq3IyheO3CoqZnoM2t6edL0K702
sEVqYzqUMnOJfqsUCrzBVSrSs78R4JXvtEtd8n+d/MOo67cX9paQNS2XQJlumkUQ
2d5HdiJ4/SUxvctF+8kDGlFFDxwfo/kbWoo9Ku7oW8d8Neutb1CJGLiKO7S4/wBH
jl4qZODzrvRQetMH6Tp3mqbz/e6trWn2yadDA1rolxFcmV44i4ZyYTEvGScirkPs
FVd+uQLUvyy8z6nJLZR2dsTaLq2nm/vSyso1W8S7i1C0IVwzwx1VhyDVWgIzofkL
Tb6Ftc1O6iktk1jUGuLazmXjIkUUUdsHZa/CZvR9WnX4t98lebIXrui+ar3znYal
Db2zWGkLNPaStcyD1WkgeMQPbFGjR/Uav1gGoSq03OEo/L7zTP50u9UaWOwt7kXE
6X0MxlaKS5sxbCOO0ZBCssT/ABG4+06/CRQ5IPyz8oar5U0a803ULuK7V76aezaG
IQgQPxC8lBPxniWb3PU4h+Y/lnX9X+qzaMkE0otb/Tp4riQwhY9RjSMzqwWTl6Xp
14U+LxGFnm3yRrmq6fZQQaXZTX9hFJp1jqct1LFLaxukXG+iVEK81ki5en12FH64
aWWl+bZ/zA/SOrWNs+jWFu9vo90lyWlQuF9SZ4DF/eTU41D/AAqKb1OTTNiF99cN
jcfUigvfSf6qZa+n6vE8OdN+PKlcL/KOh/oLy1p2lE8pLaECdyxflM3xytyIBNZG
Y1OG+Qe60LzdL58Gvm3tWttOt5obIG4kb6ws1OC+k6Mtq6b85Er6goKUwjk/KzX7
vzJqk/1z9F6fJBqMNlNDM1zvqsscszpbyKnomsZ5/vGLFvhKgACV/ln5X1Tyx5Qt
9F1KeK4uLee6dGt09OMRTXMksahfZXH6sJ/zI8j695gv+WmGA29/p8mkXzzOyNbx
yTxz/WEUK3q09LjwqvXrhzq2gajqeueXdVa3t4JNKvp5bpuZZ2tjb3EEQVggqSZl
Yqdl364H0XQvMf8Ajy/17U4oIbYWpsrYxTyT+splV0kWORQLXiqUdEJ5t8R6DJhm
ws8z22rXXl7UbbR3jTU54HjtXmLCMO441YruOvbBOk6bbaXpdpptqCtvZwxwRA7n
jGoUVO2+2+Cshf5qeSNY83aALLTNRSynhLyJDNCs0EshXjGXr8S+nUlSO/bpgLz9
5N1nzDbW/DTrO61K1Wa0tNSluJYJbcXEcY+vQiNSodJE5en12FGGFXnD8qdYvdTt
dV0aSNLy0RZLmX15YJ7u4kQQzcJV5/VQyors0Yq7AV716bpcF7BplpBfTi6vYoY0
ubkLwEkqqA78R05NvTBObIx518o3uvaXqlvb6lNGb2xe0jsXKfVPUY8hK1E9UPtS
oeg/lwBolh5402y1m8XT7I6trE02oLavdOYYbgRQ28MLSCLk6ssJdnCinSnfIve/
lp5jvtCseem2kfmU/WY7jWHvZmuLWW5mWU30LxxxrI3JB8BVSAFUNQZKNX0fUrv8
wLEJNfWVuNKdW1W0VOJkjuY3MEjyJKq+ou9KVPY4YWei6rpuv6/qtpBBNFqX1EWt
vzMW0IZZ2chGAPx8hTr7ZGdc8lecdX1fVdSkjtIJESBbBTcSzJc/VruG6joHT/Qu
SwcHCcgzHka8Rh95Ktdc0ySfTtSsgj6g93q893C3O3hmu7kt9UDEKXZFavOgr4YS
eSvJXmrQ5Y/rMNqyWtjDocLLOz+pbRyyyteMrRijVkA9Hf8A1sLdL/K3zEnlXX9M
u0tvrF5YpY2CyTyXQMsKuouVlkQPbxt6nwQICse9OuTDy7a3a+evM11JbTRWzW+m
28NxIhWOV4UmaT0iftKvqgEjvt2xfz/D5tudAks/LMEEt1dn0bp5pzbMluwIkMLi
OX96RspI+HrvSmReH8vNaHmG19O2tLTQvrNhqUqrK0hhaysfqZslh9NVdWG/q8ht
+zg6Xy75y0rybqWmaBDa/X7/AFG9lSlw9uIbS7nkkrFIIpOMyowC/DRTvvTeYaDZ
Cx0SwsxbpaC3gjj+qxt6ixlVAKh+KcqePEVwdmzZs2bNmzZs2bE7i2t7mCS3uYkn
glUrLDIodGU9QytUEZCPOnk/ynFbaQYtGsY66vYKwS2hUMGnCsCAtDUNk0sdPsNP
txbWFtFaWyklYYEWNASakhUAG+L5s2bNmzZs2bNmzZs2c3g84+Y1Fv5jluopNKvt
Rn0pdB9JVMIgkmiEwuB+8aQm35MpHHidgKVxCw/N/Vp0065udEit7SeHTbnUAtz6
ksUetzGGx9MCNVdgy1lqVoOlTh15J/MG88wXDR3umLYLLYpqVlwmE5aBpHhPqfCg
VucdVAr8J3odsi9v+bnmbV/0RJp2mx2dvfatp8RmmE/GSwvRLVA0sMYM6+lVvT5J
QijHDbzf+adzo/mC40SC3iYNDNFb3SO8skd4tpJdJ6qCP0VQLH9hpfUOx48TXJxo
F3Pe6Dpt5cENPc2sM0rAUBeSNWag7bnOe+Z/NXnTRNQ1qODUY76FUtFEhtVSOwnv
72O2gjjYE+s/oyNIyyHYhT9lqYvo/m/za82jW1xcW88K6/e6HqN0Y+M9yLVJ/TcI
tI4ifRDPT5ADDvTb7zOvn6602W+j1HS/qzXF1EsAhWxLuFtIkkBZpHlQO0gc7UBF
AaYT6V5+1/UNXjtLeCOZNTmvZYQzpD9U0+wuV09mUkP6szTt6nFiF47A12yUeSNZ
v9V0QtqXBtSsbm50+9kiHGOSa0maFpEB3Afjyph/myNQavrn/KwrjSLhoRpJ00Xd
pHGpMvMTCN2kc061oFA26132IZfMHnBfPs9pdyvpmj3BntNDV47aa2mmhtfXM0zK
y3KgUY0+EfDTvhl+Xet65fNrVhq9ybqfSbwW6TTQpbXTK0SyVmgjrGqktWIg/ElC
d8D/AJmeYPMGmm1t9HvFsX+p6jqU0piSZnGnRxyLDxfYJIZKMw+IdsC+efMvm6HS
dKv9KElpp/1R9T1zUbZbaZoYYkRiixXRHKodm+GrfDTvhr5e8wa7d+ete0m+aD9H
WlnY3WmpCDz4XDzqWldgKs3og8QKL0365Ls2EfnrXLrQvJ2s6zaKrXNhaSzwq4LA
si1HwgivywD+XetanqOm31tq08k+p6XdtaXZnhihlU+mkyB/QZoWPCVTVKeBFQcl
WbCnzZe6xZ+XL+40W3+taqsfGyhqi1lchFP7wqnw8uVCd6Uwu/L3VNRv9ClXU7ma
61SyuprS/a4jgidJYyCUpbfumADCjLknzn/lbzP5ivPNccd5dpNp2pnV1t7NYlQW
36JvUtVMco+OT1Vfk/Poem2HflbV9du9d8y2OqtDx066hSyjt1ICQzW6SgM7bu1W
qTQeAyS5sjf5h61qWjeVp7vTA316Se1tYDGiyyA3VxHByjjchGcepVQxpXrtivkb
VbzUvL8cl/M02oW0s1pes8aRuJreRonVhEWjLAruyfCeoph/kW/MDWPMWk2Gn3Oj
+gsTajZQag8wLP6FxcxwssS/Z5N6n2idvA5X5iXuv2GjfXdH1BbOeE/ubb6uLiS8
uGosFsvI/Csjn4yqlqbilDkL8y/mF570Lzbb2F/GkWn6jOiQxxQrNNwhjSVxZKrc
pml/eK5kAWOgp1Fer2N9aX9lb31nIJrS6jSa3lWtGjkUMrCviDi+RDz55xbStJ1K
HTHZNZtkgZS8ErIFuZ0hHouyiGWb4/3cfPdqA7YW6T5l1u9/LfUdUu9SNnf6ZLdI
96kEP1jjZyEcJreT9ylw4XiyDYMdsQnvfzCsdC8uXU2ri41e7kiR9M+pIrXT3D8+
E5G8K28H22RRuKnbbDm681TWX5gy6beXDrpZsLT6tbRWzzE3dzPMpeSSNXZFCQgf
FRd9zgPTNW86ahb+bbS6u4bHUNOv1hsJbWET+nA9tDOERZSgllPqEAsKcj0piaea
PNUn5VX+t28sH6bsobwma6jKlfqbSKWmgT4VnAj+OMHiHqK0wR5h1bzTFP5fudLv
4i1+9vGNFMCsbgPRrqWSapaNIYasCoA5UDE8hkq1DWLGwuLO3uTKJL6T0bf04ZZV
50r8bRq6xj/KcgZCvy0/MeTzhrfmtEngaw06eBdKiShkWB4yC81CTV5EZqdhQdcK
NU82fmBpml+bIYL6G81DSIIr2C5vbZbciFzJ6jW8MRYTQ0i4xO7V5cuVabzPQdX1
Ofzl5h0y5nE1naQ6fcWcfBVMX1pJRInJd3FYeQJ33xTz3c6paaBNeWGqLpRtgZJJ
hbrcyyUHwQxRuePOR6L0JPQb5DYvOnndfMFsL14YQt3YaTd6OIx6Bub3T/rbyfWC
GlDJL8FOnHsThhZa55tvPId/f6lq0elalp1/fRXl3Z2q3H7q0uJI0it4ZSQzNxVV
5AlvCpyaeX59UuNDsJ9WiWDU5YI3vIUrxWVlBYCu43wwzZs2Y1oade1ciQ1D81AW
romjkVPEjUbgbdq/6Icv9I/ml/1Y9I/7iVx/2R45NR/M0fFJomlFQd0j1GYuR/k8
rVF+84waj+anI10PR+P7I/SVxX6f9Dy/0j+aX/Vj0j/uJXH/AGR5cd/+Z7SxCTRd
ISIuomcajOzCOo5lV+qLUhegrkrzZG/PP+8ukf8AbY07/qIXJJmzZs2bNmzZs2bN
mzZsikVr+XEvnS8ijFm/mqSA/W4Q1ZfTdeLHhXiHKUDEDlx67YO/wP5R+s6Zcfoy
D19IiWDTjQgRxxika8a0YR/scgePUUOC9N8uaFprxvYWUVu8NuLOMoKFbdXMgj/1
eTE4Ty+Tfy90xYkmsre2F3qME9uHdhW+Ri8Aiq3wlTUqi0XrtgrWPKHku4vZdc1X
T7ZrmKJmmvJRTiixujO2/GvpOyluvHatMU07y3osd7Z6tpkjxQLDJ6UEMhNtKtwk
Kq5Q1HwpboEpsBXxyO22n/k7HdeZjE1kZirt5mVp3ZR6jc3eRWcqG5qPiXcEAdaY
baOn5ejS9BXTHszYmcyaDxcEvcCKTk0ZY83k9MvyrVutcQ8u6f8AlvF5u1aXQ3tz
5lqzausU8jvylILF0LlK1UA0G3TbpiL+XfIUM+p3txcQsNJu3vmaZkKabcTRiSQq
SKBWNJij1UN8VOmHnk600O08vWtvolx9bsE50u+fqNLKXJleR+7tJy5e+HObCq5t
vLl3rE9tN6MmryWJiniD0n+pSOQahSGCM9d/HCOHT/ywXzbc2qLZP5kFp6d1bO/N
/q/AI3KNyUqY6BjTkV67YM8hP5EOlTR+TZLeXT45iJntmaQGUgN8UjFmb4SKb9Nh
thhr/lby/wCYYYYdZskvI7d/VhDllKtSh3UqeLD7SnY9xhHeaR+WWra4dCuUtbnW
LaQ6g1gZG9RWcKpJUN9kqi8o/s0pVcHWOueRX823VnaXlp/ieWMW91ArAXDR2tXC
Fe4j9UnbxyR5sB6y+lR6TePq/p/otYnN76wBj9Knx8we1MKvI8nko6MYvKEtvLpk
ErJIbZzJSagZhI7FnL0YfaNaU7ZIc2A9Zh0qbSbyPVljbTDC5vRNtGIgpLliegAF
a9sLfJL+UW8vQ/4TeKTRgziKSEs6s/L4yXers1epYnD7IfZaV+Wd75j1m2sltZdd
fgdXhikb1Fo4forUSrqC/ClT9rfD/TjoTalqb6e0LagZY11b0mDOJViURiWh2YRc
aA9sMc2FnmZdAbQb0eYTENG9Mm8M54xhAa1J2IINKEb16b43ysvl1dBtP8OmI6OU
ratASykHqSxqxav2uW9eu+GuFvmD/D5tIV1xoFtWubcQC4YKrXQlVrcLUir+qBxH
jhB530T8tGW1l82iCMS3Reze4nkiP1mVBGWQq6kHgoB7AfPFNai/LTU7m6sdVayu
Lu3S2triOR/30ayOGt0Ug81LOR9k1PfJXFFFDEkUKLHFGoWONAFVVAoAANgBjsDa
lpthqdhPYahAtzZ3ClJoXFVYH9R7gjcZGtRsfy20G2s9F1AWtlBqCGytbOZ2pMpc
OwIYnkS9CXbevU5vONn+XH6a0i98ztbx6uG9LRpJZZI5SeakrGEZeQ5leW1OlcML
Gz0mfzhqOr2eo+teRW0OmajYI0bpG0bNcRFwBzSTjOduVKHpgO7/AOVdXvlvVtTu
HtJdBvpGk1W85/upJYKQFjIDXmhiCgqa1G2+J0/LbTvK36R5WsXlu7tFsTNyZoJL
eQtSMip5F2kbkT8RJ3wFcf8AKotW1nQNVkubOfVJYwvl+dLh1Zo4XqFjCOqlQ60o
w3Ipku0TSk0nS4NPSea5SAECe4b1JW5MW+Jtq9cJdIP5f63fahd6S9pd3kNzG+oy
27fF69uhjjMhUjlxUkd1wn0+b8mbXy9rL2c+nLokspt9YYScoy7bCIkknif2VT4e
vHvh15aXy9P5h13U9M1Uajd3S2SXUCtGyW8UcTNbqnAA0cSM9WJrX2xv5gWnkK40
mA+dGgXTop1e3a4leICehClCjK3IAnp064Hgtfyzj83WUcRsz5mS0T6kgkLyG3Re
MbgcirME+yx+Lj0NMD6/B+U8/lZ5NXksm8vLqEkzSCVhH+kPVf1GVom5GUSlq0Ox
r4ZLtNisYtPtorAg2SRItsVYupjCgLRyWLbd64JzZs2bNmzZs2bNUVp38M2Rvzz/
ALy6R/22NO/6iFySZs2bNmzZs2bNmzZs2bOYr5V8zCOHQBp6iPT9RudXTXvVj4Ti
d5pEhVK+sJj64jfl8PEV5H7OENh+W3muwm8uJDZOLiG00o/pH61y+oXNvKZdW9Qs
5dzeIfTqgYGlDQZJvy48m6/oN2sl1G8K3WkxpqDNcGYtqCzyGpqzn4YWVVI2A2HT
Ibon5Z+bIlsZdS02S6uLLXNMu7pXe3VZWtjKLm/j4yuzs3qqS8hV2A+xthz538l+
edR89y6hptkn1J4pIXu0mUNJbS2UsXouZZOS/wCkFSY0ThSjVLVyd+XdSubJNJ8v
Xun3EFytpwFxRHgItIoFcl0ZuPJpiqA7ni3bIR5i8u+avMOo63IdAkshYrbx6CGl
tfRmhttQivLgr6bllmujCKB1CrxFTUnDDRvJesB9H1W405IL4+Yb3VrhGaNprWzv
UuGETMpZS3ORA4RiPc0wz0i01e6/MW5vtQ0GWw0/Trea20W7D2xhb1pFe5mKxyGT
ncFVoCmwWp3bOeeYfJXmfV9Nv9Mg02TUb23bWLeaMz/VQt/fXAuLTUOblBIn1Q+l
UVO/AilTnS/y5guOOu34VotM1HUpJtMgdTGQiRpFNIEIHETXEcko8eVe+TDNkVfQ
7mz89XfmC0sBJDLpLRytGY1knukmDInxFd+C0BY0GR7zP5c1/wAx+YkjbSJrXTI7
O8EkhuYI4pHvLRoQ0ZiDTR3YaT02ZgyBKkVNMOvy00vXdPsb6O/huLLT2mT9Eabe
3Au7m3iSJUkDzK0lQ8qs6DmaKe3TJjnL4/K/me189SXw01p7Cz1O91yK6SSICdbr
ThZpaxqzKwmDip5gJx/ayW6Zo9+/nHVdb1CPjEsVvZ6QhZXCwhPVnlA3KPJLIUbx
CLkjzYhfvdJY3D2kSz3axO1vCx4q8gUlFLdgW2rhX5L0SXRvLVlZXLGS/KerqEzk
M73Mvxys7D7R5GlfAYd5sJfOek/pfyvqGn+hLc+vGP8AR4Jvq0snBg/BJqHgW40r
+rrgT8vrPW7TQXTVUmgL3M0ljaXUwuLiC1Yj0oppQ0nNxufttsaVyS5zTQtE8z6Z
5jFxJo7vbaS2rGKaOWCl3+mL+O5j9AFwy+jGp9T1OO/2a5JvK/l6TSdf8yzJbJbW
GoXNvNacCtHItkWZyq7gmQGvLc5Jc2Rn8xtG1HV/Kk9ppwka7Se1uUSF1imYW1zH
O6xO/wACyMsZCltq4r5DsdWsvLyRanG8MzTTyQ28ziWaKCSRmhjmlUt6kqIQHbk1
T3OSHIt+YPlo63p1gYLRbm/stQsrm3diqmJI7uJ53Ut/xUh6bnphB+a3l3zHr1tT
R7K5S89K80oXEclrT0L+KMPIUmO0ZZAGYHmtDRDWoIfN/wCV/mBdX03VtBt2e409
VuLiRJYfUE8sawyrYJOPTRv3ays8vhRKEnOu6WNRGmWg1IxtqIhj+uNDURmbiPUK
V348q0wTlOGKMFbixBCtStD40zlvm/yd55m1PTbqC4l1S9+qS2Zv4DFZxRzNcpNF
LdwFj6kKIpUovLl3U7YM85aN5k1LWLLVNI0y+tdY4fVbe+F9HHbWwiuSxe5tlekq
Sx1I2c9AVBw+8peWf0L5g8zzQWaWmn6jc289oIytHK2yrM/FdwTIDXl1yHeX9H1y
+/LtZbWSW5W2n9bTtHWCO3mgurO+eTlzuCqyfEteD8VP83fDPS9I852H5eXuiw2k
zazeLPMt3LNArq2o3bmTk0ZCieCKT1DxHDlspOBfMfkbWF1aGx0jTUm0y6t9Itxe
ho40tv0TetdSNMhIcmRGonAH4utMmtrd6jrtnpeqabcS6XbGRpLuyurZTLLGrFfT
bkwMX2a1Fcjvlyz8xxeadS1a70SaGC5SDT4YZZraT0kjd2ZoDEUH1TcNRl9TkTtT
CsW/ni0/T+uWnluWbUrkW1rpdlPPZvJbmIyhpIGVo4vq0Ql5Rq37wsWBoDsN/K+w
isNZ1azgtZ7SKy07SLWSK4Uc1nVbiSRGZC0TP+9DN6bFRWmHv5iSa+mgMmg6Q+qa
hcE24eNrdXtopVKyzp9YaNWYLsq13PXbIdbeRdZj12zsbbSmt9C+tadqAllliaOG
Cz076lJaOqs0hmJPVQUI/awxh0fzL5a8jX1joWhmW/k1O/OnQW72wa1trm4kMdxG
JWSMlImqqV67Hvk28s6fDp3l7TbGG3e1jtraKNbaUqzpxUDi5QspYd6EjDLNmzZs
2bI1qn5beRtV1CXUdQ0eC4vZzWWduQZiBTsw7DAx/KP8uCKHQoCD1BMn/NWOb8qP
y9ZVVtGiKJURxlpOKA7nivKgqetMb/yqX8uf+rHB98n/ADVhloPkfyn5fupbvRtN
isrmdBFLLHy5MgPIKeRPfDzI355/3l0j/tsad/1ELkkzZs2bNmzZs2bNmzZs2QGH
z5rnODW5obb/AAzeXs2mW9qvP66kkEksXrvIW9Jld4G+ALsCDyJqMSsPzjtLr9Hy
yaLeW1peR2c1zNK0PK3i1SQxWDOiuxf1nU1C14Dc4b+UfzDtfMc7xDT7mwBtUvrU
3HAma3Z2iLgRs/GkkZAB3Ioci9v+d36Vk09dE00Si61Wys5WeeJwLK99XjN+7b4J
v3JrC3xL3G+HXmr80rXQtcm0NrQ/W2tpXspnliIkuEgedVMCv6/pcYjWTiBXb3yW
6Jey3+jWF9KqrLd20M8irXiGkjDECu9KnIJ5i8+ebdC1HVbWaOwuuENvLZiESgWh
vL1LO3F0zN+9MnNpKIEpwI7hsX0rz75jml0i1ubO2Yy6zd6Jql6jMitJaJNR4ISW
ZfUMFTyYhRtucNrHXfMy+epdEvktJ7GW2e8j+q+oJbSNZBHD9YdzxkNx8ZAVRx4H
r1yN6h+ddnpLifULYNaXlzdDT443WOUWenyi1nmIkYetK09eEMY5FcmHlHzBc6ou
pWl8qLqekXb2l36IZYmBVZoJFDEkc4JUZlqeLVGH+bIrqGueYrLztpmmn6pLpeqe
qkVqiyfW0SCL1JLp5CRHwWQrHw41+IHl2xRNf1+fzbq2grb29rHb6fFdaZcyFpWe
SSSSMvKilAEDRiihuXXcbY38vdb8w61pE+oau1rJE1zLFp81pFLB6kUDGJneOV5S
tZUbj8X2aHAv5h+a9c0T6tFo6W3rNbX2oTyXSu6mHTo0keFVRkIaX1KByaLTocD+
evzKHl3QNIvLeKJ9R1eS29O2meixwSPGLiViCpIjWWg8WIweuveZofPkWjXCWk+m
3kM08cdv6guLWGGipNO7ni4mduARVHE923yV5sJ/OOvP5f8AKuq62kQmbTrWS4WJ
iQGMak0NAT92AvIPmK/1rSrg6i0bajY3LW10scMtqQwRZF5wSmRo2KSKac22IOxP
ESXNhV5q1a90ny7fahY2cl/ewR1trSJDIzysQqDgpDEBmq1O2AvIet6hq+hGfUpY
5NShnlt7xIrd7X0pIzvE0Ukk5DKCN+ZrkiyEeW/OWu6h5oFpdx2w0y+OpCwjiDie
E6TdLav6rliknrF+Q4qvHpvht5Z8warqWseYLHULSO0GlXMUVqiOZHaKWBZQ0jfZ
5Hl0XYDapOSHNkf8++Yrny95YuNTtkV7gSW9vDzR5VV7mdIFcxR0eTiZK8FIJ6VG
K+TNautY0CG7vDGb1XkguxHG8PGaFzG6tFIWaNgy/EvJqHox64d5GvPPmPWdCtNP
uNOso7qO4v7S1vZpXKrDDcXEcJZVX4nc+p8PYd8rz9rHmHRtGfU9JazWO0BluUu1
kdpqUEdtCIynF5nIUOSeJ/ZORDXPzY8xaN5mXTtQ06Kz0+4njhS6lSYmBVjSWQ/B
X608qF/TWEfDxPLOo29xBcwR3FvIssEyiSKVCGVkYVVlI6gjFMi3nXzta6LpepCw
ntptbsYopXsnfk8Uc0qxCZ4lIkdV58gi/E/2V3OFFv598xTfl7LrVtp/1/WRctY2
yWsMjpKwm9FblrYus0S0+N4nYMo2OEyfmtrIuNIg9e1kX0vX1q5Nlcxop+uNaNEw
9R/qpideLM3qVboKVOTC684pZeeZNG1C6tLPTjZWz2nrEpNNeXU0yCNGZgtAsGy8
aknrgXSfMnm/VoPMtutrZ6ZqWlXwtbP6wzzRLC0EU3qzemV5vxlJ4qQO1e+Arrz7
rMf5c2vmEJbpd3U6W6XfpTSwGKSYxLeR2qH15FdAJFiU8t/bCQfm35jN/okP1W0C
3cdu08dJCbg3F09szJLy4WfpqnqBJ/ievAfEDnT77WdJsJ7S3vryG2nv5PRsopXC
tNJ14Rg/aPsMjHkX8wD5r1fzLBbxxDT9Jnhi02ZWJeeN4yWlfrRWkVuFB9nfAK+a
PO4i8wWsk2mm60doXl1GG3u5YIBKpkkt/q6M01xLHHwaqlQefQEUwb+XvnLWvMU9
2NSgt4EW0sb22S3JYqLsSq6u/Jlb4oOQpSgNDuMNvOuoa3p2hzX+lT2dr9UVp7u5
v1kkRYYlLELHGULM1OP2tvfpkSt/zH8zPrdsk9hBb2jTWWn3OmNyN0t3fWP10ET8
hFxQ/u+JT3qOmDrLzZ5t1DyTeavJ+jtF1CwvL2K/e5E1zbwW9lNIjHjG0bSPxjFd
wOpHYZLvL+oXeo6HYX95bfU7q6gjmmtq8vTZ1BK1wfmzZs2RWfzP50jupYo/JtzN
AjFY51vrEcwDQMFaQEAjffGf4q86/wDUk3f/AEnaf/1WzDzV515ry8lXSx/tv9es
SQPZRKa5X+K/OhduPkq7MX+63N7YKSPEqZar8sv/ABV51/6kq7/6TtP/AOq2U/mv
zxT4PJF0WqNmv7AD7xKclqklQSOJI3HWmXkb88/7y6R/22NO/wCohckmbNmzZs2b
NmzZs2bNmyLR+TPKD6o+pI7OLlJJ4rQXDG0V5BxluoYA3prIwko0ijv4nGRflv5O
lbSbmGJ2h063toLdEncwTw2fxWZnUHjN6LfHGW6HfDDS/KflzQjFcW0foi3s105G
lkYqLcSNIqnmaV5yHfrhdbflh5Yt4Y4Yzd+lb3kF/Zo11Kwt3tSTDFCCaJEvIjgN
qGmXf/l15M1rVW1uWJpZ5iXcwzusLS+i9q0pRG4GT0XMZbwA8MFWGk2djrltbWWs
SKlpbyGTQ3mEtY3WGKKTizc0SIQELtSrt3wptfI/ki7h1i/j1Ke/sdbl5XjNftNb
rcLKpSSE8iscsbooTifhoAMMrDy15QsZNO0eOUNf6dO+qwxS3Be7kmkV4pLqarc5
C/rNyZhSuP0jyho2l+ZtQ1a2vbt9R1IGW7tJruSWIhiFVxCxIULw4p2A2GFkP5ae
X7i5lka6lkgt7yeW0jtZWgaFLhhLdWcjxMC8Lzj1ChpQ4feWvLw0eG7aWb63qGoX
Ml3f3nARmSR/hQBQWoscarGoqfhUYcZsilx5V8uTecrjUf0rdRa9c2npyWMV+6D6
txaIOtsG+EKzlgwH29+uDYYPKra7LEt7FNrZsksJ7c3Ie4+rxlpByj5cuX7wktSu
DfL0ejQ6JZ2uizRz6ZZxLa2rxSCZQkA9MLzBapXjQ74E80eTdG8yxwJqPrI1vzCy
W0rwO0UwCzQuyEFopQoDr3piGrfl75U1iwaw1ayW+tvWWeAXH7xoOBjIjt2beKP9
yvwrt9+bT/J2jWXmy9163vLxtSvFBu7V7uR4OJHGP9wTRVXiQnYb075I82A9Us9L
1Oxu9Mvwk1rPEUu4Gan7qQEfFQ1ANDQ4A8oaPoOm6TXRrg30F3I1xNqLz/WpLmQ0
QySTkt6hAQJWvQUw7zYE1ezsrzTLq2vXMVpJGwmlWQwsigV5iRSpQrSvKu2AfKWl
aJp2ixpo1wb20nZrhr9pvrL3Ekh+OV56t6jGnWuGVzf2NrJBHc3MUEly/pWySOqN
JJSvBAxHJvYZGW8meUrDV5Ln63NZ32qM62cP1xo+DySLcXC2UZYcDM6BpQn2sN9O
Xy9FrmqfUrmJ9XuzHLqVusweRfSjWFCYqkoOIA6YbZsK/MFlouqaTeWWpTKlpGFe
4lWX0XgaMiVJfUBBiZCA6tXbrl+WtM0jTtHgg0mT17N6zLdGT12naU83meUk+o0j
HkWrvhngDXNL03UrEQ6kaWsM0N0TzMYD20qzRlmBGwdASMIvN/lHy5qgtZNY1W8s
Ql4JrJ4797UfWXQIix/EATRTwXxJI3x/mHyl5O1y5Z9Tmrf2MUUKXC3JjuLUO/JG
RgwMTTHYt1cbZI7OztbK0gs7SNYbW2jWKCFNlREHFVHsAMWwBrehaZrWnT2F/Fzg
nC8mQlJFZGDxujrRlZHUMpHQjChPIvl+10o6UlxdQw3HIGUXUqTyXLv6zXPqhg7X
Bcci/X6MAXP5f+QreXSrW4la3lUtHFA92yNfn1DcMtwpYG5PrEymtfiNcM7TTLOX
zvqGsQahBcEWVvYXmnKEeSGWGWSaN2cMSnJZmHEr71xHUvLnlLUNG1wzXjRafrEn
rateQXjRDlCiQsPWRh6ahYQrAGnWuNPkzy/d6BFbvqV5c2CQxNbXxvZGaP0XaWO5
inB+Fxy/vB+zQdML7jyX+WtrqWmQT3EdvdxLEI7J7zgb305TNA1xEXH1hknZpELA
/GSclejabcWOmW9pe3b6lcwA8r2ZQJHJYkEgdKA0wl0Xyj5It9S1G88vrDaXc1zE
2qDTZFjHrWyFVilSI0XZyWQjc7nfCyz8n+R7TQdShg1+7Gni59W4vjqshe0uVYli
twXrE7NJ8YJ3rvhl5O8r6XouqapJpt5DLavDZWsFhCF/0WK2R2USMGcu8rTs/Igd
fpxfz15f8va1pUMWvX82n2VvcRzJPFdtZ/vlP7rk4KhqNuoPemB18o+UF80W1zJc
vLrMUcc62Ut2z+q9unopeSW5b45VT4fVpieueU/Js3l2ezvNQlsNLN/JfT3Ud81t
S6kmaRucwYbeq32DtWm22Smyt0trOC3SR5kijVFmlcySOFFAzud2J7nFs2bNmzZs
2bNmzZsjfnlgLXRwTQnWNOA9z9YU5JM2bNmzZs2bNmzZs2bMQCCD0OxzhVx+Xnmu
LTLu6tbeVNQ0V20PRYomZeWmzCWPmi/tBfranmd6RkmpUVkPlez84af5y0/R2tb2
HRNPu9UZ5F208WcsSfo+GOhoVQA8VAonTrka8zeX/PuqXHm+C/j1KeyLSyLa24uO
M8KXkUlkIH9UR844Eb4YEBJ/vDWmS38wI/Nz+ZtCk0K1v2hg+rP68ckvpBDdIt0s
sSvHHzEB39cPyH2AGUnBn5fanF5b8r6Joes21xYX11dTW1vHJE3Fpbie5nRQwqP7
uIsfCo8cJ/O2lHV/Nt5YaboV3a3cdhfPFrMds0Ud3f3Fk0MSPeCgEUcZIIY7uVp9
nCmTylean5b1O5tNDu7SL9K6PPpmnPE1q3K1NtFdTNagqKKUdgWH+UPHJdqdvb3X
5paYiaLc262Za7uNcSzJS5na3aKOE3a/ZjjjJ5BtmbiB0ORzzTBrE2p+ZbW3truf
W59QtTytZZomGlm3Isz/AKO8MjRi5Eobg68WPKSqjD/8rzqD6pqUtwrrM1hpS63z
FAdaFufrnT4eYjMQfjty9650TNmzll3pt9b/AJhyXZ0e5kkh1RtWOpxQc1bTl0n6
t6CTjcubkbW/+ypgjXfK82vaz5l1FNFKyRaObbRy6rayXF1ewP60gnUB0cIUgJav
HenU4J/JzSdSsdP1WW8tJbVbq4jaAzQCxZxHbpEx+pL8MPF0K1H95Tn3zoWbIfof
l59P/MnzHqUdvKtrqdjYM105Z1eeOW5DorMT9hGT4RsAcmGbOY+a/J+qzP5/XSLS
Uza1pdmIJi5Hr3CNc+oiuzfsoyjjsACBh3+WVjNBBrl2LCXS9P1LUmudLsZ4vq7x
wfV4YjW3/wB1Vljc8ab/AGu+TPNhb5ka1XQr17vT5NVt0iLPpsUYmkn47iNYzQMW
PY7YRflZaNB5XMslpNYXF5d3F1cWU0DWoheV6+lFC1KRotFBGzGrd8jP5v8Al7WN
S1RDZabNfNeaXLYadPEnNbe+e5ilWR2/3QPTRv3vbpXA/wCaOiazrWs2NxpWn3Mk
9ykVkjy2pZITa34md1m5qbUyIh/estGSnHfDXyDpF9p3nbVxFbXv1ORbmTUb7Ura
CJnu5bkPCLaeJQ80RiLVq7UovQ7Z0jNnJ9U8n3lpY+dIrHT7iW2utY03UAjKZ3uo
oRayXZRXLGaojdeJ6/ZyYflzZXNr5fmMtq9lFdX15dWVnKvpvFaz3DyQI0X+6yEY
fB+z0yUZz/8AOvRfNes+UHsNCs47+NiZb20MzQSyelR4UjISQMPVAZlNK0p44Ufm
rp+u6tLpdza6bdSvZQ3tq8Mdql3G19PFC1tVZlK/V+asrzhdhUVWtcJfOnkbzJa+
Y7PXdMs57maNkvtSMcImjhlkVECRwqyteNHLEHRWakS167Z2jS5b+XTbSXUIVt79
4Y2u4EbkiSlQXRW7hWqK4Jyn58G4U50PGvSvatMg+taDrt3f+UtR1GCK61ew1Qm4
msRKtvDbPb3Cl/TldqE1RS3XfwwB5+kttWvdHtl0C+aS5uVW51hbB5ZLa3t7ipRJ
B8cLTOtVfoE+I9sDfl9oWpWvnBpZdJmsTZQalDqV7IvBLmW71AXFsY5P+PjjAD8e
/H7OIeUZpIvy0kuG0u317QI/Way0eytzNdSXS3knISqW9JgJNz8NR3rgmPRFv/ym
v9AbT7yW8m065vPq728tnG91OZWEEcTEcVEv2YTsF49sNtQ8sHVvMPldb7TY3tNP
tTd31zLDG/K4hCLbQeoRzUxyOZRQ0+HD631a81qz0zUvL8tu2l3DsbtrqOUStCpK
n0QCnF+Sn7YIyAfljpuo6RfIbvR7u1jj0+30m/P1Yp618s80jz/D/exiNlBn7+OI
WdrZzaf5i1H/AAte2MRkgt7HTP0Sr+hFCsgiuvqjkJdSc3Zm4VIUqP2cMfycsvqO
p6rZSQLbXttpukR6hbhxI6T0uW4yt15+myGh+yKDoMP/AM0WjXy4eOhS65eSMYrN
I7X64LZ5UKm5ePqRGpJoNz0HWuQqz8p6hD5osLW1069MYuNNuLfVZ42R0023036r
PHJdV5pKZTvDWtd/fByaSPLv5d3tkvlufUpE1fUP0RZvafXfSE1zL6N3JExZnRUb
mT9pvmc6H5UsorHyzpdnF63pwWsSL9ZVkmoEH94rfEreIPTDXNmzZs2bNmzZs2Rz
WvIej6veS3dzc36SS8SY4r24SEcV4ikHMw/8J1365HNb8i6Toj6PeWdzfyyfpbT0
Zby+urqPiZwPhjmkdFO/UDOjZs2bNmzZs2bNmzZs2Y1ANBU9hnNF/OiGNLR7vSpY
4msZbjUpo35pa3kazN9TY0FXP1Vx9K0BBrkh0H8wdM1KXT7GeJ7fVryW6tZbdQXi
S6sEVrpBLtyRS9EanxYUeYvzm0HTF1SKztLnUL/TmKJbxqFFw0U6QXIhatT9XaUc
6ge1ckOuedtL0W/sLO+gulF+UX60sVYITK4jjEzkjdnYLReRHeg3xTydr/8AiXy5
Z6zJbC3eZ5qQ8vU4GGZ4ahqDqEr9OFHmXz1qvl7V2W90lZNGaC5lt5oJg9031O3N
zLK8PEKkO3p8udeZWoocK2/NTV7LSp5NR0RX1G1vrG0uVtJudrHFqHpNHK0sixv8
KTgFeG7bDbfJDqHmbWbHzdp+lzWEJ0nU3a3tZ1nLXZlSFpnlMATiIEC8GbnXkRtQ
4V6z+ZcOm+YWtI9KmvbWO4/R73VsPUne5W1ku3hiiA+LgqpyLMB8XXbDjyt5stNa
u722ihESxpBfWcyH4LmyvULw3AqFIJZXRgR9pckWbNjJ5fRgkl4NJ6alvTjFXbiK
8VHcntkW0bz2b3yNfearrT5LX6gL9ptPDrJKBp8kqFeQ+Hm3o9tge5x3kLznN5ki
1GK6hgivtLmSG5NnN9YtiZoUuECSFUPJUlAcFdmrkqyFWv5g3M3nX9CNYKumyXk+
lwXYkJmN5bWovJC8XHiIjG1FIYty7UxulfmLPfefrryw1iqxQtNErrIWuYzbqret
cQ8QI4JudIWDHkewyb5shuq/mL+jG80tdaZKkHlu1gukYunO6ExlWqr+wvKGgLGp
60wy8neY77WYdQg1K1jtNU0i7NjfJBIZYDIIo5g0TssbFeEy/aUb1yQZsDalNfQ2
E8lhbrdXqqfq9u7iJXfsGcg8R4mhwq8meYLzXNJkuL23jt7u2uZ7O4+ruZbd5Ld+
DvBIyoXTlUVKjcEdsKPPf5hXPlm9SGCwW7ht7R9T1N3kMbLaRzJARAoVucvKUGjF
RTvifnj8yW8s6zbWQtIprcRQ3F7JLN6UhjubkWkaWqcSJZfUNWUlfh74t5P8+3Hm
LzDqlj6EFtY2hlWz5NOt3MIZvReUxyQxx+nyU7xyNTavXJnmyCz/AJlXSWPmGY6Q
1tcaRf2um2kN1IE9Z730Vhll4K/pJyuBWnI8d+u2SHynr02taU89zAtve21xPZXs
UbGSMT2shikMbkKWQsvwkqDTthzke89+b4/Knl6XVPqr31wGWO3sozxaRmPxGtDR
UTk7HwGB/PvmPzDoOn213o9nZ3rzTJbehdzywPJNMwSCKHhFKCzuaVagGR3U/wA4
m03zLLot7pqW6iZIPrks4SKHiqPPJcs6qEQpJWDjUyUOwzpSsrKGUhlYVBG4IOXm
wm81eZrPQNE1DUX4zzWFu1z9UDhXZV2rTcha9TTAGiebNUutG1Wa800NrGjTva3V
lZSepHLMIkmX0ZJRF8JSZalgKb4DH5iTmx8oXS6TIyeaHt0mlEi+ja/WImkAL0rI
1VoAF99sM5/MC2Pm630EQQW9jLZSXsl20gjPq+usSxqnGhLFySeWF3l7z5d6p5jf
TprGOCxuHvo9MnSUvMW0udbe5+sRlVVOTuCnFm260whf85pklvo20+BpCK6VAtzW
UA3q2CtfqU/cK0r86ry+AHvkv8jeaI/Mfl8agsUUTwz3FpOLdxLA0trK0UjQSUXl
GzKSpIG2Fnkbz/d+ZJ3insorX6xZpqemGOVpOVpLI8SCeqJwlDRnkF5D3wv/AMe+
cU0fzBfz6bpcKaDP6Utyby4NuwiUtcrUW/qc4vhGyUJJFdsOfJnmPVdT1HUbLVtK
g0rULe3sruZIJfWJ+to/wyNwj+JDCR32phj5t1XWtL0mS80q0t7l4Q0ty93P9Xgi
hiUvI7MFkYmi0AA+ZAyL235p3Vxq9qn6JMWmTNa20odyL5Lu9s/rsSehx4cAnwk+
pXl2pg2x876/qnlGfWrDSYLS8t7u6t7m31K69GK3is5XR5ZpY0k3pHuqg0J60Fck
2g6r+ltFsdU9B7X67Ak/1eX7ac1DcTg/NmzZs2bNmzZs2bOYedvPszR6TH/hvWUC
6vZt+8tkBf05uXGICQ8mbhtUjOgaHqzarp6XjWN1pxdmX6rfRiKccTSpVWcUPbfB
+bNmzZs2bNmzZs2bNkQn/K7yzNpupWDLIsWp3y6hKylQ0bgj93H8OyEc1oeztj7D
8t9IsvNK+YIbq6DRS3Vxb6eXX6tHLfKq3LhePMlyoO7fD0G22ALj8oNBln1yWO6u
Lc62XdvSW3DQyyyrPJIshiMkhMqBgJWZV6AUww8yflxo/mDVrHU7+4uPWshDRU9O
jPbTrcRP8SMYzzU8vTK8waNWgo7TfKGp6Hb6XY6Hqjpplrc+peW9ykchkgYzySIj
KikM8syGp7L861qHkCHUPMN5q15qt5Lb31pJp8+lt6P1cW0sZR442EfrR8mPNir1
JArsAMQt/wAstOGi3enXmoXd7NfXNrdXV/IYlmY2LxtbpSNFjCqsCqaLU/PB8nlC
R/OUfmY6tdkxxegumMsDWyxlfiCEx+qhZqMxV/ioAdhTCrUfy2a91q8u49Tnsbaa
f9I2htSqzQ3727Wk7EusiyRSQlfgbbkMMvKfk8aFeXk5lDxmG10/TYVqfRsLFCsK
Mx3dyzu7N706DJLmzZsIrHynBY6e1ha3tzFbS3F7czhWQO7XzySOOYXkoR5apxod
hWuM8neTLDyvbXMdvNJcz3kgkubmRYoy3BBHGBHAkUShI1A+FRXqd8kGRN/y60//
ABDPrcN9dQzSPNdW9upjMUF7cQfVpLpOSFi5hAXi5Kd+OP078vNKsfND6+lxcSOZ
J7iCzcr6UVxdqFuZlIUSMZAv2WYqv7IGSnNhDq3kvR9VfWTemWSPW7OGxu4g3ECO
AyshQgVDVnPfwxXyv5Zh0G1uU+tTX95fTm6v7+44CSaYosfIrGqRrSONVoqjp44c
5sCatYy3+m3NlFdzWElxG0a3lsVE0XIU5Rl1dQw7GmA/Knl7/D2iQaSt5Lex2/IR
TTJEj8SahSIUjU08aVPU74X+bfy/0vzNdw3F3cXEAELWl5FAyhbm0d1laCTkrFQX
jU8kKt74n5g/L2z1+ezfU7+5mitndpIKQ8ZUMvqpHX0+cfEhV5RFWZRRicGaX5RS
y8w3Otz6jdX87xvBZw3JQpawzSLLJHGVVWYM6L9ssQBQYf5sjmpeRtOv4tZV7ieO
XWJ7e7aZClYJ7NYxA8QZSvwtArUcMCfbDDy7oNvoemizilkuHeSS4urqbj6k087m
SWVggVAXdiaKAB2wzyPedPIflrzjpv1HW7YyqiusE6MUli9UBXKMOnIDfBE3le1n
nsZJ7iaSLTboXVlbnh6acYDCkZHGrKnIuvI8g29dsL/Nv5eaV5mu4L27ubiC8s1H
6PlhZKW8lTzlWN1ZGd0PAlwaL0pkh03T7XTdOtdPtFKWtnEkECEliEjUKoqdzsME
ZsKNd8p6DrcF3He2kfr3ls1nJeoiLciFt+Cy0LU5b06e2BdA8otpAkP6UuryS7aW
XUZJhCDczyqiCZ+EaBSkcQVQlFp1BOXF5L0yLR9B0lJp/q3l+W3ltGLKXc2sZjQS
njuCGqaUxLU/KX6R85WurXkVpeaVDYvbtaXMfqOtwJ0mimj5Bk+HifcdsQs/y8tr
PVZ9RttTu43Z5pLGI+iyWpu51nuxHWPk3rum/qFuI+zTEm/LSwe71a7fUbpp9Tjk
ijfjbgwJM6ySKKRfvgzRqP3/AD+EcemDPK3lKfy46Wdpeero3oyPPDIiiWS+mm9S
S4qgREUgkcEUKOwwP5e/Lu10G4E1nqV2xjEcFusghIjsYWZ1s1pGKpykJLn4/wDK
wXH5G0pPLQ8vmaeS0NwLqaZ2Uyyv9Z+tEStxo6s3wMCN12xTSNBv7XzXr2s3DwmD
Uo7OCzii5c1jtFkqZeW3JmmNOPYZfnHyr/ibS105tSutNiEqyyG19I+rw3EcqzJK
rR8qErTfvtgAfl3YNr8GsT31zOY3guZrVvSWKW9toRBHdNwRXDiPbgrBP8nNqn5e
2955fudFg1W8sYby9mv7maL0GeRp5WmeFxLG6GIs+68dxse+Saxt3trOC3eVp3hj
WNp3CqzlRTkVQKgJ/wAkAYtmzZs2bNmzZs2bNkb88gfVdI/7bGnf9RC5JM2bNmzZ
s2bNmzZs2bMRUEeOcFlvPPdlpc+oQ3l2F8th/Lpt3PqCeSYSol1LU/FJzktenfoQ
K5JPKfm/XIfNumeUJrhmFrdapbXNvMhecWVpFH9QaSZhUs4JPMmsnXI15q87eeL2
XzdYnUv0Xaae8lWiEXr2sVtexJDKihTIqzwlndpjQj7G1cmH5geddb0bzNoVrpt0
7QzG2aa2EMRjuI7i5W3dzI1ZG9NW5EQgcNi5owGGX5Xa/af4O0u31HUA2pyyzxhL
mWs7s9zcGJfjPIkpC3EeC+2RzzpqNovna/g8vaxPH5nt9NvZ7uATvIXIs2NrZW9s
T6fLn+/JReS8RU/HhIlxN/hPU5vLur3f6Ds9W0c2jQTSTLM0zWou4/XkMkvATO5k
VW67dKjJhqd5ojfm9pllZam0euIjS6pFJdPxNr6DelZxWxPpMZG/fMVXkvGpPxDC
vXvM+sWnmPU521U6TTVItMeaSI3EdrZxWZurdhb9ze3Lely6t9lPiyW+Q7i5F/5j
0wSPcadp98v1G5kLMa3EKTzwhmJNIZZGUKTVfsnpkuzZs5Nc6pFbfmjJNPfSxajD
qLLNA8siouhJpXqtIYK+l6IvB/e8a8tq9sS8y6hGfPjyeWtVYarNp9412/q3Nx6Q
Foz2zSWYBjW0DcXWSNSzP8O9Th1+S7wrpOp2ttIl9bW9ygTWoZbmWG9Z4EaR0+tS
TspjcmN+L05A7A7YG/Oq5jhj08Xd1Na2X1bUZLdo5ZIFbU44kNgvOMqWk58vTjJo
2+xphJ+ZWvXMiaCzXq8bO0uHuYmmngZ9YgW3eK1j+rNGTduHdURzQVLcWpTB/l24
ul/N2c3dwmqXt0bpXiia8jk0u1ijQ24nid/q7CX7IYRCrbhmzrObOXea5vMllL+Y
R0++vLi6XSbO4sFWp9Bna6Vlt0UUWiICSPiPU4c/lRPDJY60mnzvdeXodSdNAnaR
50a1+rws3pTSFnkQTtJuWO9R2ycZsK/NEulxeXtQl1a6ey0xIWa8uo3aN0iAq/F0
+MVG3w7+G+EH5STW8/k9bi0uhcWM1zcPYwic3JtrcyH0rdpmLszIu7cjVSePbIt+
c17fQavbiK5uIJ006WXy/HC8iepqwuYlRUVCBNJ6LPSNuQpXbEPzY1a9/T+mXGk3
pmlKxxaVBBcSROl3HfCO6eOJRwun9HlGYzXjQlgBvhl+Xkrr+YWtxTXsWr306XEt
7dQPdj6mUugsVpLDNI0SM0ZqvGNPsE7g1zqObORaw2r2Wm+eYbjVLq7hTV9N+sXM
jtGIrKdbU3aK0fD0Ykhd6lKUFTWu+TH8spml8tOUlefT0vbyPSZnZpOVgk7C1KyO
Szr6VOLEmo75LM57+d+r+YdP8myLo0F8TKS13facqtLBFDSTjTmjD1iAnJa0FfbA
f5veaNYj8sRLocN+wE8TapcaeqvNb+k0Un1aQB1ZGm5hWpX4a+ORr8wLjzNoHnMX
638sunXcyXd7berNFAluvH6st7JxkW3jSZSgEQrLy+Loc7Vpd61/plpetBJbNdQx
zG2mFJIzIobg47MtaHBOU5YIxVeTAEqtaVPhU5Bdcu9fmv8Ayff3SXOkySaqba50
dJkliZGt7g85nhqHHwAgVoD75G/zQ1Z5de0u50vUUmmcRw6TDFdSQmO6jvfTupI4
owVupPT/AHfpmvGhJoMOvJWteYb78zPM8eqWuoWlv9Wt2sba5RVtYo4ppog0TK7h
mn4+oT9HbAHl68U/lxcQ66s9vogE0ja5LeyKJ3ku5KpI8Ra4hjrRXbYBem2AG1mJ
/wAs9MtbzUGW3+vwfpUieRQmjvevGXW5qsxtfTTjHMxBZQCeuEsV9qYuvLN1fXwv
44pI00XQXe+ju7iF9RkjF1HJHJHHMsVsIn/eLJ8CmtOVT2mfV7iT6hLpNqNTsruQ
rPeQzxBIYxt6nxH95vtRd85j+V2t+nczCTUJGe6sIhqnqSvMw12SaYPFxmYhJzEi
/uloPbCHQdb8yxeTvMJ0pry7up7a3juJtPlkvXtriZZTdXUn1lkaO7VUX1II/hjb
iRXfJ3+Vd1PcahfSyNcj61pGh3ckF07s6zSwSpIxV2cIziJeXHr164O/N2/8u2Xl
Yy63dSQK0nCwt47mS0Wa7ZT6IkkjKkIjfGxJ4ilTXIVa3WpL500+D9LzX2u+tptv
b3Mcjn1tLk03lc3S21fRaI3XxGTj9rauDJb3SdO/LLUP8VandXqW+sahb2rzXctq
95Ot1KtvHLPEYysdRU0oqgV6DOl+VBOPLOl+vejUZvqsRkv1IYTEoDzBGxB8e+Gu
bNmzZs2bNmzYA1ux1K9svR07Un0q45q31qOKKZuIPxJxmV1+LxpkePlLzt6ruPOl
yvIUBFnZk+3wshQU/wAlRXvleYLPULPQ9Btr+/fU7uPV7AS30kccTSVugQSkQVBQ
bbDJjmzZs2bNmzZs2bNmzZiaAnwyFxfm15OdrBJJJbdtQ0+TVY1lj48IY1dispqQ
r0gk2/yTXelTrSPNvl/U0szDcLFd33qKllLRbhZYFDTwulTSSHlR17YXa/8AmV5G
0SHVZbzUImk0r0l1KCKjyr6zrGoK/tUZxyp9nvhrfeaPLdhqNhp95fwwX+o7WEDn
4pAadPAE7CvU7DENHutA826Xp2uJaepFFO89ibhAJIpoWkty4AJoftgexwHq3n3R
tI1lrPU7O6tLdElaPVpIR9Wklhga4kijIJkZhDGzcuHE0IrXbAEf5reW4NMNxe2d
3p063kFkdNkiVpxJdlGhekTPGEZJVcty2HXfbDi6812dt5mttHuNOuoxcv6FtqzR
qLV7kxtL6CsW9Qt6aMeQTjtTlXbAt95o8l6br+oy3ZS2vLaO1t73UHAVGeVne3t+
RPxSLu/T4QakjFPIuu+WdSsJYtDt3s0jKXUttInByL9BdJN1bl6okrWvWo7ZJs2b
I/cea7ODzPBo1xp11GLs/V7fVXjUWsk/ptP9XVi3qE+mjNXhw2pWuB9Q896Rpety
WOpWdzY26xSmPWJo1S1kNvEbiWNG5ep8ESs3Irx2IBrgryZ5pg8y6SdRtrCewtS5
WAXBgJkWgPNfQkmUbmhBIIPUY7zZ5lh0CyS7m0261GFeUs5tY0cQQwrzknkMjIoC
DegPI/sg4D81edbPQdNtNT/RV3qljdFXE1msJKF+IiPCaSJmeTmAioCxOO0vzzpu
qea73QrC0mmewBS91FWg9FJVAJhZfU9fkpbj/d0rUVyTZsjdz+YHly2fXxM8qp5c
ijm1KYxNwpJzAWI/7sIMRBptXavXBflbzJZ65ZzvDazWFxZTG1vtPuVVZYJgqycG
9NnjNUkVqqxG/jhzmwNqd6LKwnuzBLdeipYW1unqSyHsqL3JP0eOAfK/mC01zTnu
YLaWylgmktryynVVlhnjI5o/ps6E7g1ViN8L/Nnn3RfLl5b299BPOTG13cyworra
2qOsTXEvJlPEPIFogZvbN5l896J5f1O3sbu3nlLItxc3EKK0drDLL6EcstSrUeU8
PgDHxFMf5c86adr2s6nY6faS+jp7mObUiYDDLKjemVUJI0uxVgC6AGhpkkzZE/8A
lZPlySx1q6t0uLiPR7qOwlRYqG4uJwgiSDmVDB2mVAxote9N8OfLmu2mt6Yt5bRS
W/B5Lee1mAWSGaBjHLE4UstUZSPhJHgcM8KPNfmnSPK+iTaxqzstpCUQrGvORnlc
Iiovckt/HAvnHzcPLFkl62kXmpwOSJTZCAlDsFBWWWIszk0VUqSdsLZfzS8tLro0
KSC5OoTyrbWsRiBE8o4mdV+Lb6t6imUvQDtXJnmzYB1zWbHRdIu9VviVtLKMyylR
yag7KPE9BhXpvnDSrzRbzVbi1nsG0uR47+ynjDXEEyqr8OMJlDMySKRwJrXAuofm
NpdloOn699Qvp9Lvrdb2a5jhHG1tSoYy3FWFOIb7C8m60G2CtKuNA0jVLfylpVg8
MU1rNqa+mo+rIjTAOCWblyeSUniFxPR/O+karrc2kRWk8QH1iO0u5UQQXX1OQQ3S
xUZm/cyMFPNVr2qML7n8ztNs7zU7a+0bULWTSERw7pAyymaYQQRxtHK/BpmI4CTj
8O5oMPfKNzpk/l20k0yybTrHifTs3VV9P4iWA4F0YciTyRip6g4A8sefNE197kQW
09oscQvoJLhEUXFoxZFuouDOeLFCPjo3thdD+a+itZGaPS78XVy8H6M0/wBOIT3y
Xiu0E0P7z0wsiQSN+8ZSAu46YL8ka/5U1rVNXvdFs5ILu4SzuL27lXibhJI3SFh8
TH936ToQQKEHxrhv5m11dGsRcfo261Qs1Pq9nGrsFA5O7mRkRVVR3bfoKnCS2/M/
yxPqdtBBFO1lcRwiPWPTVbZZLiD61FA1WEoZoPj+xxHQmuL2/n/TtT8tjWtJ0u/1
WGS6ltI7OGBVmZoZGjdyszRqifASC5HbuaYf6PqljqulWmpWDcrO7iWa3YgqeDCo
+E9MGZs2bNmzZs2bNmzZzrzv5/8AKDyWlgmpRtdafqlrNfRhXrFFazBpnY8aEJx3
pkx8v+Z9B8w20tzo14l5BC/pSugYcXoG4nkF7EYaZs2bNmzZs2bNmzZs2c4uvyeg
m0jV7Jb3jLqGofW7aYqT6UBLB4WFfiLLNNvtuwNNtxWk/ltqGn+codXGoxPpNrda
he29mYT65l1NFEnOXlx4xlPhou4O++FF5+TV9Je6/cwahDyv2uJtLeZbiRoZby5S
6lV09b0VTnEF/dIrMOprh55z8gat5j1fT7tdUW2tbb6s9xahZOLSWtylx8ISSNXW
TiVPqhuNAVoS1VvLuieavLGmaRo1oLbUrFLplvZzyhkigme4nkkALEMQ7RKoHufk
lr/kvzHrnmK7nvL60/QU9hc6bbW4hk+s263cXCWVHL+m0jOF3K7KKDqag4/y21q5
0HUrbU9Rtxqep3mn3EsltE4t1j0x4eCqruX5Olv8RLdT4YdXXl3zFc+e7TW5rqzk
0WwieOzsmilFxE0yUllEgk9NnYgL8SfCtabknCO/8h6/L5gvpbKWCGBr46rZXc6C
dC95ZtYXkEkIZCSkdHiPQk0bDLyD5T1PRrqd77j6drYafotiy0rNDp6PW4ZQW4ep
LM/FK7KB3yZ5s2RLUPLvmq586R62t3YPp9lbSw6XaTQzepDLNHR5WdZArl3Cg/Ds
gIG5JwLfeTfMuqeZJ7/VLrTp9MewlsLa1NtK7QfWIwJmo8vpSepIo5cl+wOI6kkf
5F8pXmgJqU97JbG71OdJpbfT4jb2cQiiWBBDExYryWMM+/2jl+f/AC95g8waVHpu
l3Vpb20kgbUoruOWQTxLRhCGikiZFZh8ZB3G3fH6h5d1bVL/AEmW+uLcWelX7Xgt
YY3HqKkBS3BZmPFo5nL7bEUFML7PyDcReel8wNJZw2du9zPbpaW3oXM0l6oWQXcg
YrKEpVTStevTJpmyJeYvIf6bbzIst36MWv6fbWC8Eq0Rt2mbmamjVM429sGeTfLu
o6RDqNxqlxFcapq94b69+rI0duj+lHCFiVy78eEKk8j1rkhzYE1aPVJNMuY9Kmit
9SeNltJ7hDJEkhFAzopQsB4VGFnkjQb/AELy9Dpt9JBNdRySyS3FusiiVpXMjSP6
rSNzdmJbenhQYS+ffy8vPMt+s9rex2sN1ZPpeprJGzv9VeZJy8BVlCyho6DmCtD0
xDzr+W+o+ar6xnubm1hSJgl08ccwm9GG5+sQemwkCMw4rUSqyq1WWhwf5c8k3um+
a7vWZ3sY7b0preygsLb6uzpcTrO8l38RV5FZKKVHcnqcmGbIbrPkK6v4vMRju4km
1e8sr+0DxsUSTT1g9NJgGBdXe2HLiQaHDjyjoVzo2lPDdzJPfXVzcX148SlIvXup
WmkWJWLMEDNReRrTDrIp+YvkIecdIWzXU7nTLiESG3mtypTnInCskbqwaik0pQiu
xwTqXlq+1OXS0vbmN7PS7+O9WPgS8y28R9H1GqKSLPSSqihpSmR7z5+VI8x6n+kr
Oa2tJkCu0LwkpdTU9NjdvGySOixbKoI+Lc1oMnWl2b2OmWllJcSXb20McL3UprJK
UUKXc/zNSpwTmwp826AvmHy1qOiNL6Av4Gh9WnLiT0JG1RXrhZ5Y8u+YdN+uyX9z
aSzavLNeal9XjkRVuGjigiEAd2PpiOH4uVST0wp1DyL5rHlby75e03UbJrPSY7dd
Sju4JSt4bYL6YrFIpROa8yu9aAHatR+teWbrU/PVlczwzDSY9OZGvLa5a3ZblLlJ
UjYROkjIyg7br44E0vyHr2m65JqEF9aPDbS3smlxvDIH/wBytylxd/WSHoxX0+MX
AD/KxTVfy6m1HR/MVtPdxS32t38d8k0kRMXC1eNrW3mjDfEirCEcrQke+C/JWga3
5fH6KmSCXT5luL6e6g/dpHe3NwZGt4ISWKwIrHjXCzyj+Xut6BMjNe2lxFb28WlW
6+jIK6dFJJKWkq7A3DNL2+D2wqh/J/UYrHU2E+n/AKRupLf6rSO7WAR2nqCMlhP6
8T8J2T91IFVRxA4k4cflr5MvvK9/qNq8RXT4bPTrGyuSUAnNuJ3ldEUsURWuOCht
9sOvPmi+Y9a0J9N0S9t7JrhuF61zHJIJLcg84VMTxsnqfZLA1ArTffCNPy61M+Zb
bUJLu2i04T2eo3NvBE6yC8srX6okcTMxUW5TehXl74vf+SvMY8qajoulajawTanf
3dzdTTQylfqt5M8rwL6ciOrFX4cwfEjemS3SrWS00u0tZViWSCFI3WAMsQKKARGG
LMF22qcFZs2bNmzZs2bNmzZGvPSK1toxYVK6zp5U+BM4H6jklzZs2bNmzZs2bNmz
Zsx3BHT3zjL+fNe09ZXGp/W7TSGRdKnmVlXVI5NQFnPNK/w8xZxsV+E7sPVb4SMf
rf50apaW0t7aPZTQWupX8Ppxo0v1i0s7lYEKy+qiR1L0ZxzNeiUw/wDKn5ga/qXm
pNOv4rT6hfT6vBYC3EgmjGj3KwlpSzMrGUSDZQONO9aCK6t+aPnW/TV4LJrfSoba
8RIL2RBWFLfVYrJ0as3KUTqxYvwQIPh3qGyWecfzD1DRPOWlaTbtbyWtxLaQXluY
2MpN9N6KP6xkRUC0LKFSTlQg8djht+WGtz6n5F0O61C8FzqNzbq00jsvqOxLGpAp
+yuRTztrur6X5g1mXQ9fknurPS7u71CwlaKSC3Cw/wCiRQwKAwm51lLGvwA8uq4F
n1vzDY6fLDpvmCW603TvMum2Iu52S6uLi2uzaM8X1kUUrzuJASFrSi1FMkN3qVzb
/mnptvbaxNPb3xngvbEzRPBEYrZpUhFqg9SOSqiT1m2p8PcYTeZfzB17TBrepQXk
UTR6hLp9nYTwtMqQ6fCZZXVRJbrzmLcizyDilOIbJL+X/mLUNUvdUiuZDLbvDYap
aBiGMCanC0jWvIAchE8ZKk78WA7ZNM2RNNQ1SD8ybq1u78HSTpH1qG04qiQlJwjS
MxJZmNTUkgAdupyBeZPN/mbTfN+ptBqcir6eoCIq8VzZQ20GnG4tmFohMxnEyFna
n2aDfkMlP5P6xql/YapDf3ctz9UuIlhW4lS7ljEtukrBrqICOXkzlgF+wDxPTE/z
b1e/svqUNvqkulRCz1K+EkDrE0lzZRRvbRM7A8kZnPKP9r6MA/mFr2tHSNIu4dSS
1s7e0lvtYit74WN7NLDHG3oQD05ixpIx4fD8XEE4h5Q83a1dfmVd2t9czvb3V5qF
la2gmRo44rFFeNpLXhyiqrUEnOrt1FKZ1nNkPsrjzLL5w80acNSQ8LOxm0tXiBit
fWe5Q/AGDSMfSBYs256UGCPyw1HUNR8g6Le6jctd30sH+kXT8eUjq7KWPEBd6dsl
GQK21CZPzNuLe219rm1ht5JdcsriWIwW5biLWGCNeJjkUVeQmtVpy6jINrHnTzZZ
a9rkKanOPUi1MyOJIZraJba6his1tVjLNbv6MxWV5ABz3P2TnRPyq1K/vvLU3164
kuJLW9uLZDPItxKiRkcUe5T4JyK/3i7duoyOfm55l1vS9VAsdRlsRY6VJqVlDGyq
tzeJdRQrFIpBMq+m5/djr1xb8zNd1S017Tp4tQEeh2UcctxZ2V+La+uJ5btYKLFw
l9ZI6brVR9reuL+R/Ouq61+aHmrTLtp4LKytrc6fp0sMkQjWOeeGSYs6JyM5QMNy
ONKdDnSM2c8tbzzaYfP9vNrSm8sJg1hdLCnC1iexjm4RxEndeR3cnfc+GS7yneTX
vlXRr2dzJNc2NtNLIaVZpIVZmNKdScNc5/8AnV5v1Ly35ReTTXntbq4Y11GK3kuF
t4oqPIW4JIFaQfAhbbevbC781/NepWkmkfo29kt7P6te6hdiGdbSUtZxxSxxlpI5
eTMsjUgK/GacqAHCHzX5w86aL5qs5JL+Q6Vq8kdwlirxLIbZI0eIAuFSzBflHM7s
eZICjw7NpeoW+paba6jbhhb3kKTwiRSr8JFDLyU9DQ9ME5TtxRmoW4gnivU07DIR
rHmDWZr7ynewG50myvdUNnd6VdQpHPLW3nYc2DSUQekGAXr3PbE/OiTaj5o8uWWl
a3eWd3dSSvOlncAQi0szznd4irLIxkKQ7nbl02wu8ha1rE3nm/t9XvPrdxew3Nzb
xWl8LqytooLlYhE0AjT0ZeLL+21fiy/L2vyXPkO5TW9S1HTo4Fmnu/M8hijVkN04
9O3matGCgIPgqO2+KS6ncr+Uz3eqapcxX0cJuLYwXKR3pV5itlBNPGHBdyUikcCh
auR6/wBZ80+XvMWj6df6teXUWm2mmm5JuIo5p59Ru5IJQ0Jjf61w+D9ocEBNSxzr
V9q/1aayjitLi8W9kMfr2yLJHDQfbmYsvFPcVznn5W+Y9Svb/wBPUNWkvF1HTIL+
5E0qP6F9PPLG0MPEL6Q4RgrF1GFw1rWtF8k+Y9e0/VtS1CG9uJbHQZ7gPqK26wc4
2vm9OMyceauaEcfhUdyckn5Za1fanfXks19Pd21zpWjX8K3FRwkuYJRKUQqrIHMQ
Yqe+/fDP8zLu3s/Lb3E+sXGk8WpbraSxwz3VwQRBbo8gP25KVApt1PGuQqHzF5rj
812kd1rHq6kt3p2mSWkTKbKWO6076xPcC3WjNS4/3YGpTYYYWt7rFx5BvF1bX521
O31bULdLi2uLfTpLo29zKscEc0gMcS8V6Dei0r1yceTL+51DynpF9dT/AFm5ubSK
SafgYubMoJbgelcOc2bNmzZs2bNmxG8W7e0mWzkSK7ZGEEsqmRFcj4SyBkLAHtyG
RVtN/NYyjjrelBdqt9Qm40p/vv1+Va9/Up7ZvMUerRaJoUerzw3OoDWLD1p7aJoY
m/0oEcY2eUr8NP2jkwzZs2bNmzZs2bNmzZszU4moqKbjrkWt9f8AId7baZbIts9v
dRzLZ27wALDGnK3lWRGWkA5VhIalWPD2wbLB5Ih+q280emR/v3gsoXFuv+kMOEkc
Sn/dhX4WVd8GWf8Ah57xo7L6o15bc2dIfTMsfrufUJC/EvqOh5eJHthRrN/+XWmw
6rc6kdNRZZbeDW+Sws7STMqW63SgFiSWHHn236Ya3g8tfpSzS8+p/pV0YWCzel9Y
ZEIdhCG+MgFQx4+AOF2l6d5P1+20bzBptvGYLdvrWmTRIYNzFJbglAEqAkrgBhtg
C48wflvZ+ZbwXVtb2uq28c0k+qS2npq/CPlcRpdFAJHWLd1VieON07zd+W8Oi2iR
RQ6ZZyX8dlbaVNaG1lW+kdWjX6oyKysTIsnLj0IauD01zyh/jVrEWwTzC8ZgGoG1
ZRJxX1TbLdlAruqDmYw2w3wJe3n5eW/mi8hv2g/SdwbeS9+sLyt1lt4meGR2cGKO
VYj9qoPHj7YZ+V4vLUcmrpowCzrfOuqqQwkW5VFAVg3RRDw9Onw8ONNsPc2FB1Ty
1ea9daGWguNXjtA95blA7C1lbiEkahFGP7BPvTCiXzH5A03zHcwzQxWWo29qyTam
9qYojDbx+q9ut2UCP6cS8zGG2A6bYY+TtR8uXulH9AWn1CzikYNZm1ayKM/x8jCy
Rkcw3IGm9a4h521zyhpltaL5kt1u45JfVt4DbG7KGAcnuCgV+CQhqtJT4a9cCebd
Y8jaLZ21/q+mfWrOaY3yXUFg15HHMAtLl2jjfg5BXi53PbDLStU8oXnmbVINN+ry
a/aRQDVpoowJgknL0Y5ZQu9OB+Gvw4e5sJofMfldtS1aKO6gF5pMcTaxLsoiR+Zj
EspAXbixpX4fpwR5c1PRdU0Oz1DRCjaTdRiSzaNDEhjJNCqELSvywxyJW97+X135
qu9LXT7ca04kWW4lsgguStDPHHcOgWZk+H1FVjTviLecPy5h1LWw6QxXSRuup3LW
pUXYtyIpYkl4f6U0TOI2RS1CQvfDryjqOgX2iRNoUAtLCBmg+o+gbVreRD8cT25V
DGwJ3UjAXmzzF5M0u/02PX445LlXNxaSvbmf6qFIQ3LuFb6ugZgvqEgVPXK17UfK
GlanpVtd6b9a1F5ZJtPW1sWupIGdwJbgmJHMIZpPikNKmvvhna6zoFx5jv8ASraS
N9bsYIH1BFT40hmLmAO9O9GIWu3XvhpmyOReb/JDW2vXiXlt9V0mQxa7chfgEixK
xV2p+8IjIXav8vXbDvTri0uNPtriyp9TmiSS24rwHpMoKUWgp8JG2CMLfMesaHo+
jXOoa5LHDpcQUXDyrzU+owRV40bkWZgAKYV+bNR8maPDDJrlkk0c0/1r4bM3PCSI
DldycEf0xEtOUrU4jvgbUPOX5eXOoz6PfPBc3U7QWvoSweoLpnYMkURKlZ/TLhmC
14VqaZL+mbNhF5k80+XtFuLOPVg/KRvUjmW3kmjtwPgM0siqywqOfHmxHXEr/XPK
mh6tZac9vwvZw7Rm1tXkEKTyfFJK8SEQpLKPtMQGb5Y3Qde8oXXmDUrLS4Vg1ZiZ
LuU2zW5uxEfTaVJWRPrCxseBYEgHC7R7jyLb+QPVtrea98srLN6VtcQTXckjm5YF
Y4ZFeRx61fTHH5bYIXV/INp5ZTWYbKFdNk4WsdtDZ/vzIsx42otlT1PUWfl+741D
Vxlx508g3F9o93cKs1xPvY38lq7C1aVzCEknKUtnkkBj4swJbbJJo+kafo2mQ6bY
R+lZ2wIiQsWoGYsfiYk9Wws8vnyVqi3lxolvZzJBfv8AW5oYUUG+hA5ScuI5uvP+
8FfniEvnPyhZWmpQ29Z49JuRYXdjZW0kz/WZUEphSGJDzYq/JuI8a98R8mX3k2/1
bV73QJJJbmeOya7ZhKIvQETC2EAcBBGBzFE2Dcq74M863vlW006N/MViuo27Pxht
vqhvmLcTyZYlSQgKlSzU2GF9r5n/AC7/AMQWcVqlv9eNrHFZ6pHbUhSGSP1orZbw
J6a8ovjWPl9nemVdeZvy91Dyq18LVNY0O4u5IVtreye8E1zHKwkZYEjcvR0ZufGn
euSnTb2xvrC3vLCRZbKeNZLeSP7LRsKqR9GCM2bNmzZs2bNmwnl85+UIpJIn1uxE
0TFJIRcxGRXBoVKBuVR4UzW/nPyhczx29vrmnzXEzBIoEuoWkZz0VUDcifbAfnn/
AHl0j/tsad/1ELkkzZs2bNmzZs2bNmzZsxrQ03PYZyvUPyy8z3Nrf3Alsm1HXPSn
1WCnCKKezuxeWywOqcijBRFJUfa/e0rUEt1X8qPO+oafLEZdOgur291C9neMk+ib
uZJ0CSvC8jCicGCcDyo3Knw5IvK35cajo/me21c/VUH1jW579oeQkmGo3MctryPE
czGiEHkdu2R2X8nfMHra1KwtrySScz6cbib93MJNSjv2SSNYP3fFY/TDO0p8OIqM
kvnDyL5i1nzfpmqWklrFY2sllNKxASYfVbkSyRlhE7uHQ/BSRAtCCG5bDfKFp5j8
r6L5d8uXGnreRrS1ur+2lJSECKWVpXVkU8earGN9+WAPNflDzZ5k1rUo7uKyj0d9
PubDR7j13eWCS5jo9w8BiCl3PwfDJ8KV68jjJPIvmPUrC5ub+OztdWvdbsNUeGOR
5khgs2tldEmMaMzSJacvsgVNO1cN7zQPMV7+YGnatMlumlaWsxhnWaVpJFmiMfpG
1ZfSR1duXrK3Lj8NKE5FNb8heY73V7+OCxtbtIL+71KCTUCwhuE1K1MCqjKsvGW2
dSPiB+GlOopJvy+0DUtNv9Vmu0dIlhsNMt3kFGuP0bAY5LvjUkCV3IWu5Cg1oRk0
zZHp9Dv4vNs2vWaQsp0t7VIGYxmS59USKXIVgFIUAtufbI55n8peb/M+q3kV/FZ2
+kvpd1Y6bMlxJJJBPeW/CWd4DEqu1fgQiQcU5d2oDT8tvK2r6BY3q6h6dut1Kj2+
mwTSXEVuI4UidhLIEZmndDK/w9W7nfGfmL5X17Wfq02jC3klW1vtOniuXaICLUY0
jaZWVZKmL068KfF4jFbry3rV9+gLK5ECaXo16k1xR2LzxWtuRbOF40U/WKMyGuw6
4O0/y7NaeddV1tRElnf2VpbqibOZoJbiSR2FKfEJ13rU75IM2ENp5cMfmjWNSlSF
rDUbWzgWClSZLeS4eRnUjj8Xrrl+RdCu9B8pabpF2yPc2cZSRoyShJdm2LAHofDD
3IY+mecZPO1xrNzY2M9jaW0lvoS/WpA6FypkeRDAwV5qcSyt8KgDepyMan+VHmG9
1rVrmOWC2tGivl06MzSTRyPqE8VxLSJkH1Zi8J5OGc8m5LxChcmn5eeXtR0LQXtt
QCJcT3M1z6CSvcmJZTURvcyBZJ2FN5HFT07YSfmP5D1zzDqHqaa8Agv9PfSL5p2Z
Wgie4juPXjVVYSkenx4Er1+1lec/JGta/q1nqFvZWVtfrxt/0z6831uzhhuvWV4A
qhH9VBRl+Egk/Ewxfyf+X2raB5617XZtTW+sNYhTijRKk4m+sSynmy7MqJIET27b
bzvNkUt/KM8MvmzilukOtsjWMa14qVs0grIONFPqIT8Nfvw78uafPpvl7S9OuGV7
iytILeZ0rxLxRKjFa0NCVwwyGfml5H1XzfoS2Wm6mthPCXkSOWFJoJZCvFDIGHIe
nUlSvfN530Pzbrfl+XR7aO1dZyYJZ5LiaBuJReNyViQqwV+XO3YFXG3LI95x/KjV
L/U7XVNGeCG6tEV52EkttJdTughlCSR8vqiFEVm9IVdgAdhnS9LgvLfTLS3vbj63
eRQxpc3XEL6siqA78R05NvTBOU6lkZQxUkEch1Fe4rkI8x+WfNc1npmj2co1jSFu
BPrM2pXXo3UyJIHSD9zbmNo6/bBA5Ace5OF/mvyP5l1vzJZ6zDHb20/pLaNOLmXn
ZrBdtOlzCqoqyySRnjxPHjU/EQTh1oOl+am86anrGvWlmsDQ/VtInt7h5Xitlk5e
m0bxR0eU/HIwfsq0+GuFXk7RfMtt5MklgFyupSLNCND1GT6tboBcycmikhQzRtKh
qsnJuxpiMvkfzQfI8WgCK3aS3ljvlC3Usbu/1l5mtfrSx+srKhUfWvts1SQK5ovK
PnSG28s6PJbWF3oWnyi61RDcSRyNN6zSRinouJkg5cqsQ0jgMab1l1rFqGt2Wmah
dNeaHPE5ln02N4iJACVEc5ZH5KQK/CVO/XAmjaHrGkSauYVgkTVdVNzHxcp6Fq9v
FFyAKMGkVoq8ehr1yKeXfy382eWNL8y2ttewayNXuYpYVmklsJpI/QCTs9zbhnjm
d9wwBG3auxl+Wnl/VdG1TU7W9ibha2OmWS3Yi9GGaSEXDyeiNuSp66qWpua4eefb
XzXeaBJY+W0t2ubo+ldPcTPbstuwIk9F0jmpKw+FWI+Hr2yMQ/l3rI8w2rLBaWuh
/WbHUpUSRnaJ7Ky+p/U0iMaq6MN/V5D/AFcMf8L+YtP8p6jplhb21xLe6je3Bthd
T2Q+q3c7yKI7mFC8cihl6LTqMk/lnS59J8v6dplxIk09nbxwySxII0ZkUAlUHQYZ
Zs2bNmzZs2bNhbP5Z8uTljNpdo7OSzMYI+RY7k1pWvvlw+XPL0LxvDpdpG8LB4nS
CMFWHRlIXY++Fnnn/eXSP+2xp3/UQuSTNmzZs2bNmzZs2bNmzGpBAND45yf/AJWR
5htJLmOee3vF0B4ormSOifpI3V/9RSRDxoiwcv3nDrKCuyjcRrf5x3WnJNOlhA8F
lqN5aXaerK8zW9nOsHqRLFE4Usz9ZCqA/DyqcNvLP5i32q+Zf0Xd6altaXMupQad
cRzeo7tpNwIZmlQqoQP6i8KEnY17ZG9U/N3zRdrqcOh6ZHCbe8jhs724E/pcItSj
sZ0ldovTLyFyY/SZ6LXlRgBko80/mDcaJ5q0zSRbQz2t1Jbw3bh5WnR7yX0YSFSN
okXlv+9kUsK8a0wz/LrWdQ1vyRo+q6i6y313AJJ5FUIpbkRso2HTIx508y+b9A1j
U7iy1CK+toNMu76bTngVIrOOGOls5lUmR5ZZtuLNQqGoBxwLd+aPPGlW8tn+kYb4
6b5g0/TbzUbiFEuJba9+qvwEUQWJW/0pl5dlA2J3w/vdW8wWX5jaZaHUDNpGqetD
9UMEa28RhgaUKs4LTNclk5FWonp17jcBN5+18a9cw2VtDcwyahLp9laTSCALHpsX
q3szy0f45C3GMH4RT4qb5IfJ2s394+saZqMguL7RL5rWS6CqgljkjS5gbiuwYRTK
r0FOQNMkebIVquq+YLH8wNJgF+ZNI1OR7VrMwRrbRmO3ean1gFpjdMyclXZPTr3G
5LH5w83SfmPdaZbzpJYma5sbW3ljVLIyQWguEC3Kgzm55/3qEcAnTfJR+WutarrX
kyx1HVpUm1GSS6juJYk9ONjDdSxDilTQcUHfJPnN7Lzh5if8w1tZLpG0m41W70Vd
P9NQIxaaet6LhZR+8MjMeLAnjx6CuGemS+ZZfzJ1G2TWZbjQrGBZLqykt7cRJNdA
mKCKaNVk5RInqPzYmjrt3ya5sidpq3muXzR5l0yto4tLWzn0aEh1RfXa4UmeQAux
PogkKNug8cE/l1rGp6z5J0jU9UkWXULmHldSIgjUuGKkqgrxG3TJHkPt73zPH+Yj
WA1BL/S5LeS4vLP0FjSxjqFteMq8neWZg3IOegqoGQjV/wAxvOmna3q9s8xjMkWo
G0hntgsEAs7mGG2NrNT/AEiWeKfmysSofivw7jJ5+Wus6tqnl+ZtUlea7tLue0Lz
xpDdcYiOIuoov3SS0bcJtSmEH5oecvMei6ky6VcrbQ6XpcmszxNGkgujHcxwCCRm
3SOkhJKUavfBH5i+YvNGl6zYvbPPY+WrRIp9W1C1W0lcvNcLDHE0VxV+HiYxX4vb
N5K/MWXzH+YvmbRknhOm6XDCLG3UD1uaTTQ3Mkm/KhdBxBptQ986FmyBW2ved3t/
O8UslmmoaTMP0V8DmCKF7OOdef2XlYciTWlTtsMlflm/n1Dy3pV/Owae8s7eeVgA
AXliV2NBsNzhlkF/ODz8/k/yx69pcwW2qXbcbSW6/ulWKjzOa7EiPZV7sR2riv5h
3munTtJfy7rMun3moXMVraCGC3uEla4oRJIJldvThQNI3Dfj9+RXzP5989+XvOMO
nXrA6bf3Cx24jhjkneKBFkJs41bk7TDmJTLRYzTj2r1iwvrTULG3v7OQS2l1Gk1v
KKgNHIoZW38QcXzZsjFprGtn8w73R7qSH9GDTYryyhiU+oGM7xu0rnqWpsoFBTvk
f84eYfNmh6xqk1nqcV1bw6bc30lncQLHaWKRJS3Zp05SNLLL+yx3WtAKYD0/zf5r
b8vvNNxLeOmr6PIYrW4u7eKO9j5RRSg3VslYFceqeAWoK8Sd64YeVPMvmO481xwX
179ZsNSfVo4bZoo4xB+iLmO3RonQBn9YScn5136UGB7/AM66x5Z17WTrGoi80xLN
ry19aGO3iEpmjhhitZIyzPGrShZnlPwtQjauSP8ALLzFdeYvI2laveXUF5e3EbfW
p7XaEypIyPwA/ZBWgwP5SvPMr+YNbsbzUf0rY2np8bxrdbdI7t6s9tD6e0kcacOR
ZiwbYnI3quv/AJhab5f82z2GpQ6m2jhXj1S6tlhRZVVpLqG3ji+CVYl4KpZtmLBi
eNMl2g6pqc3nHzDp1zc+tZ2sOn3FnEURTD9ZSUSJyUAuCYeQ5b9cf59uNStfL813
Y6r+iTb1keZIEuZpSB+7ghSSq8pZKL9kk9Bua5DYvOPnhPMNt9emihK3dhpF1pCx
r9WNxe6f9beT16NMGSX4AK049icMbDVvO2o+R7ye41A2+uWmo30EzaZaxTSyR2tx
Iiw2sVw3Anio+J6mgPfpLvKWp3Oq+WNL1K6eKS4u7aKWZ7evpFmUE8K70w2zZs2b
NmzZs2bNmyLfmGsx03TGtwrXKatYtbrISqGT1gFDlQxC1O9Bgb61+bvqKv6P0Pfq
wubr0wP9b0edfbhT3yTaO2stp8Z1mO3i1Creqlo7yQ05HjxaRY2+zStVwZmzZs2b
NmzZs2bNmIBBB6HOfy6x+TMzp5cmmsOWmia1jspAyemJGEMyAsBXk7qCa/aoetDh
5/yrvyF9VgtTotp9WheR4Iig4c595DT9ouRyNe+/XfDG18t+X7S6juraxhiuYGuJ
IpVWjK164kuGH/GV1BbAU3kLyZN+kXl0m3f9LcTqBINJOLCQHr8PxqGPGlTud8u+
0fyZqHmK1N5b2txrsEAuLUOA0ohilUrKB34S04t2PTqcDz+WvKelz6PPFJ+io7C6
jjtIIZPTilleKS3igdNww/fkqv8ANQ4tceTfJdvqN75gudPt47ueNzqF7KTR4zHw
f1eR4FfTFNx0wjsdR/J6z8q2rWs9jH5ekvUe25FiDexSCRWPOsnNGVWq3QU7Uw+t
tL8lt5tl1C3itW8zfVkkmkQgzCCWqJIVBoOfDiHpUgUrTAieU/JWt3+o33GLU43u
42urYsskEd/Zj02cKOkhWiyLWhpuOuHGgaDa6LaSwQySTy3E8t1dXUxBllmmYszM
VCjb7KgCgUADDLNhJe+UPKk+pz61d2EP1+S3eCe8aqn0WQq9SCADw+Hn1ptWmAPL
Fr+Xmp3r+ZPL6WtzdxL9UkvoiSyhAFoQ3Q8VA50qV7kYb+Wj5eOjQN5eMDaQzStb
takGEsZWMpUjY1l5V98M8iRs/wAt7vzhfWvC0k80T2xS9jBImMLrxboaBinWnx8e
u2HWnyeX49X1G0sXgGq/ubjVIYyDKOaelC8oG+6Q0WvYYZ5sByw6VYy3eryrFbyP
EgvLxqL+6g5MnNj+ynNj9OBPKd55Zu9Ct38tSQvo6cktxb7ItGPJeJoVNT0OG+Q2
20n8sLnzbqsFtHav5llUtqqI7iZhIFDc6EAmiqDTddumPsbD8sb7zBrllZxWNxrU
yenrUC0Zir/aBH2dz9vh+19rfDjynB5Zg0OCPy16J0gNIIWt25xsyyMsh51Yseak
Ek4Xebx+Xx1HSP8AFH1T68ZqaV9Z+0ZKjbbbjWn2/hrTvTENesvy0tdZ0iLWks01
VpZJNKWckuXkcyOdz9kyNUc/h5dN8PLEeXZ9a1C6svq8mrwiOz1KWIqZUCgyxxSk
dKCUsAfHDPNhVqMXlzSbLVdSv1htbS6X1NWuJNlkAjEVZPH4AFA+jFtBu9Gu9Gs5
tFkjk0r0lSzMP2BGg4qoHbiBSnbB+F/mA6ENGujrxgXSOFLs3RAh4kgUbltuTTCz
zDeeSfLqwarrckFmGu/UtriXkx+tPC0dYwOR5GEMNh0rgXWpfy01e7vLPVnsrq8R
ba3uo5T+9USvzt4wdmBZ2Bou/jkriijijSKJFjijAVEUAKqgUAAHQDHZsDXep6da
T2tvdXMcM99IYbOJ2AaWQKXKoDuxCqTthL5gvfI9tq0VprU1tFqmtQGxiSQlZZoO
RPp8l3VOb7VI3PjgDStK/K/UPM2rSadFZ3OvIDDrAQlmYOgjZZFJ4OOK8DsadMD3
Fj+W7flvqNvYXkWmeVp1lin1C0YDi6yem7K7h+biReIqD4DDDTPL3kCe0uPMNpFb
zRakiXF3qgYqJBEwk9RiCoj+NOT0C7j4sD2l/wDldoWpW95ay2dtfebKS2ssfJzd
hyDySnIBWaQE0oCTU74eWHljTNP1CO7sQ9tHDamzjsY242yo0vrFhGP2+R6+GEHl
PSfytllvk8sx2rPaXIe+W2d6LcIXPMjlQ/E7/ENia4A0uX8lNP8ALusPp8lhFoTu
LXVkRmMTOSaJwJPLmWNOA+Lfrh95YPlq58wa5qelap+kLy6WyW7hDIUt4kiZrdUC
qp4uJGapJ3+VMr8wIPIUukwt50FudPjnU231ksKTkEKU4HlyAJ3HTrga3i/LKPzf
ZRQGzPmWOzQWQVi0n1ZVpGQalC3AfCT8XHptit3p/wCW+p+V7x7gWU/l2C4uLq8n
DgQpcRyMbiUyqRxYScuRB8cktitmtnAtkqLZiNfq6xgBBHT4eIG1KdMWzZs2bNmz
Zs2bNiUt3aRCss0cYJ4gswG57bnrkc89XEX1fRVDBi+taeooQaH1g3/GuSjNmzZs
2bNmzZs2bNmzZx3WdB8+eZI9ah1Ly1LBdarNbxw3jX1r6Vvp9pdxTLAgikMnJwru
zAA8jTsMC69+W/nZ7GOw02xhMVlf6hLokvrpysommWS09PmSI19NWA4DmrUGyk4z
WfIfmXSrHVtWVDB9aGtyatIk0kjzwS3sc1jCUjEjkGH1FCqvwcj4nDLQNF1jWvyo
1+30i1l086nfSz6XZTM6H6mHiPoD1wOKvHG8QVgE7fY3wT5A8g6vo/mfSdVutN9K
NNJvbRneWBpLRpbxZ4bcLDRBGI+QUR1C9K4UaJ+X3n6DzBPdXNlBDZtfWN3LHDMn
pzTW168k1wAS0jcoSvFpWLnoc6dba5eX9rqkMmizLfWMUfKxmaP055JYBL6UcxJj
YAt6bN0rnNLryf55v7EaxNojR67eSapFqlk91bMR+k7WO2imikVuHo2yRKnEnmQK
0rks0jyRq2l6lK9iYLSR/L1vp36SRQwN/CXX1Wj+FnCjidz02xf8qfKuv+WdF1DT
tZe3kZ9RnntZLZWUPHIFJlfm8rc5JOTtU9Tk1zZsAa/p8mpaDqWnRMqy3trNboz1
4hpY2QFqb0qchPkLyzrttJqT67pKxQaxFZ2E9o0sUvCKwtDA0knAlWSZvsqNxX4q
ZIfy60O90Lyja6XeQpbzQTXZEMbBkWOW7lkiAK7f3brt2ySZzJPKfmi389PqC2Cz
adaalea5BcrNGPXN1pws1tVRiGWQOvIs1Ep3yR6J5alsPPet6xFaR21jqllZguhX
lJdRy3DzM6jetJU+I9clWbCnzbpA1nyxqelen631y2kiEXP0uRZdh6lG418aYR/l
joWv6ZY6td66HXUNZv2vnimaJ5kBgihpIYP3PWGqhNgtB1yZZzCw8p+abLzs2ofo
5ZbDTbzVdRt50miH1r9KhAsKKxDI8XE8y9F8CcW1Typ5x1XzVf3NrGmjRRWF3ZWF
+8iXMPO7dGE1rDGYpYXZVPr8ju3Er0rh3+VPlvWPLfki00XVlt47m1muvTjta+ks
L3MkkQHJnP2GB67dOuEn5oeTvMWt6gTpVqlxDqemS6PPM0iR/VTJcxTieRW3eMCI
ghKt7YM872/mXVrjTdPh8ttc6TNcI2tTi4tVcwW0/KKKjsGKOQJW47gfDTkdjnyz
5el0rX/MlwtvHb2Go3FvNaCPj8XG2RJXZR0JkB69euSTNhD540y71Ly3cQWUDXF7
G8NzaRLIkTGa3mSaMq0itHUMlaOOJ6Ejrgb8utF1TSfLno6oHF9c3V1eyrK6SSr9
amaULK8f7suOVDx28Mk+QX83/KHmTzT5Z+oaJPbB42M0lldxs0dw6CsPxrJHw9N/
jFaitPDA/n/y/wCYtXitLiz0+4fV7NLi0tL60v8A6oIZLiOPje+mHHqxpIm6M3Kg
6NXCDzn+V/mKbWrHW9GjMt7Z/wCl3brMiSvdToIp/qPqgxwseCysXFKii0q2dX0t
dRXTLRdSZH1EQxi8eIUjM3EeoUB/Z5VpgrKcEqQrcSQQGFDQ+O+Q7U/Kery3Plm6
mnTVdR0vUvWu9TeOK3lFoYZ1KKqCn25EBC9euBPO9h5q1yOxs7bRikclwjXNwbqE
RqtvPULdRU5TQSJ8YEbcg3UDAXkvyVr+mee7jULiOSDRbK2vLTT4pZYplYXl2t2Z
ITGFkoWDc/VFRsBUCuN8nDzRa+Q3vtMt31OeMTR2Plu5jjs/SuY7uQFzNKFb/Ko3
+xx7eVPNF/8AlxJ5Zt4W0q+u4TLfXV60c3rzTzO93DL9VkXj69alkNKNTxGFFh5E
86WVv5W9G1eDXLax020vtUtb4paW6WMnKaCSzLUlWSFmTkvLfstAc6Ja3Ooa7ZaZ
qdlPPpMPNnu7C4gQySoCU9J+fxR7itVOQ78v/Lfm3RryB9Q0oIllYQaGpFxFIJUj
nllN2tKERUkA4MA/ttlQaP5yB1/VX0OVLq7EFvbWiX9ubqNIjKGewuCvpRxoJeUS
ShTXnWlQMW/KjSr3StU1TTruERzWGn6VaztHG8cJmX6zK4jZhxchZl5lCRyOSH8w
z5jOgPF5e0r9J6jccoOYlghe3ilUrJNGZyql+OyivXrtkPtvIeuJrtpZwaULXy99
a0/UPVeeN1his9P+pPZvECXMh/nWqEd8rXPy08yXf5Zat5Y0kW2nNPqGoXENg4LQ
T2ks0skEHKNo/TDckPcDoRnSdAt7220LTra+4/XYbaGO59P7HqJGA/GpO1R44PzZ
s2bNmzZs2bNkWm/K38vZZJJW0G0WWUsZZUTg78zV+TLQnl3wr17yb5W0KDS5NF0y
305pdY0z1TboI+fCei8qdaczk9zZs2bNmzZs2bNmzZsxrTbY+Oc0P5naxaT3MF9b
27toLQxa0YHBNw95d/VLc2wLfAgr6khatGrH1BODNW/Nyz06OSeTT2+rW2oXVhdy
PPGjBbSQRvJFGatKzcqqgp88G+XvzIi1fzC2kPps1okkt/DY3bujrO+lziG5+Ffi
RfjUqT13HbeO6p+dU7/pK20HShc3llcxwwmWZQjIl/HY3HrBR+4fnJ+6VieQ+LtT
JT5i8+w6J5h03SZ7XlFfvFE9z60aur3EgiiCQbvIOZHM/DQb74M8ha9e6/5O0rWb
1US7vYBLMsQIQNUj4QSx7eOR3zd5y81eXNXvH42V9YJp93fpYIHSeCK1jHCeWYsV
cSzN6fAIKdQTQ4FuvPXnLTLc208dnf3FlrtlpWo6iFe3QwXv1Zw0dtylPqUuuH95
T4eXthpB5q8wv+YZ0y7jbT9CaR7SwWa0JN5NHb+u7x3Qm+EAcqD0aHg3xVwBq35k
67ba7JFYaal9pyXV1YpCG9OZnsLX17iVpHPBEDniNmJp77SDyf5sl1u71G3lVeMK
217YSoCpex1CIy2/qKSeMqlHVgD2B70yTZsjsGvau3ny40Ke3ij01dPF5bTBmaaR
/WEbFuiqu+w3PfCRvNvmkeeLjT3tjb6Z++t9ItZ7Yp9fuIbf1yUvfVPBetKwUop3
rh1+XnmDUvMHlGy1bU44or6Z7hJ47fl6QaC4khonL4iKR9TgD8xPNGuaN9Wh0hoI
5ja32ozSXEbShotOjSRoVVXj4mX1Kc6/D4HAvnXzh5jstP0m60qBra0uLd9Q1bUz
am9htbeNEZlZRNbbn1OVQSeKminK0bzlr115+l0zUUbTtKme4g0e3ms2BvPqqIzz
x3XrHY8iwUwj4f2icnubItb+YvMkvmHzHpi2EDnTba1n0qH1SrTfWGnUmaQgqgJg
FAFNBgryDrt/r3k7StY1BI4768h53KQhhGHDFWCciWpt3w/yHL5j8w2/5ixaDeNb
SadfwTT20aRSxPEkNOLC4kPp3LuSecaKDGKHcHG2XmPzPe6v5v0ub6ppR0hLZ9Lu
WDXCiKZJGMtwOUINfSrxUig7nDH8v9S1/U/K1rqWtvBJcXvKe2e3iaAG1kPKAyRu
0nCQoQWHI06YQ/mP5613y9fcNNS3MFhp8mrXqzqztPHHcRwfV0ZWX0ifV5cyG6fZ
wy856p5qs9X0S10O6tUbU7gW5tLm2eaojBmmlMqTR+mqwoQPgb4yvjgbyn+Yf+Iv
PfmHRLcQHTNIhg+qzI4aWWX1ZYrliAxoivEFXb375N82Qi383ebZLbzj6mnWsd/o
UvHTbcysUaNrRJ0eaQDfdySFHTbrkn8u6jLqfl/TNSlCrLe2kFxIqVChpY1cgVqa
VbDDIf8Amh57HlDy613btbtqs7cbG3upBGjBCGmc1KkiOOp270HfGfmT+YEXlTRr
ae1ktX1G9ljFtFcyqiGASJ9Yl+0tQkbbUPUjI95h/NLzHovm5tNurSKHSri5EVtc
PFM8ixRqsrSxCPl9a9aLmVVAOBRuVds6hbXMFzbxXNvIstvMiyQyoaqyMKqykdQQ
cUynZUUuxoqgkn2GQnzN5yvv0RZ695XvrK800zLB6BR5ZL2d5REltE6sixEkn42D
U7ilcvz3+YX+Hte8t6JbCB7vWL6CO8EzAelZyP6RkUVB5tIVVe3XwxHyb5w8wap5
rv7DWYn02N45ptK0u4szDK0EE4haYXPrSLIKkHiY02ZSK5flzzjqut+Vp0ivrJfN
cSSzTQpDLIIIfXdI3+rq5eRvTTYBhybwwPcefdcH5f2GrRxqdVv71NNimjgeQcnn
aBZ/qZdZFZuNTC7goTRjscV0fz1r97q3lW2MFtJp2rx3iX96vNJBdWiMTEsLE+lx
aNg9WbfYE9cmGo63pWnT2dve3UdvPqEnoWUchoZZaV4L74VeTtf1fV11tdRght7n
TdSlsoooWZl9NYopY+bHq1JfioKZE9S87edNOGpWU89lI9td20E2uRWsxtbD6xG8
rpLD6nKb0lSNeYZQTINgRTDX8sfPOreaRczXyQxxNZ2N7bJCrqyC6EqSI/Mkn47c
suwIBoelcPPOt7rdjoU99pd3aWJtFae5ub2KSdBHGpbiscbRklyAv2tuwJ2yJW/5
h+am1y1W5s4be2aey0260tgTKLu+sfrnNbnlxAjb92U9P3r2y286+fbrycLm20wL
5gfVrrT5ktIDex28VrNKpdkaa25/BFx5cwORG2Try9qK6noVhqCzpdC6gjl+sRoY
kcsoJYRsWZK/ykmmGGbNmzZs2bNmzZH9X1rzba30sOneXP0jaqqmK6F7DDzYj4lK
OOS8fxwJb+Y/PTrH6nlIryYBnF/bgBSaFuJHLYb0xfzz/vLpH/bY07/qIXJJmzZs
2bNmzZs2bNmzZjShqaDuciL+Sfy/utO06zCRtbvFNFp7pcNznSas8hEgflMef74N
UlXHMUO+Mb8pPIrWiWhspPRVp2f/AEiflKbphJN6zc+UgaRRJRifiFcNrDyZ5dsL
6C+tbUx3Ns95LC/NzR9RkEt0aEkHm6g+3bC68/Lryb6OpC4SWK21R0aZPrU0ccUh
nWYG3HMLAzzhWPp05Ng7VPI/lvVNWh1a8tme9g9Eh1lkRWa2lE0DSIrBXaJ68Cw2
qR3wPpnlPTLePRn0DUJrbStPbmlrBM01vcQiGSJYzyZhx5S86jqyjAj+UPIlx5q1
a4mumuNXvbYjV9MkvpHjNs6ekDJaGTiqca8TxABJI3y9I8t/l+3l2KOzuY7/AEua
+hu1v3vWuWmvIJU9EtctIzSMrxIiqW7BcEnSPJKeeEu3u4/8StG0sOnPeMSKp6bX
EdmX4hzGCpkVPs1wHf8A5b+VtS1e/a7keT6w63q2cUzwvbXEsbW808TRMjqLiNeL
diQx7nDXyv5d0vS59SubOdbiS8mWNinHhBFar6MNoiqTxWBQRT+Yse+H2bCS6tvL
Nz5hljkuYxr81g1u1ulxwuRZs9SyxqwdRz6SAde+I23lHyzb+ZBqytI+qwxBlilu
ZZETknom4EDuUWR0Xg0nGp3364L8qw+XINFih8uTQz6Ukkxie3lE8fN5WklAkDP/
ALsdtq7dMS8zeTtC8yxwJqsUjfVi3pvDLJA/CQBZYmaJlLRyAAOh2bvhbqXlLyRq
12dGuLhnu4CbqTTYr6VHFvKFjaN4UkB+rP6YHpkcMHW3lPy1a+Zm1eNT+lZEZooX
mdkjDAJJLDbsxSMvsrsiivfD/NgC3sNKj1q8voeP6TuIYIrujkt6URkMNUr8O8j0
NN/oyvL9hpGn6Na2ejlTpkSkWpR/VUqSTs5Lctye+GGRVPLPkufzLqEsNyX1wx8r
i2jvHMlqJ6cpYoQ/+jtNxHJ1VeWCtQ0vyev+IJr6WGIajbR2+vvJPwVbcRvHH6lW
AiBSRqHauGei3mj3Wmwto91Dd6fGohhmt5FmjpGOPEOpYGlPHCbzZ5e8l6nf6bJ5
geOO6Zzb2cb3Bg+tciHNs6Bl+sISob0yCNumK3R8n6XrNjNqGowW+rKtwlit3dhZ
WS8lRpFRJHBZTJGoXbalBgiw8u+VbHzFe6nYWltb63dQRx3zQhVkaESO6M6L/M7N
8VPip7Yc5sKE0ry8H1t1KFtQI/TX70mhECx/H8X7v9yF8Nt8HaZa2VpptpaWNBZW
8McVqFbkPSRQqUbevwgb4Jwp8z6D5c1rSZrTzBbQXGnlT6huAtEB2LB2+wfcHAHm
Xy/5Gn076n5kW1Njdzolsl9IiqspC8I7YyEcK+mKIn3YzzD5b8j65dTLqbxNe2Uc
MRZLgxTWgd+cRQoytC0jUFRTkNtxkjs7S2s7SG0tY1htrdFighQUVEQcVUDwAGK5
sj3mTyloGsalpd9qE9xb3tjI36ONvdzWtZGHJhwjdFkJVD1B2r2xHWfLnkSW40q2
1sW0t6l59a0b67KGuDcRyGYLA0jeowVm+wKinbH6DoXk+21/U7zS5ln1VGMd5F9Z
a4NoZiJHjWJnf6uJWAcoAAetMA6XoHl238gyaZqGsR32jwNOz6vHMLX01Fw0oPrw
uODQsacgw3G+XceUvIY8rn1rox6F6Ucw1D69IiBlkMyXguRIKTNJJyMwarV3JwRp
tj5Bgby8tldWrSQLPJoBW6Vmn9ZCLiRPjPrlgxLNvua4d6Jps+naVb2VzeSajNAC
GvJ6eo9WJBangDTC/TLDyvcTX50q6WSUagbrUhaXJYreiNY2WYRuafAoBjbb2yO2
flT8tLPy9qcUGtSDSUued7dnV5m+qXSMSxW4M1YJCz/EOQrXfDbyh5d0fStW1afS
7+K4gljs7ZLCEJ/okVvG7IrMrMzNL67Scm3NcX896L5V1XSYk8y3jWNhDPHJHOLx
7EetWkdZEeOp5H4QT1wLH5W8jR+a7adrgSeYI4I5o7OW8d3lECCGO7e2ZyJJEX4f
WK1982r6F5ETy7cJeXw0/Shey3cl+l89qY7uWVjKRcrIhUl3ZSvKnamSLSLfTLfS
7SDSxGNNjiRbT0SGj9KnwlWFQRTvgvNmzZs2bNmzZs2bI355/wB5dI/7bGnf9RC5
JM2bNmzZs2bNmzZs2bMeh75xa78s+a4ILrULDSLi3+vKs2k2sMhM+mpDqH1u5goX
opvIVLDh+2fSPw8cQ1i1/Mi7sDcW2l6ml5JqWo3umiSZuUCmZXtlkjjnSNf3PIp6
nNB9jhU1ySeUNH842Xm6G9u/rxtb641v9I/WJjJCsKXatpgWNmZY19NpCnEVod+w
ER1byp511D/EY1W21G8iW6jmktIvVC3SpqkU1s8Dm44s0NmrLxhjjH81WocmPna0
82y+d9Hn0qzu2trd7RvrccrmFYWuQt4rRiWONW9Ft/UjkLD7PErgz8vtR/w75W8r
+W9XtLiz1KdBaRI0dU9URS3BUupIHFIjX3oMj/nXRrzXfMmr2Gn+Xbq1kt9Ovlsd
UWBYYby/uoAjM9yrA8BH8Chh8TGu3EYnc+Vb7WLCTVYdCuLQnzLpuoaZYzqsEsME
P1SG5la3V/TWnoSHuabjrh5a6Rqlr+aUl1a21+8V3M8+p3l2kDWQtfqnpxJayj96
HWZV+EnoW7HI75lstduLnzFZWun3N1rUuq+rNJBJJGTaNbU016Qy2zPErKUJ9SiN
UsrZKPywF++oa3PPGyK6ael+WAUPq0dqF1BxT4Sa+mjlduSkdQcn+bOeauzSfmRa
cPL99Ha6Wst/LqtvaoyXt0bVo0j9cOr0jiLLRtmcqP2a5WteVru81jzPdWGmM36c
8upB/pDtEJbsvPSB5FYvGVR1B47LXbFPyf0jVrGw1SfULWW3N5cRNC9zClrPIsVv
HCxe1iJii4shVSv2xRjuc6BnJ4tD1q1/MaS+bSbh4rPU73V5L+NFZZrOfTVtooIn
ryeX1l/uu3XDTSNE85J+cF5rmoWlu2k3WnS21rfRyyc44EmiaC3aJkAV6+o7fEep
32AzombIdZ+U7dvOHmlp7N10zWbOxWabmy+vIrXPqqHVuY4q6ClRQbDBP5YaVd6T
5B0XTbu3a0ntIPSa2YAFAHbitBUfZpkozm8tlex/maNVg0K4jsdNgujcyJDEqyy3
HHjNbyxEPcvKNnjl+xSo3wTZeX7jSNd8/X9ppDXEWoW9rc2sLkOt7dRwzGRAXL/t
8F32G1NskXkjQI9C8sWNj6Sx3RjE2oOqBDJdygNPKwG3JnJr/TIT+bnlvWtU1MfU
dNlvvr+ly6ZaTxhWW3u3uoZlllJIMScIz+8HTJH5g0lvMWu6DFPpzfou2mubm/ku
IkPNrQhLeFuVW4SSv66EbH0xUb4TeRvLvnKw/M7zTquuW8RtdUtrc29/DK0isIp5
xDCEZEKenCy8hvvvU126Tmznlr5Jiih/MCxGnSGx1aUTW0bux+su1jGrkMW5EGVS
vxH26ZLfKNtc2vlTRbW6jMV1BYW0U8R6rIkKqymngRhtkA/OnQvNeueUJLDQraC9
jJMt7ZSyPFJL6VHhWJlVwaSgMymlaDfCr809M8xatJptxZafdNLaQ31lIsEUVwhu
7mKFrZmWYFWtfUQiSThUCooK4S+dPIXmaDzBZa7pdpNczwlb2/McccxgllVEKWsT
cRcenLGJFWRjwXlx+0Kdk0uS/l0y0k1GJINQeGNruGM8kSUqC6q3cBq0wVlOGKkI
QGoeJIqAe222QjW/L2u3d95Sv9QihvdW07VS9xd2aPFDFavbzqWEckklKlkVjUn6
MIfO1h5j1DzfZalYadetDLbxWlujQQPClzbXxd3u/ULGOJoTVGT7W24IGLfl95f1
m082iW60p7Iafb6nbXt64AW5e71AXNs0UgJMyCEHc7qdsS8n3N1b/lu95Fp0Ov6P
D6xstEs7fldtdpeycvUMknpMA+/2ARTvjhpTy/lvBplxYa1yV01G/is7eKCZ3kun
kmhjglZkCq+/pfyU41yP6j5S84XU2ht9Qn+uXhsDPK9tCUig07UHuIw0sbL9Ume3
esv7sh2+EEbjOsW2qXmt2emanoM8K6bO7NdrdQyeq8SkqVjo6em4ZerBh7Zz78vd
I1zTpWW50e8tGj0yHRbl5EUereCaZzcBkZvUhCuo9brhf5btPMOi+Vbw3vlm81e4
traytora5tLZpm1GFZI5ZUVDR7WNSrK5JJJanXJD+U1nY2Ws6tY2YdRaaZo8VzHM
npzJNwuGZJY6twYKy/ByPFaDph5+Z8rx+XT6GhS67eyloLVYrdLr6uZUKNO0blah
FJ2H2uneuQuy8palF5msLK10u9Fktzpt3b6jcAKqWFtpv1SaGSYOZEmLneP6a4IP
k/6h5JFhLp+rJZWWvX1zDZaWIZbhoJLiYwSMkxYSJ8av3atD450fyqmqp5b0xNWj
SLUltoxdxxBVRZAo5AKvwj5DbDTNmzZs2bNmzZsbJGskbRv9lwVahINCKHcb5Ez+
VnlX1EcPqA4dK6jesdulHaVpF/2LCvfEtf0Sx0fStKtbIzGJtbsJCbiea5fk1wtf
jneR6e1aZM82bNmzZs2bNmzZs2bMa0NOvbIAPzPngd49R01rd9KaOLzEVbmIpbmc
W1qtuP2/VLLLVqcYz3bbB1/+aXl+yR5ZYLo20N9cafd3ASNY4WtXEckjF3XktW2C
BnI344J0T8xND1jXJNHghuoZle6ignni4QzyWEvo3SxMGYn02ZTUgAg7VINCLWfz
p0e2F7DpljcajfWk8cUUCmJROgvI7K4eP4+S+jLJxpIqkmlKrvkk1rztpuj61YaX
dwTg37JGt2AghjeZ/TiRuTq7F3IX92rca/FQYt5L19/MflXTNclgW3kvoRMYFPMI
SSKBiB4YQ+ZvPut+XdVuRe6XDNpS2l3dWxt5i10Fsow7SzIVCJE7MI1oSQxFeuBZ
vzI1+wtlhv8ASYp9Qg1m00jUZ7SYi0iW89BklUyhZWPG6VQvD7QO4GDdO/MGW98/
Xfl1YoEtLWV7MlmlFwbhIFuOQ+D0CrRvsnPnsWpQY/UPzFgsJtVuX06a403TrhLB
bm3MfOSdEMlzy9VoURIahfiarNXiDhn5W80xazc6jbCJYzaNDPbSISUnsrxPVtrg
VAKlxyVlO4ZT2IyQZsZPK0UEkqxtK0aswiSnJiBXitSBU9BU5F/L/niW/wDJF55m
1DT3s5LE3/1jT42E0i/UJZYygKgBnIi7bV6Zf5e+atR8xaXPcaiLWG9hlVJLS2Fy
rwh41kVZkuo4ZA1HqDxoRQjJVkItfzAvpfOw0V7GNdLlvZ9KguBIxuPrVraC8d3S
nD0mjbitG5cvbB6+ZNei87RaJd2EA0+9jnks5oJTJcIltxrNcoVVUjkZwqcSTXr1
yUZsKvNevR+XvLWp65JF6yabbyXLRAheQjXlTkemA/I/mW41/SZZ7sW4vLad7e4F
qZeHJQrj4J0ilSquDRl6bjYjJDkSg83asPPx8tXVnb/V5oJLi2eCZnuI4ozQS3KM
qoEmaoTgSQR8WA7n8x7u2fzgLjSJIh5bW3NmlfVkuvrIYRtwiDlVaRdqVbjvSu2H
fknXL7WtDW8vzbC9WWSK4jtPXCxuhpwdbhIpVcdwy4fZDtA87ajqPmVtPuLSGLTr
r6+NNljdmnB0u4W1n+sKQEHN35R8Cduu+CtJ8y63L5vu9B1Ozt4kFsb20a2laWSO
ES+iguqqqq027R8SdlYdsk+bCLzt5lHlvy5carxRnR4YIjKWEQkuJlhRpOAZ+CtI
C3EE06Yr5T1qfWdCgvrhIkuGLxzpCXKCSJijgCVY5E+Jd0dQy9Dhxkd86eabvy9b
afNBp73yXd9bWc8odUSBLidIfUetWP8AefCANz4ZXnvzgPK+kJeR23127mmihhtA
3AlXkVZJCaGixISx+7vkX1n84JdK803Gj3VhHDaJcLbpfTymJYQgR5ZJwy04vG/O
H0yeVGrTic6Ujo6K6MGRgCrA1BB6EHLwr1vVZYbO8TTJ7NtVtYvXNvdSMFWMblpF
iDyheNaELkXfz/rVr+XMPmfULO2ivLuSGO0Eckj2xS8mWK2nYlBKEZZFZl48u3XE
3/MPWzoWk65BZ2U9jPKtvqCRzy+s87T/AFcQ2kbxo5kDAkpKFI+z1w+fzU0XnebQ
bj6vBZRWFvcx3EknCWS4uZpY1iRTRSOMBPWte2FVv581I6P5svE0F4rny9PJHDYG
SNXmAtkuBJIw+BOXqb0Lbe+DfMXnK607yVba7Z2nr318lqLS24TSp6t1xoH9BJJe
K8uqphB/ytHVg9i6Wlnd2iRWUmsTQSyqa6hdtZR/VUkRWrFLGfVWUKew3GdCmvLG
1eGKeeKCS4bhbxu6oZH68UBI5H2GRvyv5r1fUtc1fR9QtraO408JIr2krypGJSeE
FwXVKTBQGPGqkHbCm286edzpnmCe4tNJU6PcC3W/FxcLZgxryuTMGi9X9z8Iqo3J
8Bhl5D85XnmK4vRdaelgVtrK8h4vzdo7tJBRzQA8Xhbiw6qQdsNPN2p65pukSXmk
QWkrwBprmS+maCCOGJS7sWRXapC0G1B1O2Re2/NDUJ9ZtIzpXo6dM9paTwyMRfJe
X1mb2NQtPSKKg4NVgeXtiVz+ampL5WttR/Rsdjqt7ql1pUNpdNLKiPatMaOLZJJG
d0tyAqKfiPhk80fUV1LSrTUFCBbqJJgI3EifGK/C4A5D3pgzNmzZs2Rg+drwO6Hy
vrVUZk5CK2KtxNOSkXHQ9s3+N7r/AKlfWv8AkTb/APZRlf46mAYP5a1pX29OP6vC
S/jxKzFRT/KIxsfnm8dOTeVNcQ/ytDbV/C4OP/xtdf8AUr61/wAibf8A6r4c6Lqk
upWX1qSwudNbmyfVrxUWWimnKkbyLRu2+Dsjfnn/AHl0j/tsad/1ELkkzZs2bNmz
Zs2bNmzZsx6HenvkLn/KvyzPZRwetcrK0bxz3qyr61yzym6SSZipDvFcH1o9qKdq
cargW4/Jfyzc2a2s97qEoaS5muZnmRpJmvHWWQuSm1JUDKUCkfZ+zth1pfkLRNN1
O11G3ecz2kmozRB3BXlqsyzXFRQbBkHDwHjhXJ+Uvl/hqyRXd3bx6pKJwImhU28n
1lbtmib0+TFp1DfvS9OgoMMNc/LzRdZ1611q6muVubY27CKN1EbvaTCeF2BVmBVq
ghSAwPxVoKXpXlG70WHRbLRNUlj0fTm43NpOElMsAhkUIrhVKn1XVyf8mmB7z8ut
Ov8AX9V1G91W+uY9WtWs7vS3eH0Ft3QoEjpGJkUElhR/tbmuOtfy90f9EtaXN/d6
jJPf2+p3GozyRmea4tHjMPIxokfFRAiUVRUDx3xeHyLo8Xmw68t1cer6j3i6YZF+
rLdSQ/VnugnH1ObQ/B9vj7Vws1L8r9P1K+1Bbq8lTTru5+vw20JCvHNNEYbxCXDq
0c60bpyVqlSNsNfKHlFdBlvpjcG4e4EFtb/8VWdjH6NtET+0wHJnbuzHtTJJmzYR
6f5XsbSwazs7y4S1kuLy4nCSAF3vXkkkHNQGXhJKSnEgig3zeVvLFnokV1JHeT6l
eX8glvdRu3R5pWjQRR8jGsafBGgUUXtvvh5kUb8vtH/xHcazFeXUV1I0tzFbI6en
Bdzw/VpLuNWQt6jRDj8RKf5NcW0/yclp5vvPMX6Zvrm4u4xHLYTNA0CRj7CoBEJU
VTVgOdKkk1yS5sB6zpFjrGk3elXyl7O9iaGdVJUlXFDQjocBeVvLlnodlMsN1Nf3
F7Mbm91G5ZGmnlKrGHf01jj2SNVHFQKDxw5yMy+SbObzBLq7anetdokgsYWkR0sm
uABM9uGQsPUCdHLKP2QMFy+VbBrzWbyO5ube61qGCK4mhl4NELZXWN4SB8DDmSa1
rj/K2gWWiaa9vbXMt8880lzd31wyPLNPIfjd/TVEB2AoqgbYcZErT8vdMttWur61
1O9jlYyta26yRlLM3cy3Fz6IKFv9Ikjq3Mt/k0wV5f8AKUek69q2qLrF7fyam/O4
tLp4XjiNaoI+EaSKqL8KKWIA998kebC3zHodnrekTafdyyW8bFJUuYGCSwywuJYp
UYhlDI6BhUEeIyvLuh2ui6YtnbzSXPN3nnu5irSTTTMZJJW4BUq7MT8KgeAwzwv1
3RLTWbFLO6eRIknt7oGJgpL2syzoCSD8POMVwn82/l55X81WjW3mGL64DIWs5ZOC
yW/PgWjhcAEKxjFQa1yvM/5faD5iuYbm6nngvLBFTT57eRVa1YGpdAysvJ1PA8wf
hqB1OSHTdPtdO0+20+0Xha2kSQQISWokahVFTudhgjCzV/LmlapbX0U0Qhm1C2a0
uL2ALHc+k4pxEoHLbtgbXPKdnq2nixlup7a2jSIW4tykfozW8iyw3EdUNHjZBSvw
+K4TL+WenKdJms9av7dNKlluuMb27Q3FxPIZZridHidS7szbpx41PGmD38sxzedZ
NduTaXWn3NlbW8EEyc5UubWaWVJY2aqUKznoOQI64M/wvpnHXYjLKf8AERZr5S4q
vK3W1PpbfCOCDx3xK48rpLpw0y01e+sUt7eC2ga1ljWSE2/2JASjVZl2YOCrD9nC
f/lU/lpJrSUXF0kdusRv4vUT07wwTtdxSXNVqGS4dpAYynWnTbJDpmkSPptiuutB
qupWhMi3xhQAPyPF4wQeB40FVwBpXkeLTtRl1AavqF1duyKstzJHIy20btILWvpg
tHykJq1X/wArKXyjptr5bXR7DVbvT1ineePUoZkFyJnkaRubOrJJ9srxdTt8sR8l
+TF8u6lqUlvNE2mSwWdpp8EfIyJHarIzGZiSC7yTsfhoKYN85+VovMulpYT6nd6Z
CsqSO9m0SmTifhSQTRyqycqHjTfAS/l9pJ8wwarPf3c88ZhuZbKR4/Rlu7aIQR3j
oqKwkCbHiQn+Tjr7yDpb6b6EWoXdhNFqE+qW+pQyRieG4umkMvEyI8ZRhM6cWU7H
x3w/0jSrPSdLtdMslKWlnGsMKsSxCoKCpOC82bNmzZs2bNmzZsjfnkgWuj1NK6xp
wH/SQuSTNmzZs2bNmzZs2bNmzGlDXp3zh1xFr1jbNf2FpqEViiiXykCrSPaW8d96
l+rxcKxvJaBjFy39H92vxCh2sebPPUlh9dsV1b1W1LUZ9KQwyRK8EUym3iliELuy
+iWZUk4Ky1+Lltkk8n3vnX/GETahcXs+n6hca3HNBcRcYIIrK7VbH0yFXjzjkb4i
fjFP5ch2t3PnnU18yRandahDaWd3FJc21qtwZEWLVYvqrwcYAir9TBdlieXl9o8S
KZNPO+seZrbzxo0OmC/NvztOaRqxtJIJ7kQ3TOqROHMcbAn1JE4VBUNvQd+WWsWW
m+TfLOjanI9pq08SwRWtwkiSNLwkm4VZftenGzHftkV85x2V75w1y28vWt5beYLf
S70y3kMV0j31zLABHbrOyek0UKfEBzH7zjx35Yh+h4rzRTeaBa3ltocHmjTJ9HsI
IprSEwcrNLlzasqPwSVZW+JQtat74Z6Tb6jF+ct3JNatLcS3cxErWsgaLTDZJ6co
vvsOhuV4LBXapYrWhBR5ouNQ/wAS397JNqNve2mpXkV3Np8bzSwWg0//AHHUVVl4
Rys1SyqasT03pNfy1nv31TXo5wVHGwmv4v2ItWntud/GgqQtP3bMq7cmPcnJ5mxG
9CGznDo8iGNw0cRIkYcTUIQVPI9qHOY/l3+jreHzJHDY3MeiX85TTLa2t7m0V1jt
2M0ccElJIpwF4ySlwJH3XfDP8oLeOK21x7O3Nvo819y0tUgls7cxCJFb0bScerEV
cFZSdnerDrnQc4/BFcWn5qTXsttcpdW+oXt1qF4IpWB0U6aq26+qqlZIxdD4YlJY
Nvxw205/L9z+cMv6OguLO7tIJjf3RgukF/NKE/dtNInpPDAm6jn9o/CNjnSs2R38
xINTuPImvQ6UrtqMllMtqsRIcyFDQLQqfuNcKPyijMeg3qQW4h0sX0n6KlW3eyWa
AxxkyC1enogSl0oFWvHlSpJM5zl5NhafmzJqFpZzwRW1vctrs629wjl34+k80zeo
l1Cw/uY4t4yCem2MvdAvI778yI0uL+CDUYLCX68YnvHoyS+ulvGaB1WP4OCdB75I
PynSKPyq0VtaJa6fHdTrpzpa/UvrFuCOE7W/FODPv+yK0rkzzknleVNP88XN3PZ3
UF3A2qjzFc/VpyZBcX8X6L5yBCJwIK+nwLcFrXjhn5LbQp/zK16TSbeaxW1ga3ul
kt7mJr24M/KW5kmmQJKse0cRDE0L0+GmdIzZEfzWhvpfJF4tohkpLatcoImuAbVb
mM3PKBPilT0eXJB9obYp+WSsnlG3QQejbJLOtl+6a3ElsJW9GUQNT0Q8dG9OgC9g
OmSrOe/nhH5on8mTWuiafNfRSVe/+qTLFcKkNJI1QHdg8gAfjvxqKGuBfzak07Uv
LXpyWEs2qoXhsle3uJkivGjVhGrw/DFOwakNwQUVu/UZE/OmheY9K8y2+tWy3N1H
L6N5qnOKaRIkCosCXqwNyu/SuI/gVB8KsxOwGdu0u6ubvTLS6urZrO5nhjkntHIL
ROygtGSOpU7YKzZG/wAyIdTn8h65FpayNfvaSCBYamQmm/EDcnjXYdemc/5t/wAq
980Wfl62nt7K9uXufL1oLS4SP6hGLUXKpblUZUL+rWLZn+LiN8jPmLTNQm8r2baX
ZmSIm+tfLUZs7q3T1Xlilt72CONaWtx8LxxhxGvVq9Qel6oL5fzM06Wwgt7nVU0R
gY7uVouMLXcQmZSiSnl9FD4jCHymw0/zvc3U1vcw3UM2qjzDcm2nBkS4vY/0VzkC
UnCw8uBQtwXrQYUX1h5zudf8+y63YXVtb3EGnzwstbq1ltLS7k/0ZFg5uVmgH77i
hYAmqnYGafk/eGLy6uk3hS3vZJby9sbBBIqppz3TC3MKSgOkKqQqKwBHgMW8oRto
8XmW2uBd8bnXJ0spJfVeSQzW0JDCQhuKtJyAb7Iznfl7RprjyjrtvLpC3crx2MMc
dxp0iQpqbyNC8tzbThjLcw+qGnuI/gZdx0zoHkDRtL0Pzh5j0fS41hs7Ky0iMRI3
L4wlwCz/AOUVVevYD2xf83Z9Ah8rE6vpz6mXcx2NsIbi4iFw6FUlmS3VyEj+1yI2
p8PxUyE2emXK+c9OghN7dakJdN+qavJDKsr6Oum+ndN9ZZAoVrg8miY8ue/HGalo
lxaeSLSxuhcto1v5k1L9JS3lpLqLG0eS69GWW34s0oMrRlWKlQaN0zrPk9rxvK2k
m9tzaXf1WL17YliUbiKrVyzbe5w3zZs2bNmzZs2bNmznv5m+VJL+40q+XWtTsw2q
WEX1W2nVIVrLw9RFMbEP8Va1wzh/L65jUqfNOt7sDxS4jC7GtByidhXvvkvzZs2b
NmzZs2bNmzZjWm257DIfb/mTYyFEmsp4JreOeTWoiGdrIwOIlQqilpHnkYeiqirr
8Q2xVvzR8lIlqXvnR7oORE0E4kiEUixTGdSlYfSd1EnqU413wZY+e/K99r76Ba3n
qamnrUjEcgR/qxVZ+EpX039N3CNxbZtuuFOufm35U0uG7ZPrF7NaTRQmGCCU+rzu
UtZHgYrxmWGSTjIUJ4t8J3Iw91Hzbomn6ra6XdSSLdXRUIwhlaFDIeMSyzBTHEZG
+FA7DkdhjfLOr2PmjQNL1/6oI/rCfWLaOYK8kLMGQkN2PEkVHY4Ua9+Yh0HVJ4dU
0i4i01ILia11BHjkMxtIvWl/cqeUacdldju21BUVQl/MTVotIvbtvLsjX2kztHrF
ol1CY4I0gS59RZyFEhaKVeKqv2qio64vpf5jwaj5gg06LT5o9PupDaQahIwV/ri2
ovWhe3I5qBA326/a2pktW2t1uHuViQXEirG8wUc2RCSqlupALGnzzQW1vAGWCJIg
7tI4RQvJ3PJmNOpY7k4pmyLHzyB5sGifUH+pm5/R36S9Rf8Ae76r9c9L0acuHob+
pWnLanfAU35o2MWvavpv1J5oNHine4khlje6aS2iWZ1Wz2kKlXAVgdz2pvhl5I85
L5osrmY2n1Sa0lEUqpKlzA3NFkUxXEfwSfC4DU+y1VPTBXmTzPBob6aklrNcHUry
CyVolHCIzyLGJJXNAAC426nsOubzB5nh0a70m1ktZrhtVu0s1ljA9OIyVo8jmg67
ADc/fhXon5iWmr+br7y/BbcVspJoPrBni9Qy2xCy8raokVKn4X3r4DbJdmyF6/8A
mQNAv72PVtJmhsILa4urO7SSOR7gWgX1f3K7xqS4CMzb+2HHlPzM+u296tzZNp+o
6Zcmz1CzMizKkojSUcJVADqY5VNaDfbth5kcj823S+bU0G70qa2hulmbTr8yI4m+
rBTKXjSrRJ8XwMx+L2wFq/5l6Vp2p6zp/wBWmnk0W1guJpU4iN5bqX0Y7dWJ+0GK
8yfshhht5T8yfp/Tpp5Lb6nd2lzNZX1sJFmWOeBqOqyqAHAr1oPDA3nDzZdeXIY7
saTNfacnx6hdRSIvoxlgg4Rn45pCW2RRv412xfzJ5tsdCu9HtJopJ7nWrxLKCOKn
wB/tTSV6RpVQT4so74H0fzhLfeaL3QLrTmspoIjcW0hmjlZ4VcRlpkjqYCxYGNWP
xLU9iMkmbIPqH5lz6bc39rqGhz208UaS6YGljIuVluUtE9Rl5fVy00q/ar8O/YjJ
F5Y18a5phuzbtaXEM01peWrMH9O4tpDFKgddnAdTRh1w2yKef/P9n5Rt7HnHDPe6
jK0drBcXCWcZWNecjtPIGRQgp18c3mvz1JoFtZOmmSX89xbzXtxDFKiiK1tEV7l1
dvhkdRIOKCnLxwqm/OPR49ebSBZytzkSK2uucax1pG0xn5EGBY0nRgW+2DtnQM2b
In5w8/xeXL6K2Ni94i273+oyq6p6FnHIkTyqrA+qwaQfACDTN5q/MC38v6rDZPZt
PCscU+o3PqLH6ENxN9XhZEYVmZpAfgWhp49MX0jzlJe+abzy/dabJZywRtNbT+rH
MJIo2VD6qxkmB25qyI32l38RgODzXYT+U289XGhv9btIboQQRqk936UcjKUSQAcV
k9IMQTQd+mC/Mfnmy0XyfF5keIOLlLc2ttJIsIeS64+nGZSGVftdTthLJ+bUEM1g
k2m8opo7N9SnguoZkt/0lM1vaekRx+sB5EPLhQqN6HJ4be3+sfWfST6yE9MTcRz4
V5ceXWld6ZF/J35gReZLiWH6i9pyt1v9PYyLJ69nJI8SSEAL6b84yDGenjhbffmn
cafBdR3+iPa6pFNbx29rJdQiEpd+p6L3FzT07cn0WDK1aHiN+Qww8jeaNL16+1Oa
10g6ZcSRWd3NM6ostwlxG6oZeIDco2hdPirsAQaHDfzPrWpaTp31qw0t9VlUkyRL
LHAqRopZ3aSTYbDYU3Ph1yO2n5qWV3qtpb2+nTtp919WiF2zKkq3V5bfXIIDbtRv
ii6vyoG298YfzN1BTJYSeX5YvMP1qG1t9Me5iEcn1iGS4jJuVDIjelA/JSNmoO4O
S3QdZtNb0Wy1e0DC2voUniDijBXFaEeOD82bNmzZs2bNmzYXa7r1lolkLy7juJIi
4jpawS3LgsCQSkKuwXbdjsMhWu+edL1ttGtLK3vUk/S9gzvcWk8MXETj7MzL6Lmo
6K5zo2bNmzZs2bNmzZs2bNmyMap5Gjvl8x8dQmtpPMIgrJFRTC1tGsa0oRzVuPxq
eoqvfI9p35LWVlpV7p41WVhe215byOIY0Cm9uUuWZEXYBGTiq+GV5W8h+ZbHz/ca
rdtHB5fspNRfSbVZRM7tqkqSzOx9OJkPOMtQs1AeI6VN/wDKl7ON9ZktdSFvLqMo
ntJxaxNLA5vEvpOchPKYNNGKD4QF2364b+Zfy6j17zFY6xNqUsa2T20q2npo6+pa
TidWjZt4xJTjIB9r4elN1dC8s6/5cs9C0jTL6K60eyPpX31iPhMYFhk3jKVBdpmQ
79FBwLqv5d3+ra9qt9qGttLpmp2Mumrp62yK9vbyqKrFccid5Bzaq/EQAdgMB3/5
Y69d6PPZt5m/0zUL1b3WLlrGJorr0o44oojbh1CIqwpyAb4iN9jTDKy/L6S381Jr
cmqvLbJO+oDT/RRR9flthaSzeqCW4NENo6bHevbJhmzZsh11+X9xJ5ll1iDV3gt3
nbUIrIwRvw1E2n1JZ/VJ5GMQ/wC6iKct64Cn/KeG61a8u7vVZWs7315pbaGNIZRe
XVp9SmnFwp509KvBP2T37Yc+RvJa+VrO6ia7F3cXkqyzvHClrCOEaxII7eMlE+BB
yI+01Thl5g0NNZt7WF5mhFre2t8CoDcjazLMENezFKE4G1Py5cambb63flhZ6nFq
VsFiVeKQj4YDvuK1PPrhTpn5bWth5vk18XryQC4ur61sPTVfTur9FS5kaYHlIrKv
wqR8PjkyzZBtV/La81jV9budV1o3OnaxaPYR2QtY0ltYSQyrDcBuVOa82BX4jSvQ
YeeUvLMuhW9411enUdS1K5N5qF56awK8pjSIcIlLBAI4lFKnffvh7kSi8n+YI/Nm
o6/+n1cXcBtrS2ezjJtYwQyIknOrLyqzCnxHqdhgOT8pdETWNZ1Syurm3l1q0ltp
4JHa5gWSeYzyTCGdnj+Jj9njSnSlcOvJPlOPyvozaeLgXMs00lzcTLEsEZkkpX04
UJCLRRtU+NcD+cPKesa9eaXLaayNOtdOnW6ks2tUuUmmjYNE7FnQj06VXtyo3YYG
8w/ltp/mDUdO1TULy4XUtNuY5Yp7aSSBXghuDcJA8SOEPYF6V2wXo/k+6svNV75g
u9Ua9e4ia3tYfQihMcLOJOMskdDOUKhY2YDitR3JyS5sgU35a6xdTa5Lf+YjcSaq
8E1rL9SiWS2ezmE1qtSzLLFGV+wVFak1qck/lfQTomlm1kuTeXM0011d3RQRiSe4
kMsrLGpIRSzGi1NMNsIPOHlq81+xW1tdR/RxYSRXDehHcLLbzpwljo/FkLL0ZGFP
fphRrf5ayahp9lYW+ryWkFjby6dF+5SQnTriCOCaBqlf3hEQKyihXwOJ+avyn03X
ntZVu2tZtPhjjsiYo5kLxgxl7iNqCesLFAG+zUkZMNL0+PTtMtNPid5Y7SGOBJJW
5SMsahQXbuTTfBWU6q6lGFVYEMD0IOQfWvyp0y8FtBpdydI05beWxvrGKJZFmtJ5
VnkRGc8onLrXmK/LFPM35cy+Y7qwl1HU0eO1dvWT6nCXeL1hNGscp+OJ04qvIEg0
rxB3wdpHkuWy813nmK61J72eeJra2j9KOEpAziThM8dPXMZWkbMAVWo3rhd5V8gL
a+WLy01K3htdbv4LqxvL61Yyc4ZJJTEw5BdwkgNCNjthtceWdXGjwadp+smz+qW1
tDZzG2imKS223qssmzB1oCu1OoYZHbj8nLC4bRVmvzJDpjiecNbxerLOLk3nOKYU
eCsxNV+IcdhTrkotNDfUbLTLjzPbW8+tafI00csHL045akB460P2KVrhN5W/Lu78
v3Imi1lrgwxx2VoHt414afE7yCBuJHN+Un97sfbC8/lVqlxpt9b6j5gW9vrq+j1K
O9ewhAMsatHwuYeZjuY/SYIqNTjQU3GGfkXydfeXNT1JZCH00WthZadKZDJLItqs
rSPICBw+OfiqgnYYY+ePLWqeY9GOmWOrfopJXH1tvq6XImh/ahZWZPgf9qh3G3fC
pvy4uH1+PVX1g+mHgvJrRbaNVbULW2+qxzq4PJY+G/o7ivfAdr+WWvQ2J9XzN62s
x6idVttUNhCD6zxNBJ60XMrKDE/Fd14gCnTJnoGjW2iaLZaRbMzwWMKQRu9ORCCl
TTB+bNmzZs2bNmzZs2RvzyB9V0j21jTv+ohckmbNmzZs2bNmzZs2bNmzZs2bNmzZ
s2bNmzZs2bNmzZs2bNmzZs2bNmzZs2bNmzZs2bNmzZs2bNmzZs2bNmzZs2bNmzZs
2bNmzZsjfnj/AHl0j/tsad/1ELkkzZs2bNmzZs2bNmzZs2c+j/MHXLDV9di8wQWM
GlaCYFmltHnknmkvVBtkijZFBZmYKQT1xVfzb0+XWbawh0y8MbW99NfyMEV7WXTy
olgePlu/xjdTx3G9Om0D819P8w67pVhpds/1e++vx3bzkLLDNYCI8KIZEYOJq1DY
T6v+dc1nAbuHT4TZK+oypLPMY/WtdLlWCRYvhI+sSuWKIduI3x+o/m9qUF3r/o2M
IttLST9HQzi6Wa8aKOJ3kjYRGJo09X4ghLACtMlHlbz7p+t2V1PJ6drPZxLPPZeo
HnSPhVndBuo5qyr40wj/AOVj+Zk8qp5qm0i2XSL76o+mgXDmcR3dzHConThx5enL
z+BiO3vkq8oeZDr+nXE8kIt7qyvLmwu4Q3JVltZTGeLbVDABh88O82bNmzZs2bNm
zZFPzF826p5V0Y6vbW1rNZ24L3ZuZ2idtwI4LdFR+c0rGi12rhTrP5j67o+r3dvd
6KrWf6MuNU0wJKyzyC1VC0cnNFjDsXPwozFQKnqMOfy884y+atHuL2WGJGtrl7b1
rZ2e3m4qrepEXCPx+PiQyg1ByUZs2bNmzZsiPnzzjqnlhrG5jtbafTZporeYSTMt
1LLPKsaQ2kKo3N6MXNWGwwn1j8z9Z0XUtY07UdKhE9tFbzaZ6cz0kF3dC1iEnJFr
QkO5j5BRt1yV+T/MUmu6XLPPCtve2dzPY30UbF4xPayGNzGxCkoSKiowu81+d7vQ
/Mnl7SI9KluLfWrtbWbUywSCHkrlVHVnkPDpSlO+Rj/ldFx6Usp0yMLehzoQErVf
075bBvrPw/B+8cP8Ffh98Oj+Yt1/hNdRFlGNYOp/oM2pkJtxe/WPq3L1OPIxV+L7
NaYS2351sb6O3vdNW0hNu/rXTyN6KXMNw0Ev7woF9Eemx5Vr7Z0+3uILmCO4gkWW
GVQ8cqEMrKwqGUjqDimbIlP54vIvzIs/KB0qVLS6s57oatIwCO8PD93CgqWpz+It
T2wsvPzMurbzfqmlS20cOm6YjenJKtwJruWO2+sOlswj9Fio248uR6jK0f8AMjU7
vyNrfmC4t7UajpNu1w2lIbiOSIiD1ljuBPHG6kg/aUFSOmHeoa95htvJsGsJFYLf
GFLi9a4neKzhjKc3f1OBchR7YTaz+aN3ZflhbedbXQ7i7kubdbg2QYKsKkVMksjU
IjA3BC1O22Pk/MyVfNUemfUk/Rq3Fnp9zc+ofWF3qEBnh4Jx4mNQvFiWrU5ObiUw
wSShGlMalxHGKu3EV4qNtz2yFeX/AMypb/yfr3mTUdKk046HPeRSae7q03G0HKjk
fCrt3FSBhLqn5w6xpflfUtQuNB+tanpc9tHdRWstbZILyNJo53kcK6gJJxICn4vb
Jd5f8zahf+Z9d0W8t4Y10sW0ttPC7MZIrpCyiRWA4svHehIySZs2bNmzZs2bNmzZ
s2bOB/nP/wA5Dy+SfzO0DQLVGbTrUrN5kHCpeK5HFFjqKkxr+826mg8c6p51dJ7H
Q5o2Pptq+muvbkrTrSoO/euSjNmzZs2bNmzZs2bNmzZG9S8gaBqLa2116zHXTbNd
Uk4+nJZgCCSEgfAyFQ3ffCm5/J3yvcwCOa4vWldLxL259ZRJdG/4mZpjwpy5RIy8
QtKeG2C9A/LHQ9F1aHVoru9ur6GS5l9W5lVgz3iRpKWVUQdIFoBSmAo/yn06XTpN
Kvryd9JF9d3UNlCwSN4L1/Ve3nVg/IB2biy8WA79cOE8i6cNd/TEl7ezywiT9H20
soaCzaaMRyNbLxqtUFACSB2GN0T8vPLmjaxdarZpJ693bJZyxSPyi4IAGYLT7UlB
zPemAV/KrQxpz6U1/qL6SDEbPTmuB6NssE63CJEAlaBkA+MsQuwOHHk/y22g6bcQ
SzC4u728ub+8mUcVaa6lMjcVNaACgHyw8zZs2bNmzZs2bNkX84fl/p/mi+0u+ur+
9tJtHkaeyW1eMRiZhQStHLHKrOo+ySNu2Ian+WOhatdXc2r3V9qMVzFNDHaXE/KG
3+sKqyvAAoZGbgO5A7AYa+V/Klj5dt7pLeee7uL6c3N7e3TK80spVYwzFVRdkRV2
UdMOs2bNmzZs2RbzD+X2n635m0zzFLf3ttf6QrJZJC8RhXmau3pyxyDm4+EsN6dM
DXX5WaFezXk1/eX95Ncp6dtNNccpLRBMLgC2fjyXjKisOXLpTptkg8vaBZaFpwsb
RpJQ0kk89xMQ0ss0rF5JJCAoLMx7DGa35bsNZuNLnu2kV9Iu1v7URtxBlRGQBxQ1
Wkh2yPD8o/K3G7QyXZSev1RfW/3ircC6P1Q8ap+/Af4uXh02xU/ldoZ09bH65frG
hEyuswDC8E/1n66Ph4+v6h+1SlNqUxeT8t9Ak8vroRkuRZiOZSyyASGW4f1HuC3H
+95EmtKb9MPtH0q00jSrXTLMEWtnEsMQY1PFRTc+ODMRvLO1vbSW0u4lmtp1Mc0T
bqysKEHCK58haHLeWN1A09k+m2Vzp9ktrJ6Yjiuwodl2JDrwHFq7YjJ+XthPqEN5
eanqV39WUG1gmuKpFOITB9YjIVXWUoSdmpyNaVwPP+XNsnlvzBp1rfTz6pr9s1tc
6tfkTytSIwxc+AjBCKewGBNS/KXRtd0CGy1lmttQkFsdUudMb0kuntQBGJFlEoeM
EA8WBw3vPItnf6NqWkahqN9dWuqW0dpOHlQcFjXjyiVEVI2f9qi0Phga/wDy10a5
1R9UjuLmG6ZEb0lk/cG5ghMEF0yUr6sSNsVIHthra+V7FrTSBqv+5PUdIRPQ1Cap
l9VVCtJWvVqb4X/8q60T6veWpnuzZ6jd3d7qFr61I52vUKSxyAAVjHVR1B74gPyt
8vt5b1PQZ7i8uItXMZvr2WUG5cQBFiXmFC0RY1X7PTBegeWdSsPNWva3d3EMkWqL
bRWkEKOrRxWqsq+oWLcnbnvSgyS5s2bNUVpXfrTNmzZs2bMCCKjcHoc2bNmyB+eP
ye8seb/N/l3zLqSD6zoMjM8XEFblB8UUcp/ljl+IfSO+HHnla2ujn+XWNPI/6SFH
8ckmbNmzZswINaGtOubNmzZsxIAqTQeJzZs2cit/PXnH6lpJltZvqT6/c2za0Z7Y
rcQRXN0Eg9EVlWoiCfZ7Vwrt/wA1/O2pWmlakVgsbU3tvcSRmPg08FxZXM/1HiZp
WDKYABLQcyRRBxIJt5Z/NPzlq66bE1lZxS6ldxIk8qtGBbyWUt7IghSWZzJEIeAZ
mAevRaZVt+bHmGW0g309ptVOnTWlyA/o2EWpNMPSux6h5yQ/V/iYMlS3QU3T0H84
fMuq32hR/U7b07tLd79YQWjkW6uprfnDPJLHwESwc/7t/UrT4cRtfzk81HR0nura
z+talaWd5p72ySSLAl3eNZ/vY3kT1aFOezp149qkDqn5i+e7nUNNOnzwWF7LHp7z
Ws1ZYJmklv4zGESRvT9c26dGZhULuRnRfJPmnUfN1hcahJF+jdOuPUisrYhlvQqh
UMxepX+85heK+HeuRK3vNU8uW3mK/HmG9vprLU10fT49TkN1AvrRW8ikxRLCXlDS
MBykVfFhjtJ/OW71DRkupY7WCW4j05bdeZRppLvVJtOnMY5HosIdQOXEmhJwwsrr
zp5F8oSz6/crrGoTagRF6kt5dIlu6/AoeC0lnqOG/JCK/tCoGGer+Ydc1H8q7/Xr
C4TS9RWyubkTJHK3piBXPwLdR27hjw6vHt4HL/MHzfd6J5Aub6xZm1aS2jSGRI3n
MDzoaXMscSu3COjNUrQkUyMHzRqUlr5F1a31ydpr+LS0vrUtF6YW8CK8k9rxE8pu
CSquu0ZHL7Nclnm6/wBTSDQdOn1H6hb6tO1vqms2lIfTC27yoIpJPUWL1ZEVASSd
6DfIbrfnjzHol8k+m6xDrWm6XpOoXl21wpUXEdnewxABk4q03FzH6w+DvxPTDry7
F5y1rzdBrsWotF5dsrnUrO9sPrLkyPDczRRfuTGyFQvH9sH6BQmfknz/AH3mHWLm
wntIoEgiaQOiX6sSsgT/AI+rS1j7/suT9G+B4L7V3HnKz1XXTB9VvYIra7h9G29C
Oe2gkEETSB1Qs0nEO9TU18MgY86eZTYRSS61PFcaTC81pCzpynlTVDZmC5dRwvPT
hABePZj8Q65KfzG8y6zYeY7GbT76QW0Ys/qsFtNCInkmv/q939biJ9SRREVEYUfa
5dxhv5IgvW80eY706vfXWj21wdPtYLu4SeJrhSHndBwRo/TkYwBP8mu9RQt88eeN
ctfM8ekWFzbWcNvd6bFIshP1ic3rO1UFaGNRHxdaVO5DClMAaR+YGv6P5B8uateO
ur6hr0L393LMt6yo0gVwkK2drd8I15UCtT2rki8/6rIPJ1pqI1afSbyZEeyt7Nki
e5vJUBhhrcIr8A55OpVfhB5UAOE+n+eNem/N7S/LN5Oy2sWlzrcIkEqQ3d4kcEr3
McjJxMShyqUc71r2ws81675r1TXxa6bPfNG+rXOnR6Vp1zBYzenYWZlL+vMCP3kk
nMg9uOTY6h530PyPZzXFj+nfMMYVLuOFguzE/GeIPNlXircBuakbYVeadb1K40Hy
usmpyaausTMNQvbZWsZFCWU9wqp9YDtDWaJVIbc9O+E2rebtcv8Ayb5Mln1R9Out
Ws5LrVLm2KQSevDp7XUaVYMEDygVWnxDbCqHz35oeCPW21N/0uVW2Ok/D6BjOgfp
H1vqlOfP61tzr0+HEtO8za5cSRaLceY7pdMuXtppNV9aNLhZJtLlvXhW548FX6xG
o402Hw5JfLurebNe1LTY7zVzbQaz5WF5HFbxiJ4LwSQBrgklix5Smg2Wm1MOLTzR
rd9+WF95ikkjt7v9ETXEIjWjR3EMMnNyWJUqzoGTbYeOFmgyedtB0rW/Muq3v6Rs
rqC3udKtHmuLgIHFX5pFbvLGTz6RhxTttXBh896nqH5da9riCLTruxjmEEirdcVK
IGDMtzb20g69eBA65GF13Vm8m3HreYbyx1Ozv3tdHtvrFtPcTXLxRPDFPchfSuY0
aRnbhtw2Y1XGeb/NXnry75wt4bu+ZrHUpkItbd4uMkMSIyei8oUWvNw8chkb4iU4
9TTsOmahbalptrqNqWNteRJPCWBVuEihlqp3BocE5s2bNmzZs2bNmzZs2bOZata+
f4fzTN/DfadBpa6VKsVzc2lx6KRtdR0hlkFwiGWu4O21fhyRMfzDWZIG1XQxPIC0
cRtbnmwHUhfrVSBiv1f8zP8Alv0b/pDuv+yrN9X/ADM/6uGjf9Id1/2VZvq/5mf8
t+jf9Id1/wBlWb6v+Zf/AC36N/0h3X/ZViVza/meYWCaloqGm7GxumFO+31oZGvy
4t/zHtPJGg2s1/pNrI9uFgtbu0uVuBxqSjA3KlmUdfhyU/V/zM/6uGi/9Id1/wBl
WX9X/Mz/AJb9G/6Q7r/sqzfV/wAzP+W/Rv8ApDuv+yrN9X/Mz/lv0b/pDuv+yrN9
X/Mz/lv0b/pDuv8AsqyJfmDZ/mYy6By1HSih1qw4JFZ3IIkEhId+V0aotKlR9+Sw
W/5mUFdQ0Wvf/Q7r/sqy/q/5mf8ALfo3/SHdf9lWb6v+Zn/Lfo3/AEh3X/ZVm+r/
AJmf8t+jf9Id1/2VZvq/5mf8t+jf9Id1/wBlWNeH8ylRmOo6KoAJLGzuqCnc/wCl
ZEvK9t+ZNt5s80JPqWkxz3l5A8XrWdyi3HCxgBe2U3QJRQOLU5fEDv2yX/V/zM/5
b9G/6Q7r/sqzfV/zM/5b9G/6Q7r/ALKs31f8zP8Alv0b/pDuv+yrN9X/ADM/5b9G
/wCkO6/7Ksr6v+Zn/Vw0b/pDuv8AsqyIfman5hXfkDW+GqaPPbpE0c6WtrceoWDq
OCv9aYKwPtnRdBi8wRWJXXbm1u73mxWWyheCL09uI4SSTHl1qeWGObIdpHnnyXqV
++k29ncQPYM1zN9Z064toLdwDMZHkmiSONmBLhiRWtcM4rXyJDBatFFpcdvqF2t3
ZFVt1Se8J5LNFTaSbuGX4sLLfzH+WemaHLq9kbKDTrbUJoAbWBQzakHaGRIY415P
O7VX4AWYeIzaroH5fazoOo2SzW9hY3VyJNVksJY7R2uk+NluGj4/vNqsr7+OGFto
nkbSX0m19Cxiu7KOT9ENP6RuVWheZ4Xf95vUtIV+Zxa9tfJUdr9WvotNS1uESy9G
ZYBG6SEvHBxbZgxqyp36jE7228jR27Q3I02CK0EMI5ehH6HpuRbqpNPTKPX0/Bum
+BtEvfJWlaha+WdOKpqFqsljChR2lpDHHdSq0zDeqzpIatuT44J13VfJFjpmr/pe
WwFlCBJrNvL6T1MoAT1otyzScQFDCrbUwv0DXfy18wLaTaallIEeSHTGkgSIu3wz
Tra+oql+L09T0+jjfcYc3/mzy5p89rBd6jBHLeXTWMC8wf8ASVjaZo2pXiQi1PL2
8RgTzf5v8u+X9NE+tRzzabco/qPBaTXkPphRy9X0UkVVYNty+1hpZRaZdwJfw2qr
9ct41ZpIfTlMNCyRyKwDgLzPwN0qcJ9dvvJ+j6npJu9PEup8Wg0prWye5mghoEfi
YY3aCKjAE7LiN7J5O0HT9M8nXNnJe2dzELa304W0t+voIypyuOKShYwzD4pNvuOP
0bXPImuXk2k2EcE8lpA1ukbW/GKS0RxHItuzoElhSRQj+mSoYAHtga7/ADK8j6Rf
zaapm9WJ5pLv6nZXEsUfpvxuJpXhjZFVZCQ7k05Bq9Dkt+s2/wBX+s+qn1bh6nrc
hw4Ury5dKU3rkf8AMuv+TtIP1TWEjZNXBN2gtzOjQgLE011wVlWEVVC8nw9BXENc
vvy/0a80aw1Gyt1ltSraUq2glSyUsIll5IjLaoWogc8RXbAb+Z/yva8lZ4bY3Ogm
ae2mazNQ5l9O4axkMf71/XfhJ6JJ5mh3OJ6r5v8Ay2udNs1vJGht7q6W9aJYJopI
Z7S5VmmvFVA0ASdVEjS0Fdjhpf8AmHyCb+7ubx7Wa80Z7e0vLtoRIbZrpwYUaXie
IL0J3op60yR29vb20CW9vEkMEShYoo1CIqjoFUUAGBNX8v6DrUSRaxp1rqUURLRx
3cMc6qSKEqJA1CRglbKzV4XWCMPbIY7dgigxo1AVQ0+FTxGw8BgSHy/pMOs3GsRw
KL+6EfrSHcFokMayAH7L+m3AsOqgDthjgXUtK0zVLRrPU7SG+tHIZre5jWWMlTVS
UcEbHcYle6BoV9FJFe6da3UUrpLLHNDHIrSRACN2DAgsgACntin6H0n9JjVfqUH6
UEfoC/8AST1xFWvp+rTnxr2rTAp8qeVzpr6WdHsjpkkhnksTbxeg0pbkZDHx4FuW
9aVxfUdE06/tpoJouBmga1aeH93MsL05Iki0ZVNOgOI2PljRLGW5e2tgqXcEFpNA
SWiMNsjRxIEaqgBHIPj3wzREjRY0UIiAKqqKAAbAADKkjjkjaORQ8bgq6MAVKkUI
IPUHCibyV5NmsINPm0LT5LC1LG1tHtYWiiLmrmNCvFeXemDbrRtIu4ZIbuxt7iGa
NYpY5YkdWjjPJEYMCCqtuB2wYAAAAKAbADNmzZs2bNmzZs2bNmzZshHny5uIND1K
XXdEh12xSZP0NYWsE967uykK13AEK8UJqaVFPemQbT9Bu4NZ0OCG0vbqZU0JtJ1S
W1mBjtrWSRtRUzSqGtuSNxaKQqWWgo2dwzZs2Rbzfput6po3mGwuIopdJmsJRZJa
yTLeSS+maxuFCrxY7Di2+c/82aHqk66Gr6VdXOoSaNp0GlTLEzfVr+C5SWcmQA/V
X9Lq7FeQHGvbO05s2bNnMfzk0y5vJLX/AHGTalDJp2p2ln6UTTiLVLhYfqTlVDei
QUfjOaBP5hXOj6ekyWFsk9fWWJBLU1PIKA1T33xfNmzZFvzR0X9M/l/r1iEnmkey
naG3tWcSSyLExjj4oQXDNT4e+RDzXpl7L5rsKaZcz30sWjHSb5YGkS3NrdvJqA+s
AEWxMBXkCV9Qbb9M6xmzZsbLx9J+YJXieQFa0pvSm+cKSx0275atb+X7y28uQaza
nUfL7aZcJWxhtbiJZ5LRo/8ASpJbiVXcoGIUJy3XOp/lvY6lYeRdEs9TjeK+gtUS
aKRubqR0UtU9FoMkmbIF5p8iazq9p5wht544G1s2L2DBiDWzVCySVVgvqNHxrRhQ
7g9Mjr/lb5kj03RhaW9qL5J7iW9NxcCaOAXMyzECM24ilVeP2YkhNfssBXDSP8tt
VOgLpbRWcbQ+aW1qJ13U2pvDccqcBxlCPxp7fawpsPym8wSnTo9SttOS20+50tbi
JHaRb2LTWnZ7yVTGo9ab11qjcum7HD/zX5E1fVfNyXkUFnPpl1+jxcXE7ET2iWE7
yyxwx8GDrdpJ6bUdduvIZFrz8lvMqabbwxXi6hMZrm3uRLOIm+pvHHb2rCVoLjeG
GCvEKGDO3Bx3Hax+U/mF9N1WPT1083mpavcXbyyqpka2lt1ghJmkinKtERVl4HkK
gMpNcMPKP5ceY9J1/R9QvZreSKxVxcFXdnZn0uzs6jku/wC9tXO56Uwpn/J7XLjV
ddluPq88VzcSTWMssoZZEur+K8dJIRCGHpJFwUySSf5PEE5rH8ofMNnqukMPq50+
GYyXMcEwgEHp6nPfRsi+g7P6iTKjBHj+zQllwXYfllr9nBpKPY6bcy6Nq5u2uCzC
W9t2iuUMszGNgslblRx+LZftHbJD5203zjfyaRbabpVneaNb0uNSsJrw24lmjH7m
DaCUGKN6SdqlQKUriXmj8vNQ8z39hqlxdWlhcRW8ST2j2aX1HVjIwSdmhbjU0Hw+
+X+YPkzU9a1OyvNLs7X66EW3/TMs8sVzYqsyy+rAihkk+ydvhP8AlUxDzV5R8waz
rVhqUOm2Vvfho4ZNXF1N9YtILa7MyGJAgST1oiQy/CVLEVYZXkLyHruh+aL/AFC+
eH6oUuIoGjdpPW+sXX1hXSFlVbNUX4GjiJWRvjO4wk8u/lXNfaoia9HcR6fpVpc6
W4jnntjeM961yJj6LKJoJYZByV2PxclIydea/Ium+YbayieZ7Q6ceVmsaxyQAgAK
JLeVXjdRxHYGmwIqcJfzD8m+YtauVOlfVnivdPm0i+ad2iMEc8sUpuIwqv6nH0qe
nVf9bEPN/lHzfrWqGeCG0jgvYBpt2XnflBBBei5juEAj/eNIi0MdV4n9o4Tz/lb5
qle4QPaLHpv1x9IkMjn6217qkWqcZl4f6PwMHpVBeteXamJ6j+V/nG9guJSLOO51
6LULXVYfWcrZR6heJdepE/pj6wY/T4laJWvXJH5n8t6rFb+b3srJLw+Yba1sLG2i
2KysskUk0u3FFQzepy9vHJxY2721lb27uZXhjSNpD1YqoBbevWmLZs2bNmzZs2bN
mzZs2bNmzZs2bNmzZs2bNmzZs2RX8x9c1bR9GtJdLeSO4ub2G1Z4bb65KEkDFvTg
qvNvh8cKb7z/AKloUOlW93B+lJ70RxvLIRZXRmuGKwobTjJw32Yu6+1cfd/mnQka
fpZvDHCbqY+usaiGCJZLoK3FgZIearx2qe4x2ofmpb2tjLdpp0kqJLeRRD1AvP6n
ai65bg05qePscF6b551CbzFa6LqOlpYSXEQYO1xyLSen6h9ANGizRgbEq3IEH4Kb
4X6j+ZF/p19f2y6f9eNrcXjOWlSAR2tjDDNIVor824TfCNq+OAbf819Ut/W+uael
yG1G6jthA0nP6hAY6MFSKTlN+9HwGlfHDaL8zH+t3UVxphhh9ea10qT1gWup7eVY
njKcB6bHmGXc7VwHZfm1JfwytZaO0zyXFvDppaVo4pVuZWiQyyPEBG6slWVefwkE
E4FtvzQ1abXUE9sltpDR2hdUYSypK7Xa3CGqryStr8LDf232HQ/mhqVwkUEGiKdT
u3gaxt2ulWJre7hlnglkl9MlG4wEMnE0PQnJj5f1iLWdEstVijMSXkKzCJtyvIbq
SOtDkOXzL5juPzE1LS1upodK02SEelHYCWBka1WZxNelwImLNtt4ZVr+bUAa4TUL
FIGgYqHguPWjLvEZbePmY4/jl4Mvw1WvQnH3P5pTWqyTXGkFbV39OwdZwWlaK6jt
LgOvAen6ck3w9eQHbF/+Vj3cupXdlZ6M9ybE6gZ+Mw5lbCQRD00CEu0rMPh7e+DL
Dz2svk+68wXVsiyWhZJLW3m9UGQMFRebpE68iwrzQEeGB7nz3rFjNBBqOirDNEsc
uriO6Egghnm9CF4T6a+tybcg8CAPlhHcfmtr9zBENP0iKCe5mhezM9xzWS1+viym
LhY/3b13Ub7H2pgq2/Nq5ls7W8fRuEEsX125AuQzxWDz/Vo5QPTAeRpKkx1FAPtV
2yV+T9WvNV0UXd5w9f6xdQngOI4w3DxptU/soK4dZs2bNmzZs2bNmzZs2bNmzZs2
bNmzZs2bNmzZs2bNmzZs2bNmzZs2bNmzZs2bNmzZs2bNmzZs2bI153/6UH93/wAd
mz/vP9n9j/K8MgX5m/8AkwLHp9nT/wC6+x/vYf8Ae33/AOWf/KrhXq//ACjMP+8f
/KRan/vD0+2/95/xT/y0f5NMD+Y/+Uv1n/eb+7vev+8f/HLH91/xZ/v3/Jpkns//
ACay9OsX95/vH/vKP7v/AJfP+NMD+Yf+Ozrv+8n91rv2/tf8c61+1/xv7Uwhvf8A
eiDr/wAdQ/7w/wDMHbfb/wCKP9//AOVTJTP/AH+i/wC8P/KX3P2+v+7v7r/i3xwt
8v8A/HQufsf8d+0/vP7j/eiT/eH/AIq/l/yq4hpn/KT6R/vH1j+z9n/e2++3/lfy
/wCzy/Iv2tP/AN5/+Owf73++/wB5bj+5/wCXf/fH+Tyzpn5ff8oVo393/vMn9z/d
/wCx9sB6d/x3POf+83W3+19n/eJf96Pb/jXOR+Wf+OXJ/c/71aD/AMdLp/vQ/wDc
f8Vf749sM9T/AOOn+YH+8/8AdTf3v2P72P8A3k/4s/37/wAW8c3lf/ji6r/df8c/
WP73/er/AHqj/vf+Lf5/8vJH5W/8lXr32Ol1/wAdL/ej+7H+93/Fn8v+TxyJ6b/v
R5P+1/fzf72/339/H/x0f8n/AH3/AJfHFbz/AI4dp/vL/vA39z/ef8d1P7n/ACvD
/LwVJ/xzfIP+8v2X+x/cf36/70/8u3h/xZTOm+Qf+Ud/3X/vXe/3X2f96pPx8ffJ
FmzZs2bP/9kK">
<p style="top:677.6pt;left:79.0pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">FIG. 2.</span></p>
<p style="top:677.6pt;left:117.5pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">Forest plot of end neurological severity score (standardized mean difference). Neurological esverity</span></p>
<p style="top:690.6pt;left:79.0pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">score at 28 days with exception of Yang and associates (2020), Zhang and colleagues (2014)</span><sup><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">46</span></sup><sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">(both 14</span></p>
<p style="top:703.5pt;left:79.0pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">days), and Oron and coworkers (c-e)</span><sup><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">51</span></sup><sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">(27 days). Control total value includes duplicates from varying test</span></p>
<p style="top:716.5pt;left:79.0pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">conditions compared with single control group. SD, standard deviation; CI, con&#xfb01;dence interval.</span></p>
<p style="top:29.7pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">6</span></p>
<p style="top:29.7pt;left:481.6pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">STEVENS ET AL.</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:735.0pt;left:59.2pt;line-height:9.0pt"><span style="font-family:AdvTimBolLiebert,serif;font-size:9.0pt">Table 2. Dosing Regimens of Studies and Substudies Included in Meta-Analyses</span></p>
<p style="top:624.8pt;left:95.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">f</span></p>
<p style="top:594.7pt;left:95.0pt;line-height:8.0pt"><span style="font-family:AdvPSMP10,serif;font-size:8.0pt">k</span><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt"> (nm)</span></p>
<p style="top:551.8pt;left:77.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Average</span></p>
<p style="top:554.9pt;left:86.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">irradiance</span></p>
<p style="top:554.8pt;left:93.8pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">(mW/cm</span><span style="font-family:AdvOT56309c18.I,serif;font-size:5.6pt">2</span><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">)</span></p>
<p style="top:487.0pt;left:77.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Average</span></p>
<p style="top:490.1pt;left:86.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Irradiance</span></p>
<p style="top:503.8pt;left:93.8pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">(cortex) (mW/cm</span><span style="font-family:AdvOT56309c18.I,serif;font-size:5.6pt">2</span><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">)</span></p>
<p style="top:422.9pt;left:86.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Exposure</span></p>
<p style="top:425.1pt;left:95.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">time (min)</span></p>
<p style="top:372.8pt;left:95.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Administration</span></p>
<p style="top:298.3pt;left:86.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">First dose</span></p>
<p style="top:305.8pt;left:95.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">post-injury (h)</span></p>
<p style="top:240.8pt;left:95.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Doses</span></p>
<p style="top:171.4pt;left:86.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Brief results of intervention versus</span></p>
<p style="top:169.4pt;left:94.9pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">control (</span><span style="font-family:AdvOTce3d9a73,serif;font-size:8.0pt">p</span><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt"> value where available)</span></p>
<p style="top:735.8pt;left:111.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Oron et al., 2007</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">50</span></p>
<p style="top:634.9pt;left:113.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:113.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">808</span></p>
<p style="top:552.2pt;left:113.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">10 or 20</span></p>
<p style="top:482.3pt;left:113.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0.899</span></p>
<p style="top:407.8pt;left:113.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:359.0pt;left:113.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull</span></p>
<p style="top:284.1pt;left:113.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:113.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:110.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Improved NSS at 28 days (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.05)</span></p>
<p style="top:735.8pt;left:120.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Wu et al., 2010 (a)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">54</span></p>
<p style="top:634.9pt;left:122.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:122.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">665</span></p>
<p style="top:544.2pt;left:122.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">150</span></p>
<p style="top:475.3pt;left:122.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:407.8pt;left:122.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:359.0pt;left:122.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:122.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:122.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:119.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Improved NSS at all time points to 28 days (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.05)</span></p>
<p style="top:195.6pt;left:128.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">and lesion size (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.05)</span></p>
<p style="top:735.8pt;left:138.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Wu et al., 2010 (b)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">54</span></p>
<p style="top:634.9pt;left:139.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:139.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:544.2pt;left:139.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">150</span></p>
<p style="top:480.3pt;left:139.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">9.39</span></p>
<p style="top:407.8pt;left:139.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:359.0pt;left:139.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:139.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:139.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:137.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Improved NSS at all time points to 28 days (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.05)</span></p>
<p style="top:195.6pt;left:146.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">and lesion size (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.01)</span></p>
<p style="top:735.8pt;left:156.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Wu et al., 2010 (c)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">54</span></p>
<p style="top:634.9pt;left:157.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:157.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">980</span></p>
<p style="top:544.2pt;left:157.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">150</span></p>
<p style="top:480.3pt;left:157.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">9.39</span></p>
<p style="top:407.8pt;left:157.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:359.0pt;left:157.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:157.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:157.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:157.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">No effect on NSS at 28 days</span></p>
<p style="top:735.8pt;left:166.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Ando et al., 2011 (a)</span></p>
<p style="top:634.9pt;left:166.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:166.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:542.2pt;left:166.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">50</span></p>
<p style="top:480.3pt;left:166.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">5.25</span></p>
<p style="top:411.8pt;left:166.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:359.0pt;left:166.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:166.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:166.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:166.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Moderately effective for improvement of NSS at 28</span></p>
<p style="top:195.6pt;left:175.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">days</span></p>
<p style="top:735.8pt;left:184.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Ando et al., 2011 (b)</span></p>
<p style="top:634.9pt;left:184.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">10 Hz</span></p>
<p style="top:589.6pt;left:184.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:542.2pt;left:184.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">50</span></p>
<p style="top:480.3pt;left:184.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">5.25</span></p>
<p style="top:411.8pt;left:184.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:359.0pt;left:184.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:184.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:184.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:184.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Most effective for improvement of NSS at 28 days</span></p>
<p style="top:195.6pt;left:191.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.001), and brain lesion volume (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.01)</span></p>
<p style="top:735.8pt;left:202.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Ando et al., 2011 (c)</span></p>
<p style="top:634.9pt;left:202.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">100 Hz</span></p>
<p style="top:589.6pt;left:202.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:542.2pt;left:202.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">50</span></p>
<p style="top:480.3pt;left:202.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">5.25</span></p>
<p style="top:411.8pt;left:202.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:359.0pt;left:202.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:202.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:202.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:202.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Moderately effective for improvement of NSS at 28</span></p>
<p style="top:195.6pt;left:211.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">days</span></p>
<p style="top:735.8pt;left:219.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Khuman et al., 2012 (a)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">49</span></p>
<p style="top:634.9pt;left:220.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:220.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">800</span></p>
<p style="top:544.2pt;left:220.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">500</span></p>
<p style="top:478.3pt;left:220.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0.5</span></p>
<p style="top:407.8pt;left:220.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:359.0pt;left:220.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Cortex</span></p>
<p style="top:284.1pt;left:220.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:231.0pt;left:220.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:218.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">No effect on lesion size at 14 days (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.12)</span></p>
<p style="top:735.8pt;left:228.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Oron et al., 2012 (a)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">51</span></p>
<p style="top:634.9pt;left:229.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:229.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">808</span></p>
<p style="top:542.2pt;left:229.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">21</span></p>
<p style="top:477.3pt;left:229.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">10</span></p>
<p style="top:407.8pt;left:229.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:359.0pt;left:229.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull</span></p>
<p style="top:284.1pt;left:229.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">6</span></p>
<p style="top:231.0pt;left:229.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:229.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Effective for improvement of NSS at 28 and 56 days</span></p>
<p style="top:195.6pt;left:236.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.05)</span></p>
<p style="top:735.8pt;left:246.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Oron et al., 2012 (b)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">51</span></p>
<p style="top:634.9pt;left:247.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:247.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">808</span></p>
<p style="top:542.2pt;left:247.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">21</span></p>
<p style="top:477.3pt;left:247.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">10</span></p>
<p style="top:407.8pt;left:247.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:359.0pt;left:247.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull</span></p>
<p style="top:284.1pt;left:247.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">8</span></p>
<p style="top:231.0pt;left:247.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:247.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">No effect on NSS at 56 days</span></p>
<p style="top:735.8pt;left:254.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Oron et al., 2012 (c)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">51</span></p>
<p style="top:634.9pt;left:256.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:256.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">808</span></p>
<p style="top:542.2pt;left:256.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">21</span></p>
<p style="top:477.3pt;left:256.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">10</span></p>
<p style="top:407.8pt;left:256.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:359.0pt;left:256.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull</span></p>
<p style="top:284.1pt;left:256.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:256.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:256.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Effective for improvement of NSS at 56 days</span></p>
<p style="top:195.6pt;left:263.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.001), and brain lesion volume (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.01)</span></p>
<p style="top:735.8pt;left:272.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Oron et al., 2012 (d)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">51</span></p>
<p style="top:634.9pt;left:274.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">100 Hz</span></p>
<p style="top:589.6pt;left:274.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">808</span></p>
<p style="top:542.2pt;left:274.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">21</span></p>
<p style="top:477.3pt;left:274.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">10</span></p>
<p style="top:407.8pt;left:274.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:359.0pt;left:274.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull</span></p>
<p style="top:284.1pt;left:274.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:274.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:274.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Effective for improvement of NSS at 56 days</span></p>
<p style="top:195.6pt;left:281.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.001), and brain lesion volume (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.01)</span></p>
<p style="top:735.8pt;left:290.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Oron et al., 2012 (e)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">51</span></p>
<p style="top:634.9pt;left:292.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">600 Hz</span></p>
<p style="top:589.6pt;left:292.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">808</span></p>
<p style="top:542.2pt;left:292.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">21</span></p>
<p style="top:477.3pt;left:292.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">10</span></p>
<p style="top:407.8pt;left:292.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:359.0pt;left:292.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Skull</span></p>
<p style="top:284.1pt;left:292.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:292.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:292.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Effective for improvement of NSS at 56 days</span></p>
<p style="top:195.6pt;left:299.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.001)</span></p>
<p style="top:735.8pt;left:308.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Wu et al., 2012 (a)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">40</span></p>
<p style="top:634.9pt;left:310.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:310.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">665</span></p>
<p style="top:544.2pt;left:310.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">150</span></p>
<p style="top:482.3pt;left:310.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*9.39</span></p>
<p style="top:407.8pt;left:310.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:359.0pt;left:310.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:284.1pt;left:310.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:310.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:308.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Effective for improvement of NSS at 28 days (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.05)</span></p>
<p style="top:735.8pt;left:317.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Wu et al., 2012 (b)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">40</span></p>
<p style="top:634.9pt;left:319.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:319.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">730</span></p>
<p style="top:544.2pt;left:319.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">150</span></p>
<p style="top:482.3pt;left:319.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*9.39</span></p>
<p style="top:407.8pt;left:319.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:359.0pt;left:319.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:284.1pt;left:319.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:319.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:319.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">No effect on NSS at 28 days</span></p>
<p style="top:735.8pt;left:326.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Wu et al., 2012 (c)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">40</span></p>
<p style="top:634.9pt;left:328.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:328.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:544.2pt;left:328.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">150</span></p>
<p style="top:480.3pt;left:328.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">9.39</span></p>
<p style="top:407.8pt;left:328.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:359.0pt;left:328.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:284.1pt;left:328.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:328.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:328.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Effective for improvement of NSS at 28 days</span></p>
<p style="top:195.6pt;left:335.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.001)</span></p>
<p style="top:735.8pt;left:344.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Wu et al., 2012 (d)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">40</span></p>
<p style="top:634.9pt;left:346.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:346.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">980</span></p>
<p style="top:544.2pt;left:346.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">150</span></p>
<p style="top:480.3pt;left:346.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">9.39</span></p>
<p style="top:407.8pt;left:346.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:359.0pt;left:346.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:284.1pt;left:346.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:346.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:346.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">No effect on NSS at 28 days</span></p>
<p style="top:735.8pt;left:353.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Xuan et al., 2013 (a)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">41</span></p>
<p style="top:634.9pt;left:355.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:355.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:542.2pt;left:355.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">25</span></p>
<p style="top:480.3pt;left:355.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2.63</span></p>
<p style="top:411.8pt;left:355.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:359.0pt;left:355.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:355.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:355.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:355.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">No effect on NSS or lesion size at 28 days</span></p>
<p style="top:735.8pt;left:362.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Xuan et al., 2013 (b)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">41</span></p>
<p style="top:634.9pt;left:364.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:364.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:542.2pt;left:364.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">25</span></p>
<p style="top:480.3pt;left:364.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2.63</span></p>
<p style="top:411.8pt;left:364.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:359.0pt;left:364.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:364.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:364.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">3</span></p>
<p style="top:203.6pt;left:364.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Effective for improvement of NSS at 28 days</span></p>
<p style="top:195.6pt;left:370.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.001) and lesion size (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.01)</span></p>
<p style="top:735.8pt;left:380.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Xuan et al., 2013 (c)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">41</span></p>
<p style="top:634.9pt;left:382.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:382.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:542.2pt;left:382.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">25</span></p>
<p style="top:480.3pt;left:382.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2.63</span></p>
<p style="top:411.8pt;left:382.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:359.0pt;left:382.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:382.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:235.0pt;left:382.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">14</span></p>
<p style="top:203.6pt;left:382.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Effective for improvement lesion size at 28 days</span></p>
<p style="top:195.6pt;left:388.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.01)</span></p>
<p style="top:735.8pt;left:398.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Giacci et al., 2014 (a)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">48</span></p>
<p style="top:634.9pt;left:400.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:400.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">670</span></p>
<p style="top:545.2pt;left:400.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0.02</span></p>
<p style="top:479.5pt;left:397.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:411.8pt;left:400.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">30</span></p>
<p style="top:359.0pt;left:400.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:400.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0</span></p>
<p style="top:231.0pt;left:400.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">7</span></p>
<p style="top:203.6pt;left:400.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">No effect on lesion size at 7 days</span></p>
<p style="top:735.8pt;left:407.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Giacci et al., 2014 (b)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">48</span></p>
<p style="top:634.9pt;left:409.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:409.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">830</span></p>
<p style="top:545.2pt;left:409.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0.01</span></p>
<p style="top:479.5pt;left:406.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:411.8pt;left:409.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">30</span></p>
<p style="top:359.0pt;left:409.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:409.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0</span></p>
<p style="top:231.0pt;left:409.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">7</span></p>
<p style="top:203.6pt;left:409.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">No effect on lesion size at 7 days</span></p>
<p style="top:735.8pt;left:416.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Xuan et al., 2015 (a)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">42</span></p>
<p style="top:634.9pt;left:417.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:417.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:542.2pt;left:417.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">50</span></p>
<p style="top:480.3pt;left:417.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">3.13</span></p>
<p style="top:411.8pt;left:417.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:359.0pt;left:417.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:417.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:417.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:415.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Effective for improvement of NSS at 28 days (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.05)</span></p>
<p style="top:735.8pt;left:425.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Xuan et al., 2015 (b)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">42</span></p>
<p style="top:634.9pt;left:426.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:426.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:542.2pt;left:426.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">50</span></p>
<p style="top:480.3pt;left:426.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">3.13</span></p>
<p style="top:411.8pt;left:426.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:359.0pt;left:426.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:426.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:426.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">3</span></p>
<p style="top:203.6pt;left:426.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Effective for improvement of NSS at 28 days</span></p>
<p style="top:195.6pt;left:433.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.001)</span></p>
<p style="top:735.8pt;left:443.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Zhang et al., 2014</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">46</span></p>
<p style="top:634.9pt;left:444.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">10Hz</span></p>
<p style="top:589.6pt;left:444.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:544.2pt;left:444.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">150</span></p>
<p style="top:480.3pt;left:444.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">8.85</span></p>
<p style="top:407.8pt;left:444.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:359.0pt;left:444.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:284.1pt;left:444.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:444.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span></p>
<p style="top:203.6pt;left:442.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">NSS at day 7 significantly reduced (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.001)</span></p>
<p style="top:735.8pt;left:452.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Xuan et al., 2016 (a)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">44</span></p>
<p style="top:634.9pt;left:453.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:453.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:542.2pt;left:453.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">25</span></p>
<p style="top:480.3pt;left:453.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2.63</span></p>
<p style="top:411.8pt;left:453.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:359.0pt;left:453.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:453.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:231.0pt;left:453.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">3</span></p>
<p style="top:203.6pt;left:453.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Improved NSS versus control and versus 14 day</span></p>
<p style="top:195.6pt;left:460.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">treatment duration from week 2 to week 8 (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.001)</span></p>
<p style="top:195.6pt;left:471.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">post-injury</span></p>
<p style="top:735.8pt;left:479.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Xuan et al., 2016 (b)</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">44</span></p>
<p style="top:634.9pt;left:480.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:480.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">810</span></p>
<p style="top:542.2pt;left:480.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">25</span></p>
<p style="top:480.3pt;left:480.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2.63</span></p>
<p style="top:411.8pt;left:480.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">12</span></p>
<p style="top:359.0pt;left:480.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp*</span></p>
<p style="top:284.1pt;left:480.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">4</span></p>
<p style="top:235.0pt;left:480.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">14</span></p>
<p style="top:203.6pt;left:478.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Improved NSS versus control at week 7 (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.01) and</span></p>
<p style="top:195.6pt;left:487.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">week 8 (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.001) post-injury</span></p>
<p style="top:735.8pt;left:497.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Yang et al., 2020</span><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">45</span></p>
<p style="top:634.9pt;left:498.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW</span></p>
<p style="top:589.6pt;left:498.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">808</span></p>
<p style="top:544.2pt;left:498.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">350</span></p>
<p style="top:477.3pt;left:498.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">25</span></p>
<p style="top:407.8pt;left:498.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:359.0pt;left:498.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp</span></p>
<p style="top:284.1pt;left:498.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span></p>
<p style="top:235.0pt;left:498.6pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">15</span></p>
<p style="top:203.6pt;left:496.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Improved NSS throughout protocol (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:8.0pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.05)</span></p>
<p style="top:726.8pt;left:516.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW, continuous wave; NSS, neurological severity score.</span></p>
<p style="top:726.8pt;left:525.5pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Scalp* denotes scalp route of administration with underlying craniotomy.</span></p>
<p style="top:726.8pt;left:532.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">#, data not available, cortical irradiance is calculated from available data, or extrapolated from available data using transmittance penetration data (Ando and associates (2011) where</span><span style="font-family:AdvPSMP10,serif;font-size:8.0pt"> k</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 800-810 nm).</span></p>
<p style="top:726.8pt;left:543.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*data not available and incalculable.</span></p>
<p style="top:758.6pt;left:302.4pt;line-height:9.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:9.0pt">7</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:341.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and probe trials. As such, these were not deemed suitable</span></p>
<p style="top:354.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">for meta-analysis, and the &#xfb01;ndings of individual studies</span></p>
<p style="top:366.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">for MWM will be described in the narrative below. Sim-</span></p>
<p style="top:379.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ilarly, other functional outcomes were used by studies</span></p>
<p style="top:391.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with varying frequency: forced swim test (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 1),</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tail</span></p>
<p style="top:404.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">suspension test (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 1),</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">wire grip and motion test</span></p>
<p style="top:416.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 2),</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">41,43</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">rotarod score (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 1),</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">48</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">bilateral asymmetry</span></p>
<p style="top:429.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">test (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 1),</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">48</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">beam balance scores (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 1),</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">47</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">nose poke</span></p>
<p style="top:441.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tasks (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 1),</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">52</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">open &#xfb01;eld, elevated plus maze, Y maze,</span></p>
<p style="top:453.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and fear conditioning (all</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt">=</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">1),</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">45</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and are discussed below.</span></p>
<p style="top:466.4pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Khuman and coworkers (2012)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">49</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">performed MWM tri-</span></p>
<p style="top:478.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">als, with inclusion of probe trials and analysis of progres-</span></p>
<p style="top:341.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sive improvement. Statistically signi&#xfb01;cant improvements</span></p>
<p style="top:354.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in outcomes were mixed, although 60 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">delivered ei-</span></p>
<p style="top:366.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ther transcranially or directly for a single administration</span></p>
<p style="top:379.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">demonstrated a statistically signi&#xfb01;cant improvement ver-</span></p>
<p style="top:391.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sus controls in all measured MWM domains. All PBM</span></p>
<p style="top:404.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">groups versus controls exhibited greater progressive im-</span></p>
<p style="top:416.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">provement (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.0001).</span></p>
<p style="top:429.0pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Administered directly, 60, 120, and 210 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">but</span></p>
<p style="top:441.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">not 30 or 105 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">resulted in MWM hidden platform la-</span></p>
<p style="top:453.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tency improvements, and 60 and 120 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">elicited probe</span></p>
<p style="top:466.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">trial improvements. Single dose transcranial administra-</span></p>
<p style="top:478.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tion of 60 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">resulted in improvements in all MWM</span></p>
<p style="top:61.7pt;left:62.0pt;line-height:9.0pt"><span style="font-family:AdvTimBolLiebert,serif;font-size:9.0pt">Table 3. Subgroup Analyses for End-Point Neurological Severity Score</span></p>
<p style="top:80.6pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Variable (n interventional animals)</span></p>
<p style="top:80.6pt;left:245.8pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Effect size [95% CI]</span></p>
<p style="top:80.6pt;left:390.6pt;line-height:8.0pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:8.0pt">p</span></p>
<p style="top:80.6pt;left:475.7pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">I</span><sup><span style="font-family:AdvOT56309c18.I,serif;font-size:5.6pt">2</span></sup><sup><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt"> </span></sup><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">for heterogeneity</span><span style="font-family:AdvOTce3d9a73,serif;font-size:8.0pt"> (p)</span></p>
<p style="top:97.5pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Mode</span></p>
<p style="top:106.5pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CW (220)</span></p>
<p style="top:106.5pt;left:246.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">- 1.31[-1.88, -0.73]</span></p>
<p style="top:106.5pt;left:377.7pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimBolLiebert,serif;font-size:8.0pt">0.00001</span></p>
<p style="top:106.5pt;left:486.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">82% (</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.00001)</span></p>
<p style="top:115.5pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">PW (42)</span></p>
<p style="top:115.5pt;left:246.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">-2.94 [-4.48, -1.39]</span></p>
<p style="top:115.5pt;left:382.2pt;line-height:8.0pt"><span style="font-family:AdvTimBolLiebert,serif;font-size:8.0pt">0.0002</span></p>
<p style="top:115.5pt;left:491.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">79% (0.0006)</span></p>
<p style="top:124.5pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Wavelength</span></p>
<p style="top:133.4pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">660&#x2013;670 nm (18)</span></p>
<p style="top:133.4pt;left:246.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">-1.19 [-1.91, -0.47]</span></p>
<p style="top:133.4pt;left:382.2pt;line-height:8.0pt"><span style="font-family:AdvTimBolLiebert,serif;font-size:8.0pt">0.001</span></p>
<p style="top:133.4pt;left:495.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0% (0.98)</span></p>
<p style="top:142.4pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">730 nm (10)</span></p>
<p style="top:142.4pt;left:246.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">-0.11 [-0.99, 0.77]</span></p>
<p style="top:142.4pt;left:382.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0.81</span></p>
<p style="top:142.4pt;left:511.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:151.3pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">800&#x2013;815 nm (216)</span></p>
<p style="top:151.3pt;left:246.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">-1.93 [-2.59, -1.26]</span></p>
<p style="top:151.3pt;left:377.7pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimBolLiebert,serif;font-size:8.0pt">0.00001</span></p>
<p style="top:151.3pt;left:486.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">83% (</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.00001)</span></p>
<p style="top:160.3pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">980 nm (18)</span></p>
<p style="top:160.3pt;left:249.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0.06 [-0.59, 0.72]</span></p>
<p style="top:160.3pt;left:382.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0.85</span></p>
<p style="top:160.3pt;left:495.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0% (0.86)</span></p>
<p style="top:169.3pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">First dose timing post-injury</span></p>
<p style="top:178.3pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&#xa3;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 4 h (249)</span></p>
<p style="top:178.3pt;left:246.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">-1.60 [-2.18, -1.02]</span></p>
<p style="top:178.3pt;left:377.7pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimBolLiebert,serif;font-size:8.0pt">0.00001</span></p>
<p style="top:178.3pt;left:486.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">83% (</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.00001)</span></p>
<p style="top:187.2pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&gt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 4 h (13)</span></p>
<p style="top:187.2pt;left:246.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">-1.20 [-3.22, 0.81]</span></p>
<p style="top:187.2pt;left:382.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0.24</span></p>
<p style="top:187.2pt;left:491.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">79% (0.03)</span></p>
<p style="top:196.2pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Number of treatments</span></p>
<p style="top:205.1pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&#xa3;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">3 (217)</span></p>
<p style="top:205.1pt;left:246.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">-1.81 [-2.36, -1.27]</span></p>
<p style="top:205.1pt;left:377.7pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimBolLiebert,serif;font-size:8.0pt">0.00001</span></p>
<p style="top:205.1pt;left:486.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">77% (</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.00001)</span></p>
<p style="top:214.1pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&gt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">3 (45)</span></p>
<p style="top:214.1pt;left:249.4pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0.31 [-1.18, 1.80]</span></p>
<p style="top:214.1pt;left:382.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0.69</span></p>
<p style="top:214.1pt;left:491.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">88% (0.0003)</span></p>
<p style="top:223.1pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Energy per dose at cortical surface</span></p>
<p style="top:232.1pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">0</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> E</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &#xa3;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 1 (J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">2</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">) (16)</span></p>
<p style="top:232.1pt;left:246.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">-2.75 [-3.95, -1.55]</span></p>
<p style="top:232.1pt;left:377.7pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimBolLiebert,serif;font-size:8.0pt">0.00001</span></p>
<p style="top:232.1pt;left:511.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*</span></p>
<p style="top:241.0pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">1</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> E</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &#xa3;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 2 (J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">2</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">) (101)</span></p>
<p style="top:241.0pt;left:246.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">-2.77 [-4.33, -1.21]</span></p>
<p style="top:241.0pt;left:382.2pt;line-height:8.0pt"><span style="font-family:AdvTimBolLiebert,serif;font-size:8.0pt">0.0005</span></p>
<p style="top:241.0pt;left:486.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">90% (</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.00001)</span></p>
<p style="top:250.0pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">2</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> E</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &#xa3;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 3 (J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">2</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">) (95)</span></p>
<p style="top:250.0pt;left:246.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">-1.12 [-1.68, -0.55]</span></p>
<p style="top:250.0pt;left:382.2pt;line-height:8.0pt"><span style="font-family:AdvTimBolLiebert,serif;font-size:8.0pt">0.0001</span></p>
<p style="top:250.0pt;left:491.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">67% (0.001)</span></p>
<p style="top:258.9pt;left:70.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">E</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt"> &gt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 3 (J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">2</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">) (50)</span></p>
<p style="top:258.9pt;left:246.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">-1.36 [-1.90, -0.83]</span></p>
<p style="top:258.9pt;left:377.7pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimBolLiebert,serif;font-size:8.0pt">0.00001</span></p>
<p style="top:258.9pt;left:486.3pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">26% (</span><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> 0.00001)</span></p>
<p style="top:276.8pt;left:71.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">CI, con&#xfb01;dence interval; CW, continuous wave; PW, pulsed wave.</span></p>
<p style="top:285.8pt;left:71.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Subgroups strati&#xfb01;ed from those in Figure 2 and Table 1. Neurological severity score at 28 days with exception of Yang and associates (2020), Zhang and</span></p>
<p style="top:294.8pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">colleagues (2014)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">46</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(both 14 days), and Oron and coworkers (c-e)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">51</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">(27 days).</span></p>
<p style="top:303.7pt;left:71.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">*, heterogeneity not applicable because of small sample size. Energy per dose at cortical surface is calculated where not reported by respective study as</span></p>
<p style="top:312.7pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">described in Table 2 caption.</span></p>
<img style="position:absolute;transform:matrix(.64022329,0,-0,.6401824,72.43536,638.96139)" src="data:image/jpeg;base64,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">
<p style="top:677.6pt;left:79.0pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">FIG. 3.</span></p>
<p style="top:677.6pt;left:117.5pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">Forest plot of lesion size (histologically or radiologically determined). Values at 28 days post-injury</span></p>
<p style="top:690.6pt;left:79.0pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">with exception of Oron and associates (2012) (56 days),</span><sup><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">51</span></sup><sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">Khuman and colleagues (2012)</span><sup><span style="font-family:AdvOT46dcae81,serif;font-size:7.0pt">49</span></sup><sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">(14 days), and</span></p>
<p style="top:703.5pt;left:79.0pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">Giacci and coworkers (2014) (7 days). Control total value includes duplicates from varying test conditions</span></p>
<p style="top:716.5pt;left:79.0pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">compared with single control group. SD, standard deviation; CI, con&#xfb01;dence interval.</span></p>
<p style="top:29.7pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">8</span></p>
<p style="top:29.7pt;left:481.6pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">STEVENS ET AL.</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:61.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">domains if given 1 h after injury, but not after 4 h or daily</span></p>
<p style="top:73.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">for seven days. Esenaliev and colleagues</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">47</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(2018) used</span></p>
<p style="top:86.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">transcranial NPLT in a BINT model. The NPLT was</span></p>
<p style="top:98.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">demonstrated to improve MWM (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.05) at seven</span></p>
<p style="top:111.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">days post-injury, although this effect was not observed</span></p>
<p style="top:123.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">on subsequent days&#x2019; MWM testing.</span></p>
<p style="top:136.3pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Xuan and associates (2016)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">44</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">also used the MWM test</span></p>
<p style="top:148.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">at 22 and 49 days post-injury. Groups with TBI receiving</span></p>
<p style="top:161.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">3</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &#xb7;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> daily PBM treatments at day 22 demonstrated signif-</span></p>
<p style="top:173.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">icant improvements in latency scores for both platform</span></p>
<p style="top:186.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and probe trials, compared with TBI controls (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 6,</span></p>
<p style="top:198.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.05 and 0.01, respectively). The effect was not sig-</span></p>
<p style="top:210.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ni&#xfb01;cant at day 49, although the effect was still observed,</span></p>
<p style="top:223.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and the group receiving 14 days of treatment had</span></p>
<p style="top:235.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">results similar to TBI controls at both time points</span></p>
<p style="top:248.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">post-injury.</span></p>
<p style="top:260.8pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Giacci and coworkers (2014)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">48</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">found no signi&#xfb01;cant</span></p>
<p style="top:273.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">differences between control, 670 nm, and 830 nm treat-</span></p>
<p style="top:285.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ments at seven days post-injury in rotarod score or in</span></p>
<p style="top:298.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the bilateral asymmetry test contralateral versus ipsilat-</span></p>
<p style="top:310.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">eral latency. Xuan and associates (2013)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">41</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">used a wire</span></p>
<p style="top:323.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">grip and motion test and showed no statistically signi&#xfb01;-</span></p>
<p style="top:335.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cant improvement in vestibular function in any treatment</span></p>
<p style="top:347.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">group. Xuan and colleagues (2014)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">43</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">utilized the wire</span></p>
<p style="top:360.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">grip and motion test (WGMT) at 7, 14, 21, and 28 days</span></p>
<p style="top:372.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">post-TBI with single or triple doses of PBM (810 nm,</span></p>
<p style="top:385.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">25 mW/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">, 12 min transcranial).</span></p>
<p style="top:397.7pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The authors demonstrated statistically signi&#xfb01;cant im-</span></p>
<p style="top:410.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">provements in WGMT performance in both single</span></p>
<p style="top:422.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.05) and triple (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.001) doses at 28 days post-</span></p>
<p style="top:435.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">injury, with signi&#xfb01;cant improvements recognized also</span></p>
<p style="top:447.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">at 14 and 21 days in PBM versus control. Khuman and</span></p>
<p style="top:460.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">coworkers (2012)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">49</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">also found no improvement on motor</span></p>
<p style="top:472.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">recovery in a stationary wire grip test.</span></p>
<p style="top:484.9pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Esenaliev and associates (2018)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">47</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">used transcranial</span></p>
<p style="top:497.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">NPLT)in a BINT model. The NPLT was demonstrated</span></p>
<p style="top:509.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to improve beam-balance test scores on day 1 post-injury</span></p>
<p style="top:522.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.01), beam walk test scores on day 1 and 2 post-</span></p>
<p style="top:534.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">injury (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.001 and</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">0.05, respectively), not observed</span></p>
<p style="top:547.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">at later time points. Quirk and colleagues (2012)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">52</span></sup></p>
<p style="top:559.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(670 nm, 50mW/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">, 5 min exposure time, daily expo-</span></p>
<p style="top:572.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sure for 72h) found some improvements in movement do-</span></p>
<p style="top:584.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">mains (nose poke tasks) though not all, and their</span></p>
<p style="top:597.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">functional testing was limited to this assessment.</span></p>
<p style="top:609.5pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Ando and coworkers (2011)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">found statistically sig-</span></p>
<p style="top:621.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ni&#xfb01;cant improvements in the forced swim test (for de-</span></p>
<p style="top:634.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">pression) in the group receiving PW 10 Hz (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.05) at</span></p>
<p style="top:646.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">28 days post-injury and signi&#xfb01;cant improvements in the</span></p>
<p style="top:659.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tail suspension test for anxiety and depression in both</span></p>
<p style="top:671.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">PW 10 Hz and PW 100 Hz at 28 days post-injury. The</span></p>
<p style="top:684.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">CW groups did not demonstrate statistically signi&#xfb01;cant</span></p>
<p style="top:696.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">improvements in these domains. Yang and associates</span></p>
<p style="top:709.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(2020)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">45</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">performed more extensive functional assess-</span></p>
<p style="top:721.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ments in their repeated TBI model. Open &#xfb01;eld (mobility),</span></p>
<p style="top:734.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">elevated plus maze (anxiety), Y maze (spatial memory),</span></p>
<p style="top:61.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and fear conditioning testing all demonstrated statisti-</span></p>
<p style="top:73.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cally signi&#xfb01;cant improvements attributable to PBM ad-</span></p>
<p style="top:86.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ministration after repeated closed TBI.</span></p>
<p style="top:114.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Histological outcomes</span></p>
<p style="top:126.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Wu and associates (2012)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">40</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">marked fractional defects on</span></p>
<p style="top:139.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">morphometric brain sections with hematoxylin and eo-</span></p>
<p style="top:151.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sin staining and identi&#xfb01;ed that 665 and 810 nm LLLT</span></p>
<p style="top:164.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">resulted in statistically signi&#xfb01;cant reductions in numbers</span></p>
<p style="top:176.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of mean fractional defect areas (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.05 and</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">0.01, re-</span></p>
<p style="top:189.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">spectively,</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 10 per group).</span></p>
<p style="top:216.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Mechanistic outcomes</span></p>
<p style="top:235.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.5pt">Metabolic activity.</span></p>
<p style="top:235.1pt;left:400.9pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Ando and colleagues (2011)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">per-</span></p>
<p style="top:247.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">formed ATP &#xfb02;uorometric assay for specimens imme-</span></p>
<p style="top:260.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">diately after laser exposure versus control, &#xfb01;nding no</span></p>
<p style="top:272.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">signi&#xfb01;cant differences between control and intervention</span></p>
<p style="top:284.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">arms. A trend, however, suggested a mild increase of cor-</span></p>
<p style="top:297.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tical ATP content with 10 Hz PW treatment, correlating</span></p>
<p style="top:309.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with this as the treatment condition with greatest effect</span></p>
<p style="top:322.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">on improving NSS and lesion size. Zhang and coworkers</span></p>
<p style="top:334.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(2014),</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">46</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">although principally using W-1 KO mice, per-</span></p>
<p style="top:347.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">formed ATP assay on WT mice with and without LLLT</span></p>
<p style="top:359.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">after mTBI, demonstrating that at 24 h after injury, there</span></p>
<p style="top:372.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">was a signi&#xfb01;cant increase in cortical ATP levels with</span></p>
<p style="top:384.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">LLLT (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.001,</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 6 per group).</span></p>
<p style="top:397.0pt;left:321.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Dong and colleagues (2015)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">39</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">included LLLT therapy</span></p>
<p style="top:409.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to cultured SH-SY5Y neuronal cells in varying condi-</span></p>
<p style="top:421.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tions. They report that hypoxia (induced by CoCI</span><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">) re-</span></p>
<p style="top:434.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">lated cell death was signi&#xfb01;cantly reduced by exposure</span></p>
<p style="top:446.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to 3&#x2013;10 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">LLLT at 2 h post-exposure to hypoxia,</span></p>
<p style="top:459.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with increasing survival with increasing energy or expo-</span></p>
<p style="top:471.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sure periods (up to 10 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvPSSym,serif;font-size:10.5pt">&#xb7;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 3). The effect was aug-</span></p>
<p style="top:484.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">mented with the addition of mitochondrial substrates to</span></p>
<p style="top:496.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the media (glucose/lactate/pyruvate). They further dem-</span></p>
<p style="top:509.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">onstrated that this increased survival with LLLT expo-</span></p>
<p style="top:521.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sure correlated with suppression of lactate level at</span></p>
<p style="top:534.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">0&#x2013;18 h, increase in ATP level, reduction in reactive oxy-</span></p>
<p style="top:546.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">gen species (ROS) level, and increase in mitochondrial</span></p>
<p style="top:558.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">membrane potential. In an</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> in vivo</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> model of hypoxia</span></p>
<p style="top:571.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(using cortical topical Oxyrase), they reported complete</span></p>
<p style="top:583.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">prevention of hypoxia related hippocampal tissue loss be-</span></p>
<p style="top:596.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cause of Oxyrase in the presence of LLLT.</span></p>
<p style="top:621.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.5pt">Neuroin&#xfb02;ammation.</span></p>
<p style="top:621.9pt;left:408.4pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Khuman and coworkers (2012)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">49</span></sup></p>
<p style="top:634.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">performed quantitative analysis of microglial activation.</span></p>
<p style="top:646.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The 60 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">resulted in a signi&#xfb01;cant reduction in activated</span></p>
<p style="top:659.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">microglia compared with control treatment (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt">=</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">0.03,</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt">=</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">4/</span></p>
<p style="top:671.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">group). Khuman and coworkers (2012)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">49</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">also found no</span></p>
<p style="top:684.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">signi&#xfb01;cant difference between treatment and control for:</span></p>
<p style="top:696.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">magnitude of brain edema at 24 h, brain tissue loss, or</span></p>
<p style="top:709.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">protein nitrosylation.</span></p>
<p style="top:721.6pt;left:321.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Yang and associates (2020)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">45</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">also found that PBM low-</span></p>
<p style="top:734.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ered microtubule-associated protein 2 (MAP2) dispersion,</span></p>
<p style="top:30.2pt;left:59.8pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">PHOTOBIOMODULATION IN ACUTE TBI</span></p>
<p style="top:30.2pt;left:544.4pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">9</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:61.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">increased amyloid precursor protein and myelin basic</span></p>
<p style="top:73.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">protein, and reduced cleaved Tau, with the authors con-</span></p>
<p style="top:86.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cluding that PBM attenuates axonal injury after repeated</span></p>
<p style="top:98.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">TBI. Yang and associates (2020)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">45</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">found that PBM was</span></p>
<p style="top:111.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">associated with attenuated astrogliosis at the lesion site,</span></p>
<p style="top:123.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and attenuated the increases of ionized calcium binding</span></p>
<p style="top:136.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">adaptor molecule 1 and interleukin (IL)-1B associated</span></p>
<p style="top:148.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with pro-in&#xfb02;ammatory shifts post-injury. The PBM associ-</span></p>
<p style="top:161.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ated elevation of IL-10, in combination with reduction of</span></p>
<p style="top:173.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">IL-1B was attributed by the authors to a shift from &#x2018;&#x2018;pro-</span></p>
<p style="top:186.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in&#xfb02;ammatory&#x2019;&#x2019; to &#x2018;&#x2018;anti-in&#xfb02;ammatory&#x2019;&#x2019; phenotypes after</span></p>
<p style="top:198.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">exposure to PBM.</span></p>
<p style="top:210.9pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The NPLT-treated rats (Esenaliev and colleagues</span></p>
<p style="top:223.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">[2018]</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">47</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">) demonstrated lower CD68</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt">+</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> microglial cells</span></p>
<p style="top:235.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(marker of microglial activation). Xuan and associates</span></p>
<p style="top:248.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(2016)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">44</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">stained for glial &#xfb01;brillary acidic protein (GFAP)</span></p>
<p style="top:260.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in multiple brain areas in their study using 3/14 day PBM</span></p>
<p style="top:273.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">courses post-injury. While the 14 day course did not corre-</span></p>
<p style="top:285.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">late with functional improvements (MWM, NSS), the three</span></p>
<p style="top:298.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">day course did improve these outcomes. Both 3/14 day</span></p>
<p style="top:310.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">courses were associated with reduced GFAP staining in</span></p>
<p style="top:323.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">all tested brain areas at 56 days post-injury, to a similar</span></p>
<p style="top:335.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">extent.</span></p>
<p style="top:360.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.5pt">Apoptotic markers.</span></p>
<p style="top:360.4pt;left:154.9pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Quirk and colleagues (2012)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">52</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">per-</span></p>
<p style="top:372.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">formed Western blotting on tissue extracts from four</span></p>
<p style="top:385.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">brain regions in TBI and sham</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &#x2013;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> PBM administration.</span></p>
<p style="top:397.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Glutathione levels, vastly increased in injury site versus</span></p>
<p style="top:410.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">same brain area in sham, were not signi&#xfb01;cantly changed</span></p>
<p style="top:422.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in the lesion site with the application of PBM. They</span></p>
<p style="top:435.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">identi&#xfb01;ed a statistically signi&#xfb01;cant reduction in Bcl-2-</span></p>
<p style="top:447.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">associated X protein (BAX) levels (pro-apoptotic protein),</span></p>
<p style="top:460.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">however, after application of PBM compared with con-</span></p>
<p style="top:472.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">trols. Levels of Bcl-2 (anti-apoptotic marker) were also</span></p>
<p style="top:485.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">signi&#xfb01;cantly increased after PBM compared with no ther-</span></p>
<p style="top:497.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">apy. B-actin levels were not signi&#xfb01;cantly altered.</span></p>
<p style="top:509.9pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Esenaliev and coworkers (2018)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">47</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in their transcranial</span></p>
<p style="top:522.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">NPLT BINT model found that at post-injury day 3 (PID3)</span></p>
<p style="top:534.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in injured cortical neurons (FJC</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">neg</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">) from rats exposed to</span></p>
<p style="top:547.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">NPLT there was lower expression of BAX, caspase-3,</span></p>
<p style="top:559.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and STAT3, with higher levels of BNF</span></p>
<p style="top:559.7pt;left:253.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">expression.</span></p>
<p style="top:572.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">This effect was not observed on PID7. Similarly,</span></p>
<p style="top:584.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">NPLT-treated rats showed lower immuno&#xfb02;uorescence</span></p>
<p style="top:597.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with caspase-3 staining on PID3, with no observed im-</span></p>
<p style="top:609.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">muno&#xfb02;uorescence at PID7.</span></p>
<p style="top:621.9pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Similarly, Yang and associates</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">45</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">also found a sig-</span></p>
<p style="top:634.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ni&#xfb01;cant and marked reduction in cytosolic caspase-3</span></p>
<p style="top:646.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and caspase-9 associated with PBM administration af-</span></p>
<p style="top:659.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ter repeated closed head injury. Xuan and coworkers</span></p>
<p style="top:671.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(2014)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">43</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">found signi&#xfb01;cant reductions in caspase-3 ex-</span></p>
<p style="top:684.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">pression at PID4 in both single (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.05) and triple</span></p>
<p style="top:696.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.01) treatment regimens versus control.</span></p>
<p style="top:721.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.5pt">Neuronal damage and proliferation.</span></p>
<p style="top:721.6pt;left:228.7pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Yang and associ-</span></p>
<p style="top:734.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ates (2020)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">45</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in PBM treated rats after repeated closed</span></p>
<p style="top:61.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">head injury found that synaptic degradation was pre-</span></p>
<p style="top:73.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">vented by PBM based on expression of synaptophysin</span></p>
<p style="top:86.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and spinophilin in the hippocampal cornu Ammonis</span></p>
<p style="top:98.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(CA) 1 region. The NPLT-treated rats (Esenaliev and</span></p>
<p style="top:111.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">coworkers [2018]</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">47</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">) demonstrated higher cell prolifera-</span></p>
<p style="top:123.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tion</span></p>
<p style="top:123.8pt;left:338.7pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in</span></p>
<p style="top:123.8pt;left:356.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the</span></p>
<p style="top:123.8pt;left:378.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">subgranular</span></p>
<p style="top:123.8pt;left:436.9pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">zone</span></p>
<p style="top:123.8pt;left:465.9pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(bromodeoxyuridine</span></p>
<p style="top:136.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">[BrdU] immunohistochemistry). Xuan and colleagues</span></p>
<p style="top:148.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(2013)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">41</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">demonstrated statistically signi&#xfb01;cant reduction</span></p>
<p style="top:161.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in degenerating neurons in three day treatment regimen</span></p>
<p style="top:173.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">specimens through Fluoro-Jade C staining compared</span></p>
<p style="top:186.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with sham treatment (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 8,</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.05).</span></p>
<p style="top:198.5pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Xuan and colleagues (2013)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">41</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">also showed statistically</span></p>
<p style="top:210.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">signi&#xfb01;cant increases in BrdU staining (proliferating cells)</span></p>
<p style="top:223.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with three days&#x2019; treatment versus sham (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">n</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> =</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 8,</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.001).</span></p>
<p style="top:235.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Xuan and coworkers (2014)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">43</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">found signi&#xfb01;cant increases</span></p>
<p style="top:248.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in BrdU/4</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt">&#xa2;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">,6-diamidino-2-phenylindole (DAPI) ratio in</span></p>
<p style="top:260.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">hippocampal dentate gyrus (DG) at PID7 in both single</span></p>
<p style="top:273.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.01) and triple (</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.001) treatment regimens ver-</span></p>
<p style="top:285.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sus control, and at PID28 (single [</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.05] and triple</span></p>
<p style="top:298.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">[</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt">p</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &lt;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.01]). Similar results were also shown for neuro-</span></p>
<p style="top:310.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">genic subventricular zone (SVZ) and in perilesional tis-</span></p>
<p style="top:323.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sue all at seven and 28 days post-TBI.</span></p>
<p style="top:335.5pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Xuan and associates (2014)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">43</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">found signi&#xfb01;cant in-</span></p>
<p style="top:347.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">creases in PBM treated specimens versus control in</span></p>
<p style="top:360.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">microtubule-associated migration protein double-cortin</span></p>
<p style="top:372.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(DCX) suggestive of presence of maturing neurons.</span></p>
<p style="top:385.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The DCX/DAPI ratio in the DG and perilesional tissue</span></p>
<p style="top:397.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">was increased in treated subjects at seven and 28 days,</span></p>
<p style="top:410.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and in SVZ at seven but not 28 days. Xuan and associates</span></p>
<p style="top:422.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(2014)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">43</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">also performed staining for neuron-speci&#xfb01;c class</span></p>
<p style="top:435.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">III</span><span style="font-family:AdvPSMP10,serif;font-size:10.5pt"> b</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">-tubulin (TUJ/1) (expressed in differentiating neural</span></p>
<p style="top:447.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">progenitor cells) at seven and 28 days post-injury in PBM</span></p>
<p style="top:460.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and control specimens, &#xfb01;nding an association between in-</span></p>
<p style="top:472.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">creased TUJ1/DAPI ratio and PBM treatment at both</span></p>
<p style="top:484.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">time points in both DG and SVZ.</span></p>
<p style="top:497.4pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Xuan and coworkers (2015)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">42</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">demonstrated a tran-</span></p>
<p style="top:509.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sient upregulation in brain derived neurotrophic factor</span></p>
<p style="top:522.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(BDNF) at PID7 in the DG and SVZ, not observed in</span></p>
<p style="top:534.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the perilesional region. The lesion and SVZ at 28 days</span></p>
<p style="top:547.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">post-injury showed upregulation of synapsin-1, sugges-</span></p>
<p style="top:559.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tive of synaptogenesis.</span></p>
<p style="top:586.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.5pt">Cerebral blood &#xfb02;ow.</span></p>
<p style="top:586.8pt;left:411.5pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Shemesh and colleagues (2022)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">53</span></sup></p>
<p style="top:599.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">used a terminal anesthesia model with TBI and subse-</span></p>
<p style="top:611.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">quent craniotomy for dual-wavelength speckle contrast</span></p>
<p style="top:624.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">imaging, with 20 min of baseline data, delivery of PBM</span></p>
<p style="top:636.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">directly, and a further 20 min of data taken. Cerebral</span></p>
<p style="top:649.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">blood &#xfb02;ow, saturation, and overall oxygen consump-</span></p>
<p style="top:661.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tion increased in animals receiving PBM therapy versus</span></p>
<p style="top:674.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">control.</span></p>
<p style="top:703.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Experimental factors</span></p>
<p style="top:721.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.5pt">Transmittance.</span></p>
<p style="top:721.6pt;left:387.6pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Ando and associates (2011)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">per-</span></p>
<p style="top:734.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">formed pro&#xfb01;ling of the laser power transmission to</span></p>
<p style="top:29.7pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">10</span></p>
<p style="top:29.7pt;left:481.6pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">STEVENS ET AL.</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:153.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">brain tissue for each of their treatment protocols, measuring</span></p>
<p style="top:166.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">transmission through scalp alone and skull and scalp. Using</span></p>
<p style="top:178.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">these data, they calculated an approximation of irradiance</span></p>
<p style="top:191.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to cortical surface based on the dimensions of overlying</span></p>
<p style="top:203.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">scalp/skull in their model. Oron and colleagues (2007)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">50</span></sup></p>
<p style="top:216.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">similarly used cadaveric mouse tissue to simulate their pro-</span></p>
<p style="top:228.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tocol with a power meter positioned within the cranium to</span></p>
<p style="top:241.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">directly measure transmitted irradiance. Shemesh and co-</span></p>
<p style="top:253.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">workers (2022)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">53</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">also directly measured power outputs to</span></p>
<p style="top:266.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">calculate incident dose at the &#x2018;&#x2018;sample plane&#x2019;&#x2019; (cortical sur-</span></p>
<p style="top:278.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">face in their direct delivery model with a 200 mW output</span></p>
<p style="top:290.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">source at 20 cm from cortex).</span></p>
<p style="top:316.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.5pt">Temperature.</span></p>
<p style="top:316.0pt;left:128.5pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Khuman and colleagues (2012)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">49</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">reco-</span></p>
<p style="top:328.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">rded temperature changes in their model of direct appli-</span></p>
<p style="top:340.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cation of PBM to the cortical surface: PBM treatment</span></p>
<p style="top:353.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">&#x2018;&#x2018;increased brain temperature by 0.2</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &#x2013;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.1</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt">&#xfffd;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">C (30 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">),</span></p>
<p style="top:365.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">2.5</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &#x2013;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.4</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt">&#xfffd;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">C (60 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">), and 4.1</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &#x2013;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> 0.3</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt">&#xfffd;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">C (120 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">),over</span></p>
<p style="top:378.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the 2-min application period. In the transcranial protocol,</span></p>
<p style="top:390.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">LLLT (60 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">) increased brain temperature by 1.8</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &#x2013;</span></p>
<p style="top:403.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">0.1</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt">&#xfffd;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">C.&#x2019;&#x2019; The authors reported that brain temperature</span></p>
<p style="top:415.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">returned to baseline within 3&#x2013;5 min.</span></p>
<p style="top:442.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Risk of bias assessment</span></p>
<p style="top:455.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Risk of bias assessment for the included human clinical</span></p>
<p style="top:467.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">study is presented in Table 4, with overall study quality de-</span></p>
<p style="top:480.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">termined as &#x2018;&#x2018;Fair.&#x2019;&#x2019; Overall risk of bias for animal studies</span></p>
<p style="top:492.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">was high across most studies, as illustrated in Figure 4.</span></p>
<p style="top:519.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.5pt">Discussion</span></p>
<p style="top:532.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">This systematic review presents a comprehensive sum-</span></p>
<p style="top:544.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">mary of the available literature on the use of PBM ther-</span></p>
<p style="top:557.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">apy in the context of acute TBI. The meta-analysis,</span></p>
<p style="top:569.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">although limited in its scope because of literature hetero-</span></p>
<p style="top:582.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">geneity, combined with supplementary narrative sum-</span></p>
<p style="top:594.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">mary presents clear and robust data of the therapeutic</span></p>
<p style="top:607.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">bene&#xfb01;t of PBM in pre-clinical models on functional, his-</span></p>
<p style="top:619.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tological, and radiological TBI outcomes. The presented</span></p>
<p style="top:632.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">data on speci&#xfb01;c mediators amalgamates a broad variety</span></p>
<p style="top:644.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of mechanistic insights into the action of PBM in TBI.</span></p>
<p style="top:657.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Subgroup analysis based on variables of PBM parameters</span></p>
<p style="top:669.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">also offers an important quantitative summary toward</span></p>
<p style="top:681.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">establishing the translational potential for PBM.</span></p>
<p style="top:709.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Establishing an optimum modality</span></p>
<p style="top:721.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The subgroup analysis presented in this review identi&#xfb01;ed</span></p>
<p style="top:734.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">that the available evidence supports both CW and PW as</span></p>
<p style="top:153.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">therapeutic modes of dose administration. The greater ef-</span></p>
<p style="top:166.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">fect size of PW is suggestive that there may be an advan-</span></p>
<p style="top:178.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tage to this approach, although this analysis is not able to</span></p>
<p style="top:191.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">draw conclusions on the relative merits of PW in compar-</span></p>
<p style="top:203.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ison with CW. Both approaches generated an effect size</span></p>
<p style="top:216.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">favoring intervention with statistical signi&#xfb01;cance.</span></p>
<p style="top:228.6pt;left:321.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">It is noteworthy, however, that Ando and associ-</span></p>
<p style="top:241.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ates (2011)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">compared CW with PW (10 Hz) and PW</span></p>
<p style="top:253.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(100 Hz) and found PW 10 Hz the most effective, with</span></p>
<p style="top:266.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">a statistically signi&#xfb01;cant further improvement of out-</span></p>
<p style="top:278.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">comes compared with CW. Oron and coworkers (2012)</span></p>
<p style="top:290.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">too found that PW at 100 Hz was associated with im-</span></p>
<p style="top:303.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">proved NSS recovery at 56 days post-injury compared</span></p>
<p style="top:315.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with CW. The application and mechanistic effect of</span></p>
<p style="top:328.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">PW light delivery is not fully understood and warrants</span></p>
<p style="top:340.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">further well-controlled studies.</span></p>
<p style="top:353.1pt;left:321.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Given the presence of one article in the literature de-</span></p>
<p style="top:365.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">scribing the technique, insuf&#xfb01;cient evidence on the appli-</span></p>
<p style="top:378.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cation of NPLT in TBI is available to draw conclusions as</span></p>
<p style="top:390.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to its ef&#xfb01;cacy, particularly in comparison with CW/PW.</span></p>
<p style="top:402.9pt;left:321.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The subgroup analysis also identi&#xfb01;es a clear dichotomy</span></p>
<p style="top:415.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">among the used wavelengths: wavelengths in the region of</span></p>
<p style="top:427.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">665and810nmcorrelatedwiththerapeuticeffect,andwave-</span></p>
<p style="top:440.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">lengths in the region of 730 and 980nm did not. This appar-</span></p>
<p style="top:452.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ent failure of 730/980 nm wavelengths to elicit detectable</span></p>
<p style="top:465.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">therapeutic bene&#xfb01;t in</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> in vivo</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> models of TBI has two poten-</span></p>
<p style="top:477.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tial explanations: (1) 730/980nm do not elicit the same pho-</span></p>
<p style="top:490.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">totherapeutic and biochemical effects at a cellular level in</span></p>
<p style="top:502.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">TBI; (2) penetrance of 730/980nm photons to the target tis-</span></p>
<p style="top:515.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sue is impaired in comparison with other wavelengths.</span></p>
<p style="top:527.5pt;left:321.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">These potential causes of therapeutic failure are not able</span></p>
<p style="top:539.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to be informed by the current available evidence identi&#xfb01;ed</span></p>
<p style="top:552.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">here. Longer wavelengths penetrate farther; however,</span></p>
<p style="top:564.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">980 nm light has increased levels of absorption by water</span></p>
<p style="top:577.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and oxygenated hemoglobin than the shorter wavelengths,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">55</span></sup></p>
<p style="top:589.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">which may in part explain this phenomenon. A further con-</span></p>
<p style="top:602.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sideration is that no included study reported full width at</span></p>
<p style="top:614.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">half maximum value, a measure of the bandwidth of a</span></p>
<p style="top:627.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">light source at 50% capacity (although spectral transmit-</span></p>
<p style="top:639.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tance was reported by Giacci and colleagues [2014]</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">48</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">for</span></p>
<p style="top:652.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">their spinal cord injury model). As such, it is not possible</span></p>
<p style="top:664.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to evaluate whether sources outside the emission maxima</span></p>
<p style="top:676.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of 660 and 810nm may have included these peaks.</span></p>
<p style="top:709.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Establishing an optimum dose</span></p>
<p style="top:721.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">In the subgroup analysis on overall dose, all three sub-</span></p>
<p style="top:734.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">groups of dose demonstrated ef&#xfb01;cacy with statistical</span></p>
<p style="top:61.7pt;left:59.8pt;line-height:9.0pt"><span style="font-family:AdvTimBolLiebert,serif;font-size:9.0pt">Table 4. Risk of Bias Assessment for Human Clinical Studies, Based on Cochrane Risk of Bias Tool</span><sup><span style="font-family:AdvTimBolLiebert,serif;font-size:6.3pt">37</span></sup></p>
<p style="top:98.6pt;left:140.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Randomization</span></p>
<p style="top:80.6pt;left:227.2pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Deviations</span></p>
<p style="top:89.6pt;left:220.9pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">from intended</span></p>
<p style="top:98.6pt;left:223.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">interventions</span></p>
<p style="top:89.6pt;left:298.8pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Missing outcome</span></p>
<p style="top:98.6pt;left:319.6pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">data</span></p>
<p style="top:89.6pt;left:387.7pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Measurement</span></p>
<p style="top:98.6pt;left:391.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">of outcome</span></p>
<p style="top:89.6pt;left:466.2pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Selective</span></p>
<p style="top:98.6pt;left:465.1pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">reporting</span></p>
<p style="top:98.6pt;left:526.2pt;line-height:8.0pt"><span style="font-family:AdvOT56309c18.I,serif;font-size:8.0pt">Overall</span></p>
<p style="top:115.5pt;left:59.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Figueiro Longo</span></p>
<p style="top:124.5pt;left:67.7pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">et al., 2020</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:5.6pt">31</span></sup></p>
<p style="top:115.5pt;left:158.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Low</span></p>
<p style="top:115.5pt;left:236.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">High</span></p>
<p style="top:115.5pt;left:319.9pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Low</span></p>
<p style="top:115.5pt;left:385.8pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Some concerns</span></p>
<p style="top:115.5pt;left:465.1pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Low</span></p>
<p style="top:115.5pt;left:526.2pt;line-height:8.0pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:8.0pt">Fair</span></p>
<p style="top:30.2pt;left:59.8pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">PHOTOBIOMODULATION IN ACUTE TBI</span></p>
<p style="top:30.2pt;left:538.9pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">11</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:572.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">signi&#xfb01;cance. The optimal dose is a subject of much de-</span></p>
<p style="top:584.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">bate in PBM research that has not been resolved with</span></p>
<p style="top:597.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">wide-ranging and thorough reviews from across the</span></p>
<p style="top:609.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">large body of PBM literature in multiple tissue types.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">56</span></sup></p>
<p style="top:621.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The well-established &#x2018;&#x2018;biphasic dose response&#x2019;&#x2019; of PBM</span></p>
<p style="top:634.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">creates potential problems of both under- and overdosing</span></p>
<p style="top:646.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of target tissue.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">57,58</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The Hamblin laboratory investiga-</span></p>
<p style="top:659.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tors have argued that greater mitochondrial concentration</span></p>
<p style="top:671.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(as in cerebral tissue) is more likely to respond favorably</span></p>
<p style="top:684.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to relatively low levels of &#xfb02;uence and have a greater pro-</span></p>
<p style="top:696.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">pensity for failure because of overdose.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">56</span></sup></p>
<p style="top:709.1pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The doses, however, delivered at any depth within</span></p>
<p style="top:721.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cerebral tissue because of impedance from scalp, skull,</span></p>
<p style="top:734.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">periosteum, dura, cerebrospinal &#xfb02;uid (CSF), blood (and</span></p>
<p style="top:572.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">brain itself) are greatly attenuated even in rodent tissue:</span></p>
<p style="top:584.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">this issue is ampli&#xfb01;ed in larger mammals such as hu-</span></p>
<p style="top:597.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">mans.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">59</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Delivery varies further on factors such as skull</span></p>
<p style="top:609.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">thickness, differing between species, patients, and ana-</span></p>
<p style="top:621.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tomical locations. In the absence of subject-speci&#xfb01;c com-</span></p>
<p style="top:634.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">plex computational modeling, even establishing &#x2018;&#x2018;the</span></p>
<p style="top:646.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">dose&#x2019;&#x2019; reaching the target tissue is dif&#xfb01;cult, more so if</span></p>
<p style="top:659.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">attempting to resolve this to discrete anatomical locations</span></p>
<p style="top:671.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">within the organ. Study therefore on &#x2018;&#x2018;the optimum dose&#x2019;&#x2019;</span></p>
<p style="top:684.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">is an even greater challenge.</span></p>
<p style="top:709.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Establishing an optimum dose regimen</span></p>
<p style="top:721.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Subgroup analysis has also demonstrated clearly that</span></p>
<p style="top:734.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">two key factors in the PBM dosing regimen should be</span></p>
<img style="position:absolute;transform:matrix(.64023986,0,-0,.6402206,-62.526674,-71.074039)" src="data:image/jpeg;base64,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">
<p style="top:532.7pt;left:146.5pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">FIG. 4.</span></p>
<p style="top:532.7pt;left:185.1pt;line-height:10.0pt"><span style="font-family:AdvOT46dcae81,serif;font-size:10.0pt">Risk of bias analysis for the included studies using the SYRCLE tool.</span></p>
<p style="top:29.7pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">12</span></p>
<p style="top:29.7pt;left:481.6pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">STEVENS ET AL.</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:61.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">considered. First, the time to initial dose is of great im-</span></p>
<p style="top:73.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">portance: the therapeutic effect appears to be lost or</span></p>
<p style="top:86.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">greatly diminished when &#xfb01;rst dose administration is</span></p>
<p style="top:98.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">given more than approximately 6 h post-injury in rodent</span></p>
<p style="top:111.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">models. Further, the bene&#xfb01;cial effects of PBM appear</span></p>
<p style="top:123.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to be lost where repeated administrations are given on a</span></p>
<p style="top:136.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">daily basis over a number of days, although the optimum</span></p>
<p style="top:148.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">duration of a treatment course cannot be established from</span></p>
<p style="top:161.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the current literature.</span></p>
<p style="top:173.6pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Xuan and associates (2013)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">41</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">examined this directly</span></p>
<p style="top:186.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and showed that in their model the ef&#xfb01;cacy increased</span></p>
<p style="top:198.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with 3</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &#xb7;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> versus 1</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &#xb7;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> doses, but any derived bene&#xfb01;t was</span></p>
<p style="top:210.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">lost if the course continued to 14</span><span style="font-family:AdvPSSym,serif;font-size:10.5pt"> &#xb7;</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> doses. While direct</span></p>
<p style="top:223.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">comparative data are limited to this study, Yang and col-</span></p>
<p style="top:235.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">leagues (2020) found considerable therapeutic bene&#xfb01;ts,</span></p>
<p style="top:248.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">particularly in functional outcomes, with doses given</span></p>
<p style="top:260.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">over a 15-day course.</span></p>
<p style="top:298.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Establishing an optimum delivery technique</span></p>
<p style="top:310.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The speci&#xfb01;cs of delivery varied greatly between studies</span></p>
<p style="top:323.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">using a transcranial delivery method. The PBM parame-</span></p>
<p style="top:335.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ters (irradiance, &#xfb02;uence, and exposure time), positioning</span></p>
<p style="top:348.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">factors (direct to skull, direct to scalp, or a speci&#xfb01;ed dis-</span></p>
<p style="top:360.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tance from the scalp), and specimen factors (underlying</span></p>
<p style="top:372.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">durotomy/craniotomy/closed surgical wound) all have</span></p>
<p style="top:385.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">considerable effects on the dose delivery to the target</span></p>
<p style="top:397.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tissue.</span></p>
<p style="top:410.3pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The included results are not able to inform conclu-</span></p>
<p style="top:422.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sions regarding the potential bene&#xfb01;ts of varying specif-</span></p>
<p style="top:435.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ics of a transcranial application method, nor inform</span></p>
<p style="top:447.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">conclusions on the bene&#xfb01;ts of either direct or trans-</span></p>
<p style="top:460.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cranial application of PBM. Only one study used both di-</span></p>
<p style="top:472.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">rect and transcranial approaches (Khuman and coworkers</span></p>
<p style="top:485.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">[2012]</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">49</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">), and they were not directly compared. Dosing</span></p>
<p style="top:497.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">at 60 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">60&#x2013;80 min post-injury were concluded by</span></p>
<p style="top:509.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the authors as the main factors in eliciting functional im-</span></p>
<p style="top:522.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">provements in MWM testing, with this dose performing</span></p>
<p style="top:534.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">best in either direct or transcranial administration.</span></p>
<p style="top:547.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Administered directly, 60/120/210 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">but not 30/</span></p>
<p style="top:559.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">105 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">, resulted in MWM hidden platform latency</span></p>
<p style="top:572.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">improvements, and 60/120 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">elicited probe trial</span></p>
<p style="top:584.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">improvements.</span></p>
<p style="top:597.1pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Across all MWM outcomes, 60 J/cm</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">2</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">given at</span></p>
<p style="top:609.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">60&#x2013;80 min post-injury, whether delivered directly or</span></p>
<p style="top:621.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">transcranially, were deemed to elicit similar modest im-</span></p>
<p style="top:634.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">provements (although direct statistical comparison was</span></p>
<p style="top:646.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">not presented). The remaining outcomes were not sig-</span></p>
<p style="top:659.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ni&#xfb01;cantly improved by any PBM regimen tested in this</span></p>
<p style="top:671.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">study.</span></p>
<p style="top:684.2pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">While this review has principally considered the in-</span></p>
<p style="top:696.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cident energy exposure to injured target tissue (i.e., de-</span></p>
<p style="top:709.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">livery to neural/glial cells), there is growing interest in</span></p>
<p style="top:721.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the systemic effects of PBM. Given the low penetrance</span></p>
<p style="top:734.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of R-NIR light to the brain from external application, it</span></p>
<p style="top:61.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">has been hypothesized that transcranial PBM has con-</span></p>
<p style="top:73.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tributory effects from photon absorption in super&#xfb01;cial</span></p>
<p style="top:86.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tissues (scalp with its rich vascularity, skull with cal-</span></p>
<p style="top:98.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">varial bone marrow).</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">12,34,60</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The PBM directed to the</span></p>
<p style="top:111.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tibia in a mouse model of Alzheimer disease has</span></p>
<p style="top:123.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">been shown to activate mesenchymal stem cells</span></p>
<p style="top:136.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">(MSCs)</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">61</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with neuroprotective effect. Calvarial bone</span></p>
<p style="top:148.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">marrow niches have interfaces with CSF, which is a</span></p>
<p style="top:161.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">possible conduit for activated MSCs from skull in</span></p>
<p style="top:173.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">transcranial PBM.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">62</span></sup></p>
<p style="top:186.0pt;left:321.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Further to this, PBM application to anatomically dis-</span></p>
<p style="top:198.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tant sites has been observed to result in therapeutic effects</span></p>
<p style="top:210.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in neurological disorders. Termed the &#x2018;&#x2018;abscopal effect,&#x2019;&#x2019;</span></p>
<p style="top:223.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">therapeutic action distant to irradiated tissue has been</span></p>
<p style="top:235.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">recognized in radiotherapy since 1953</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">63,64</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and more re-</span></p>
<p style="top:248.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cently considered in PBM.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">65</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Research in Parkinson dis-</span></p>
<p style="top:260.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ease has identi&#xfb01;ed therapeutic bene&#xfb01;t for improvement</span></p>
<p style="top:273.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of clinical signs in a short series of patients receiving</span></p>
<p style="top:285.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">PBM to the abdomen and neck,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">66</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with similar bene&#xfb01;ts</span></p>
<p style="top:298.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to those observed with transcranial delivery.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">29</span></sup></p>
<p style="top:310.6pt;left:321.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">In animal models, however, direct stimulation appears</span></p>
<p style="top:323.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to carry greater bene&#xfb01;t.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">67,68</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The mechanism for this is</span></p>
<p style="top:335.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">not known, but has been proposed as activation of remote</span></p>
<p style="top:347.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">immune and stem cells that become systemically active</span></p>
<p style="top:360.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">after PBM.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">67</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">It is noteworthy here that the deep brain</span></p>
<p style="top:372.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">target in Parkinson disease (substantia nigra) receives</span></p>
<p style="top:385.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">signi&#xfb01;cantly attenuated doses in humans, even with trans-</span></p>
<p style="top:397.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cranial application.</span></p>
<p style="top:422.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Establishing the translational effect in humans</span></p>
<p style="top:435.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">This review has focused on the acute phase of injury. The</span></p>
<p style="top:447.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">applications of PBM in patients with TBI in clinical stud-</span></p>
<p style="top:460.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ies is, however, much more broad when considering</span></p>
<p style="top:472.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">chronic or rehabilitative contexts and has been well sum-</span></p>
<p style="top:485.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">marized elsewhere.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">30,54</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">This systematic review identi&#xfb01;ed</span></p>
<p style="top:497.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">one study reporting the application of PBM in acute TBI</span></p>
<p style="top:509.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in human subjects. While the study was not suf&#xfb01;ciently</span></p>
<p style="top:522.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">powered to detect any functional bene&#xfb01;t, this study pro-</span></p>
<p style="top:534.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">vides some evidence of a physiological effect of transcra-</span></p>
<p style="top:547.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">nial PBM through radiological outcomes. Whether this</span></p>
<p style="top:559.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">will translate to clinically relevant effects should be the</span></p>
<p style="top:572.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">subject of further study, but Figuero Longo and col-</span></p>
<p style="top:584.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">leagues</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">69</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">were able to demonstrate a favorable safety</span></p>
<p style="top:597.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">pro&#xfb01;le to support further study.</span></p>
<p style="top:609.5pt;left:321.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Similar to the presented pre-clinical literature, the</span></p>
<p style="top:621.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">included clinical study raises issues with regard to mea-</span></p>
<p style="top:634.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">surement and reporting of delivered dose. Data on &#xfb02;uence</span></p>
<p style="top:646.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">at a cortical level were not presented. Further, the total</span></p>
<p style="top:659.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">number of doses received by enrolled patients varied</span></p>
<p style="top:671.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and was not transparently reported nor considered in</span></p>
<p style="top:684.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the data analysis. For this reason, the overall quality of</span></p>
<p style="top:696.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the study was deemed &#x2018;&#x2018;fair,&#x2019;&#x2019; and consideration for</span></p>
<p style="top:709.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">dose, dose regimen, and dose delivery should be a key</span></p>
<p style="top:721.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">consideration in the planning of further clinical trials of</span></p>
<p style="top:734.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">PBM in TBI.</span></p>
<p style="top:30.2pt;left:59.8pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">PHOTOBIOMODULATION IN ACUTE TBI</span></p>
<p style="top:30.2pt;left:538.9pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">13</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:61.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Establishing a mechanism</span></p>
<p style="top:74.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Through presentation of molecular substudies from the</span></p>
<p style="top:86.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">included literature, this review has illustrated the broad</span></p>
<p style="top:98.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">range of potential therapeutic mechanisms of PBM in</span></p>
<p style="top:111.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">TBI. A full discussion of the complex and not fully elu-</span></p>
<p style="top:123.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cidated mechanism of PBM is beyond the scope of this</span></p>
<p style="top:136.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">review; however, there are key themes observed from</span></p>
<p style="top:148.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the included articles.</span></p>
<p style="top:161.1pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">In summary, PBM therapy in acute TBI appears to</span></p>
<p style="top:173.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">correlate with: (1) increases in ATP levels</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">38,39,46</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">; (2)</span></p>
<p style="top:186.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">reduction in reactive oxygen species</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">39</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">; (3) increase</span></p>
<p style="top:198.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in mitochondrial membrane potential</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">39</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">; (4) reduction</span></p>
<p style="top:211.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in microglial activation/astrogliosis</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">45,47,49</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">; (5) reduction</span></p>
<p style="top:223.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of proin&#xfb02;ammatory mediators</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">44</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">; (6) reduction in apopto-</span></p>
<p style="top:235.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tic markers</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">43,45,47,52</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">; (7) decreased neuronal degenera-</span></p>
<p style="top:248.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tion</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">41,45</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">; (8) increased cell proliferation and maturation</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">41,43</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">;</span></p>
<p style="top:260.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and (9) increased cerebral blood &#xfb02;ow.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">53</span></sup></p>
<p style="top:273.2pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Given the heterogeneity of PBM parameters and injury</span></p>
<p style="top:285.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">models, it cannot be concluded whether such mechanisms</span></p>
<p style="top:298.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">are speci&#xfb01;c to a particular PBM parameter/injury interac-</span></p>
<p style="top:310.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tion or representative of a broad mechanism of effect that</span></p>
<p style="top:323.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">is common to PBM modalities in acute TBI. The pres-</span></p>
<p style="top:335.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ence of bene&#xfb01;cial effects on multiple discrete TBI patho-</span></p>
<p style="top:347.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">physiological processes, however, is encouraging for its</span></p>
<p style="top:360.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">prospective translational bene&#xfb01;t.</span></p>
<p style="top:372.9pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">This systematic review has identi&#xfb01;ed multiple studies</span></p>
<p style="top:385.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">reporting reduction in neural degeneration in TBI after</span></p>
<p style="top:397.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">PBM, reducing hippocampal (CA1) synaptic degrada-</span></p>
<p style="top:410.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tion,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">45</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and reducing degenerating neurons.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">41</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">There is</span></p>
<p style="top:422.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">also signi&#xfb01;cant evidence to support neurogenic and syn-</span></p>
<p style="top:435.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">aptogenic activity stimulated by PBM.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">41,43,47</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Included</span></p>
<p style="top:447.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">articles have identi&#xfb01;ed increased subgranular cell prolif-</span></p>
<p style="top:460.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">eration</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">47</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">; increased hippocampal, SVZ, and perilesional</span></p>
<p style="top:472.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cell proliferation</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">41,43</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">; and neuronal maturation and dif-</span></p>
<p style="top:484.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ferentiation of neuronal progenitor cells.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">43</span></sup></p>
<p style="top:497.4pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Upregulation of BDNF post-PBM has been corre-</span></p>
<p style="top:509.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">lated with increased expression of synapsin-1, with the</span></p>
<p style="top:522.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">authors concluding that early BDNF upregulation may</span></p>
<p style="top:534.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">mediate synaptogenesis in later (28 day post-injury) re-</span></p>
<p style="top:547.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">covery phase.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">42</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">In the wider literature, BDNF upregula-</span></p>
<p style="top:559.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tion has been observed in PBM treated animal models</span></p>
<p style="top:572.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of Alzheimer disease and has been proposed as a neuro-</span></p>
<p style="top:584.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">protective mechanism for PBM.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">70</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Similarly, increased</span></p>
<p style="top:597.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">neurogenesis</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">71,72</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and synaptogenesis</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">71</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">have been ob-</span></p>
<p style="top:609.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">served in occlusive and prothrombotic rat stroke models</span></p>
<p style="top:621.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">after PBM treatment. Upregulation of BDNF expression</span></p>
<p style="top:634.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with PBM has also been demonstrated in an organotypic</span></p>
<p style="top:646.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">hippocampal slice model</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">73</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and a methanol-induced tox-</span></p>
<p style="top:659.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">icity occipital cortex damage model.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">74</span></sup></p>
<p style="top:671.7pt;left:73.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">While the accumulated evidence presented here offers</span></p>
<p style="top:684.2pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">insights into potential downstream pathways mediating</span></p>
<p style="top:696.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the therapeutic effects of PBM in acute TBI, understand-</span></p>
<p style="top:709.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ing of an overall mechanism of action for R/NIR light on</span></p>
<p style="top:721.6pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">injured brain tissue remains incomplete. Integral to pho-</span></p>
<p style="top:734.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tobiological interaction, photons must be absorbed by a</span></p>
<p style="top:61.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">biological molecule to elicit an effect&#x2014;i.e., a chromo-</span></p>
<p style="top:73.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">phore. CCO has been understood as a primary chromo-</span></p>
<p style="top:86.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">phore of PBM,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">71,75,76</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">with photon energy resulting in</span></p>
<p style="top:98.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the dissociation of nitric oxide,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">77</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">increasing MMP and</span></p>
<p style="top:111.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ATP production, and modulating ROS production.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">74</span></sup></p>
<p style="top:123.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">While there is a clear role of the mitochondria in medi-</span></p>
<p style="top:136.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ating the biological effects of PBM, the speci&#xfb01;c role of</span></p>
<p style="top:148.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">CCO has not been fully con&#xfb01;rmed.</span></p>
<p style="top:161.1pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">A novel mechanism disparate to CCO has recently</span></p>
<p style="top:173.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">emerged for 980 nm light: activating heat or light sensi-</span></p>
<p style="top:186.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">tive calcium ion channels.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">78</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">It remains possible, or even</span></p>
<p style="top:198.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">likely, that there are further chromophores that contribute</span></p>
<p style="top:210.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to the wide-ranging biological effects of PBM, with dis-</span></p>
<p style="top:223.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">crete and unidenti&#xfb01;ed downstream mechanisms, with spe-</span></p>
<p style="top:235.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ci&#xfb01;c chromophores related to wavelength of PBM.</span></p>
<p style="top:264.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Risk of bias</span></p>
<p style="top:276.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The risk of bias across the included animal studies was</span></p>
<p style="top:289.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">found to be generally high. In most cases, reporting of</span></p>
<p style="top:301.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">factors as per SYRCLE guidelines was not adhered to.</span></p>
<p style="top:314.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">All studies described baseline characteristics and had</span></p>
<p style="top:326.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">clear primary outcomes; however, randomization and</span></p>
<p style="top:339.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">blinding were overlooked by the majority of studies. To</span></p>
<p style="top:351.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ensure replicable and robust data to inform the ongoing</span></p>
<p style="top:363.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">direction of PBM research in TBI, adherence to such</span></p>
<p style="top:376.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">guidelines is strongly encouraged for future studies.</span></p>
<p style="top:405.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Controls</span></p>
<p style="top:418.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Included studies in this review have used control pro-</span></p>
<p style="top:430.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cedures that include the equivalent restraint required to</span></p>
<p style="top:443.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">facilitate PBM, but without its application. It is arguable,</span></p>
<p style="top:455.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">however, that this is an inadequate control: application of</span></p>
<p style="top:468.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">a broadband light source at equivalent irradiance would</span></p>
<p style="top:480.5pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">be a more robust approach. An ideal source would elicit</span></p>
<p style="top:492.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">similar transient temperature changes to a PBM source to</span></p>
<p style="top:505.4pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">control also for this secondary effect of PBM therapy and</span></p>
<p style="top:517.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">would robustly identify that wavelength-speci&#xfb01;c doses of</span></p>
<p style="top:530.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">incident light are the bene&#xfb01;cial factor.</span></p>
<p style="top:542.7pt;left:324.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">A typical broadband source would deliver a fraction</span></p>
<p style="top:555.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of its energy in the form of wavelengths of therapeutic in-</span></p>
<p style="top:567.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">terest. Such wavelengths could also be &#xfb01;ltered. If explor-</span></p>
<p style="top:580.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ing such options as controls, spectral irradiance should be</span></p>
<p style="top:592.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">comprehensively measured and presented in the study</span></p>
<p style="top:605.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">reporting.</span></p>
<p style="top:634.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">PBM parameter reporting</span></p>
<p style="top:646.9pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The detail with which PBM parameters were employed</span></p>
<p style="top:659.3pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and reported in each study and substudy varied greatly.</span></p>
<p style="top:671.8pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Average irradiance and exposure time were reported</span></p>
<p style="top:684.2pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">across studies, but reporting of results of cadaveric mod-</span></p>
<p style="top:696.7pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">eling with direct measurement of transmitted PBM was</span></p>
<p style="top:709.1pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">infrequent. No study presented data from computational</span></p>
<p style="top:721.6pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">modeling of dose delivery or distribution. This enhances</span></p>
<p style="top:734.0pt;left:313.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">dif&#xfb01;culties in the between-study comparison of ef&#xfb01;cacy:</span></p>
<p style="top:29.7pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">14</span></p>
<p style="top:29.7pt;left:481.6pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">STEVENS ET AL.</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:61.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">variability lies not only in PBM parameters but also in the</span></p>
<p style="top:73.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">transmission of those parameters to the target tissue. This</span></p>
<p style="top:86.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">is a salient and common shortcoming of much of the</span></p>
<p style="top:98.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">PBM literature.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">79</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The accurate reporting of radiometry</span></p>
<p style="top:111.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in future studies should be prioritized.</span></p>
<p style="top:136.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Limitations</span></p>
<p style="top:148.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">There are a number of limitations for this study. Because</span></p>
<p style="top:161.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of heterogeneity in the included studies&#x2019; selection of out-</span></p>
<p style="top:173.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">come measure, the meta-analysis is not comprehensive in</span></p>
<p style="top:186.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">scope and is able to represent only a subsection of the lit-</span></p>
<p style="top:198.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">erature. Further, because of common outcome measure</span></p>
<p style="top:211.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">preference within laboratories, high availability of NSS</span></p>
<p style="top:223.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">data or lesion size data is inherently biased toward a se-</span></p>
<p style="top:235.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">lective pool of publications.</span></p>
<p style="top:248.4pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">A narrative review on PBM in TBI and stroke</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">32</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">from</span></p>
<p style="top:260.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the Hamblin laboratory presents an excellent summary</span></p>
<p style="top:273.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of the available data, with outputs categorized by re-</span></p>
<p style="top:285.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">search group. Subgroup analyses were performed here</span></p>
<p style="top:298.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to maximize the value of meta-analysis by providing</span></p>
<p style="top:310.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">some insight into the ef&#xfb01;cacy of varying PBM parame-</span></p>
<p style="top:323.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ters. This, however, is not entirely robust given the in-</span></p>
<p style="top:335.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">clusion of only a single study in some subgroups, and</span></p>
<p style="top:348.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">conclusions should be guarded with that consideration.</span></p>
<p style="top:360.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Similarly, the statistical component of the meta-analysis</span></p>
<p style="top:372.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">cannot account for the duplicate appearance of control</span></p>
<p style="top:385.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">groups as though they were independent, where a single</span></p>
<p style="top:397.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">control group is common across multiple substudies</span></p>
<p style="top:410.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">where the data are taken from a single article.</span></p>
<p style="top:422.7pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">As described above, PBM parameter reporting varied</span></p>
<p style="top:435.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in its quality, and in some instances the dose for PBM</span></p>
<p style="top:447.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">parameters was calculated based on available beam trans-</span></p>
<p style="top:460.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">mittance data and may not be entirely representative of</span></p>
<p style="top:472.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the &#x2018;&#x2018;true&#x2019;&#x2019; &#xfb01;gure that was not directly measured in the</span></p>
<p style="top:485.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">reported data.</span></p>
<p style="top:497.4pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">This review does not comprise the available evidence</span></p>
<p style="top:509.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">for applications of PBM in chronic TBI, although a re-</span></p>
<p style="top:522.3pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">view summarizing these data is available in the litera-</span></p>
<p style="top:534.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ture.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">30</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The study of chronic TBI is predominantly in</span></p>
<p style="top:547.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">case reports</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">80&#x2013;83</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">or short case series</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">84&#x2013;86</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">from human ap-</span></p>
<p style="top:559.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">plications, in contrast to the evidence in acute TBI that is</span></p>
<p style="top:572.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">predominantly in animal models. This is likely attribut-</span></p>
<p style="top:584.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">able to the availability of replicable acute TBI models</span></p>
<p style="top:597.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in animals (in contrast to chronic TBI models), and the</span></p>
<p style="top:609.5pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">practical logistics of patient recruitment in chronic (ver-</span></p>
<p style="top:621.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sus acute) TBI contexts. An ongoing randomized con-</span></p>
<p style="top:634.4pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">trolled trial for patients with chronic TBI is likely to</span></p>
<p style="top:646.9pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">provide more robust evidence on the ef&#xfb01;cacy.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">87</span></sup></p>
<p style="top:659.3pt;left:70.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">In contrast, applications of PBM in patients with stroke</span></p>
<p style="top:671.8pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">have predominantly been in the acute setting (NEST</span></p>
<p style="top:684.2pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">studies</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">33,88,89</span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">), and there is little quality evidence for</span></p>
<p style="top:696.7pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">applications in the chronic rehabilitative phase post-</span></p>
<p style="top:709.1pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ischemic stroke.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">90</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">While some comparisons between</span></p>
<p style="top:721.6pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">pathologies (TBI, stroke) and time points (acute, chron-</span></p>
<p style="top:734.0pt;left:59.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ic) can be considered, the mechanisms, pathophysiol-</span></p>
<p style="top:61.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ogy, interventional goals, and outcome measures are</span></p>
<p style="top:73.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">discrete and speci&#xfb01;c, supporting the focused nature of</span></p>
<p style="top:86.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">this systematic review and meta-analysis.</span></p>
<p style="top:117.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOTce3d9a73,serif;font-size:10.5pt">Future directions</span></p>
<p style="top:129.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">This study, in accordance with previous work,</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">56</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">has iden-</span></p>
<p style="top:142.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ti&#xfb01;ed parameter heterogeneity and incomplete reporting</span></p>
<p style="top:154.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">as factors that impede accurate conclusions to be taken</span></p>
<p style="top:166.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">from PBM literature reviews. Accurate and comprehen-</span></p>
<p style="top:179.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">sively reported radiometry should be prioritized in future</span></p>
<p style="top:191.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">work for clearly established dose</span><span style="font-family:AdvTimItaLiebert,serif;font-size:10.5pt"> delivery</span><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> to target tissue</span></p>
<p style="top:204.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to be compared between studies.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">79</span></sup><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt"> </span></sup><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Given the lack of a</span></p>
<p style="top:216.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">well-established therapeutic dose window in TBI, accu-</span></p>
<p style="top:229.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">rate representation of dose delivery for comparison with</span></p>
<p style="top:241.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">outcome measures is key to advancing this knowledge.</span></p>
<p style="top:254.1pt;left:321.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Transcranial approaches to PBM have a clear bene&#xfb01;t</span></p>
<p style="top:266.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">in animal models, as illustrated here, but PBM delivery</span></p>
<p style="top:279.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">via this route is inherently impeded by the thickness of</span></p>
<p style="top:291.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">scalp and skull when translating this approach to humans.</span></p>
<p style="top:303.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Thorough clari&#xfb01;cation of the effective dose window will</span></p>
<p style="top:316.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">be invaluable, alongside computational simulation, in</span></p>
<p style="top:328.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">determining whether this approach is the optimal route</span></p>
<p style="top:341.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">for clinical practice or whether more elaborate or novel</span></p>
<p style="top:353.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">approaches</span></p>
<p style="top:353.7pt;left:367.1pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">may</span></p>
<p style="top:353.7pt;left:395.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">improve</span></p>
<p style="top:353.7pt;left:439.4pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">delivery</span></p>
<p style="top:353.7pt;left:483.3pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and</span></p>
<p style="top:353.7pt;left:508.2pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">functional</span></p>
<p style="top:366.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">outcomes.</span><sup><span style="font-family:AdvTimRomLiebert,serif;font-size:7.4pt">91&#x2013;96</span></sup></p>
<p style="top:396.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.5pt">Conclusion</span></p>
<p style="top:409.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">This review has provided clear evidence of the bene&#xfb01;cial</span></p>
<p style="top:421.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">effects of PBM in acute TBI. While speci&#xfb01;c parameters</span></p>
<p style="top:434.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">for optimum effect cannot be determined, the literature</span></p>
<p style="top:446.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">supports: wavelength selection in the regions of 665 or</span></p>
<p style="top:459.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">810 nm; minimizing time to &#xfb01;rst treatment; and lim-</span></p>
<p style="top:471.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ited total applications of daily PBM. Included studies</span></p>
<p style="top:484.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">comprising mechanistic considerations support the hy-</span></p>
<p style="top:496.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">potheses that PBM reduced cellular apoptosis, reduced</span></p>
<p style="top:508.9pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">microglial activation and neuroin&#xfb02;ammation, attenu-</span></p>
<p style="top:521.4pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ated neuronal degeneration, promoted neurogenesis/</span></p>
<p style="top:533.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">synaptogenesis, and modulated metabolism.</span></p>
<p style="top:546.3pt;left:321.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Precise radiometry reporting in the literature for the</span></p>
<p style="top:558.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">purposes of comparability between studies is encouraged</span></p>
<p style="top:571.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">for future work. While clinical data in acute TBI are lim-</span></p>
<p style="top:583.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ited to a single study, a considered approach toward study</span></p>
<p style="top:596.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">protocols should be taken to ensure that further clinical</span></p>
<p style="top:608.5pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">study is utilizing optimal parameters and is conducted</span></p>
<p style="top:621.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">to a high standard.</span></p>
<p style="top:646.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.5pt">Authors&#x2019; Contributions</span></p>
<p style="top:659.3pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">All authors have read and approved the full version</span></p>
<p style="top:671.8pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">of this article. AS was responsible for conceptualization</span></p>
<p style="top:684.2pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">and manuscript preparation. AS and ZA performed the</span></p>
<p style="top:696.7pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">searches, risk of bias assessments, extracted the data</span></p>
<p style="top:709.1pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">from the included articles, and performed the analysis.</span></p>
<p style="top:721.6pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">All authors contributed to the development of the ideas/</span></p>
<p style="top:734.0pt;left:310.8pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">writing/&#xfb01;nal review of the submitted article.</span></p>
<p style="top:30.2pt;left:59.8pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">PHOTOBIOMODULATION IN ACUTE TBI</span></p>
<p style="top:30.2pt;left:538.9pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">15</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:61.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.5pt">Funding Information</span></p>
<p style="top:74.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">This article presents independent research funded by the</span></p>
<p style="top:86.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">National Institute for Health Research (NIHR) Surgical</span></p>
<p style="top:99.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Reconstruction and Microbiology Research Centre (part-</span></p>
<p style="top:111.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">nership between University Hospitals Birmingham NHS</span></p>
<p style="top:123.9pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Foundation Trust, the University of Birmingham, and</span></p>
<p style="top:136.4pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">the Royal Centre for Defence Medicine). The views</span></p>
<p style="top:148.8pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">expressed are those of the author(s) and not necessar-</span></p>
<p style="top:161.3pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">ily those of the NHS, the NIHR, or the Department of</span></p>
<p style="top:173.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Health.</span></p>
<p style="top:199.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.5pt">Author Disclosure Statement</span></p>
<p style="top:212.1pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">The research group has submitted a patent pending ap-</span></p>
<p style="top:224.5pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">plication relating to the invasive delivery of PBM (UK</span></p>
<p style="top:237.0pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvTimRomLiebert,serif;font-size:10.5pt">Patent Application No 2006201.4).</span></p>
<p style="top:264.7pt;left:62.0pt;line-height:10.5pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.5pt">References</span></p>
<p style="top:277.1pt;left:69.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">1. Maas AIR, Menon DK, David Adelson PD, et al. Traumatic brain injury:</span></p>
<p style="top:286.0pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">integrated approaches to improve prevention, clinical care, and re-</span></p>
<p style="top:295.0pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">search. Lancet Neurol 2017;16(12):987&#x2013;1048; doi: 10.1016/S1474-</span></p>
<p style="top:304.0pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">4422(17)30371-X.</span></p>
<p style="top:313.0pt;left:69.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2. Dewan M, Rattani A, Gupta S, et al. Estimating the global incidence</span></p>
<p style="top:321.9pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">of traumatic brain injury. J Neurosurg 2018;130(4):1080&#x2013;1097; doi:</span></p>
<p style="top:330.9pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">10.3171/2017.10.JNS17352.</span></p>
<p style="top:339.8pt;left:69.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">3. Ng SY, Lee AYW. Traumatic brain injuries: pathophysiology and potential</span></p>
<p style="top:348.8pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">therapeutic targets. Front Cell Neurosci 2019;13:528; doi: 10.3389/</span></p>
<p style="top:357.8pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">fncel.2019.00528.</span></p>
<p style="top:366.8pt;left:69.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">4. Brain Trauma Foundation. Guidelines for the Management of Severe TBI,</span></p>
<p style="top:375.7pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">4th ed. 2016. Available from: https://braintrauma.org/guidelines/</span></p>
<p style="top:384.7pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">guidelines-for-the-management-of-severe-tbi-4th-ed#/ [Last</span></p>
<p style="top:393.6pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">accessed: 8/26/2021].</span></p>
<p style="top:402.6pt;left:69.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">5. Ahluwalia M, Kumar M, Ahluwalia P, et al. Rescuing mitochondria in</span></p>
<p style="top:411.6pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">traumatic brain injury and intracerebral hemorrhages &#x2013; a potential</span></p>
<p style="top:420.6pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">therapeutic approach. Neurochem Int 2021;150:105192; doi: 10.1016/</span></p>
<p style="top:429.5pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">j.neuint.2021.105192.</span></p>
<p style="top:438.5pt;left:69.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">6. Simon DW, McGeachy MJ, Baylr H, et al. The far-reaching scope of</span></p>
<p style="top:447.4pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">neuroin&#xfb02;ammation after traumatic brain injury. Nat Rev Neurol</span></p>
<p style="top:456.4pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2017;13(3) 2017;13(3):171&#x2013;191; doi: 10.1038/nrneurol.2017.13.</span></p>
<p style="top:465.4pt;left:69.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">7. Chamoun R, Suki D, Gopinath SP, et al. Role of extracellular glutamate</span></p>
<p style="top:474.4pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">measured by cerebral microdialysis in severe traumatic brain injury.</span></p>
<p style="top:483.3pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">J Neurosurg 2010;113(3):564&#x2013;570; doi: 10.3171/2009.12.JNS09689.</span></p>
<p style="top:492.3pt;left:69.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">8. Khatri N, Thakur M, Pareek V, et al. Oxidative stress: major threat in</span></p>
<p style="top:501.2pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">traumatic brain injury. CNS Neurol Disord Drug Targets</span></p>
<p style="top:510.2pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2018;17(9):689&#x2013;695; doi: 10.2174/1871527317666180627120501.</span></p>
<p style="top:519.2pt;left:69.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">9. Khellaf A, Khan DZ, Helmy A. Recent advances in traumatic brain injury.</span></p>
<p style="top:528.2pt;left:78.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">J Neurol 2019;266:2878&#x2013;2889; doi: 10.1007/s00415-019-09541-4.</span></p>
<p style="top:537.1pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">10. Chung H, Dai T, Sharma SK, et al. The nuts and bolts of low-level laser</span></p>
<p style="top:546.1pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">(light) therapy. Ann Biomed Eng 2012;40(2):516&#x2013;533; doi: 10.1007/</span></p>
<p style="top:555.0pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">s10439-011-0454-7.</span></p>
<p style="top:564.0pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">11. Stepp H, Stummer W. 5-ALA in the management of malignant glioma.</span></p>
<p style="top:573.0pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Lasers Surg Med 2018;50(5):399&#x2013;419; doi: 10.1002/lsm.22933.</span></p>
<p style="top:581.9pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">12. Hamblin MR. Photobiomodulation for traumatic brain injury and stroke.</span></p>
<p style="top:590.9pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">J Neurosci Res 2018;96(4):731&#x2013;743; doi: 10.1002/jnr.24190.</span></p>
<p style="top:599.9pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">13. de Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodula-</span></p>
<p style="top:608.8pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">tion or low-level light therapy. IEEE J Sel Top Quantum Electron</span></p>
<p style="top:617.8pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2016;22(3):7000417 doi: 10.1109/JSTQE.2016.2561201.</span></p>
<p style="top:626.8pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">14. Dompe C, Moncrieff L, Matys J, et al. Photobiomodulation&#x2013;underlying</span></p>
<p style="top:635.7pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">mechanism and clinical applications. J Clin Med 2020;9(6):1724;</span></p>
<p style="top:644.7pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">doi: http://dx.doi.org/10.3390/jcm9061724.</span></p>
<p style="top:653.7pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">15. Yadav A, Gupta A. Noninvasive Red and near-infrared wavelength-</span></p>
<p style="top:662.6pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">induced photobiomodulation: promoting impaired cutaneous wound</span></p>
<p style="top:671.6pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">healing. Photodermatol Photoimmunol Photomed 2017;33(1):4&#x2013;13;</span></p>
<p style="top:680.6pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">doi: 10.1111/phpp.12282.</span></p>
<p style="top:689.5pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">16. Yang WZ, Chen JY, Yu JT, et al. Effects of low power laser irradiation</span></p>
<p style="top:698.5pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">on intracellular calcium and histamine release in RBL-2H3 mast cells.</span></p>
<p style="top:707.5pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Photochem Photobiol 2007;83(4):979&#x2013;984; doi: 10.1111/j.1751-</span></p>
<p style="top:716.4pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">1097.2007.00116.x.</span></p>
<p style="top:725.4pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">17. Zhang P, Wu MX. A clinical review of phototherapy for psoriasis. Lasers</span></p>
<p style="top:734.4pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Med Sci 2018;33(1):173&#x2013;180; doi: 10.1007/s10103-017-2360-1.</span></p>
<p style="top:61.9pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">18. Ocon CA, Dos Santos SA, Caires JR, et al. Effects and parameters of the</span></p>
<p style="top:70.8pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">photobiomodulation in experimental models of third-degree burn:</span></p>
<p style="top:79.8pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">systematic review. Lasers Med Sci 2019;34(3):637&#x2013;648; doi: 10.1007/</span></p>
<p style="top:88.7pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">s10103-018-2633-3.</span></p>
<p style="top:97.7pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">19. Baxter GD, Liu L, Petrich S, et al. Low level laser therapy (Photobiomo-</span></p>
<p style="top:106.7pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">dulation therapy) for breast cancer-related lymphedema: a systematic</span></p>
<p style="top:115.7pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">review. BMC Cancer 2017;17(1):833; doi: 10.1186/s12885-017-3852-x.</span></p>
<p style="top:124.6pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">20. Cronshaw M, Parker S, Anagnostaki E, et al. Photobiomodulation and</span></p>
<p style="top:133.6pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">oral mucositis: a systematic review. Dent J 2020;8(3): 87; doi: 10.3390/</span></p>
<p style="top:142.5pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">dj8030087.</span></p>
<p style="top:151.5pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">21. Ferroni C, Del Rio A, Martini C, et al. Light-induced therapies for pros-</span></p>
<p style="top:160.5pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">tate cancer treatment. Front Chem 2019;7:719; doi: 10.3389/fchem</span></p>
<p style="top:169.5pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">.2019.00719.</span></p>
<p style="top:178.4pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">22. Zhou F, Yang J, Zhang Y, et al. Local phototherapy synergizes with</span></p>
<p style="top:187.4pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">immunoadjuvant for treatment of pancreatic cancer through induced</span></p>
<p style="top:196.3pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">immunogenic tumor vaccine. Clin Cancer Res 2018;24(21):5335-5346;</span></p>
<p style="top:205.3pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">doi: 10.1158/1078-0432.CCR-18-1126.</span></p>
<p style="top:214.3pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">23. Chung HH, Dai TH, Sharma SKS, et al. Editorial. Shapero BG, Mischoulon</span></p>
<p style="top:223.3pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">D, and Cusin C. eds. Investig Ophthalmol Vis Sci 2019;9(1):57&#x2013;62; doi:</span></p>
<p style="top:232.2pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">http://dx.doi.org/10.1089/neu.2017.29011.abstracts. PLEASE VERIFY</span></p>
<p style="top:241.2pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">24. Nishinaga Y, Sato K, Yasui H, et al. Targeted phototherapy for malignant</span></p>
<p style="top:250.1pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">pleural mesothelioma: near-infrared photoimmunotherapy targeting</span></p>
<p style="top:259.1pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">podoplanin. Cells 2020;9(4):1019; doi: 10.3390/cells9041019.</span></p>
<p style="top:268.1pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">25. Ramezani F, Razmgir M, Tanha K, et al. Photobiomodulation for spinal</span></p>
<p style="top:277.0pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">cord injury: a systematic review and meta-analysis. Physiol Behav</span></p>
<p style="top:286.0pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2020;224; doi: 10.1016/j.physbeh.2020.112977.</span></p>
<p style="top:295.0pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">26. Hamblin M. Transcranial photobiomodulation for brain disorders. Biol</span></p>
<p style="top:303.9pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Psychiatry 2017;81(10 Suppl 1):S155; doi: 10.1016/j.biopsych.2017</span></p>
<p style="top:312.9pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">.02.397.</span></p>
<p style="top:321.9pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">27. Montazeri K, Farhadi M, Fekrazad R, et al. Transcranial photobiomodu-</span></p>
<p style="top:330.8pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">lation in the management of brain disorders. J Photochem Photobiol B</span></p>
<p style="top:339.8pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2021;221:112207; doi: 10.1016/j.jphotobiol.2021.112207.</span></p>
<p style="top:348.8pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">28. Moro C, El Massri N, Torres N, et al. Photobiomodulation inside the brain:</span></p>
<p style="top:357.7pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">a novel method of applying near-infrared light intracranially and its</span></p>
<p style="top:366.7pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">impact on dopaminergic cell survival in MPTP-treated mice.</span></p>
<p style="top:375.7pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">J Neurosurg 2014;120(3):670&#x2013;683; doi: 10.3171/2013.9.JNS13423.</span></p>
<p style="top:384.6pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">29. Liebert A, Bicknell B, Laakso EL, et al. Improvements in clinical signs of</span></p>
<p style="top:393.6pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Parkinson&#x2019;s disease using photobiomodulation: a prospective proof-</span></p>
<p style="top:402.6pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">of-concept study. BMC Neurol 2021;21(1):256; doi: 10.1186/s12883-</span></p>
<p style="top:411.5pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">021-02248-y.</span></p>
<p style="top:420.5pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">30. Hamblin MR. Photobiomodulation for traumatic brain injury and stroke</span></p>
<p style="top:429.5pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">(Vol 96, Pg 731, 2018). J Neurosci Res 2019;97(3):373; doi: 10.1002/</span></p>
<p style="top:438.4pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">jnr.24376.</span></p>
<p style="top:447.4pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">31. Figueiro Longo MG, Tan CO, Chan S-T, et al. Effect of transcranial low-</span></p>
<p style="top:456.4pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">level light therapy vs sham therapy among patients with moderate</span></p>
<p style="top:465.3pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">traumatic brain injury: a randomized clinical trial. JAMA Netw OPEN</span></p>
<p style="top:474.3pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2020;3(9):e2017337; doi: 10.1001/jamanetworkopen.2020.17337.</span></p>
<p style="top:483.3pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">32. Hamblin MR. Photobiomodulation for traumatic brain injury and stroke.</span></p>
<p style="top:492.2pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">J Neurosci Res 2018;96(4):731&#x2013;743; doi: 10.1002/jnr.24190.</span></p>
<p style="top:501.2pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">33. Acke W, Schellinger P, Albers G, et al. Transcranial laser therapy in acute</span></p>
<p style="top:510.1pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">stroke treatment: results of neurothera effectiveness and safety trial 3,</span></p>
<p style="top:519.1pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">a phase III clinical end point device trial. Stroke 2014;45(11):3187&#x2013;</span></p>
<p style="top:528.1pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">3193; doi: 10.1161/STROKEAHA.114.005795.</span></p>
<p style="top:537.1pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">34. Hamblin MR. Shining light on the head: photobiomodulation for brain</span></p>
<p style="top:546.0pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">disorders. BBA Clin 2016;6:113&#x2013;124; doi: 10.1016/j.bbacli.2016.09.002.</span></p>
<p style="top:555.0pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">35. Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for</span></p>
<p style="top:563.9pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Systematic Reviews and Meta-Analyses: The PRISMA Statement. BMJ</span></p>
<p style="top:572.9pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2009;339(7716):332&#x2013;336; doi: 10.1136/bmj.b2535.</span></p>
<p style="top:581.9pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">36. Hooijmans CR, Rovers MM, De Vries RBM, et al. SYRCLE&#x2019;s risk of bias</span></p>
<p style="top:590.9pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">tool for animal studies. BMC Med Res Methodol 2014;14(1):1&#x2013;9;</span></p>
<p style="top:599.8pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">doi: 10.1186/1471-2288-14-43/TABLES/4.</span></p>
<p style="top:608.8pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">37. Cochrane. Risk of Bias 2 (RoB 2) tool</span><span style="font-family:AdvP4C4E74,serif;font-size:7.5pt"> j</span><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt"> Cochrane Methods. n.d.</span></p>
<p style="top:617.7pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Available from: https://methods.cochrane.org/risk-bias-2 [Last</span></p>
<p style="top:626.7pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">accessed: 2/1/2022].</span></p>
<p style="top:635.7pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">38. Ando T, Xuan WJ, Xu T, et al. Comparison of therapeutic effects between</span></p>
<p style="top:644.7pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">pulsed and continuous wave 810-nm wavelength laser irradiation for</span></p>
<p style="top:653.6pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">traumatic brain injury in mice. PLoS One 2011;6(10):26212; doi:</span></p>
<p style="top:662.6pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">10.1371/journal.pone.0026212.</span></p>
<p style="top:671.5pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">39. Dong T, Zhang Q, Hamblin MR, et al. Low-level light in combination with</span></p>
<p style="top:680.5pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">metabolic modulators for effective therapy of injured brain. J Cereb</span></p>
<p style="top:689.5pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Blood Flow Metab 2015;35(9):1435&#x2013;1444; doi: 10.1038/jcbfm.2015.87.</span></p>
<p style="top:698.5pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">40. Wu QH, Xuan WJ, Ando T, et al. Low-level laser therapy for closed-head</span></p>
<p style="top:707.4pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">traumatic brain injury in mice: effect of different wavelengths. Lasers</span></p>
<p style="top:716.4pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Surg Med 2012;44(3):218&#x2013;226; doi: 10.1002/lsm.22003.</span></p>
<p style="top:725.4pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">41. Xuan WJ, Vatansever F, Huang LY, et al. Transcranial low-level laser</span></p>
<p style="top:734.3pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">therapy improves neurological performance in traumatic brain injury</span></p>
<p style="top:29.7pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">16</span></p>
<p style="top:29.7pt;left:481.6pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">STEVENS ET AL.</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:61.9pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">in mice: effect of treatment repetition regimen. Borlongan C V. ed.</span></p>
<p style="top:70.8pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">PLoS One 2013;8(1):e53454; doi: 10.1371/journal.pone.0053454.</span></p>
<p style="top:79.8pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">42. Xuan WJ, Agrawal T, Huang LY, et al. Low-level laser therapy for trau-</span></p>
<p style="top:88.8pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">matic brain injury in mice increases brain derived neurotrophic factor</span></p>
<p style="top:97.7pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">(BDNF) and synaptogenesis. J Biophotonics 2015;8(6):502&#x2013;511; doi:</span></p>
<p style="top:106.7pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">10.1002/jbio.201400069.</span></p>
<p style="top:115.7pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">43. Xuan WJ, Vatansever F, Huang LY, et al. Transcranial low-level laser</span></p>
<p style="top:124.6pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">therapy enhances learning, memory, and neuroprogenitor cells after</span></p>
<p style="top:133.6pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">traumatic brain injury in mice. J Biomed Opt 2014;19(10); doi: 10.1117/</span></p>
<p style="top:142.6pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">1.JBO.19.10.108003.</span></p>
<p style="top:151.5pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">44. Xuan W, Huang L, Hamblin MR. Repeated transcranial low-level laser</span></p>
<p style="top:160.5pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">therapy for traumatic brain injury in mice: biphasic dose response and</span></p>
<p style="top:169.5pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">long-term treatment outcome. J Biophotonics 2016;9(11&#x2013;12):1263&#x2013;</span></p>
<p style="top:178.4pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">1272; doi: 10.1002/jbio.201500336.</span></p>
<p style="top:187.4pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">45. Yang B, Xu J, Li Y, et al. Photobiomodulation therapy for repeated closed</span></p>
<p style="top:196.4pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">head injury in rats. J Biophotonics 2020;13(2):e201960117; doi:</span></p>
<p style="top:205.3pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">10.1002/jbio.201960117.</span></p>
<p style="top:214.3pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">46. Zhang Q, Zhou C, Hamblin MR, et al. Low-level laser therapy effectively</span></p>
<p style="top:223.3pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">prevents secondary brain injury induced by immediate early respon-</span></p>
<p style="top:232.2pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">sive gene X-1 de&#xfb01;ciency. J Cereb Blood Flow Metab 2014;34(8):1391&#x2013;</span></p>
<p style="top:241.2pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">1401; doi: 10.1038/jcbfm.2014.95.</span></p>
<p style="top:250.2pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">47. Esenaliev RO, Petrov IY, Petrov Y, et al. Nano-pulsed laser therapy is</span></p>
<p style="top:259.1pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">neuroprotective in a rat model of blast-induced neurotrauma.</span></p>
<p style="top:268.1pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">J Neurotrauma 2018;35(13):1510&#x2013;1522; doi: 10.1089/neu.2017.5249.</span></p>
<p style="top:277.0pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">48. Giacci MK, Wheeler L, Lovett S, et al. Differential effects of 670 and</span></p>
<p style="top:286.0pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">830 nm red near infrared irradiation therapy: a comparative study of</span></p>
<p style="top:295.0pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">optic nerve injury, retinal degeneration, traumatic brain and spinal</span></p>
<p style="top:304.0pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">cord injury. PLoS One 2014;9(8):e104565; doi: 10.1371/journal.pone</span></p>
<p style="top:312.9pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">.0104565.</span></p>
<p style="top:321.9pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">49. Khuman J, Zhang J, Park J, et al. Low-level laser light therapy improves</span></p>
<p style="top:330.8pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">cognitive de&#xfb01;cits and inhibits microglial activation after controlled</span></p>
<p style="top:339.8pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">cortical impact in mice. J Neurotrauma 2012;29(2):408&#x2013;417; doi:</span></p>
<p style="top:348.8pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">10.1089/neu.2010.1745.</span></p>
<p style="top:357.8pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">50. Oron A, Oron U, Streeter J, et al. Low-level laser therapy applied trans-</span></p>
<p style="top:366.7pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">cranially to mice following traumatic brain injury signi&#xfb01;cantly reduces</span></p>
<p style="top:375.7pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">long-term neurological de&#xfb01;cits. J Neurotrauma 2007;24(4):651&#x2013;656;</span></p>
<p style="top:384.6pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">doi: 10.1089/neu.2006.0198.</span></p>
<p style="top:393.6pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">51. Oron A, Oron U, Streeter J, et al. Near infrared transcranial laser therapy</span></p>
<p style="top:402.6pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">applied at various modes to mice following traumatic brain injury</span></p>
<p style="top:411.6pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">signi&#xfb01;cantly reduces long-term neurological de&#xfb01;cits. J Neurotrauma</span></p>
<p style="top:420.5pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2012;29(2):401&#x2013;407; doi: 10.1089/neu.2011.2062.</span></p>
<p style="top:429.5pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">52. Quirk BJB, Torbey M, Buchmann E, et al. Near-infrared photobiomodu-</span></p>
<p style="top:438.4pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">lation in an animal model of traumatic brain injury: improvements at</span></p>
<p style="top:447.4pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">the behavioral and biochemical levels. Photomed Laser Surg 2012;</span></p>
<p style="top:456.4pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">30(9):523&#x2013;529; doi: 10.1089/pho.2012.3261.</span></p>
<p style="top:465.4pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">53. Shemesh D, Aburus O, Turgeman G, et al. Quanti&#xfb01;cation of the ef-</span></p>
<p style="top:474.3pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">fectivity of laser therapy shortly following brain injury via dual-</span></p>
<p style="top:483.3pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">wavelength laser imaging. Opt Laser Technol 2022;145 (1):107506;</span></p>
<p style="top:492.2pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">doi: 10.1016/j.optlastec.2021.107506.</span></p>
<p style="top:501.2pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">54. Wu QH, Huang YY, Dhital S, et al. Low level laser therapy for traumatic</span></p>
<p style="top:510.1pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">brain injury. Hamblin MR, Waynant RW, Anders J (eds). Mech low-light</span></p>
<p style="top:519.2pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Ther V 2010;7552(Conference on Mechanisms for Low-Light Therapy</span></p>
<p style="top:528.1pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">V); doi: 10.1117/12.841014.</span></p>
<p style="top:537.1pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">55. Bunce SC, Izzetoglu M, Izzetoglu K, et al. Functional near-infrared</span></p>
<p style="top:546.0pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">spectroscopy. IEEE Eng Med Biol Mag 2006;25(4):54&#x2013;62; doi: 10.1109/</span></p>
<p style="top:555.0pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">memb.2006.1657788.</span></p>
<p style="top:563.9pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">56. Zein R, Selting W, Hamblin MR. Review of light parameters and photo-</span></p>
<p style="top:573.0pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">biomodulation ef&#xfb01;cacy: dive into complexity. J Biomed Opt 2018;</span></p>
<p style="top:581.9pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">23(12):1&#x2013;17; doi: 10.1117/1.JBO.23.12.120901.</span></p>
<p style="top:590.9pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">57. Huang YY, Chen ACH, Carroll JD, et al. Biphasic dose response in low</span></p>
<p style="top:599.8pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">level light therapy. Dose-Response 2009;7(4):358&#x2013;383; doi: 10.2203/</span></p>
<p style="top:608.8pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">dose-response.09-027.Hamblin.</span></p>
<p style="top:617.7pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">58. Huang YY, Sharma SK, Carroll J, et al. Biphasic dose response in low</span></p>
<p style="top:626.7pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">level light therapy &#x2013; an update. Dose Response 2011;9(4):602&#x2013;618;</span></p>
<p style="top:635.7pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">doi: 10.2203/dose-response.11-009.Hamblin.</span></p>
<p style="top:644.7pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">59. Salehpour F, Cassano P, Rouhi N, et al. Penetration pro&#xfb01;les of visible and</span></p>
<p style="top:653.6pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">near-infrared lasers and light-emitting diode light through the head</span></p>
<p style="top:662.6pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">tissues in animal and human species: a review of literature. Photo-</span></p>
<p style="top:671.5pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">biomodul Photomed Laser Surg 2019;37(10):581&#x2013;595; doi: 10.1089/</span></p>
<p style="top:680.5pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">photob.2019.4676.</span></p>
<p style="top:689.5pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">60. Salehpour F, Mahmoudi J, Kamari F, et al. Brain photobiomodulation</span></p>
<p style="top:698.5pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">therapy: a narrative review. Mol Neurobiol 2018;55(8):6601&#x2013;6636; doi:</span></p>
<p style="top:707.4pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">10.1007/s12035-017-0852-4.</span></p>
<p style="top:716.4pt;left:63.5pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">61. Farfara D, Tuby H, Trudler D, et al. Low-level laser therapy ameliorates</span></p>
<p style="top:725.3pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">disease progression in a mouse model of Alzheimer&#x2019;s disease. J Mol</span></p>
<p style="top:734.3pt;left:76.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Neurosci 2015;55(2):430&#x2013;436; doi: 10.1007/S12031-014-0354-z.</span></p>
<p style="top:61.9pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">62. Mazzitelli JA, Smyth LCD, Cross KA, et al. Cerebrospinal &#xfb02;uid regulates</span></p>
<p style="top:70.8pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">skull bone marrow niches via direct access through dural channels.</span></p>
<p style="top:79.8pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Nat Neurosci 2022;25(5):555&#x2013;560; doi: 10.1038/s41593-022-01029-1.</span></p>
<p style="top:88.7pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">63. Yilmaz MT, Elmali A, Yazici G. Abscopal effect, from myth to reality: from</span></p>
<p style="top:97.7pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">radiation oncologists&#x2019; perspective. Cureus 2019;11(1):e3860; doi:</span></p>
<p style="top:106.7pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">10.7759/cureus.3860.</span></p>
<p style="top:115.7pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">64. Craig DJ, Nanavaty NS, Devanaboyina M, et al. The abscopal effect of</span></p>
<p style="top:124.6pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">radiation therapy. Future Oncol 2021;17(13):1683&#x2013;1694; doi: 10.2217/</span></p>
<p style="top:133.6pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">fon-2020-0994</span></p>
<p style="top:142.5pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">65. Johnstone DM, Mitrofanis J, Stone J. Targeting the body to protect the</span></p>
<p style="top:151.5pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">brain: inducing neuroprotection with remotely-applied near infrared</span></p>
<p style="top:160.5pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">light. Neural Regen Res 2015;10(3):349&#x2013;351; doi: 10.4103/1673-</span></p>
<p style="top:169.5pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">5374.153673.</span></p>
<p style="top:178.4pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">66. Liebert A, Bicknell B, Laakso EL, et al. Remote photobiomodulation</span></p>
<p style="top:187.4pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">treatment for the clinical signs of Parkinson&#x2019;s disease: a case series</span></p>
<p style="top:196.3pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">conducted during COVID-19. Photobiomodul Photomed Laser Surg</span></p>
<p style="top:205.3pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2022;40(2):112&#x2013;122; doi: 10.1089/photob.2021.0056.</span></p>
<p style="top:214.3pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">67. Johnstone DM, Hamilton C, Gordon LC, et al. Exploring the use of in-</span></p>
<p style="top:223.3pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">tracranial and extracranial (remote) photobiomodulation devices in</span></p>
<p style="top:232.2pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Parkinson&#x2019;s disease: a comparison of direct and indirect systemic</span></p>
<p style="top:241.2pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">stimulations. J Alzheimers Dis 2021;83(4):1399&#x2013;1413; doi: 10.3233/</span></p>
<p style="top:250.1pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">JAD-210052.</span></p>
<p style="top:259.1pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">68. Johnstone DM, El Massri N, Moro C, et al. Indirect application of near</span></p>
<p style="top:268.1pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">infrared light induces neuroprotection in a mouse model of parkin-</span></p>
<p style="top:277.0pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">sonism - an abscopal neuroprotective effect. Neuroscience</span></p>
<p style="top:286.0pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2014;274:93&#x2013;101; doi: 10.1016/j.neuroscience.2014.05.023.</span></p>
<p style="top:295.0pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">69. Figueiro Longo MG, Tan CO, Chan ST, et al. Effect of transcranial</span></p>
<p style="top:303.9pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">low-level light therapy vs sham therapy among patients with mod-</span></p>
<p style="top:312.9pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">erate traumatic brain injury: a randomized clinical trial. JAMA Netw</span></p>
<p style="top:321.9pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Open 2020;3(9):e2017337; doi: 10.1001/jamanetworkopen.2020</span></p>
<p style="top:330.8pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">.17337.</span></p>
<p style="top:339.8pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">70. Meng C, He Z, Xing D. Low-level laser therapy rescues dendrite atrophy</span></p>
<p style="top:348.8pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">via upregulating BDNF expression: implications for Alzheimer&#x2019;s dis-</span></p>
<p style="top:357.7pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">ease. J Neurosci 2013;33(33):13505&#x2013;13517; doi: 10.1523/JNEUROSCI</span></p>
<p style="top:366.7pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">.0918-13.2013.</span></p>
<p style="top:375.7pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">71. Yang LD, Tucker D, Dong Y, et al. Photobiomodulation therapy promotes</span></p>
<p style="top:384.6pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">neurogenesis by improving post-stroke local microenvironment and</span></p>
<p style="top:393.6pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">stimulating neuroprogenitor cells. Exp Neurol 2018;299(Pt A):86&#x2013;96;</span></p>
<p style="top:402.6pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">doi: 10.1016/j.expneurol.2017.10.013.</span></p>
<p style="top:411.5pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">72. Oron A, Oron U, Chen J, et al. Low-level laser therapy applied transcra-</span></p>
<p style="top:420.5pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">nially to rats after induction of stroke signi&#xfb01;cantly reduces long-term</span></p>
<p style="top:429.5pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">neurological de&#xfb01;cits. Stroke 2006;37(10):2620&#x2013;2624; doi: 10.1161/</span></p>
<p style="top:438.4pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">01.STR.0000242775/14642/b8.</span></p>
<p style="top:447.4pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">73. Ghanbari A, Ghareghani M, Delaviz H, et al. Light-emitting diode (LED)</span></p>
<p style="top:456.4pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">therapy improves occipital cortex damage by decreasing apoptosis</span></p>
<p style="top:465.3pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">and increasing BDNF-expressing cells in methanol-induced toxicity in</span></p>
<p style="top:474.3pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">rats. Biomed Pharmacother 2017;89:1320&#x2013;1330; doi: 10.1016/j.biopha</span></p>
<p style="top:483.3pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">.2017.03.024.</span></p>
<p style="top:492.2pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">74. Heo JC, Park JA, Kim DK, et al. Photobiomodulation (660 Nm) therapy</span></p>
<p style="top:501.2pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">reduces oxidative stress and induces BDNF expression in the hippo-</span></p>
<p style="top:510.1pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">campus. Sci Rep 2019;9(1):10114; doi: 10.1038/s41598-019-46490-4.</span></p>
<p style="top:519.1pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">75. Karu TI. Multiple roles of cytochrome c oxidase in mammalian cells</span></p>
<p style="top:528.1pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">under action of red and IR-A radiation. IUBMB Life 2010;62(8):607&#x2013;610;</span></p>
<p style="top:537.1pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">doi: 10.1002/iub.359.</span></p>
<p style="top:546.0pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">76. Karu TI. Molecular mechanism of the therapeutic effect of low-intensity</span></p>
<p style="top:555.0pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">laser radiation. Lasers Life Sci 1988;2(1):53&#x2013;74.</span></p>
<p style="top:563.9pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">77. Hamblin MR. The role of nitric oxide in low level light therapy. Mech</span></p>
<p style="top:572.9pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Low-Light Ther III 2008;6846:684602; doi: 10.1117/12.764918.</span></p>
<p style="top:581.9pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">78. Wang Y, Huang YY, Wang Y, et al. Photobiomodulation of human</span></p>
<p style="top:590.9pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">adipose-derived stem cells using 810nm and 980nm lasers operates</span></p>
<p style="top:599.8pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">via different mechanisms of action. Biochim Biophys Acta Gen Subj</span></p>
<p style="top:608.8pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2017;1861(2):441&#x2013;449; doi: 10.1016/j.bbagen.2016.10.008.</span></p>
<p style="top:617.7pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">79. Hadis MA, Zainal SA, Holder MJ, et al. The dark art of light measurement:</span></p>
<p style="top:626.7pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">accurate radiometry for low-level light therapy. Lasers Med Sci 2016;</span></p>
<p style="top:635.7pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">31(4):789&#x2013;809; doi: 10.1007/s10103-016-1914-y.</span></p>
<p style="top:644.7pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">80. Naeser MA, Saltmarche A, Krengel MH, et al. Improved cognitive func-</span></p>
<p style="top:653.6pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">tion after transcranial, light-emitting diode treatments in chronic,</span></p>
<p style="top:662.6pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">traumatic brain injury: two case reports. Photomed Laser Surg</span></p>
<p style="top:671.5pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2011;29(5):351&#x2013;358; doi: 10.1089/pho.2010.2814.</span></p>
<p style="top:680.5pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">81. Bogdanova Y, Ho V, Martin P, et al. Transcranial LED treatment for</span></p>
<p style="top:689.5pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">cognitive dysfunction and sleep in chronic TBI: randomized controlled</span></p>
<p style="top:698.5pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">pilot trial. Arch Phys Med Rehabil 2017;98(10):e122&#x2013;e123; doi:</span></p>
<p style="top:707.4pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">10.1016/J.APMR.2017.08.398.</span></p>
<p style="top:716.4pt;left:314.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">82. Henderson TA, Morries LD. SPECT perfusion imaging demonstrates im-</span></p>
<p style="top:725.4pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">provement of traumatic brain injury with transcranial near-infrared</span></p>
<p style="top:734.3pt;left:327.4pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">laser phototherapy. Adv Mind Body Med 2015;29(4):27&#x2013;33.</span></p>
<p style="top:30.2pt;left:59.8pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">PHOTOBIOMODULATION IN ACUTE TBI</span></p>
<p style="top:30.2pt;left:538.9pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">17</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>


<p style="top:61.9pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">83. Nawashiro H, Wada K, Nakai K, et al. Focal increase in cerebral blood &#xfb02;ow</span></p>
<p style="top:70.8pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">after treatment with near-infrared light to the forehead in a patient in</span></p>
<p style="top:79.8pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">a persistent vegetative state. Photomed Laser Surg 2012;30(4):231&#x2013;</span></p>
<p style="top:88.8pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">233; doi: 10.1089/pho.2011.3044.</span></p>
<p style="top:97.7pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">84. Naeser MA, Zafonte R, Krengel MH, et al. Signi&#xfb01;cant improvements in</span></p>
<p style="top:106.7pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">cognitive performance post-transcranial, red/near-infrared light-</span></p>
<p style="top:115.7pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">emitting diode treatments in chronic, mild traumatic brain injury:</span></p>
<p style="top:124.6pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">open-protocol study. J Neurotrauma 2014;31(11):1008&#x2013;1017; doi:</span></p>
<p style="top:133.6pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">10.1089/neu.2013.3244.</span></p>
<p style="top:142.6pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">85. Naeser MA, Martin PI, Ho MD, et al. Transcranial, red/near-infrared light-</span></p>
<p style="top:151.5pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">emitting diode therapy to improve cognition in chronic traumatic</span></p>
<p style="top:160.5pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">brain injury. Photomed Laser Surg 2016;34(12):610&#x2013;626; doi: 10.1089/</span></p>
<p style="top:169.5pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">pho.2015.4037.</span></p>
<p style="top:178.4pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">86. Morries LD, Cassano P, Henderson TA. Treatments for traumatic brain</span></p>
<p style="top:187.4pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">injury with emphasis on transcranial near-infrared laser phototherapy.</span></p>
<p style="top:196.4pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Neuropsychiatr Dis Treat 2015;11:2159&#x2013;2175; doi: 10.2147/NDT</span></p>
<p style="top:205.3pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">.S65809.</span></p>
<p style="top:214.3pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">87. Poiani GDR, Zaninotto AL, Carneiro AMC, et al. Photobiomodulation</span></p>
<p style="top:223.3pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">using low-level laser therapy (LLLT) for patients with chronic traumatic</span></p>
<p style="top:232.2pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">brain injury: a randomized controlled trial study protocol. Trials</span></p>
<p style="top:241.2pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">2018;19; doi: 10.1186/s13063-017-2414-5.</span></p>
<p style="top:250.2pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">88. Lampl Y, Zivin JA, Fisher M, et al. Infrared laser therapy for ischemic</span></p>
<p style="top:259.1pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">stroke: a new treatment strategy: results of the NeuroThera Effec-</span></p>
<p style="top:268.1pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">tiveness and Safety Trial-1 (NEST-1). Stroke 2007;38(6):1843&#x2013;1849;</span></p>
<p style="top:277.0pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">doi: 10.1161/STROKEAHA.106.478230.</span></p>
<p style="top:286.0pt;left:65.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">89. Huisa BN, Stemer AB, Walker MG, et al. Transcranial laser therapy</span></p>
<p style="top:295.0pt;left:78.6pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">for acute ischemic stroke: a pooled analysis of NEST-1 and NEST-2.</span></p>
<p style="top:61.9pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Int J Stroke 2013;8(5):315&#x2013;320; doi: 10.1111/j.1747-4949.2011</span></p>
<p style="top:70.8pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">.00754.x.</span></p>
<p style="top:79.8pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">90. Naeser MA, Ho MD, Martin PI, et al. Increased functional connectiv-</span></p>
<p style="top:88.8pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">ity within intrinsic neural networks in chronic stroke following treat-</span></p>
<p style="top:97.7pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">ment with red/near-infrared transcranial photobiomodulation:</span></p>
<p style="top:106.7pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">case series with improved naming in aphasia. Photobiomodul</span></p>
<p style="top:115.7pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">Photomed Laser Surg 2020;38(2):115&#x2013;131; doi: 10.1089/photob.2019</span></p>
<p style="top:124.6pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">.4630.</span></p>
<p style="top:133.6pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">91. Pitzschke A, Lovisa B, Seydoux O, et al. Red and NIR Light dosimetry</span></p>
<p style="top:142.6pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">in the human deep brain. Phys Med Biol 2015;60(7):2921&#x2013;2937;</span></p>
<p style="top:151.5pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">doi: 10.1088/0031-9155/60/7/2921.</span></p>
<p style="top:160.5pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">92. Darlot F, Moro C, El Massri N, et al. Near-Infrared light is neuroprotective</span></p>
<p style="top:169.5pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">in a monkey model of Parkinson disease. Ann Neurol 2016;79(1):59&#x2013;</span></p>
<p style="top:178.4pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">75; doi: 10.1002/ana.24542.</span></p>
<p style="top:187.4pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">93. Hart NS, Fitzgerald M. A new perspective on delivery of red-near-infrared</span></p>
<p style="top:196.4pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">light therapy for disorders of the brain. Discov Med 2016;22(120):147&#x2013;</span></p>
<p style="top:205.3pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">156; doi: 10.1161/01.STR.0000242775.14642.b8.</span></p>
<p style="top:214.3pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">94. Liu Y, Lai P, Ma C, et al. Optical focusing deep inside dynamic scattering</span></p>
<p style="top:223.3pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">media with near-infrared time-reversed ultrasonically encoded (TRUE)</span></p>
<p style="top:232.2pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">light. Nat Commun 2015;6:5904; doi: 10.1038/ncomms6904.</span></p>
<p style="top:241.2pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">95. Scopelliti MG, Chamanzar M. Ultrasonically sculpted virtual relay lens for</span></p>
<p style="top:250.2pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">in situ microimaging. Light Sci Appl 2019;8(1); doi: 10.1038/S41377-</span></p>
<p style="top:259.1pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">019-0173-7.</span></p>
<p style="top:268.1pt;left:316.8pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">96. Sagar V, Atluri VSR, Tomitaka A, et al. Coupling of transient near infrared</span></p>
<p style="top:277.0pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">photonic with magnetic nanoparticle for potential dissipation-free</span></p>
<p style="top:286.0pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">biomedical application in brain. Sci Rep 2016;6:29792; doi: 10.1038/</span></p>
<p style="top:295.0pt;left:329.7pt;line-height:7.5pt"><span style="font-family:AdvOT46dcae81,serif;font-size:7.5pt">srep29792.</span></p>
<p style="top:29.7pt;left:62.0pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">18</span></p>
<p style="top:29.7pt;left:481.6pt;line-height:10.0pt"><span style="font-family:AdvOT3b30f6db.B,serif;font-size:10.0pt">STEVENS ET AL.</span></p>
<p style="top:527.9pt;left:9.6pt;line-height:7.0pt"><span style="font-family:Times New Roman,serif;font-size:7.0pt">Downloaded by Universit&#xe4;t Z&#xfc;rich from www.liebertpub.com at 12/26/22. For personal use only. </span></p>

</div>
